data_2m47_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m47 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' HG21 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG21 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 149' ' ' GLN . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 99.4 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.512 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.538 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.577 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.443 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.631 ' HA ' HG21 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.566 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.443 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.437 HD21 HD13 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt . . . . . 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 HD11 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.554 HG21 ' HG3' ' A' ' 149' ' ' GLN . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.678 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.41 ' HB3' ' HE2' ' A' ' 95' ' ' MET . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.495 ' HG3' HD21 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.495 HD21 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.481 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.481 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.601 HD11 HG21 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HG3' HG21 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt . . . . . 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.529 HD13 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.634 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 m170 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' HIS . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.418 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD13 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 17' ' ' ILE . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.515 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.524 HG21 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.524 ' H ' HG21 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 106' ' ' GLU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.506 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.541 HD12 HG21 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.587 HG21 HD11 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.508 HG22 HD13 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 102' ' ' THR . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 104' ' ' LEU . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.234 0.268 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.513 ' HB3' HG23 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.411 ' HB ' HG23 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 24' ' ' VAL . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.502 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.54 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 5' ' ' LEU . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.508 HD13 HG22 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 121.673 0.749 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.567 HG21 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.486 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD22 HD23 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.6 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.597 ' HB ' HG23 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.681 ' HB ' HD23 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 35.5 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.488 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.95 0.405 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.406 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.451 ' HG1' HG13 ' A' ' 84' ' ' VAL . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.639 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.406 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HE1' ' A' ' 110' ' ' PHE . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.465 HD13 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt . . . . . 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.758 0.313 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' HB1' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.49 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.543 HD21 HG21 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.5 ' HB ' HG22 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.503 HD13 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.399 0.618 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HE21 ' A' ' 19' ' ' GLN . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.505 HE21 ' HD2' ' A' ' 16' ' ' PRO . 40.4 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.62 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.586 HD21 HG21 ' A' ' 89' ' ' VAL . 12.7 t30 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 88' ' ' ASN . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.422 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.473 ' HG3' HD22 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD22 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HB3' HD22 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.413 ' HG2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.413 HD11 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' HD23 ' A' ' 145' ' ' LEU . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.458 ' O ' HG21 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 130' ' ' ILE . 63.7 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 149' ' ' GLN . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 HD13 HD13 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.437 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.492 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG22 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.598 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.599 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.511 HG12 HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' HD21 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.495 ' HG3' HG21 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 HG23 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.479 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt . . . . . 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.445 HG13 HG11 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG11 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.411 ' HB ' HG23 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.53 ' HA ' HG21 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 134' ' ' ARG . 93.4 mt . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.588 HG21 HD13 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 HD12 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.892 0.377 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.537 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 77' ' ' ASN . 0.7 OUTLIER 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.443 HH11 ' HA ' ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HB3' HG23 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' HG23 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.576 ' HB3' HD21 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.744 0.307 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.457 ' HG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB3' HD21 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB2' HD22 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.547 ' HB ' HG23 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HB3' HD22 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HG2' ' HG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.623 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.647 ' HZ1' ' HB2' ' A' ' 132' ' ' LYS . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.435 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.577 HG22 HD11 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 55' ' ' THR . 63.0 m . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.586 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.586 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.03 0.443 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.575 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.538 HD21 HG22 ' A' ' 89' ' ' VAL . 11.1 t30 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.538 HG22 HD21 ' A' ' 88' ' ' ASN . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.487 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.593 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 151' ' ' ILE . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.265 0.555 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 HG21 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.589 HD21 HG22 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.733 0.301 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.767 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' HD21 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.459 HD13 HD11 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.49 ' HA ' HG21 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt . . . . . 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.589 HD12 HG13 ' A' ' 130' ' ' ILE . 18.6 mt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HB3' HD21 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.702 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.445 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.445 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.702 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.531 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.706 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.589 HG13 HD12 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.426 ' O ' HG21 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.171 0.51 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.425 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HD11 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.472 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.633 ' HB3' HG22 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.618 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' HD23 ' A' ' 5' ' ' LEU . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.633 HG22 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.573 HD21 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.496 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 HG13 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.521 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.474 ' HG3' HD12 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.485 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.43 HG13 HD13 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.498 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.492 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.535 ' HB ' HG23 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.52 ' HA ' HG21 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.468 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.703 HG21 HG23 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.472 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 HG21 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.556 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.597 HD13 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.739 HD12 HG21 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 119.185 -0.436 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.91 101.24 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.44 2.76 . . . . 0.0 112.346 174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -131.56 -58.66 0.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.037 0.935 . . . . 0.0 110.222 -170.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -163.45 99.93 0.92 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? -80.93 71.78 7.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.461 ' HB3' HG21 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG21 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 149' ' ' GLN . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG22 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t -85.08 92.35 8.34 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -124.59 90.95 3.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.335 0.654 . . . . 0.0 109.523 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 tt -145.47 -49.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.707 1.203 . . . . 0.0 108.75 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -76.03 126.97 32.0 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -153.3 -175.68 5.45 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.6 m -53.08 99.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.341 0.657 . . . . 0.0 110.441 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . -164.03 48.28 0.3 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.789 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -69.39 -30.47 68.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.971 0.909 . . . . 0.0 111.22 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -130.6 21.59 5.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.862 0.865 . . . . 0.0 111.527 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m 65.67 92.92 0.06 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.051 0.94 . . . . 0.0 112.836 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.52 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 3.3 Cg_endo -90.45 -81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 124.033 3.155 . . . . 0.0 111.663 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.18 -13.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.261 0.624 . . . . 0.0 110.767 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.0 m -97.4 144.35 27.23 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.04 -56.38 4.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.86 115.52 5.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.518 1.127 . . . . 0.0 108.422 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 99.4 m -134.65 128.96 34.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.113 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.512 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.576 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -150.18 103.32 0.25 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 41.8 ttm180 -80.21 117.66 21.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 168.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.92 143.3 27.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.914 0.885 . . . . 0.0 109.296 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG21 HG21 ' A' ' 64' ' ' THR . 8.4 p -123.35 124.9 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.532 0.733 . . . . 0.0 109.563 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.6 p -130.92 158.83 73.91 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.42 -12.66 34.25 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.725 2.283 . . . . 0.0 113.244 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.79 -61.44 1.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 110.739 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -123.16 164.8 17.98 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.69 0.757 . . . . 0.0 111.981 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 HG21 HG21 ' A' ' 59' ' ' VAL . 2.7 p -132.15 106.86 8.23 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -134.95 143.89 47.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.98 0.512 . . . . 0.0 110.205 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.4 pt-20 -122.35 133.27 54.66 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.095 0.958 . . . . 0.0 110.085 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.538 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.538 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.577 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.479 ' HB ' HG22 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.443 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.631 ' HA ' HG21 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.566 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.549 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 122' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.443 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HB2' HD11 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.437 HD21 HD13 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.437 HD13 HD21 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.491 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt -68.1 -47.56 67.89 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.73 -56.7 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.897 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.4 t60 71.49 -39.89 0.46 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.57 1.548 . . . . 0.0 112.042 -167.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -76.02 152.87 36.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.678 1.191 . . . . 0.0 110.592 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 67.39 -65.29 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.733 1.613 . . . . 0.0 112.63 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -63.82 92.71 0.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.012 0.925 . . . . 0.0 110.872 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 71.89 0.38 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 124.768 1.227 . . . . 0.0 109.856 -173.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.67 80.55 2.01 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.344 2.029 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 57.1 tptt -72.05 -69.53 0.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.673 0.789 . . . . 0.0 109.564 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -176.54 99.7 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.28 85.05 6.45 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 HD11 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.554 HG21 ' HG3' ' A' ' 149' ' ' GLN . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p -98.16 101.63 13.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -158.8 137.92 11.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.334 1.053 . . . . 0.0 109.337 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -135.6 -11.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.37 1.068 . . . . 0.0 110.595 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -88.51 -56.44 3.31 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 122.749 0.419 . . . . 0.0 111.736 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 64.9 164.42 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.367 1.067 . . . . 0.0 110.906 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -93.85 -7.34 43.54 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.99 -73.8 2.57 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 62.58 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.221 1.408 . . . . 0.0 112.612 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.92 -23.99 21.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.664 0.786 . . . . 0.0 111.571 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.8 m -151.26 134.41 8.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.105 0.562 . . . . 0.0 110.079 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.65 69.53 7.91 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.676 2.251 . . . . 0.0 110.809 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.19 -17.65 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.299 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 t -93.1 109.08 20.55 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.835 0.854 . . . . 0.0 109.263 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.21 -51.36 25.17 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -163.68 113.44 1.29 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.52 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t -124.68 133.07 53.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.184 0.593 . . . . 0.0 109.53 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.678 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.28 107.24 0.65 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.91 114.87 26.74 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -92.97 143.36 26.31 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.084 0.954 . . . . 0.0 110.292 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.16 111.31 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.945 0.898 . . . . 0.0 109.179 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.5 p -120.02 153.6 55.25 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.43 -4.78 13.59 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.577 2.185 . . . . 0.0 113.471 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.66 -47.13 5.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.608 0.763 . . . . 0.0 111.029 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -146.21 133.7 20.84 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -114.62 124.86 52.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 108.813 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -144.42 141.6 29.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 0.0 109.831 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -108.19 136.21 48.23 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.85 0.86 . . . . 0.0 109.516 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' HB3' ' HE2' ' A' ' 95' ' ' MET . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.495 ' HG3' HD21 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.495 HD21 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.481 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.433 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.4 ' H ' HD13 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.601 HD11 HG21 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HG3' HG21 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.497 HG13 ' HB3' ' A' ' 159' ' ' HIS . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt -59.92 -52.37 65.72 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.79 -14.94 35.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.299 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 60.06 68.05 0.81 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.5 1.52 . . . . 0.0 109.608 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.497 ' HB3' HG13 ' A' ' 154' ' ' VAL . 49.5 t60 -89.71 50.18 1.85 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.336 1.055 . . . . 0.0 111.591 -166.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 61.56 7.79 2.0 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.629 1.172 . . . . 0.0 113.165 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 61.11 11.29 3.36 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.647 1.179 . . . . 0.0 111.697 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -87.48 105.3 17.21 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.59 146.24 44.27 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.587 2.858 . . . . 0.0 113.187 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.4 141.33 54.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 110.638 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -55.48 -39.17 70.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.605 1.162 . . . . 0.0 112.195 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.1 67.92 0.75 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.541 HG21 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.479 HG23 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.529 HD13 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -152.65 86.31 1.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.64 29.71 6.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.052 0.941 . . . . 0.0 109.573 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.57 -2.66 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.78 1.232 . . . . 0.0 114.201 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.3 m -68.72 84.36 0.3 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.295 1.038 . . . . 0.0 111.764 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -134.86 94.04 3.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -88.1 62.63 6.89 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.265 1.031 . . . . 0.0 111.374 -169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . 127.76 -45.97 1.11 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.102 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.56 127.55 33.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.373 0.669 . . . . 0.0 110.707 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.0 m95 72.63 -38.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.4 1.48 . . . . 0.0 112.399 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.405 ' HB3' HG21 ' A' ' 36' ' ' VAL . 46.2 m -135.59 99.59 11.63 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 71.8 Cg_endo -73.19 1.5 6.59 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.949 2.432 . . . . 0.0 113.187 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 30.1 m -71.61 -21.91 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.499 0.72 . . . . 0.0 111.772 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.59 77.59 4.96 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.783 0.833 . . . . 0.0 109.3 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.59 -39.73 57.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -150.04 120.9 7.61 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.919 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.13 113.86 8.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.887 1.275 . . . . 0.0 107.75 170.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.634 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.634 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 m170 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.74 99.6 0.52 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 1.4 tmm_? -87.48 104.22 16.26 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -86.22 137.99 32.21 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.785 0.834 . . . . 0.0 109.779 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 p -131.42 106.29 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.657 0.742 . . . . 0.0 109.372 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.7 p -111.11 162.5 20.55 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.76 4.45 1.41 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.566 2.177 . . . . 0.0 113.803 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.74 -48.1 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.042 0.937 . . . . 0.0 111.61 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -129.33 116.27 18.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.46 0.704 . . . . 0.0 111.09 -167.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -107.32 120.41 42.08 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -162.43 136.91 6.65 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.999 0.52 . . . . 0.0 109.798 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.519 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 37.4 tt0 -89.46 134.38 34.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.032 0.533 . . . . 0.0 110.038 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' HIS . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.418 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD13 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 17' ' ' ILE . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.419 ' HB3' HG22 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.515 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.524 HG21 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.524 ' H ' HG21 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' A' ' 106' ' ' GLU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.541 HD12 HG21 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.82 -27.12 31.11 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -98.23 -75.15 0.56 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 29.4 m80 64.3 -179.91 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.942 -172.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -65.71 125.21 24.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -67.07 -54.82 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.076 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.6 p80 57.75 -62.24 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.309 2.244 . . . . 0.0 115.273 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.66 7.67 1.81 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 57.7 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.293 -0.861 . . . . 0.0 108.988 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.56 113.61 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.489 2.126 . . . . 0.0 111.419 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.71 -176.27 5.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.753 0.821 . . . . 0.0 110.438 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 t -143.08 -54.0 0.39 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt -142.23 117.73 10.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.128 0.971 . . . . 0.0 108.946 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.587 HG21 HD11 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.508 HG22 HD13 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 102' ' ' THR . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG12 HD23 ' A' ' 104' ' ' LEU . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t -134.57 29.77 3.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.589 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 24.2 t0 -78.12 79.33 4.58 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-O 122.343 1.068 . . . . 0.0 110.982 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -119.66 -8.4 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.443 171.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 p -76.57 -26.3 54.93 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 111.776 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -86.74 55.72 3.69 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.493 0.663 . . . . 0.0 110.815 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m 62.34 21.16 12.34 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.179 1.392 . . . . 0.0 111.819 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.91 -79.23 0.26 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -148.88 31.3 0.78 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.77 0.828 . . . . 0.0 109.912 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.7 m95 61.12 23.83 13.99 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.502 1.121 . . . . 0.0 111.794 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.7 m -117.21 143.36 31.68 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.807 0.843 . . . . 0.0 110.11 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -79.42 11.84 2.54 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.649 2.233 . . . . 0.0 112.987 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.68 -33.64 57.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.63 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 20.1 p -82.88 88.46 6.8 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 59' ' ' VAL . 38.6 tt0 -60.65 -54.35 46.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.262 1.025 . . . . 0.0 110.667 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -132.2 113.89 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.773 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.63 ' SG ' ' HB2' ' A' ' 37' ' ' CYS . 71.1 m -113.03 109.98 19.73 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.15 101.6 1.62 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -85.19 119.38 25.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.372 1.069 . . . . 0.0 109.867 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 122.77 46.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 38' ' ' GLU . 13.4 p -114.64 134.49 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.093 0.557 . . . . 0.0 109.787 173.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.1 p -143.54 156.33 60.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.79 -14.29 42.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.392 2.061 . . . . 0.0 112.311 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.96 -63.27 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.358 1.063 . . . . 0.0 109.893 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -122.31 139.31 53.95 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.433 0.635 . . . . 0.0 111.781 -171.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m -116.8 109.58 17.29 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -138.46 154.56 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.459 0.704 . . . . 0.0 109.689 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -137.97 141.81 40.49 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.609 0.764 . . . . 0.0 109.044 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' HG12 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.513 ' HB3' HG23 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.411 ' HB ' HG23 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.427 HD23 HG12 ' A' ' 24' ' ' VAL . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.502 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.54 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.54 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 5' ' ' LEU . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.587 HD11 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.508 HD13 HG22 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt -80.2 -28.93 38.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 20.9 mm-40 -71.09 -17.08 62.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.15 0.58 . . . . 0.0 110.753 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -81.11 66.04 6.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.545 0.738 . . . . 0.0 109.733 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -73.95 -21.71 59.92 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.39 24.33 1.18 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.665 0.786 . . . . 0.0 111.324 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.41 79.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 0.0 110.271 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -97.8 164.93 12.18 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.248 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.654 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.06 140.65 66.57 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.697 2.264 . . . . 0.0 111.805 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.13 -171.1 3.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.251 1.02 . . . . 0.0 109.227 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m 70.19 156.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.536 1.134 . . . . 0.0 112.611 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.681 HD23 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? -87.48 42.84 1.06 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.871 0.868 . . . . 0.0 109.858 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.567 HG21 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.597 HG23 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.486 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD22 HD23 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t -145.09 122.4 11.57 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.85 19.08 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.192 0.997 . . . . 0.0 111.009 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 tp -49.42 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 C-N-CA 125.5 1.52 . . . . 0.0 111.354 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t 60.41 12.3 3.4 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 127.342 2.257 . . . . 0.0 112.688 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -83.69 -51.42 7.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.583 1.153 . . . . 0.0 109.216 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.2 p -111.73 94.77 5.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.531 0.732 . . . . 0.0 109.547 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 35' ' ' PRO . . . -120.89 68.52 0.41 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 168.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.04 -86.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.981 0.913 . . . . 0.0 112.032 -167.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -122.22 -59.15 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -118.52 90.99 40.64 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.405 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 90.0 Cg_endo -77.94 170.88 18.17 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.145 1.897 . . . . 0.0 111.906 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 36.0 m -89.16 27.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.953 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 72.6 m -143.41 117.05 9.21 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.177 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 13.8 tp10 -81.99 -57.48 3.39 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.674 0.789 . . . . 0.0 109.344 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -139.04 111.97 7.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.5 m -143.91 113.02 6.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.09 0.556 . . . . 0.0 109.892 -173.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.6 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.33 113.53 2.94 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.594 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 19.3 ttm180 -91.5 107.26 19.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 19.7 m120 -85.42 119.21 25.53 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.509 0.505 . . . . 0.0 110.224 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 14.5 p -112.05 126.23 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -144.55 161.49 43.65 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 125.297 1.439 . . . . 0.0 107.322 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.1 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.552 2.168 . . . . 0.0 112.02 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.54 -58.0 3.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.11 0.964 . . . . 0.0 110.58 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -134.62 148.94 50.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.689 0.796 . . . . 0.0 110.948 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -136.58 109.18 7.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -152.71 145.05 23.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 0.0 109.826 -174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.594 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 40.1 tt0 -106.96 125.21 50.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.196 0.599 . . . . 0.0 110.498 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.597 ' HB ' HG23 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.46 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.681 ' HB ' HD23 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.412 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.567 HD12 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 35.5 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 161' ' ' HIS . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt -81.35 -18.51 45.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.49 -31.34 26.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.57 0.748 . . . . 0.0 109.744 170.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -72.76 132.08 43.16 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.869 0.868 . . . . 0.0 109.896 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -73.42 -10.18 59.47 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.339 0.656 . . . . 0.0 111.379 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -126.38 123.63 38.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.975 0.91 . . . . 0.0 109.692 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.52 ' HD2' ' HB3' ' A' ' 155' ' ' GLU . 11.3 t-160 -87.5 108.61 19.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 109.647 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -81.43 -50.64 9.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.805 0.842 . . . . 0.0 110.142 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.385 -177.897 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.0 99.94 1.35 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.47 2.113 . . . . 0.0 111.748 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.55 -33.64 76.12 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.514 0.726 . . . . 0.0 110.13 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.513 ' HB2' ' HG3' ' A' ' 112' ' ' PRO . 28.9 t -124.27 150.38 45.42 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.525 1.13 . . . . 0.0 108.558 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 5' ' ' LEU . 0.8 OUTLIER -129.49 116.75 19.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 0.0 109.088 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG21 HD13 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.421 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.488 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -79.96 4.24 17.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.58 91.06 1.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 pt -104.24 -42.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.296 1.038 . . . . 0.0 110.902 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.5 p -127.1 73.1 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.265 1.026 . . . . 0.0 109.677 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -81.35 79.75 7.91 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.266 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p 48.23 71.6 0.34 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.265 1.426 . . . . 0.0 112.36 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.46 71.06 0.31 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.303 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -92.29 -109.79 0.1 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.191 0.596 . . . . 0.0 109.436 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -91.1 73.38 6.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.962 0.887 . . . . 0.0 109.656 -170.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -101.49 169.66 7.45 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.174 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.37 -16.72 56.62 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.153 1.902 . . . . 0.0 113.168 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.57 -14.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.48 0.712 . . . . 0.0 112.616 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.4 p -156.86 165.7 35.47 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.999 0.52 . . . . 0.0 111.329 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.44 -44.77 2.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.089 1.355 . . . . 0.0 109.641 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -171.87 137.43 0.98 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.903 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.12 144.95 43.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.605 0.762 . . . . 0.0 110.717 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.19 113.45 1.63 Allowed Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 55.5 ttt-85 -75.13 123.69 25.68 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.46 113.88 21.52 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.84 127.84 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 m -153.76 143.49 15.23 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.85 -24.53 10.4 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.098 2.532 . . . . 0.0 114.481 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -92.87 -39.5 11.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.867 0.467 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 3.6 mmp_? -134.21 138.49 45.13 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.326 0.584 . . . . 0.0 112.299 -169.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -137.85 104.99 5.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.554 1.142 . . . . 0.0 108.374 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -161.59 144.76 12.35 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.995 0.918 . . . . 0.0 109.206 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp0 -84.29 134.28 34.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.103 0.561 . . . . 0.0 109.826 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.406 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.451 ' HG1' HG13 ' A' ' 84' ' ' VAL . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.639 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.406 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.405 ' HE1' ' HA3' ' A' ' 114' ' ' GLY . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 4' ' ' SER . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HE1' ' A' ' 110' ' ' PHE . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.47 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.478 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.465 HD13 HG21 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.446 HG13 ' HA ' ' A' ' 162' ' ' HIS . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt -78.53 -23.22 46.33 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.93 -157.92 0.82 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.647 0.779 . . . . 0.0 109.762 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.6 t60 70.9 -5.29 1.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.164 1.386 . . . . 0.0 112.24 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 55.04 58.88 4.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.438 1.095 . . . . 0.0 110.535 -169.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 62.99 -140.64 0.38 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.743 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 30.8 t60 81.2 -52.27 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.929 1.692 . . . . 0.0 110.471 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.446 ' HA ' HG13 ' A' ' 154' ' ' VAL . 36.2 p-80 47.4 52.49 12.2 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.04 1.736 . . . . 0.0 113.684 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 CA--C 1.557 1.212 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.89 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.36 -9.75 21.87 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.566 2.178 . . . . 0.0 112.289 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -155.62 -165.97 2.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.87 1.268 . . . . 0.0 108.574 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -155.37 -55.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.706 0.402 . . . . 0.0 110.433 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt -114.47 91.25 3.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.827 0.451 . . . . 0.0 110.759 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.419 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -165.16 109.21 0.87 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -117.4 7.09 12.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.989 0.916 . . . . 0.0 112.018 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.452 HD11 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -71.27 3.91 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -60.95 100.18 0.11 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.6 0.76 . . . . 0.0 109.61 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 63.66 93.44 0.06 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.048 1.339 . . . . 0.0 110.64 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t -144.98 154.28 42.39 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.487 0.715 . . . . 0.0 109.613 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.49 128.69 5.06 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.084 -0.407 . . . . 0.0 112.084 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.52 -74.89 0.64 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -100.43 -53.09 3.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.836 0.855 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t -151.27 102.78 2.95 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -85.71 170.24 8.94 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.646 2.231 . . . . 0.0 113.0 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -74.76 -30.53 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.161 168.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.3 m -72.95 102.04 3.36 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 123.991 0.916 . . . . 0.0 109.753 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -60.63 -46.9 88.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.098 0.559 . . . . 0.0 110.891 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -162.7 136.96 6.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.686 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p -138.65 110.63 7.25 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.463 0.705 . . . . 0.0 109.692 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.456 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG23 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.67 100.97 0.89 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 42.7 ttm180 -85.26 116.59 23.7 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.555 0.742 . . . . 0.0 109.42 169.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -108.29 143.9 36.52 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.58 111.51 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.485 0.66 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 74.4 p -105.98 158.77 31.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.71 -14.31 44.09 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.253 1.969 . . . . 0.0 112.011 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -87.24 -44.99 11.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.705 1.202 . . . . 0.0 110.741 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -158.11 132.58 8.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.883 0.473 . . . . 0.0 110.777 -172.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -96.48 131.78 42.72 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -149.24 136.83 20.28 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.8 pt-20 -117.2 142.53 46.91 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 ' HB1' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.421 ' HA ' HG23 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.49 ' HB1' HG13 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.543 HD21 HG21 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.618 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.5 ' HB ' HG22 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.478 HD12 HD12 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.486 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.647 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.647 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.424 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.503 HD13 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.0 mt -72.37 -32.19 66.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.31 -65.8 0.97 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.494 0.718 . . . . 0.0 110.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 m170 61.37 169.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.349 1.06 . . . . 0.0 111.565 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -93.1 93.71 8.45 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 167.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.7 t60 69.94 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.349 1.46 . . . . 0.0 109.778 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -65.62 78.98 0.07 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.307 1.043 . . . . 0.0 111.061 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 175.25 39.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.98 1.712 . . . . 0.0 109.278 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.2 t60 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.234 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 37.9 Cg_endo -63.78 83.17 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.094 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -111.92 100.26 8.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t 67.9 135.56 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.653 1.581 . . . . 0.0 111.793 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -90.64 51.07 1.92 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.502 0.721 . . . . 0.0 109.64 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HE21 ' A' ' 19' ' ' GLN . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.505 HE21 ' HD2' ' A' ' 16' ' ' PRO . 40.4 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -75.5 84.69 2.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -81.37 154.93 26.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.917 0.887 . . . . 0.0 110.401 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.6 pt 68.9 -23.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 127.753 2.421 . . . . 0.0 113.516 -174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . 76.4 p -75.18 125.43 28.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.141 0.576 . . . . 0.0 110.745 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 76.5 -37.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.905 1.682 . . . . 0.0 112.092 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.7 p -78.23 83.31 4.49 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.378 0.671 . . . . 0.0 110.193 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.7 153.42 6.96 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 72.66 148.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.051 1.34 . . . . 0.0 111.249 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 91.4 m95 74.09 -60.86 0.51 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.675 1.59 . . . . 0.0 109.278 -168.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -90.69 116.17 65.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 108.819 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.45 56.38 4.49 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.594 2.863 . . . . 0.0 113.384 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.89 -31.48 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.794 0.838 . . . . 0.0 109.542 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 24.3 p -133.42 142.33 48.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 171.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -71.82 -51.91 20.12 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.0 mmpt? -132.43 147.9 52.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.307 0.643 . . . . 0.0 110.213 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 99.3 m -148.99 112.11 4.91 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.935 0.894 . . . . 0.0 109.438 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.511 ' CD1' ' HA ' ' A' ' 28' ' ' THR . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.62 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.81 117.37 3.65 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 38.5 ttm180 -83.05 101.95 11.47 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -85.76 130.18 34.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.54 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 37' ' ' CYS . 3.1 p -131.94 108.97 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.953 0.882 . . . . 0.0 109.455 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.8 p -101.83 165.94 13.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.577 1.151 . . . . 0.0 108.707 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.3 7.63 0.83 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.743 2.295 . . . . 0.0 114.168 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.46 -37.75 1.79 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.036 0.935 . . . . 0.0 111.519 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -126.89 153.33 45.89 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.106 0.962 . . . . 0.0 110.112 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.9 m -148.99 112.15 4.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.933 0.893 . . . . 0.0 108.98 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -163.63 159.37 21.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.526 0.73 . . . . 0.0 109.815 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 20.2 pt-20 -110.72 132.83 53.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.872 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.586 HD21 HG21 ' A' ' 89' ' ' VAL . 12.7 t30 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 88' ' ' ASN . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.422 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.473 ' HG3' HD22 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD22 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.606 ' HB3' HD22 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.413 ' HG2' HD11 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.413 HD11 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 2' ' ' PRO . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.424 ' O ' HD23 ' A' ' 145' ' ' LEU . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.458 ' O ' HG21 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt -69.94 -33.81 72.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -76.0 -70.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.948 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 64.82 125.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.731 2.012 . . . . 0.0 110.198 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 68.37 66.84 0.32 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.292 1.044 . . . . 0.0 108.316 -164.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -159.52 149.94 19.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.608 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -63.72 125.95 25.98 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.164 0.29 . . . . 0.0 111.011 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -84.25 157.57 21.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.412 0.685 . . . . 0.0 110.981 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 124.093 0.957 . . . . 0.0 111.361 175.571 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.756 ' HA ' HG13 ' A' ' 130' ' ' ILE . 83.4 Cg_exo -49.99 90.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.052 2.501 . . . . 0.0 112.767 166.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.95 97.83 5.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.793 1.237 . . . . 0.0 109.079 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 58.06 -75.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.574 1.55 . . . . 0.0 113.226 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 HG12 ' A' ' 130' ' ' ILE . 63.7 mt 81.01 86.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 126.687 1.995 . . . . 0.0 108.365 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 149' ' ' GLN . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 163' ' ' HIS . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -95.13 53.49 1.55 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.69 -31.29 72.41 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.403 HG22 HG23 ' A' ' 28' ' ' THR . 9.9 tt -59.82 -39.08 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.625 0.77 . . . . 0.0 111.504 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 HG22 ' A' ' 27' ' ' ILE . 47.2 p -88.32 65.06 7.87 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.885 0.85 . . . . 0.0 110.94 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -127.5 160.53 31.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.715 1.206 . . . . 0.0 108.735 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -60.45 104.41 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.104 0.562 . . . . 0.0 110.128 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.94 -69.86 1.15 Allowed Glycine 0 C--N 1.354 1.571 0 O-C-N 123.951 0.782 . . . . 0.0 113.207 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.52 -164.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.143 0.977 . . . . 0.0 112.415 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.0 m95 58.48 48.55 11.92 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.131 0.972 . . . . 0.0 109.761 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.7 m 60.88 81.38 0.24 Allowed Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.854 -165.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.18 98.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.48 2.787 . . . . 0.0 113.222 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.16 -38.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.699 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.9 t -67.75 103.4 1.41 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.847 0.859 . . . . 0.0 109.04 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 44.7 tt0 -60.53 -56.76 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 124.219 0.949 . . . . 0.0 111.068 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 45.7 mtmt -143.19 141.91 31.27 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t -146.27 109.71 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -109.9 115.95 4.32 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' NH2' HG21 ' A' ' 64' ' ' THR . 24.8 tpt180 -74.73 103.02 4.84 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -85.12 132.37 34.32 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.05 109.72 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 122.042 0.925 . . . . 0.0 109.736 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 69.0 p -119.32 159.03 47.13 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.581 1.552 . . . . 0.0 107.499 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.04 -22.37 74.52 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.6 2.2 . . . . 0.0 113.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.63 -43.96 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -141.67 141.23 33.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.755 0.822 . . . . 0.0 110.583 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.408 HG21 ' NH2' ' A' ' 57' ' ' ARG . 71.2 m -138.69 108.79 6.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.268 0.627 . . . . 0.0 110.029 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -160.17 144.6 14.51 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.547 0.739 . . . . 0.0 109.773 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 143.82 26.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.6 0.36 . . . . 0.0 110.491 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 HD13 HD13 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.437 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.453 HG23 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' H ' HG23 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.492 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.492 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG22 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.551 HD11 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.598 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.49 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.407 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.541 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.599 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.756 HG13 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.599 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' HD21 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.478 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.551 HD13 HD11 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.495 ' HG3' HG21 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.513 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.0 -31.39 62.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 15.1 mm-40 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.925 0.49 . . . . 0.0 110.093 171.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -88.25 -177.02 5.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.023 0.929 . . . . 0.0 110.014 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -77.59 86.63 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.355 0.598 . . . . 0.0 109.618 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -78.35 129.61 35.19 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.683 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -115.63 57.25 0.74 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.768 0.827 . . . . 0.0 110.077 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 t60 63.43 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.459 1.503 . . . . 0.0 111.255 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 22' ' ' ALA . 33.4 t-80 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.438 1.095 . . . . 0.0 108.129 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.76 72.93 4.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.771 2.314 . . . . 0.0 110.803 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -77.07 -176.97 4.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.582 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.423 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 20.9 t -75.12 173.01 11.36 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.32 0.648 . . . . 0.0 110.912 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? -70.03 114.8 8.54 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 HG23 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -92.92 174.44 7.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.91 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.254 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 pt -121.0 -4.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.468 0.707 . . . . 0.0 110.492 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -87.04 80.92 8.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.684 0.793 . . . . 0.0 111.054 -172.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -120.57 -18.8 7.7 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.108 0.963 . . . . 0.0 110.296 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -148.17 133.77 18.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.023 0.929 . . . . 0.0 109.196 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.42 33.94 0.03 OUTLIER Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -85.21 82.93 8.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.004 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.2 m-90 58.48 28.18 16.58 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.969 0.907 . . . . 0.0 111.579 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -64.0 137.85 97.23 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.822 0.849 . . . . 0.0 110.751 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.85 -34.68 8.87 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.851 3.034 . . . . 0.0 114.747 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG22 ' SG ' ' A' ' 37' ' ' CYS . 21.0 m -99.19 -18.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 36' ' ' VAL . 62.4 m -137.73 100.89 4.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.699 0.8 . . . . 0.0 109.838 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' NE ' ' A' ' 57' ' ' ARG . 5.3 tp10 -55.2 -60.75 2.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.661 0.785 . . . . 0.0 110.944 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -158.26 148.96 20.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.293 1.037 . . . . 0.0 108.566 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -138.24 113.46 9.38 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 106.18 0.32 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.573 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 29.9 ttp180 -85.48 108.95 18.15 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 117.423 0.612 . . . . 0.0 110.479 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -86.02 131.07 34.35 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.46 109.81 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.371 0.668 . . . . 0.0 109.622 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 p -134.97 153.11 78.36 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.95 -21.09 70.01 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.502 2.135 . . . . 0.0 112.039 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.79 -49.93 27.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.58 1.152 . . . . 0.0 110.661 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -161.89 133.21 5.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.357 0.663 . . . . 0.0 110.063 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -129.77 122.79 29.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.699 0.799 . . . . 0.0 109.763 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -161.87 146.73 12.97 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.725 0.641 . . . . 0.0 109.76 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.2 pt-20 -97.26 136.36 37.86 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.233 0.613 . . . . 0.0 109.57 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.479 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.457 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.582 HD12 HG23 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt -75.19 -11.94 60.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.73 -43.73 6.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.635 0.774 . . . . 0.0 110.132 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.15 -46.46 67.53 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.975 0.91 . . . . 0.0 111.324 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.7 m80 61.69 74.66 0.43 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.568 1.147 . . . . 0.0 111.45 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -88.52 92.65 9.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -81.61 63.58 5.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.701 0.8 . . . . 0.0 109.125 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 176.63 148.45 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.7 m170 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 169.16 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.37 41.57 1.16 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.4 2.733 . . . . 0.0 113.08 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -52.32 -56.63 13.6 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.527 1.131 . . . . 0.0 110.46 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.4 t -138.32 120.22 15.41 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.994 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt -74.89 88.85 2.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 HG23 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -84.47 12.9 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.66 3.06 20.3 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.903 0.881 . . . . 0.0 111.282 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.494 HG13 HG23 ' A' ' 28' ' ' THR . 22.8 pt -45.75 -33.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 125.905 1.682 . . . . 0.0 114.095 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 42' ' ' TRP . 44.4 p -84.6 -161.84 0.61 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.924 0.89 . . . . 0.0 111.669 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 73.89 -76.4 0.06 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.558 1.543 . . . . 0.0 110.639 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -138.91 -34.12 0.61 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.253 1.021 . . . . 0.0 110.523 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.04 93.32 0.85 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.43 -33.22 74.37 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.805 0.842 . . . . 0.0 110.677 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -62.48 -40.39 96.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.736 0.814 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -173.31 146.58 1.35 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.188 0.995 . . . . 0.0 109.616 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.42 32.11 0.52 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.795 2.33 . . . . 0.0 112.803 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -74.55 -4.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.516 1.126 . . . . 0.0 112.242 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.0 t -103.82 112.02 24.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.97 -49.53 65.12 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.306 0.574 . . . . 0.0 110.51 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -147.07 129.19 15.56 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.355 -167.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -139.84 135.62 33.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 109.538 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.495 ' HA ' HG22 ' A' ' 28' ' ' THR . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.74 120.52 1.04 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.8 ptp180 -87.25 118.34 26.6 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.376 0.588 . . . . 0.0 110.715 175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' THR . 4.8 t-20 -85.91 112.38 21.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.814 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 p -103.47 111.4 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.059 0.944 . . . . 0.0 109.6 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.5 p -133.53 153.82 80.5 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.58 -16.77 44.79 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.699 2.266 . . . . 0.0 113.044 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -74.53 -70.0 0.43 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.624 0.769 . . . . 0.0 110.383 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -137.81 149.22 46.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.063 0.545 . . . . 0.0 110.539 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 58' ' ' ASN . 80.1 m -127.71 122.78 33.81 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -156.0 141.32 17.58 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.542 0.737 . . . . 0.0 109.295 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -94.92 119.94 34.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.465 0.706 . . . . 0.0 109.402 176.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.445 HG13 HG11 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG11 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.478 HG23 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' HG23 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.408 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.411 ' HB ' HG23 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.507 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.421 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.53 ' HA ' HG21 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt -85.12 -38.87 18.58 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -115.9 54.04 0.83 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.939 0.896 . . . . 0.0 110.554 -171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -62.64 106.45 0.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.189 0.596 . . . . 0.0 110.639 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 72.73 9.24 5.59 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.861 1.265 . . . . 0.0 111.649 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -98.29 74.85 2.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -136.36 58.96 1.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -78.27 128.05 33.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.684 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.192 1.397 . . . . 0.0 111.261 176.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.414 -0.803 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.82 -39.07 39.05 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.294 2.662 . . . . 0.0 113.054 171.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 71.12 -75.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.523 1.139 . . . . 0.0 111.489 167.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -164.6 -179.27 5.83 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.948 0.899 . . . . 0.0 108.993 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 134' ' ' ARG . 93.4 mt -73.23 85.67 1.41 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.588 HG21 HD13 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.478 HG23 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 HD12 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t -85.81 168.91 13.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t0 69.01 133.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.378 1.471 . . . . 0.0 112.267 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 54' ' ' PHE . 2.6 pp -100.06 -13.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.88 0.872 . . . . 0.0 112.623 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -86.12 -64.05 1.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 56.2 -83.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.31 1.444 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 p -141.05 129.07 21.96 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 108.031 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.57 17.39 56.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.123 -0.82 . . . . 0.0 114.234 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 64.48 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.714 1.206 . . . . 0.0 110.853 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.72 -46.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.536 1.534 . . . . 0.0 112.482 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 p -166.99 164.87 9.7 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.556 1.143 . . . . 0.0 108.391 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 72.85 3.91 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.042 1.828 . . . . 0.0 112.007 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.52 3.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.71 0.804 . . . . 0.0 111.722 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 40' ' ' CYS . 45.8 t -69.36 120.28 14.93 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.431 0.693 . . . . 0.0 109.189 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.32 -47.7 80.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.701 0.8 . . . . 0.0 111.096 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HD3' ' HE1' ' A' ' 41' ' ' TRP . 39.7 ttmt -149.81 132.67 16.05 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.472 -174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 18.6 p -146.23 117.8 8.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.673 0.608 . . . . 0.0 110.32 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.537 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.437 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.545 ' HB3' HG12 ' A' ' 27' ' ' ILE . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.537 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.37 124.93 4.04 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -110.01 126.71 54.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.255 0.622 . . . . 0.0 110.236 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.34 127.57 34.39 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.75 127.54 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -155.26 141.35 12.95 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -45.78 -32.0 8.48 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.443 2.762 . . . . 0.0 114.845 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.83 -28.85 14.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.944 0.498 . . . . 0.0 112.16 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 2.4 mmp_? -133.2 131.83 40.82 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.37 0.605 . . . . 0.0 111.897 -170.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 p -145.92 122.48 11.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -164.74 145.26 7.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.876 0.47 . . . . 0.0 109.84 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.34 152.02 45.29 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.977 0.911 . . . . 0.0 109.789 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.518 HD13 HD12 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 77' ' ' ASN . 0.7 OUTLIER 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.443 HH11 ' HA ' ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HB3' HG23 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.478 ' HB ' HG23 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.457 ' HB2' HD23 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.627 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.568 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.554 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.53 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.576 ' HB3' HD21 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.413 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.588 HD13 HG21 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt -73.24 -41.03 64.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.61 -12.01 60.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 113.097 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -51.8 164.91 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.746 1.218 . . . . 0.0 114.033 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.4 m170 65.12 40.58 4.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.744 1.217 . . . . 0.0 110.056 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -116.85 -167.19 1.25 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.977 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -59.9 110.72 1.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.415 0.286 . . . . 0.0 110.672 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 66.58 86.24 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.983 1.313 . . . . 0.0 110.517 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 125.402 1.481 . . . . 0.0 111.357 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.79 122.04 8.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.909 2.406 . . . . 0.0 111.074 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -70.26 125.01 25.56 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 t -92.1 144.84 25.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.562 0.745 . . . . 0.0 112.824 -163.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.68 12.65 12.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.457 ' HG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 HG23 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG23 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.418 ' H ' HG23 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HB3' HD21 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.547 HG23 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB2' HD22 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -106.58 174.83 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 65.53 15.39 10.01 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.525 1.13 . . . . 0.0 112.294 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -31.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.045 1.338 . . . . 0.0 110.859 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p -80.94 -38.61 27.49 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.957 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.06 -37.65 88.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.464 1.105 . . . . 0.0 111.007 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.8 p -76.6 81.03 3.27 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.218 0.607 . . . . 0.0 110.018 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.19 77.06 0.03 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.09 -64.11 0.95 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.907 0.883 . . . . 0.0 110.464 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -81.11 -14.44 57.71 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.023 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m 62.03 87.87 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 O-C-N 124.624 1.203 . . . . 0.0 111.21 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.82 -69.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.746 2.298 . . . . 0.0 112.143 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.42 -21.03 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.096 0.958 . . . . 0.0 110.287 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.631 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 23.3 t -84.0 138.47 33.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.452 0.701 . . . . 0.0 109.802 175.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 31.2 tt0 -99.04 -41.47 7.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 109.592 172.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -156.05 142.97 18.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.962 0.905 . . . . 0.0 109.795 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.631 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 94.5 m -138.56 121.71 16.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.455 0.702 . . . . 0.0 110.012 173.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.84 101.53 2.11 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 38' ' ' GLU . 12.7 tpp85 -75.41 102.85 5.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 166.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.962 0.905 . . . . 0.0 109.199 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.31 109.31 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.728 0.811 . . . . 0.0 109.269 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.2 p -110.47 156.47 40.34 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.72 -23.9 28.14 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.34 -48.39 6.69 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 122.915 0.486 . . . . 0.0 111.998 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -140.05 132.16 27.99 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.338 0.655 . . . . 0.0 111.41 -168.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -108.62 117.17 33.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -151.51 139.52 20.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.857 0.463 . . . . 0.0 110.481 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 7.3 pt-20 -98.35 129.34 45.02 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.708 0.803 . . . . 0.0 109.669 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.475 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.475 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.622 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.547 ' HB ' HG23 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.674 ' HB3' HD22 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HG2' ' HG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.623 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.647 ' HZ1' ' HB2' ' A' ' 132' ' ' LYS . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.435 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.408 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.402 ' HA ' HG22 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.479 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -62.92 -40.38 97.42 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 53.5 mt-10 -68.53 -33.77 74.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.425 0.69 . . . . 0.0 111.728 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -112.05 95.26 5.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -58.77 106.75 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.816 0.697 . . . . 0.0 110.258 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -113.12 167.46 10.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.414 1.086 . . . . 0.0 109.825 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -155.4 175.51 13.79 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 108.124 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 68.7 117.52 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.339 1.056 . . . . 0.0 110.651 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.917 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.94 87.4 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.537 2.158 . . . . 0.0 111.263 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -74.82 120.26 20.12 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.168 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m 63.71 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.953 1.301 . . . . 0.0 110.783 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt -147.16 30.68 0.94 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.09 0.956 . . . . 0.0 110.279 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.577 HG22 HD11 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.5 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -87.86 92.79 9.25 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.16 97.68 8.76 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 166.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' H ' ' A' ' 28' ' ' THR . 16.1 pt -59.64 -56.46 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.946 170.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.597 ' H ' HG13 ' A' ' 27' ' ' ILE . 12.1 t 177.88 18.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.815 1.646 . . . . 0.0 109.074 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -77.54 -47.95 18.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 110.441 -165.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -99.75 123.21 43.78 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.501 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.03 23.94 1.92 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.11 119.82 17.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 m95 65.33 14.31 9.35 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.435 1.094 . . . . 0.0 111.775 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 t -156.68 89.43 2.66 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -83.42 29.77 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.43 -32.67 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.684 0.794 . . . . 0.0 111.305 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.09 85.77 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' HB2' HG11 ' A' ' 59' ' ' VAL . 39.9 tt0 -78.75 -57.23 3.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.179 0.592 . . . . 0.0 110.632 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.28 114.75 9.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 63.0 m -125.15 124.55 42.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.586 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.586 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.543 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.58 100.39 2.39 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -90.38 118.82 30.16 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.11 145.14 40.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 38' ' ' GLU . 14.7 p -131.27 131.7 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.296 0.57 . . . . 0.0 109.618 175.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 p -130.74 163.94 45.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.52 -22.29 50.38 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.8 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.19 -63.79 1.33 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.784 0.833 . . . . 0.0 110.418 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -148.52 164.41 34.29 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.824 0.85 . . . . 0.0 111.044 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.453 ' HB ' HG21 ' A' ' 59' ' ' VAL . 11.0 t -138.2 136.35 36.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.847 0.859 . . . . 0.0 109.523 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -171.69 163.7 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 108.952 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -105.35 164.69 11.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.836 0.455 . . . . 0.0 112.046 -179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.575 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.538 HD21 HG22 ' A' ' 89' ' ' VAL . 11.1 t30 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.538 HG22 HD21 ' A' ' 88' ' ' ASN . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.487 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.457 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.593 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 158' ' ' HIS . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt -70.09 -26.78 64.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -119.65 17.96 12.75 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.499 0.72 . . . . 0.0 111.331 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 16.9 t-80 -79.98 8.5 6.91 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.092 0.557 . . . . 0.0 112.091 -172.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -63.72 78.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.767 0.827 . . . . 0.0 109.89 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.09 109.02 0.09 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.052 1.341 . . . . 0.0 107.568 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -137.2 91.85 2.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -159.43 111.72 2.14 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.987 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.248 0.994 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -50.11 130.92 29.44 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.378 2.719 . . . . 0.0 113.608 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 3' ' ' LYS . 5.1 ttmp? -111.96 154.47 25.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 108.582 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -60.25 152.16 25.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.784 0.434 . . . . 0.0 109.941 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.26 85.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.307 0.643 . . . . 0.0 111.159 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 HG21 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.589 HD21 HG22 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -86.75 8.02 24.36 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.03 141.19 50.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.99 0.516 . . . . 0.0 110.457 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' H ' HD12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -131.37 9.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.006 0.923 . . . . 0.0 110.807 -175.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 p -119.5 -59.2 1.85 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.87 -0.519 . . . . 0.0 111.359 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -74.12 -26.18 60.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.508 0.723 . . . . 0.0 110.95 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -61.53 -20.92 63.78 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.25 1.02 . . . . 0.0 111.953 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.81 83.73 0.48 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -147.43 3.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.516 0.326 . . . . 0.0 111.81 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.487 ' HD1' HG21 ' A' ' 59' ' ' VAL . 17.6 m-90 74.12 -22.91 0.23 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.549 1.139 . . . . 0.0 113.151 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 14.5 m -66.91 -44.78 52.86 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 123.248 0.619 . . . . 0.0 110.889 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 34' ' ' SER . 5.7 Cg_exo -83.27 -168.43 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.431 163.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.1 1.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.7 m -103.3 137.04 41.96 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.156 0.582 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.4 -51.49 2.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.189 0.995 . . . . 0.0 109.871 173.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -151.37 122.71 7.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.245 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 60.4 m -137.94 122.34 18.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.851 0.461 . . . . 0.0 110.271 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.84 107.14 1.15 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 34.5 ttm180 -76.17 109.59 9.97 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.005 0.522 . . . . 0.0 110.141 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -86.07 113.66 22.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.288 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG21 ' HD1' ' A' ' 33' ' ' TRP . 7.6 p -97.53 125.64 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.708 . . . . 0.0 109.788 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.7 p -137.22 159.25 70.43 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.309 1.044 . . . . 0.0 108.225 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.32 -23.78 64.7 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.017 2.478 . . . . 0.0 113.187 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.46 -53.79 7.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.529 0.731 . . . . 0.0 110.622 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -156.34 144.71 19.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.177 0.513 . . . . 0.0 111.331 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.3 m -106.28 106.94 17.7 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 170.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -132.33 143.63 50.0 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.043 0.537 . . . . 0.0 110.503 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.1 mt-10 -86.65 111.11 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.513 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.425 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.767 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.446 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.421 ' O ' HD21 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.459 HD13 HD11 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.49 ' HA ' HG21 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.442 ' HA ' ' CB ' ' A' ' 158' ' ' HIS . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt -78.53 -64.88 1.07 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -151.33 -80.45 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 154' ' ' VAL . 16.4 t60 54.47 43.17 30.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.005 1.322 . . . . 0.0 111.567 175.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 54.35 8.85 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.979 1.712 . . . . 0.0 114.245 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -164.12 86.38 0.47 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.231 0.612 . . . . 0.0 109.47 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -142.96 94.6 2.65 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -162.82 89.6 0.66 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.693 0.797 . . . . 0.0 109.002 -177.471 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 CA--C 1.566 1.586 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -84.4 177.98 5.41 Favored 'Trans proline' 0 C--N 1.386 2.545 0 CA-C-N 121.803 1.68 . . . . 0.0 111.898 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -73.77 87.76 1.74 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m 59.53 -87.28 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.431 1.092 . . . . 0.0 110.083 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.589 HD12 HG13 ' A' ' 130' ' ' ILE . 18.6 mt -155.23 88.39 1.16 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 125.269 1.428 . . . . 0.0 107.593 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.466 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' HB3' HD21 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p -153.08 90.93 1.48 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.47 77.95 0.17 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 171.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.17 -4.95 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.24 1.016 . . . . 0.0 110.465 -172.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -78.36 81.14 4.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.191 0.996 . . . . 0.0 110.746 -165.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -138.79 -164.74 1.7 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.01 1.324 . . . . 0.0 108.956 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.8 m -69.15 -37.73 78.42 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.353 0.661 . . . . 0.0 110.737 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.35 39.15 0.69 Allowed Glycine 0 N--CA 1.473 1.101 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.396 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -73.64 -41.99 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.989 0.916 . . . . 0.0 110.753 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -103.09 6.61 38.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.808 0.843 . . . . 0.0 110.933 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -136.55 103.65 9.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.636 0.774 . . . . 0.0 110.072 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.6 -20.21 18.11 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.064 2.51 . . . . 0.0 112.79 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.88 -15.86 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 0.0 111.1 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 41.8 t -78.23 93.26 4.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.832 0.853 . . . . 0.0 109.565 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -89.33 -43.28 11.04 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -140.19 127.76 21.58 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.1 m -146.87 110.58 4.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.846 0.459 . . . . 0.0 110.0 173.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.545 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.15 -168.08 14.04 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -152.87 106.02 3.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -87.51 136.33 32.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.776 0.673 . . . . 0.0 109.214 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -130.04 138.26 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.435 0.694 . . . . 0.0 109.763 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.6 p -137.67 161.99 57.19 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.149 1.379 . . . . 0.0 107.616 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.24 -28.09 14.23 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.991 3.128 . . . . 0.0 115.237 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -113.51 -30.54 6.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.332 0.653 . . . . 0.0 112.355 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -123.71 134.41 53.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -162.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -128.89 118.51 22.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.891 0.876 . . . . 0.0 108.713 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -144.72 131.16 19.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.229 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -84.42 116.09 22.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.052 0.941 . . . . 0.0 108.82 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.702 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.445 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.445 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.702 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.531 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.706 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.451 HG21 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.559 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.589 HG13 HD12 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.426 ' O ' HG21 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.466 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.517 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.42 -41.15 85.31 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.92 -26.4 48.98 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.937 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -68.83 -28.31 66.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.485 0.714 . . . . 0.0 109.474 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -79.09 143.66 35.32 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.699 0.8 . . . . 0.0 109.45 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -86.46 157.46 19.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.631 0.772 . . . . 0.0 110.512 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -65.8 163.7 16.22 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.788 0.435 . . . . 0.0 110.974 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -67.64 96.79 0.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.887 0.475 . . . . 0.0 110.493 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 CA--C 1.558 1.268 0 C-N-CA 125.138 1.375 . . . . 0.0 110.791 -179.508 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.91 -64.21 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.801 2.334 . . . . 0.0 111.468 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt 67.07 150.63 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.885 1.274 . . . . 0.0 112.386 168.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 t -144.75 -60.15 0.36 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.936 -0.477 . . . . 0.0 110.137 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt -75.08 88.06 2.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.083 -176.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.425 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HD11 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.472 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.573 ' HB3' HD21 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -69.28 85.81 0.4 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.54 -18.43 33.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.601 1.16 . . . . 0.0 110.673 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.33 99.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 O-C-N 124.546 1.154 . . . . 0.0 110.001 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 HG21 ' HB2' ' A' ' 40' ' ' CYS . 20.9 p 72.43 -19.7 0.29 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 127.481 2.313 . . . . 0.0 113.204 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HG2' ' H ' ' A' ' 30' ' ' THR . 30.3 ttp180 59.98 -143.29 0.55 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.591 1.157 . . . . 0.0 109.503 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.474 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 32.3 p -78.12 91.25 4.29 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 118.817 0.735 . . . . 0.0 110.724 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.73 46.78 2.09 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.21 -56.08 6.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.042 0.937 . . . . 0.0 111.046 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -138.16 5.96 2.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.944 0.898 . . . . 0.0 110.843 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 m -57.13 111.34 3.25 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.097 0.959 . . . . 0.0 112.043 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.15 -24.17 44.83 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.99 2.46 . . . . 0.0 112.065 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.23 -13.73 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.906 0.882 . . . . 0.0 111.597 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 48.9 t -95.89 75.98 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.497 ' HB2' HG13 ' A' ' 59' ' ' VAL . 34.6 tt0 -65.43 -55.19 19.37 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.743 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -135.07 118.3 16.6 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.695 1.198 . . . . 0.0 108.193 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 22.7 p -146.07 112.41 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.868 0.867 . . . . 0.0 109.501 -176.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.544 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.13 -158.26 30.55 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -153.28 121.14 6.06 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.835 0.854 . . . . 0.0 109.278 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.98 113.83 21.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' A' ' 38' ' ' GLU . 5.4 p -121.52 111.42 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 122.06 0.934 . . . . 0.0 109.547 177.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.1 p -110.76 153.56 43.62 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.88 -7.42 6.05 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.393 2.729 . . . . 0.0 116.063 -167.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 0.4 2.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -153.46 131.9 12.1 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.89 0.314 . . . . 0.0 110.774 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.9 p -130.42 156.93 43.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.822 0.849 . . . . 0.0 110.589 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -167.93 137.88 2.65 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.94 1.296 . . . . 0.0 108.731 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.09 119.62 24.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.472 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.639 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.633 ' HB3' HG22 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.618 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.495 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' HD23 ' A' ' 5' ' ' LEU . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.41 HG21 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.633 HG22 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.559 HD11 HG23 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.573 HD21 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt -68.59 -42.48 78.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.49 160.57 17.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.0 t60 70.25 -65.67 0.31 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 -167.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 63.85 115.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.6 1.56 . . . . 0.0 114.152 161.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.8 155.5 18.1 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.487 0.715 . . . . 0.0 109.636 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -76.78 155.12 33.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 111.207 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -155.84 47.08 0.48 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.866 0.866 . . . . 0.0 108.817 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.492 1.654 0 C-N-CA 126.041 1.736 . . . . 0.0 110.095 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.449 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 23.5 Cg_endo -62.06 112.66 1.59 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.429 2.086 . . . . 0.0 110.929 167.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -68.41 -34.14 75.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.825 0.85 . . . . 0.0 110.717 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -178.35 176.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.466 1.507 . . . . 0.0 108.44 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? -101.07 42.79 1.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 HD12 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p -83.72 -21.0 32.44 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.39 96.47 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 0.0 109.837 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.87 -45.43 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.516 0.726 . . . . 0.0 110.486 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.41 -15.84 14.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.978 0.911 . . . . 0.0 111.062 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -49.42 62.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.768 0.827 . . . . 0.0 110.36 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.8 m -93.54 -57.0 2.72 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.41 -118.01 11.87 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.148 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 33' ' ' TRP . 24.2 tt0 -168.58 177.85 5.02 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 4.2 m-90 -56.72 -41.37 77.35 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.284 0.634 . . . . 0.0 110.061 166.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 p -128.37 88.32 52.86 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.883 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 149.02 42.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.224 1.949 . . . . 0.0 112.197 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.89 1.28 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.612 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 66.4 m -102.83 116.19 32.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.977 0.911 . . . . 0.0 108.926 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 32.0 tt0 -81.09 -57.56 3.47 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.533 0.683 . . . . 0.0 109.169 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 27.3 mtpp -135.36 127.53 29.97 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.173 -175.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 72.0 m -145.33 135.05 23.47 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.081 0.552 . . . . 0.0 110.058 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.496 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.87 104.99 0.46 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 12.1 ttp180 -74.61 105.11 5.56 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.103 0.477 . . . . 0.0 110.019 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -84.39 110.62 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.466 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -105.78 127.06 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.644 0.777 . . . . 0.0 110.399 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.3 p -134.33 153.65 79.46 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 164.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.13 -18.77 53.21 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.704 2.27 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -73.01 -47.8 41.9 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.282 1.033 . . . . 0.0 110.308 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -167.93 132.86 1.82 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.197 0.599 . . . . 0.0 110.644 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 m -103.69 119.31 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.874 0.87 . . . . 0.0 109.162 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -132.18 162.03 31.91 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.95 1.3 . . . . 0.0 108.799 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 35.7 tt0 -125.2 130.26 51.77 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 HG13 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 HG13 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.521 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.439 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.474 ' HG3' HD12 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG22 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.485 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.43 HG13 HD13 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HD3' ' HB3' ' A' ' 2' ' ' PRO . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.516 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt -68.5 -20.24 64.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -114.73 178.12 4.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.176 0.99 . . . . 0.0 110.727 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 69.1 t60 61.31 30.68 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.209 1.004 . . . . 0.0 109.671 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 47.5 m80 60.99 -84.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.489 1.116 . . . . 0.0 108.861 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -153.54 168.12 27.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.862 1.265 . . . . 0.0 108.373 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -113.56 -51.57 2.8 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -168.22 138.35 2.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.764 0.665 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.533 1.133 . . . . 0.0 108.684 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.6 139.02 36.39 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.672 2.248 . . . . 0.0 111.212 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' HZ1' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -70.9 122.89 20.77 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t -78.0 158.67 29.18 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.61 66.94 9.23 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.596 HG23 HD13 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m -57.7 -69.24 0.18 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.47 -64.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.571 1.549 . . . . 0.0 113.618 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.04 97.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.677 1.591 . . . . 0.0 111.662 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 p 63.27 5.66 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.812 2.045 . . . . 0.0 113.884 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -38.98 48.48 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -142.15 179.3 6.99 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.365 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.48 29.44 0.03 OUTLIER Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.13 -39.93 6.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 -173.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -88.63 -47.77 8.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.873 0.869 . . . . 0.0 110.412 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -102.39 116.97 62.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.615 0.766 . . . . 0.0 110.128 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.71 75.12 4.12 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.408 2.739 . . . . 0.0 112.089 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.25 7.11 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 124.195 0.998 . . . . 0.0 110.913 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -142.89 110.58 5.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.367 0.667 . . . . 0.0 110.026 -174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 10.3 tp10 -69.61 -56.65 6.7 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 165.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -172.88 142.25 1.1 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.368 1.067 . . . . 0.0 109.228 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m -135.0 140.78 45.93 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.383 0.673 . . . . 0.0 110.367 -176.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.498 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.71 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.492 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . -134.99 105.27 0.54 Allowed Glycine 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.663 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 30.5 ttm180 -82.22 113.71 20.23 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -95.14 135.84 36.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.493 0.717 . . . . 0.0 109.637 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 12.7 p -113.39 134.72 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.1 p -132.38 166.3 29.82 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 109.812 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.91 -18.89 23.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.169 2.58 . . . . 0.0 113.198 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.84 -85.22 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.331 0.653 . . . . 0.0 110.625 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.02 162.89 30.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.643 0.777 . . . . 0.0 110.391 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -102.66 108.88 20.3 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -115.83 133.39 56.08 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.189 0.596 . . . . 0.0 110.008 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 tt0 -90.77 112.89 24.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG12 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.586 ' HB2' HG12 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.45 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.535 ' HB ' HG23 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.499 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.596 HD13 HG23 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.52 ' HA ' HG21 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -63.78 -31.3 72.43 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -79.26 -64.84 1.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 22.2 t60 68.3 139.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.661 1.584 . . . . 0.0 111.195 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 71.15 -0.83 2.93 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.075 0.95 . . . . 0.0 111.668 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -75.69 109.71 9.5 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.967 0.907 . . . . 0.0 110.451 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.76 156.62 44.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.482 1.113 . . . . 0.0 109.174 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -65.14 110.89 2.69 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 124.748 1.219 . . . . 0.0 111.089 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.12 -55.98 2.96 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.182 2.588 . . . . 0.0 112.058 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.6 tttt 60.56 17.2 7.17 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.693 1.197 . . . . 0.0 112.42 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 62.83 -168.2 0.2 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.193 0.997 . . . . 0.0 110.282 -173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt -102.83 101.73 11.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.468 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.495 HD13 HG11 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.556 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m 63.79 -159.02 0.31 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -126.0 -174.83 3.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.566 0.747 . . . . 0.0 110.655 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.455 HD11 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -125.81 -1.58 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.662 1.185 . . . . 0.0 110.699 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.2 p -102.56 -64.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.108 0.963 . . . . 0.0 111.243 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -79.31 -63.73 1.35 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.352 1.461 . . . . 0.0 110.27 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -76.29 -60.54 2.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.698 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.9 112.18 0.02 OUTLIER Glycine 0 C--N 1.356 1.677 0 O-C-N 123.491 0.495 . . . . 0.0 112.209 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -68.81 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -103.21 69.57 1.02 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.928 0.491 . . . . 0.0 110.201 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m 54.16 74.17 0.79 Allowed Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.923 1.289 . . . . 0.0 111.442 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 159.53 37.2 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.421 2.081 . . . . 0.0 112.544 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG21 HD22 ' A' ' 58' ' ' ASN . 17.0 m -81.83 3.67 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.613 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -77.94 102.72 7.48 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HG2' ' HD2' ' A' ' 39' ' ' LYS . 30.2 tt0 -68.09 -58.61 4.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.137 0.575 . . . . 0.0 110.989 -173.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' HD2' ' HG2' ' A' ' 38' ' ' GLU . 2.0 mptp? -144.04 123.9 13.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t -147.34 130.76 16.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.9 -166.44 17.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -154.19 129.31 9.62 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.175 0.59 . . . . 0.0 109.905 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.442 HD22 HG21 ' A' ' 36' ' ' VAL . 27.7 t-20 -97.65 136.3 38.22 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.085 0.954 . . . . 0.0 108.897 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -122.9 124.18 69.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.743 0.817 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.8 p -138.88 155.27 73.16 Favored Pre-proline 0 N--CA 1.475 0.787 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.98 -22.5 69.35 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.827 2.351 . . . . 0.0 112.859 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.81 -50.06 13.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.777 0.831 . . . . 0.0 110.838 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.484 HH12 ' HB2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -157.91 147.58 19.99 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.619 0.723 . . . . 0.0 111.939 171.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 m -115.57 129.52 56.55 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.87 152.07 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.548 0.739 . . . . 0.0 110.67 -170.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.64 120.56 25.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.26 0.624 . . . . 0.0 109.453 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.703 HG21 HG23 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 71' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 HG21 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.6 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.556 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.617 ' HB ' HG23 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.597 HD13 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.538 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.418 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.484 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.468 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.739 HD12 HG21 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt -73.67 -34.44 64.91 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 30.2 mm-40 -56.93 -23.02 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.172 0.589 . . . . 0.0 111.48 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -84.01 66.23 9.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.85 0.86 . . . . 0.0 109.942 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.9 m80 60.42 99.3 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.427 1.491 . . . . 0.0 112.924 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.18 131.35 50.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.87 0.868 . . . . 0.0 108.784 172.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -73.64 -76.66 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.066 0.546 . . . . 0.0 109.863 -173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -128.42 5.57 5.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.402 0.681 . . . . 0.0 109.568 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 15' ' ' ALA . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 HD13 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 99.4 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.462 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HG22 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.462 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.449 HD12 HD23 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.445 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.65 HD13 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt . . . . . 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.627 HG22 HD12 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.578 HG21 HD21 ' A' ' 152' ' ' LEU . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.695 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.507 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.507 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 129' ' ' GLU . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.627 HD12 HG22 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt . . . . . 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.507 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.529 HD12 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.648 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.411 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD12 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.571 ' H ' HG23 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.415 ' O ' HD23 ' A' ' 145' ' ' LEU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.507 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 24' ' ' VAL . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' HD21 ' A' ' 152' ' ' LEU . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 20' ' ' VAL . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.234 0.268 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 71' ' ' VAL . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 HG12 ' A' ' 73' ' ' VAL . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 72' ' ' ILE . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.56 ' HB3' HG22 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.417 HD11 ' HD1' ' A' ' 93' ' ' TYR . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.558 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 139' ' ' THR . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 135' ' ' LEU . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.689 HD21 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 121.673 0.749 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.419 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.495 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 52' ' ' ALA . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.417 ' HH2' ' HA ' ' A' ' 134' ' ' ARG . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.467 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.689 ' HB ' HD21 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 27.0 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.95 0.405 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.427 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.635 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.635 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 108' ' ' TRP . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.427 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 112' ' ' PRO . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 19' ' ' GLN . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt . . . . . 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.758 0.313 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.499 HG21 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 HD22 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.701 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.531 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.4 ' O ' HD23 ' A' ' 145' ' ' LEU . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 91.0 mt . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.399 0.618 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 141' ' ' ILE . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.5 HG22 HD12 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 86' ' ' ASP . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 85' ' ' THR . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.478 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.619 ' HB3' HD21 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.428 ' HG2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 7' ' ' PHE . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' ILE . 63.7 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 HD21 ' A' ' 152' ' ' LEU . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG21 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 20' ' ' VAL . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' MET . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.489 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.615 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.513 HG12 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB2' HD22 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.486 ' HG3' HG23 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' GLU . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.433 ' NE2' ' HB1' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 152' ' ' LEU . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 15' ' ' ALA . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD12 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' THR . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt . . . . . 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.456 HG13 HG12 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.403 ' HB ' HG21 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.447 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.555 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.46 HD12 HG21 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 93.4 mt . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.892 0.377 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.534 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.534 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.429 ' HB3' HD13 ' A' ' 17' ' ' ILE . 2.4 m-20 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HB3' HG21 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 93' ' ' TYR . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 14.0 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB3' HD22 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.411 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.603 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 142' ' ' PRO . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.744 0.307 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 105' ' ' THR . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB3' HD22 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HB2' HD21 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.629 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.599 ' HB ' HG21 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.707 ' HB3' HD21 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 55' ' ' THR . 63.0 m . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.588 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.03 0.443 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.615 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.609 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.507 HD21 ' HA3' ' A' ' 114' ' ' GLY . 29.4 t-20 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.531 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' A' ' 88' ' ' ASN . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 151' ' ' ILE . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.265 0.555 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.768 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.733 0.301 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 72' ' ' ILE . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.768 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.502 ' HA ' HG23 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt . . . . . 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 130' ' ' ILE . 18.6 mt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 15' ' ' ALA . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.588 ' HB3' HD22 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 20' ' ' VAL . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.719 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.424 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.525 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' HG23 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.719 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.525 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 130' ' ' ILE . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.171 0.51 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.573 HG22 HD12 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.631 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.476 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.541 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.431 HG22 ' HD1' ' A' ' 110' ' ' PHE . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.486 ' HG3' HD11 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HB3' HG21 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' PRO . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 HD12 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 20' ' ' VAL . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.493 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 86' ' ' ASP . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 85' ' ' THR . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HA ' HG23 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.747 HG22 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 HG13 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.478 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.569 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.629 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 138' ' ' ILE . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 HD23 ' A' ' 135' ' ' LEU . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 119.185 -0.436 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.91 101.24 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.44 2.76 . . . . 0.0 112.346 174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -131.56 -58.66 0.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.037 0.935 . . . . 0.0 110.222 -170.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -163.45 99.93 0.92 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? -80.93 71.78 7.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 15' ' ' ALA . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 HD13 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t -85.08 92.35 8.34 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -124.59 90.95 3.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.335 0.654 . . . . 0.0 109.523 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 tt -145.47 -49.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.707 1.203 . . . . 0.0 108.75 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -76.03 126.97 32.0 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -153.3 -175.68 5.45 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.6 m -53.08 99.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.341 0.657 . . . . 0.0 110.441 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . -164.03 48.28 0.3 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.789 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -69.39 -30.47 68.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.971 0.909 . . . . 0.0 111.22 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -130.6 21.59 5.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.862 0.865 . . . . 0.0 111.527 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m 65.67 92.92 0.06 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.051 0.94 . . . . 0.0 112.836 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.532 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 3.3 Cg_endo -90.45 -81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 124.033 3.155 . . . . 0.0 111.663 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.18 -13.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.261 0.624 . . . . 0.0 110.767 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.0 m -97.4 144.35 27.23 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.04 -56.38 4.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.86 115.52 5.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.518 1.127 . . . . 0.0 108.422 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 99.4 m -134.65 128.96 34.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.113 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -150.18 103.32 0.25 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 41.8 ttm180 -80.21 117.66 21.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 168.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.92 143.3 27.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.914 0.885 . . . . 0.0 109.296 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 64' ' ' THR . 8.4 p -123.35 124.9 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.532 0.733 . . . . 0.0 109.563 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.6 p -130.92 158.83 73.91 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.42 -12.66 34.25 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.725 2.283 . . . . 0.0 113.244 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.79 -61.44 1.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 110.739 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -123.16 164.8 17.98 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.69 0.757 . . . . 0.0 111.981 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 59' ' ' VAL . 2.7 p -132.15 106.86 8.23 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -134.95 143.89 47.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.98 0.512 . . . . 0.0 110.205 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.4 pt-20 -122.35 133.27 54.66 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.095 0.958 . . . . 0.0 110.085 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.462 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HG22 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.449 HD12 HD23 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.445 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.65 HD13 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt -68.1 -47.56 67.89 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.73 -56.7 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.897 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.4 t60 71.49 -39.89 0.46 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.57 1.548 . . . . 0.0 112.042 -167.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -76.02 152.87 36.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.678 1.191 . . . . 0.0 110.592 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 67.39 -65.29 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.733 1.613 . . . . 0.0 112.63 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -63.82 92.71 0.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.012 0.925 . . . . 0.0 110.872 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 71.89 0.38 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 124.768 1.227 . . . . 0.0 109.856 -173.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.67 80.55 2.01 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.344 2.029 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 57.1 tptt -72.05 -69.53 0.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.673 0.789 . . . . 0.0 109.564 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -176.54 99.7 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.28 85.05 6.45 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.627 HG22 HD12 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.578 HG21 HD21 ' A' ' 152' ' ' LEU . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p -98.16 101.63 13.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -158.8 137.92 11.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.334 1.053 . . . . 0.0 109.337 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -135.6 -11.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.37 1.068 . . . . 0.0 110.595 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -88.51 -56.44 3.31 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 122.749 0.419 . . . . 0.0 111.736 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 64.9 164.42 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.367 1.067 . . . . 0.0 110.906 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -93.85 -7.34 43.54 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.99 -73.8 2.57 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 62.58 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.221 1.408 . . . . 0.0 112.612 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.92 -23.99 21.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.664 0.786 . . . . 0.0 111.571 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.8 m -151.26 134.41 8.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.105 0.562 . . . . 0.0 110.079 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.65 69.53 7.91 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.676 2.251 . . . . 0.0 110.809 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.19 -17.65 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.299 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 t -93.1 109.08 20.55 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.835 0.854 . . . . 0.0 109.263 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.21 -51.36 25.17 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -163.68 113.44 1.29 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.52 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t -124.68 133.07 53.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.184 0.593 . . . . 0.0 109.53 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.695 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.28 107.24 0.65 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.91 114.87 26.74 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -92.97 143.36 26.31 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.084 0.954 . . . . 0.0 110.292 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.16 111.31 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.945 0.898 . . . . 0.0 109.179 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.5 p -120.02 153.6 55.25 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.43 -4.78 13.59 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.577 2.185 . . . . 0.0 113.471 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.66 -47.13 5.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.608 0.763 . . . . 0.0 111.029 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -146.21 133.7 20.84 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -114.62 124.86 52.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 108.813 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -144.42 141.6 29.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 0.0 109.831 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -108.19 136.21 48.23 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.85 0.86 . . . . 0.0 109.516 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.507 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.507 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 129' ' ' GLU . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.627 HD12 HG22 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 159' ' ' HIS . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt -59.92 -52.37 65.72 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.79 -14.94 35.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.299 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 60.06 68.05 0.81 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.5 1.52 . . . . 0.0 109.608 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.513 ' HB3' HG13 ' A' ' 154' ' ' VAL . 49.5 t60 -89.71 50.18 1.85 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.336 1.055 . . . . 0.0 111.591 -166.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 61.56 7.79 2.0 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.629 1.172 . . . . 0.0 113.165 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 61.11 11.29 3.36 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.647 1.179 . . . . 0.0 111.697 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -87.48 105.3 17.21 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.856 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.59 146.24 44.27 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.587 2.858 . . . . 0.0 113.187 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.4 141.33 54.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 110.638 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -55.48 -39.17 70.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.605 1.162 . . . . 0.0 112.195 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.1 67.92 0.75 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.507 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.529 HD12 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -152.65 86.31 1.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.64 29.71 6.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.052 0.941 . . . . 0.0 109.573 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.57 -2.66 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.78 1.232 . . . . 0.0 114.201 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.3 m -68.72 84.36 0.3 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.295 1.038 . . . . 0.0 111.764 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -134.86 94.04 3.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -88.1 62.63 6.89 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.265 1.031 . . . . 0.0 111.374 -169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . 127.76 -45.97 1.11 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.102 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.56 127.55 33.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.373 0.669 . . . . 0.0 110.707 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.0 m95 72.63 -38.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.4 1.48 . . . . 0.0 112.399 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' VAL . 46.2 m -135.59 99.59 11.63 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.51 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 71.8 Cg_endo -73.19 1.5 6.59 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.949 2.432 . . . . 0.0 113.187 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 34' ' ' SER . 30.1 m -71.61 -21.91 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.499 0.72 . . . . 0.0 111.772 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.59 77.59 4.96 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.783 0.833 . . . . 0.0 109.3 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.59 -39.73 57.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -150.04 120.9 7.61 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.919 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.13 113.86 8.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.887 1.275 . . . . 0.0 107.75 170.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.648 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.74 99.6 0.52 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 1.4 tmm_? -87.48 104.22 16.26 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -86.22 137.99 32.21 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.785 0.834 . . . . 0.0 109.779 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 p -131.42 106.29 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.657 0.742 . . . . 0.0 109.372 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 71.7 p -111.11 162.5 20.55 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 60' ' ' THR . 59.1 Cg_endo -67.76 4.45 1.41 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.566 2.177 . . . . 0.0 113.803 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.74 -48.1 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.042 0.937 . . . . 0.0 111.61 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -129.33 116.27 18.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.46 0.704 . . . . 0.0 111.09 -167.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -107.32 120.41 42.08 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -162.43 136.91 6.65 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.999 0.52 . . . . 0.0 109.798 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 37.4 tt0 -89.46 134.38 34.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.032 0.533 . . . . 0.0 110.038 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.411 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD12 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.571 ' H ' HG23 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.415 ' O ' HD23 ' A' ' 145' ' ' LEU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.507 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.82 -27.12 31.11 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -98.23 -75.15 0.56 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 64.3 -179.91 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.942 -172.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -65.71 125.21 24.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -67.07 -54.82 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.076 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.6 p80 57.75 -62.24 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.309 2.244 . . . . 0.0 115.273 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.66 7.67 1.81 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 57.7 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.293 -0.861 . . . . 0.0 108.988 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.56 113.61 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.489 2.126 . . . . 0.0 111.419 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.71 -176.27 5.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.753 0.821 . . . . 0.0 110.438 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 t -143.08 -54.0 0.39 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt -142.23 117.73 10.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.128 0.971 . . . . 0.0 108.946 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 24' ' ' VAL . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 20' ' ' VAL . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t -134.57 29.77 3.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.619 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 24.2 t0 -78.12 79.33 4.58 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-O 122.343 1.068 . . . . 0.0 110.982 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -119.66 -8.4 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.443 171.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 p -76.57 -26.3 54.93 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 111.776 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -86.74 55.72 3.69 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.493 0.663 . . . . 0.0 110.815 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m 62.34 21.16 12.34 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.179 1.392 . . . . 0.0 111.819 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.91 -79.23 0.26 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -148.88 31.3 0.78 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.77 0.828 . . . . 0.0 109.912 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.7 m95 61.12 23.83 13.99 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.502 1.121 . . . . 0.0 111.794 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.7 m -117.21 143.36 31.68 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.807 0.843 . . . . 0.0 110.11 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -79.42 11.84 2.54 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.649 2.233 . . . . 0.0 112.987 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.68 -33.64 57.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 20.1 p -82.88 88.46 6.8 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' HB2' HG12 ' A' ' 59' ' ' VAL . 38.6 tt0 -60.65 -54.35 46.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.262 1.025 . . . . 0.0 110.667 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -132.2 113.89 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.773 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 37' ' ' CYS . 71.1 m -113.03 109.98 19.73 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 71' ' ' VAL . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.15 101.6 1.62 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -85.19 119.38 25.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.372 1.069 . . . . 0.0 109.867 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -105.05 122.77 46.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 38' ' ' GLU . 13.4 p -114.64 134.49 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.093 0.557 . . . . 0.0 109.787 173.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.1 p -143.54 156.33 60.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.79 -14.29 42.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.392 2.061 . . . . 0.0 112.311 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.96 -63.27 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.358 1.063 . . . . 0.0 109.893 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -122.31 139.31 53.95 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.433 0.635 . . . . 0.0 111.781 -171.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m -116.8 109.58 17.29 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -138.46 154.56 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.459 0.704 . . . . 0.0 109.689 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -137.97 141.81 40.49 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.609 0.764 . . . . 0.0 109.044 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 HG12 ' A' ' 73' ' ' VAL . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 72' ' ' ILE . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.56 ' HB3' HG22 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.417 HD11 ' HD1' ' A' ' 93' ' ' TYR . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.558 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 139' ' ' THR . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 135' ' ' LEU . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt -80.2 -28.93 38.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 20.9 mm-40 -71.09 -17.08 62.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.15 0.58 . . . . 0.0 110.753 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -81.11 66.04 6.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.545 0.738 . . . . 0.0 109.733 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -73.95 -21.71 59.92 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.39 24.33 1.18 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.665 0.786 . . . . 0.0 111.324 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.41 79.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 0.0 110.271 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -97.8 164.93 12.18 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.248 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.654 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.06 140.65 66.57 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.697 2.264 . . . . 0.0 111.805 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.13 -171.1 3.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.251 1.02 . . . . 0.0 109.227 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m 70.19 156.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.536 1.134 . . . . 0.0 112.611 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.689 HD21 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? -87.48 42.84 1.06 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.871 0.868 . . . . 0.0 109.858 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.419 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.495 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t -145.09 122.4 11.57 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.85 19.08 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.192 0.997 . . . . 0.0 111.009 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 tp -49.42 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 C-N-CA 125.5 1.52 . . . . 0.0 111.354 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t 60.41 12.3 3.4 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 127.342 2.257 . . . . 0.0 112.688 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD3' HG23 ' A' ' 30' ' ' THR . 3.6 tmt_? -83.69 -51.42 7.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.583 1.153 . . . . 0.0 109.216 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.418 HG23 ' HD3' ' A' ' 29' ' ' ARG . 22.2 p -111.73 94.77 5.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.531 0.732 . . . . 0.0 109.547 173.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 35' ' ' PRO . . . -120.89 68.52 0.41 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 168.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.04 -86.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.981 0.913 . . . . 0.0 112.032 -167.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -122.22 -59.15 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -118.52 90.99 40.64 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 90.0 Cg_endo -77.94 170.88 18.17 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.145 1.897 . . . . 0.0 111.906 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 36.0 m -89.16 27.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.953 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 72.6 m -143.41 117.05 9.21 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.177 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 13.8 tp10 -81.99 -57.48 3.39 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.674 0.789 . . . . 0.0 109.344 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -139.04 111.97 7.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.5 m -143.91 113.02 6.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.09 0.556 . . . . 0.0 109.892 -173.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 52' ' ' ALA . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.33 113.53 2.94 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 19.3 ttm180 -91.5 107.26 19.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 19.7 m120 -85.42 119.21 25.53 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.509 0.505 . . . . 0.0 110.224 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 14.5 p -112.05 126.23 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -144.55 161.49 43.65 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 125.297 1.439 . . . . 0.0 107.322 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.1 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.552 2.168 . . . . 0.0 112.02 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.54 -58.0 3.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.11 0.964 . . . . 0.0 110.58 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -134.62 148.94 50.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.689 0.796 . . . . 0.0 110.948 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -136.58 109.18 7.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -152.71 145.05 23.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 0.0 109.826 -174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 40.1 tt0 -106.96 125.21 50.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.196 0.599 . . . . 0.0 110.498 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' HD2' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.417 ' HH2' ' HA ' ' A' ' 134' ' ' ARG . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.467 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.689 ' HB ' HD21 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 27.0 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt -81.35 -18.51 45.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.49 -31.34 26.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.57 0.748 . . . . 0.0 109.744 170.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -72.76 132.08 43.16 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.869 0.868 . . . . 0.0 109.896 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -73.42 -10.18 59.47 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.339 0.656 . . . . 0.0 111.379 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -126.38 123.63 38.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.975 0.91 . . . . 0.0 109.692 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -87.5 108.61 19.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 109.647 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -81.43 -50.64 9.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.805 0.842 . . . . 0.0 110.142 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.385 -177.897 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.0 99.94 1.35 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.47 2.113 . . . . 0.0 111.748 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.55 -33.64 76.12 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.514 0.726 . . . . 0.0 110.13 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.518 ' HB2' ' HG3' ' A' ' 112' ' ' PRO . 28.9 t -124.27 150.38 45.42 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.525 1.13 . . . . 0.0 108.558 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.49 116.75 19.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 0.0 109.088 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -79.96 4.24 17.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.58 91.06 1.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 pt -104.24 -42.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.296 1.038 . . . . 0.0 110.902 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.5 p -127.1 73.1 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.265 1.026 . . . . 0.0 109.677 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -81.35 79.75 7.91 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.266 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p 48.23 71.6 0.34 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.265 1.426 . . . . 0.0 112.36 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.46 71.06 0.31 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.303 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -92.29 -109.79 0.1 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.191 0.596 . . . . 0.0 109.436 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -91.1 73.38 6.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.962 0.887 . . . . 0.0 109.656 -170.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -101.49 169.66 7.45 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.174 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.37 -16.72 56.62 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.153 1.902 . . . . 0.0 113.168 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.57 -14.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.48 0.712 . . . . 0.0 112.616 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.4 p -156.86 165.7 35.47 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.999 0.52 . . . . 0.0 111.329 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.44 -44.77 2.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.089 1.355 . . . . 0.0 109.641 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -171.87 137.43 0.98 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.903 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.12 144.95 43.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.605 0.762 . . . . 0.0 110.717 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.19 113.45 1.63 Allowed Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 55.5 ttt-85 -75.13 123.69 25.68 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.46 113.88 21.52 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.84 127.84 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 m -153.76 143.49 15.23 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.85 -24.53 10.4 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.098 2.532 . . . . 0.0 114.481 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -92.87 -39.5 11.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.867 0.467 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 3.6 mmp_? -134.21 138.49 45.13 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.326 0.584 . . . . 0.0 112.299 -169.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -137.85 104.99 5.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.554 1.142 . . . . 0.0 108.374 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -161.59 144.76 12.35 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.995 0.918 . . . . 0.0 109.206 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp0 -84.29 134.28 34.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.103 0.561 . . . . 0.0 109.826 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.427 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.635 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.635 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 108' ' ' TRP . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.427 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' SER . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 112' ' ' PRO . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 19' ' ' GLN . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 162' ' ' HIS . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt -78.53 -23.22 46.33 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.93 -157.92 0.82 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.647 0.779 . . . . 0.0 109.762 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.6 t60 70.9 -5.29 1.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.164 1.386 . . . . 0.0 112.24 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 55.04 58.88 4.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.438 1.095 . . . . 0.0 110.535 -169.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 62.99 -140.64 0.38 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.743 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 30.8 t60 81.2 -52.27 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.929 1.692 . . . . 0.0 110.471 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.462 ' HA ' HG11 ' A' ' 154' ' ' VAL . 36.2 p-80 47.4 52.49 12.2 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.04 1.736 . . . . 0.0 113.684 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 CA--C 1.557 1.212 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.89 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.36 -9.75 21.87 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.566 2.178 . . . . 0.0 112.289 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -155.62 -165.97 2.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.87 1.268 . . . . 0.0 108.574 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -155.37 -55.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.706 0.402 . . . . 0.0 110.433 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt -114.47 91.25 3.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.827 0.451 . . . . 0.0 110.759 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.499 HG21 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -165.16 109.21 0.87 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -117.4 7.09 12.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.989 0.916 . . . . 0.0 112.018 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -71.27 3.91 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -60.95 100.18 0.11 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.6 0.76 . . . . 0.0 109.61 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 63.66 93.44 0.06 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.048 1.339 . . . . 0.0 110.64 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t -144.98 154.28 42.39 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.487 0.715 . . . . 0.0 109.613 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.49 128.69 5.06 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.084 -0.407 . . . . 0.0 112.084 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.52 -74.89 0.64 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -100.43 -53.09 3.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.836 0.855 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t -151.27 102.78 2.95 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -85.71 170.24 8.94 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.646 2.231 . . . . 0.0 113.0 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -74.76 -30.53 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.161 168.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.3 m -72.95 102.04 3.36 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 123.991 0.916 . . . . 0.0 109.753 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -60.63 -46.9 88.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.098 0.559 . . . . 0.0 110.891 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -162.7 136.96 6.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.686 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p -138.65 110.63 7.25 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.463 0.705 . . . . 0.0 109.692 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.67 100.97 0.89 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 42.7 ttm180 -85.26 116.59 23.7 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.555 0.742 . . . . 0.0 109.42 169.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -108.29 143.9 36.52 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.58 111.51 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.485 0.66 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 74.4 p -105.98 158.77 31.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.71 -14.31 44.09 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.253 1.969 . . . . 0.0 112.011 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -87.24 -44.99 11.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.705 1.202 . . . . 0.0 110.741 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -158.11 132.58 8.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.883 0.473 . . . . 0.0 110.777 -172.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -96.48 131.78 42.72 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -149.24 136.83 20.28 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.8 pt-20 -117.2 142.53 46.91 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 HD22 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.701 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.531 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.4 ' O ' HD23 ' A' ' 145' ' ' LEU . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 91.0 mt -72.37 -32.19 66.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.31 -65.8 0.97 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.494 0.718 . . . . 0.0 110.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 m170 61.37 169.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.349 1.06 . . . . 0.0 111.565 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -93.1 93.71 8.45 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 167.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.7 t60 69.94 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.349 1.46 . . . . 0.0 109.778 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -65.62 78.98 0.07 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.307 1.043 . . . . 0.0 111.061 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 175.25 39.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.98 1.712 . . . . 0.0 109.278 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.2 t60 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.234 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 37.9 Cg_endo -63.78 83.17 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.094 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -111.92 100.26 8.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t 67.9 135.56 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.653 1.581 . . . . 0.0 111.793 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -90.64 51.07 1.92 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.502 0.721 . . . . 0.0 109.64 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 141' ' ' ILE . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.5 HG22 HD12 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -75.5 84.69 2.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 27' ' ' ILE . 35.8 t70 -81.37 154.93 26.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.917 0.887 . . . . 0.0 110.401 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 26' ' ' ASP . 3.6 pt 68.9 -23.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 127.753 2.421 . . . . 0.0 113.516 -174.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . 76.4 p -75.18 125.43 28.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.141 0.576 . . . . 0.0 110.745 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 76.5 -37.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.905 1.682 . . . . 0.0 112.092 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.7 p -78.23 83.31 4.49 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.378 0.671 . . . . 0.0 110.193 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.7 153.42 6.96 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 72.66 148.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.051 1.34 . . . . 0.0 111.249 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 91.4 m95 74.09 -60.86 0.51 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.675 1.59 . . . . 0.0 109.278 -168.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -90.69 116.17 65.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 108.819 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.45 56.38 4.49 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.594 2.863 . . . . 0.0 113.384 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.89 -31.48 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.794 0.838 . . . . 0.0 109.542 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 24.3 p -133.42 142.33 48.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 171.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -71.82 -51.91 20.12 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.0 mmpt? -132.43 147.9 52.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.307 0.643 . . . . 0.0 110.213 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 99.3 m -148.99 112.11 4.91 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.935 0.894 . . . . 0.0 109.438 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 28' ' ' THR . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.81 117.37 3.65 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 38.5 ttm180 -83.05 101.95 11.47 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -85.76 130.18 34.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.54 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -131.94 108.97 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.953 0.882 . . . . 0.0 109.455 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.8 p -101.83 165.94 13.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.577 1.151 . . . . 0.0 108.707 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.3 7.63 0.83 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.743 2.295 . . . . 0.0 114.168 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.46 -37.75 1.79 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.036 0.935 . . . . 0.0 111.519 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -126.89 153.33 45.89 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.106 0.962 . . . . 0.0 110.112 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.9 m -148.99 112.15 4.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.933 0.893 . . . . 0.0 108.98 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -163.63 159.37 21.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.526 0.73 . . . . 0.0 109.815 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 20.2 pt-20 -110.72 132.83 53.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.872 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 86' ' ' ASP . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 85' ' ' THR . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.478 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.619 ' HB3' HD21 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.428 ' HG2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 2' ' ' PRO . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 7' ' ' PHE . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt -69.94 -33.81 72.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -76.0 -70.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.948 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 64.82 125.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.731 2.012 . . . . 0.0 110.198 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 68.37 66.84 0.32 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.292 1.044 . . . . 0.0 108.316 -164.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -159.52 149.94 19.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.608 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -63.72 125.95 25.98 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.164 0.29 . . . . 0.0 111.011 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -84.25 157.57 21.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.412 0.685 . . . . 0.0 110.981 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 124.093 0.957 . . . . 0.0 111.361 175.571 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.748 ' HA ' HG13 ' A' ' 130' ' ' ILE . 83.4 Cg_exo -49.99 90.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.052 2.501 . . . . 0.0 112.767 166.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.95 97.83 5.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.793 1.237 . . . . 0.0 109.079 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 58.06 -75.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.574 1.55 . . . . 0.0 113.226 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' ILE . 63.7 mt 81.01 86.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 126.687 1.995 . . . . 0.0 108.365 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 HD21 ' A' ' 152' ' ' LEU . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG21 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 163' ' ' HIS . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 20' ' ' VAL . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -95.13 53.49 1.55 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.69 -31.29 72.41 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.415 HG23 HG23 ' A' ' 28' ' ' THR . 9.9 tt -59.82 -39.08 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.625 0.77 . . . . 0.0 111.504 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 27' ' ' ILE . 47.2 p -88.32 65.06 7.87 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.885 0.85 . . . . 0.0 110.94 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -127.5 160.53 31.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.715 1.206 . . . . 0.0 108.735 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -60.45 104.41 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.104 0.562 . . . . 0.0 110.128 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.94 -69.86 1.15 Allowed Glycine 0 C--N 1.354 1.571 0 O-C-N 123.951 0.782 . . . . 0.0 113.207 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.52 -164.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.143 0.977 . . . . 0.0 112.415 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.0 m95 58.48 48.55 11.92 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.131 0.972 . . . . 0.0 109.761 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.7 m 60.88 81.38 0.24 Allowed Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.854 -165.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.18 98.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.48 2.787 . . . . 0.0 113.222 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.16 -38.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.699 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.9 t -67.75 103.4 1.41 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.847 0.859 . . . . 0.0 109.04 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 44.7 tt0 -60.53 -56.76 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 124.219 0.949 . . . . 0.0 111.068 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 45.7 mtmt -143.19 141.91 31.27 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t -146.27 109.71 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -109.9 115.95 4.32 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' NH2' HG22 ' A' ' 64' ' ' THR . 24.8 tpt180 -74.73 103.02 4.84 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -85.12 132.37 34.32 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.05 109.72 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 122.042 0.925 . . . . 0.0 109.736 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 69.0 p -119.32 159.03 47.13 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.581 1.552 . . . . 0.0 107.499 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.04 -22.37 74.52 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.6 2.2 . . . . 0.0 113.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.63 -43.96 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -141.67 141.23 33.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.755 0.822 . . . . 0.0 110.583 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.402 HG22 ' NH2' ' A' ' 57' ' ' ARG . 71.2 m -138.69 108.79 6.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.268 0.627 . . . . 0.0 110.029 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -160.17 144.6 14.51 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.547 0.739 . . . . 0.0 109.773 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 143.82 26.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.6 0.36 . . . . 0.0 110.491 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' MET . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.489 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.615 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.748 HG13 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB2' HD22 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.486 ' HG3' HG23 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.0 -31.39 62.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 15.1 mm-40 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.925 0.49 . . . . 0.0 110.093 171.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -88.25 -177.02 5.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.023 0.929 . . . . 0.0 110.014 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -77.59 86.63 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.355 0.598 . . . . 0.0 109.618 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -78.35 129.61 35.19 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.683 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -115.63 57.25 0.74 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.768 0.827 . . . . 0.0 110.077 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 t60 63.43 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.459 1.503 . . . . 0.0 111.255 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.402 ' HD2' ' HB1' ' A' ' 22' ' ' ALA . 33.4 t-80 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.438 1.095 . . . . 0.0 108.129 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.76 72.93 4.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.771 2.314 . . . . 0.0 110.803 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -77.07 -176.97 4.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.582 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.423 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 20.9 t -75.12 173.01 11.36 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.32 0.648 . . . . 0.0 110.912 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? -70.03 114.8 8.54 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' GLU . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.433 ' NE2' ' HB1' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 152' ' ' LEU . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -92.92 174.44 7.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.91 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.254 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 pt -121.0 -4.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.468 0.707 . . . . 0.0 110.492 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -87.04 80.92 8.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.684 0.793 . . . . 0.0 111.054 -172.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -120.57 -18.8 7.7 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.108 0.963 . . . . 0.0 110.296 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -148.17 133.77 18.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.023 0.929 . . . . 0.0 109.196 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.42 33.94 0.03 OUTLIER Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -85.21 82.93 8.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.004 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.2 m-90 58.48 28.18 16.58 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.969 0.907 . . . . 0.0 111.579 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -64.0 137.85 97.23 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.822 0.849 . . . . 0.0 110.751 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.85 -34.68 8.87 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.851 3.034 . . . . 0.0 114.747 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG23 ' SG ' ' A' ' 37' ' ' CYS . 21.0 m -99.19 -18.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' A' ' 36' ' ' VAL . 62.4 m -137.73 100.89 4.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.699 0.8 . . . . 0.0 109.838 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG2' ' HE ' ' A' ' 57' ' ' ARG . 5.3 tp10 -55.2 -60.75 2.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.661 0.785 . . . . 0.0 110.944 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -158.26 148.96 20.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.293 1.037 . . . . 0.0 108.566 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -138.24 113.46 9.38 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 106.18 0.32 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 29.9 ttp180 -85.48 108.95 18.15 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 117.423 0.612 . . . . 0.0 110.479 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -86.02 131.07 34.35 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.46 109.81 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.371 0.668 . . . . 0.0 109.622 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 p -134.97 153.11 78.36 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.95 -21.09 70.01 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.502 2.135 . . . . 0.0 112.039 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.79 -49.93 27.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.58 1.152 . . . . 0.0 110.661 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -161.89 133.21 5.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.357 0.663 . . . . 0.0 110.063 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -129.77 122.79 29.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.699 0.799 . . . . 0.0 109.763 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -161.87 146.73 12.97 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.725 0.641 . . . . 0.0 109.76 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.2 pt-20 -97.26 136.36 37.86 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.233 0.613 . . . . 0.0 109.57 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 15' ' ' ALA . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD12 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' THR . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt -75.19 -11.94 60.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.73 -43.73 6.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.635 0.774 . . . . 0.0 110.132 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.15 -46.46 67.53 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.975 0.91 . . . . 0.0 111.324 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.7 m80 61.69 74.66 0.43 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.568 1.147 . . . . 0.0 111.45 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -88.52 92.65 9.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -81.61 63.58 5.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.701 0.8 . . . . 0.0 109.125 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 176.63 148.45 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.7 m170 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 169.16 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.37 41.57 1.16 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.4 2.733 . . . . 0.0 113.08 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -52.32 -56.63 13.6 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.527 1.131 . . . . 0.0 110.46 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.4 t -138.32 120.22 15.41 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.994 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt -74.89 88.85 2.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -84.47 12.9 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.66 3.06 20.3 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.903 0.881 . . . . 0.0 111.282 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG13 HG23 ' A' ' 28' ' ' THR . 22.8 pt -45.75 -33.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 125.905 1.682 . . . . 0.0 114.095 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 27' ' ' ILE . 44.4 p -84.6 -161.84 0.61 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.924 0.89 . . . . 0.0 111.669 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 73.89 -76.4 0.06 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.558 1.543 . . . . 0.0 110.639 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -138.91 -34.12 0.61 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.253 1.021 . . . . 0.0 110.523 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.04 93.32 0.85 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.43 -33.22 74.37 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.805 0.842 . . . . 0.0 110.677 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -62.48 -40.39 96.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.736 0.814 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -173.31 146.58 1.35 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.188 0.995 . . . . 0.0 109.616 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.42 32.11 0.52 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.795 2.33 . . . . 0.0 112.803 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -74.55 -4.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.516 1.126 . . . . 0.0 112.242 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.0 t -103.82 112.02 24.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.97 -49.53 65.12 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.306 0.574 . . . . 0.0 110.51 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -147.07 129.19 15.56 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.355 -167.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -139.84 135.62 33.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 109.538 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' THR . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.74 120.52 1.04 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.8 ptp180 -87.25 118.34 26.6 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.376 0.588 . . . . 0.0 110.715 175.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' THR . 32.7 t30 -85.91 112.38 21.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.814 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 p -103.47 111.4 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.059 0.944 . . . . 0.0 109.6 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.5 p -133.53 153.82 80.5 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.58 -16.77 44.79 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.699 2.266 . . . . 0.0 113.044 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -74.53 -70.0 0.43 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.624 0.769 . . . . 0.0 110.383 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -137.81 149.22 46.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.063 0.545 . . . . 0.0 110.539 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' ASN . 80.1 m -127.71 122.78 33.81 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -156.0 141.32 17.58 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.542 0.737 . . . . 0.0 109.295 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -94.92 119.94 34.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.465 0.706 . . . . 0.0 109.402 176.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.456 HG13 HG12 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.403 ' HB ' HG21 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.447 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.555 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.46 HD12 HG21 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt -85.12 -38.87 18.58 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -115.9 54.04 0.83 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.939 0.896 . . . . 0.0 110.554 -171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -62.64 106.45 0.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.189 0.596 . . . . 0.0 110.639 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 72.73 9.24 5.59 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.861 1.265 . . . . 0.0 111.649 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -98.29 74.85 2.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -136.36 58.96 1.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -78.27 128.05 33.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.684 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.192 1.397 . . . . 0.0 111.261 176.532 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.414 -0.803 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.82 -39.07 39.05 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.294 2.662 . . . . 0.0 113.054 171.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 71.12 -75.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.523 1.139 . . . . 0.0 111.489 167.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -164.6 -179.27 5.83 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.948 0.899 . . . . 0.0 108.993 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 93.4 mt -73.23 85.67 1.41 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t -85.81 168.91 13.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t0 69.01 133.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.378 1.471 . . . . 0.0 112.267 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 54' ' ' PHE . 2.6 pp -100.06 -13.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.88 0.872 . . . . 0.0 112.623 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -86.12 -64.05 1.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 56.2 -83.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.31 1.444 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 p -141.05 129.07 21.96 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 108.031 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.57 17.39 56.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.123 -0.82 . . . . 0.0 114.234 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 64.48 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.714 1.206 . . . . 0.0 110.853 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.72 -46.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.536 1.534 . . . . 0.0 112.482 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 p -166.99 164.87 9.7 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.556 1.143 . . . . 0.0 108.391 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 72.85 3.91 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.042 1.828 . . . . 0.0 112.007 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.52 3.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.71 0.804 . . . . 0.0 111.722 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 40' ' ' CYS . 45.8 t -69.36 120.28 14.93 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.431 0.693 . . . . 0.0 109.189 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.32 -47.7 80.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.701 0.8 . . . . 0.0 111.096 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HD3' ' HE1' ' A' ' 41' ' ' TRP . 39.7 ttmt -149.81 132.67 16.05 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.472 -174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.41 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 18.6 p -146.23 117.8 8.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.673 0.608 . . . . 0.0 110.32 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.534 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 27' ' ' ILE . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.534 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.37 124.93 4.04 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -110.01 126.71 54.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.255 0.622 . . . . 0.0 110.236 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.34 127.57 34.39 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.75 127.54 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -155.26 141.35 12.95 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -45.78 -32.0 8.48 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.443 2.762 . . . . 0.0 114.845 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.83 -28.85 14.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.944 0.498 . . . . 0.0 112.16 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.2 131.83 40.82 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.37 0.605 . . . . 0.0 111.897 -170.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 p -145.92 122.48 11.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -164.74 145.26 7.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.876 0.47 . . . . 0.0 109.84 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.34 152.02 45.29 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.977 0.911 . . . . 0.0 109.789 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.429 ' HB3' HD13 ' A' ' 17' ' ' ILE . 2.4 m-20 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.446 HH11 ' HA ' ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HB3' HG21 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 93' ' ' TYR . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 14.0 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB3' HD22 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.411 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.603 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 142' ' ' PRO . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt -73.24 -41.03 64.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.61 -12.01 60.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 113.097 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -51.8 164.91 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.746 1.218 . . . . 0.0 114.033 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.4 m170 65.12 40.58 4.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.744 1.217 . . . . 0.0 110.056 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -116.85 -167.19 1.25 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.977 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -59.9 110.72 1.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.415 0.286 . . . . 0.0 110.672 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 66.58 86.24 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.983 1.313 . . . . 0.0 110.517 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 125.402 1.481 . . . . 0.0 111.357 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.79 122.04 8.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.909 2.406 . . . . 0.0 111.074 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -70.26 125.01 25.56 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 t -92.1 144.84 25.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.562 0.745 . . . . 0.0 112.824 -163.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.68 12.65 12.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 105' ' ' THR . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB3' HD22 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HB2' HD21 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -106.58 174.83 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 65.53 15.39 10.01 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.525 1.13 . . . . 0.0 112.294 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -31.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.045 1.338 . . . . 0.0 110.859 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p -80.94 -38.61 27.49 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.957 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.06 -37.65 88.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.464 1.105 . . . . 0.0 111.007 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.8 p -76.6 81.03 3.27 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.218 0.607 . . . . 0.0 110.018 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.19 77.06 0.03 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.09 -64.11 0.95 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.907 0.883 . . . . 0.0 110.464 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -81.11 -14.44 57.71 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.023 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m 62.03 87.87 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 O-C-N 124.624 1.203 . . . . 0.0 111.21 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.82 -69.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.746 2.298 . . . . 0.0 112.143 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.42 -21.03 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.096 0.958 . . . . 0.0 110.287 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 23.3 t -84.0 138.47 33.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.452 0.701 . . . . 0.0 109.802 175.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 31.2 tt0 -99.04 -41.47 7.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 109.592 172.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -156.05 142.97 18.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.962 0.905 . . . . 0.0 109.795 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HG ' ' HG ' ' A' ' 37' ' ' CYS . 94.5 m -138.56 121.71 16.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.455 0.702 . . . . 0.0 110.012 173.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.84 101.53 2.11 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG3' ' HB3' ' A' ' 38' ' ' GLU . 12.7 tpp85 -75.41 102.85 5.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 166.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.962 0.905 . . . . 0.0 109.199 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.31 109.31 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.728 0.811 . . . . 0.0 109.269 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.2 p -110.47 156.47 40.34 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.72 -23.9 28.14 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.34 -48.39 6.69 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 122.915 0.486 . . . . 0.0 111.998 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -140.05 132.16 27.99 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.338 0.655 . . . . 0.0 111.41 -168.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -108.62 117.17 33.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -151.51 139.52 20.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.857 0.463 . . . . 0.0 110.481 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 7.3 pt-20 -98.35 129.34 45.02 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.708 0.803 . . . . 0.0 109.669 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.629 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.599 ' HB ' HG21 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.707 ' HB3' HD21 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -62.92 -40.38 97.42 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 53.5 mt-10 -68.53 -33.77 74.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.425 0.69 . . . . 0.0 111.728 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -112.05 95.26 5.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -58.77 106.75 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.816 0.697 . . . . 0.0 110.258 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -113.12 167.46 10.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.414 1.086 . . . . 0.0 109.825 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -155.4 175.51 13.79 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 108.124 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 68.7 117.52 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.339 1.056 . . . . 0.0 110.651 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.917 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.94 87.4 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.537 2.158 . . . . 0.0 111.263 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -74.82 120.26 20.12 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.168 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m 63.71 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.953 1.301 . . . . 0.0 110.783 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt -147.16 30.68 0.94 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.09 0.956 . . . . 0.0 110.279 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -87.86 92.79 9.25 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.16 97.68 8.76 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 166.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 28' ' ' THR . 16.1 pt -59.64 -56.46 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.946 170.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.636 ' H ' HG13 ' A' ' 27' ' ' ILE . 12.1 t 177.88 18.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.815 1.646 . . . . 0.0 109.074 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -77.54 -47.95 18.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 110.441 -165.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -99.75 123.21 43.78 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.501 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.03 23.94 1.92 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.11 119.82 17.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 m95 65.33 14.31 9.35 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.435 1.094 . . . . 0.0 111.775 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 t -156.68 89.43 2.66 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -83.42 29.77 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.43 -32.67 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.684 0.794 . . . . 0.0 111.305 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.09 85.77 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 59' ' ' VAL . 39.9 tt0 -78.75 -57.23 3.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.179 0.592 . . . . 0.0 110.632 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.28 114.75 9.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 63.0 m -125.15 124.55 42.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.588 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.58 100.39 2.39 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -90.38 118.82 30.16 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.11 145.14 40.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 38' ' ' GLU . 14.7 p -131.27 131.7 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.296 0.57 . . . . 0.0 109.618 175.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 p -130.74 163.94 45.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.52 -22.29 50.38 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.8 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.19 -63.79 1.33 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.784 0.833 . . . . 0.0 110.418 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -148.52 164.41 34.29 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.824 0.85 . . . . 0.0 111.044 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HB ' HG23 ' A' ' 59' ' ' VAL . 11.0 t -138.2 136.35 36.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.847 0.859 . . . . 0.0 109.523 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -171.69 163.7 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 108.952 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -105.35 164.69 11.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.836 0.455 . . . . 0.0 112.046 -179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.615 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.609 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.507 HD21 ' HA3' ' A' ' 114' ' ' GLY . 29.4 t-20 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.531 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.507 ' HA3' HD21 ' A' ' 88' ' ' ASN . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 158' ' ' HIS . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt -70.09 -26.78 64.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -119.65 17.96 12.75 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.499 0.72 . . . . 0.0 111.331 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 16.9 t-80 -79.98 8.5 6.91 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.092 0.557 . . . . 0.0 112.091 -172.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -63.72 78.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.767 0.827 . . . . 0.0 109.89 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.09 109.02 0.09 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.052 1.341 . . . . 0.0 107.568 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -137.2 91.85 2.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -159.43 111.72 2.14 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.987 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.248 0.994 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -50.11 130.92 29.44 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.378 2.719 . . . . 0.0 113.608 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -111.96 154.47 25.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 108.582 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -60.25 152.16 25.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.784 0.434 . . . . 0.0 109.941 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.26 85.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.307 0.643 . . . . 0.0 111.159 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.768 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -86.75 8.02 24.36 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.03 141.19 50.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.99 0.516 . . . . 0.0 110.457 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -131.37 9.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.006 0.923 . . . . 0.0 110.807 -175.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 p -119.5 -59.2 1.85 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.87 -0.519 . . . . 0.0 111.359 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -74.12 -26.18 60.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.508 0.723 . . . . 0.0 110.95 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -61.53 -20.92 63.78 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.25 1.02 . . . . 0.0 111.953 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.81 83.73 0.48 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -147.43 3.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.516 0.326 . . . . 0.0 111.81 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.513 ' HD1' HG21 ' A' ' 59' ' ' VAL . 17.6 m-90 74.12 -22.91 0.23 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.549 1.139 . . . . 0.0 113.151 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 14.5 m -66.91 -44.78 52.86 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 123.248 0.619 . . . . 0.0 110.889 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 34' ' ' SER . 5.7 Cg_exo -83.27 -168.43 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.431 163.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.1 1.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.7 m -103.3 137.04 41.96 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.156 0.582 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.4 -51.49 2.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.189 0.995 . . . . 0.0 109.871 173.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -151.37 122.71 7.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.245 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 60.4 m -137.94 122.34 18.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.851 0.461 . . . . 0.0 110.271 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.84 107.14 1.15 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 34.5 ttm180 -76.17 109.59 9.97 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.005 0.522 . . . . 0.0 110.141 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -86.07 113.66 22.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.288 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG21 ' HD1' ' A' ' 33' ' ' TRP . 7.6 p -97.53 125.64 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.708 . . . . 0.0 109.788 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.7 p -137.22 159.25 70.43 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.309 1.044 . . . . 0.0 108.225 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.32 -23.78 64.7 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.017 2.478 . . . . 0.0 113.187 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.46 -53.79 7.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.529 0.731 . . . . 0.0 110.622 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -156.34 144.71 19.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.177 0.513 . . . . 0.0 111.331 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.3 m -106.28 106.94 17.7 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 170.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -132.33 143.63 50.0 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.043 0.537 . . . . 0.0 110.503 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.1 mt-10 -86.65 111.11 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.513 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 72' ' ' ILE . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.768 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.502 ' HA ' HG23 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 158' ' ' HIS . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt -78.53 -64.88 1.07 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -151.33 -80.45 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 154' ' ' VAL . 16.4 t60 54.47 43.17 30.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.005 1.322 . . . . 0.0 111.567 175.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 54.35 8.85 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.979 1.712 . . . . 0.0 114.245 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -164.12 86.38 0.47 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.231 0.612 . . . . 0.0 109.47 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -142.96 94.6 2.65 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -162.82 89.6 0.66 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.693 0.797 . . . . 0.0 109.002 -177.471 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 CA--C 1.566 1.586 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -84.4 177.98 5.41 Favored 'Trans proline' 0 C--N 1.386 2.545 0 CA-C-N 121.803 1.68 . . . . 0.0 111.898 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -73.77 87.76 1.74 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m 59.53 -87.28 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.431 1.092 . . . . 0.0 110.083 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 130' ' ' ILE . 18.6 mt -155.23 88.39 1.16 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 125.269 1.428 . . . . 0.0 107.593 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 15' ' ' ALA . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.588 ' HB3' HD22 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 20' ' ' VAL . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p -153.08 90.93 1.48 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.47 77.95 0.17 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 171.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -131.17 -4.95 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.24 1.016 . . . . 0.0 110.465 -172.534 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -78.36 81.14 4.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.191 0.996 . . . . 0.0 110.746 -165.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -138.79 -164.74 1.7 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.01 1.324 . . . . 0.0 108.956 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.8 m -69.15 -37.73 78.42 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.353 0.661 . . . . 0.0 110.737 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.35 39.15 0.69 Allowed Glycine 0 N--CA 1.473 1.101 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.396 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -73.64 -41.99 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.989 0.916 . . . . 0.0 110.753 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' HZ2' ' HA ' ' A' ' 27' ' ' ILE . 12.8 p-90 -103.09 6.61 38.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.808 0.843 . . . . 0.0 110.933 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -136.55 103.65 9.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.636 0.774 . . . . 0.0 110.072 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.6 -20.21 18.11 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.064 2.51 . . . . 0.0 112.79 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.88 -15.86 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 0.0 111.1 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -78.23 93.26 4.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.832 0.853 . . . . 0.0 109.565 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -89.33 -43.28 11.04 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -140.19 127.76 21.58 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -146.87 110.58 4.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.846 0.459 . . . . 0.0 110.0 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.15 -168.08 14.04 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -152.87 106.02 3.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -87.51 136.33 32.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.776 0.673 . . . . 0.0 109.214 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -130.04 138.26 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.435 0.694 . . . . 0.0 109.763 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 32.6 p -137.67 161.99 57.19 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.149 1.379 . . . . 0.0 107.616 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 60' ' ' THR . 9.9 Cg_endo -49.24 -28.09 14.23 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.991 3.128 . . . . 0.0 115.237 -175.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -113.51 -30.54 6.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.332 0.653 . . . . 0.0 112.355 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -123.71 134.41 53.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -162.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -128.89 118.51 22.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.891 0.876 . . . . 0.0 108.713 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -144.72 131.16 19.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.229 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -84.42 116.09 22.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.052 0.941 . . . . 0.0 108.82 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.719 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.424 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' HG23 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.719 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.525 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 130' ' ' ILE . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.42 -41.15 85.31 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.92 -26.4 48.98 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.937 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -68.83 -28.31 66.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.485 0.714 . . . . 0.0 109.474 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -79.09 143.66 35.32 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.699 0.8 . . . . 0.0 109.45 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -86.46 157.46 19.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.631 0.772 . . . . 0.0 110.512 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -65.8 163.7 16.22 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.788 0.435 . . . . 0.0 110.974 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -67.64 96.79 0.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.887 0.475 . . . . 0.0 110.493 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 CA--C 1.558 1.268 0 C-N-CA 125.138 1.375 . . . . 0.0 110.791 -179.508 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 58.2 mtt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 12.4 Cg_endo -54.91 -64.21 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.801 2.334 . . . . 0.0 111.468 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 112' ' ' PRO . 36.3 ttpt 67.07 150.63 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.885 1.274 . . . . 0.0 112.386 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 t -144.75 -60.15 0.36 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.936 -0.477 . . . . 0.0 110.137 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt -75.08 88.06 2.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.083 -176.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.573 HG22 HD12 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -69.28 85.81 0.4 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.54 -18.43 33.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.601 1.16 . . . . 0.0 110.673 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.33 99.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 O-C-N 124.546 1.154 . . . . 0.0 110.001 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 40' ' ' CYS . 20.9 p 72.43 -19.7 0.29 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 127.481 2.313 . . . . 0.0 113.204 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HG2' ' H ' ' A' ' 30' ' ' THR . 30.3 ttp180 59.98 -143.29 0.55 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.591 1.157 . . . . 0.0 109.503 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.481 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 32.3 p -78.12 91.25 4.29 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 118.817 0.735 . . . . 0.0 110.724 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.73 46.78 2.09 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.21 -56.08 6.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.042 0.937 . . . . 0.0 111.046 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -138.16 5.96 2.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.944 0.898 . . . . 0.0 110.843 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 m -57.13 111.34 3.25 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.097 0.959 . . . . 0.0 112.043 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.15 -24.17 44.83 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.99 2.46 . . . . 0.0 112.065 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.23 -13.73 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.906 0.882 . . . . 0.0 111.597 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 48.9 t -95.89 75.98 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 59' ' ' VAL . 34.6 tt0 -65.43 -55.19 19.37 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.743 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -135.07 118.3 16.6 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.695 1.198 . . . . 0.0 108.193 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 22.7 p -146.07 112.41 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.868 0.867 . . . . 0.0 109.501 -176.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.13 -158.26 30.55 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -153.28 121.14 6.06 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.835 0.854 . . . . 0.0 109.278 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.98 113.83 21.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 38' ' ' GLU . 5.4 p -121.52 111.42 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 122.06 0.934 . . . . 0.0 109.547 177.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.1 p -110.76 153.56 43.62 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.88 -7.42 6.05 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.393 2.729 . . . . 0.0 116.063 -167.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 0.4 2.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -153.46 131.9 12.1 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.89 0.314 . . . . 0.0 110.774 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 59' ' ' VAL . 59.9 p -130.42 156.93 43.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.822 0.849 . . . . 0.0 110.589 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -167.93 137.88 2.65 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.94 1.296 . . . . 0.0 108.731 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.09 119.62 24.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.631 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.476 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt -68.59 -42.48 78.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.49 160.57 17.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.0 t60 70.25 -65.67 0.31 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 -167.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 63.85 115.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.6 1.56 . . . . 0.0 114.152 161.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.8 155.5 18.1 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.487 0.715 . . . . 0.0 109.636 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -76.78 155.12 33.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 111.207 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -155.84 47.08 0.48 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.866 0.866 . . . . 0.0 108.817 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.492 1.654 0 C-N-CA 126.041 1.736 . . . . 0.0 110.095 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.459 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 23.5 Cg_endo -62.06 112.66 1.59 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.429 2.086 . . . . 0.0 110.929 167.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -68.41 -34.14 75.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.825 0.85 . . . . 0.0 110.717 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -178.35 176.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.466 1.507 . . . . 0.0 108.44 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? -101.07 42.79 1.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p -83.72 -21.0 32.44 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.39 96.47 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 0.0 109.837 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.87 -45.43 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.516 0.726 . . . . 0.0 110.486 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.41 -15.84 14.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.978 0.911 . . . . 0.0 111.062 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -49.42 62.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.768 0.827 . . . . 0.0 110.36 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.8 m -93.54 -57.0 2.72 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.41 -118.01 11.87 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.148 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 33' ' ' TRP . 24.2 tt0 -168.58 177.85 5.02 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 4.2 m-90 -56.72 -41.37 77.35 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.284 0.634 . . . . 0.0 110.061 166.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 p -128.37 88.32 52.86 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.883 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 149.02 42.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.224 1.949 . . . . 0.0 112.197 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.89 1.28 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.612 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 66.4 m -102.83 116.19 32.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.977 0.911 . . . . 0.0 108.926 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 32.0 tt0 -81.09 -57.56 3.47 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.533 0.683 . . . . 0.0 109.169 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 27.3 mtpp -135.36 127.53 29.97 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.173 -175.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 72.0 m -145.33 135.05 23.47 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.081 0.552 . . . . 0.0 110.058 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.87 104.99 0.46 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 12.1 ttp180 -74.61 105.11 5.56 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.103 0.477 . . . . 0.0 110.019 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -84.39 110.62 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.466 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -105.78 127.06 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.644 0.777 . . . . 0.0 110.399 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.3 p -134.33 153.65 79.46 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 164.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.13 -18.77 53.21 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.704 2.27 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -73.01 -47.8 41.9 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.282 1.033 . . . . 0.0 110.308 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -167.93 132.86 1.82 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.197 0.599 . . . . 0.0 110.644 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 m -103.69 119.31 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.874 0.87 . . . . 0.0 109.162 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -132.18 162.03 31.91 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.95 1.3 . . . . 0.0 108.799 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 35.7 tt0 -125.2 130.26 51.77 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.541 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.431 HG22 ' HD1' ' A' ' 110' ' ' PHE . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.486 ' HG3' HD11 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HB3' HG21 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HD3' ' HB3' ' A' ' 2' ' ' PRO . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' PRO . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt -68.5 -20.24 64.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -114.73 178.12 4.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.176 0.99 . . . . 0.0 110.727 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 69.1 t60 61.31 30.68 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.209 1.004 . . . . 0.0 109.671 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 47.5 m80 60.99 -84.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.489 1.116 . . . . 0.0 108.861 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -153.54 168.12 27.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.862 1.265 . . . . 0.0 108.373 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -113.56 -51.57 2.8 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -168.22 138.35 2.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.764 0.665 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.533 1.133 . . . . 0.0 108.684 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.6 139.02 36.39 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.672 2.248 . . . . 0.0 111.212 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 122.89 20.77 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t -78.0 158.67 29.18 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.61 66.94 9.23 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 HD12 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 20' ' ' VAL . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m -57.7 -69.24 0.18 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.47 -64.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.571 1.549 . . . . 0.0 113.618 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.04 97.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.677 1.591 . . . . 0.0 111.662 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 p 63.27 5.66 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.812 2.045 . . . . 0.0 113.884 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -38.98 48.48 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -142.15 179.3 6.99 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.365 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.48 29.44 0.03 OUTLIER Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.13 -39.93 6.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 -173.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -88.63 -47.77 8.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.873 0.869 . . . . 0.0 110.412 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -102.39 116.97 62.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.615 0.766 . . . . 0.0 110.128 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.71 75.12 4.12 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.408 2.739 . . . . 0.0 112.089 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.25 7.11 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 124.195 0.998 . . . . 0.0 110.913 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -142.89 110.58 5.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.367 0.667 . . . . 0.0 110.026 -174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 10.3 tp10 -69.61 -56.65 6.7 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 165.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -172.88 142.25 1.1 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.368 1.067 . . . . 0.0 109.228 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m -135.0 140.78 45.93 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.383 0.673 . . . . 0.0 110.367 -176.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.493 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . -134.99 105.27 0.54 Allowed Glycine 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 30.5 ttm180 -82.22 113.71 20.23 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -95.14 135.84 36.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.493 0.717 . . . . 0.0 109.637 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 12.7 p -113.39 134.72 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.1 p -132.38 166.3 29.82 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 109.812 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.91 -18.89 23.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.169 2.58 . . . . 0.0 113.198 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.84 -85.22 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.331 0.653 . . . . 0.0 110.625 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.02 162.89 30.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.643 0.777 . . . . 0.0 110.391 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -102.66 108.88 20.3 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -115.83 133.39 56.08 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.189 0.596 . . . . 0.0 110.008 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 tt0 -90.77 112.89 24.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 86' ' ' ASP . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 85' ' ' THR . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HA ' HG23 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -63.78 -31.3 72.43 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -79.26 -64.84 1.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 22.2 t60 68.3 139.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.661 1.584 . . . . 0.0 111.195 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 71.15 -0.83 2.93 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.075 0.95 . . . . 0.0 111.668 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -75.69 109.71 9.5 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.967 0.907 . . . . 0.0 110.451 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.76 156.62 44.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.482 1.113 . . . . 0.0 109.174 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -65.14 110.89 2.69 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 124.748 1.219 . . . . 0.0 111.089 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.12 -55.98 2.96 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.182 2.588 . . . . 0.0 112.058 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.6 tttt 60.56 17.2 7.17 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.693 1.197 . . . . 0.0 112.42 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 62.83 -168.2 0.2 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.193 0.997 . . . . 0.0 110.282 -173.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt -102.83 101.73 11.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.747 HG22 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 HG13 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m 63.79 -159.02 0.31 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -126.0 -174.83 3.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.566 0.747 . . . . 0.0 110.655 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -125.81 -1.58 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.662 1.185 . . . . 0.0 110.699 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.2 p -102.56 -64.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.108 0.963 . . . . 0.0 111.243 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -79.31 -63.73 1.35 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.352 1.461 . . . . 0.0 110.27 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -76.29 -60.54 2.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.698 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.9 112.18 0.02 OUTLIER Glycine 0 C--N 1.356 1.677 0 O-C-N 123.491 0.495 . . . . 0.0 112.209 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -68.81 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -103.21 69.57 1.02 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.928 0.491 . . . . 0.0 110.201 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m 54.16 74.17 0.79 Allowed Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.923 1.289 . . . . 0.0 111.442 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 159.53 37.2 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.421 2.081 . . . . 0.0 112.544 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 m -81.83 3.67 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.613 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -77.94 102.72 7.48 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HG2' ' HD2' ' A' ' 39' ' ' LYS . 30.2 tt0 -68.09 -58.61 4.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.137 0.575 . . . . 0.0 110.989 -173.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 38' ' ' GLU . 2.0 mptp? -144.04 123.9 13.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t -147.34 130.76 16.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.9 -166.44 17.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -154.19 129.31 9.62 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.175 0.59 . . . . 0.0 109.905 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -97.65 136.3 38.22 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.085 0.954 . . . . 0.0 108.897 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -122.9 124.18 69.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.743 0.817 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.8 p -138.88 155.27 73.16 Favored Pre-proline 0 N--CA 1.475 0.787 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.98 -22.5 69.35 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.827 2.351 . . . . 0.0 112.859 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.81 -50.06 13.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.777 0.831 . . . . 0.0 110.838 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.486 HH12 ' HB2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -157.91 147.58 19.99 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.619 0.723 . . . . 0.0 111.939 171.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 m -115.57 129.52 56.55 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.87 152.07 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.548 0.739 . . . . 0.0 110.67 -170.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.64 120.56 25.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.26 0.624 . . . . 0.0 109.453 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.478 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.569 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.629 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 138' ' ' ILE . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 HD23 ' A' ' 135' ' ' LEU . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt -73.67 -34.44 64.91 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 30.2 mm-40 -56.93 -23.02 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.172 0.589 . . . . 0.0 111.48 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -84.01 66.23 9.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.85 0.86 . . . . 0.0 109.942 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.9 m80 60.42 99.3 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.427 1.491 . . . . 0.0 112.924 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.18 131.35 50.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.87 0.868 . . . . 0.0 108.784 172.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -73.64 -76.66 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.066 0.546 . . . . 0.0 109.863 -173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -128.42 5.57 5.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.402 0.681 . . . . 0.0 109.568 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 15' ' ' ALA . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 HD13 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 99.4 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.462 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HG22 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.462 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.449 HD12 HD23 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.445 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.65 HD13 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt . . . . . 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.627 HG22 HD12 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.578 HG21 HD21 ' A' ' 152' ' ' LEU . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.695 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.507 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.507 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 129' ' ' GLU . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.627 HD12 HG22 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt . . . . . 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.507 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.529 HD12 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.648 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 m170 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 53' ' ' HIS . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.411 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD12 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.571 ' H ' HG23 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.415 ' O ' HD23 ' A' ' 145' ' ' LEU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.507 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt . . . . . 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 24' ' ' VAL . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HG ' HD21 ' A' ' 152' ' ' LEU . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 20' ' ' VAL . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 C--O 1.234 0.268 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 71' ' ' VAL . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 HG12 ' A' ' 73' ' ' VAL . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 72' ' ' ILE . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.56 ' HB3' HG22 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.417 HD11 ' HD1' ' A' ' 93' ' ' TYR . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.558 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 139' ' ' THR . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 135' ' ' LEU . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt . . . . . 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.689 HD21 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 121.673 0.749 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.419 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.495 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 52' ' ' ALA . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.417 ' HH2' ' HA ' ' A' ' 134' ' ' ARG . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.467 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.689 ' HB ' HD21 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 35.5 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.95 0.405 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.427 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.635 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.635 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 108' ' ' TRP . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.427 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 112' ' ' PRO . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 19' ' ' GLN . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt . . . . . 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.758 0.313 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.499 HG21 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 HD22 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.701 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.531 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.4 ' O ' HD23 ' A' ' 145' ' ' LEU . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 91.0 mt . . . . . 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.399 0.618 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 141' ' ' ILE . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.5 HG22 HD12 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD2' HE21 ' A' ' 19' ' ' GLN . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.542 HE21 ' HD2' ' A' ' 16' ' ' PRO . 40.4 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m . . . . . 0 C--O 1.239 0.51 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 86' ' ' ASP . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 85' ' ' THR . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.634 HD22 HG23 ' A' ' 89' ' ' VAL . 12.7 t30 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.634 HG23 HD22 ' A' ' 88' ' ' ASN . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.478 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.619 ' HB3' HD21 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.428 ' HG2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 7' ' ' PHE . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' ILE . 63.7 mt . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 HD21 ' A' ' 152' ' ' LEU . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 HG21 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 20' ' ' VAL . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.724 0.297 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' MET . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.489 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.615 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.513 HG12 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB2' HD22 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.486 ' HG3' HG23 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? . . . . . 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' GLU . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.433 ' NE2' ' HB1' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 152' ' ' LEU . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 15' ' ' ALA . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD12 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' THR . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt . . . . . 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.456 HG13 HG12 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.403 ' HB ' HG21 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.447 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.555 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.46 HD12 HG21 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 93.4 mt . . . . . 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.6 p . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.892 0.377 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.534 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.534 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' HA ' HH11 ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HB3' HG21 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 93' ' ' TYR . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 3.6 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB3' HD22 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.411 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.603 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 142' ' ' PRO . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.744 0.307 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 105' ' ' THR . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB3' HD22 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HB2' HD21 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.945 0.402 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.629 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.599 ' HB ' HG21 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.707 ' HB3' HD21 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m . . . . . 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 55' ' ' THR . 63.0 m . . . . . 0 C--O 1.238 0.452 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.588 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 121.03 0.443 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.615 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.609 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.589 HD22 HG23 ' A' ' 89' ' ' VAL . 11.1 t30 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.589 HG23 HD22 ' A' ' 88' ' ' ASN . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.531 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 151' ' ' ILE . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 121.265 0.555 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.768 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.4 m . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 120.733 0.301 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--O 1.241 0.626 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 72' ' ' ILE . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.768 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.502 ' HA ' HG23 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt . . . . . 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 130' ' ' ILE . 18.6 mt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.455 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 15' ' ' ALA . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.588 ' HB3' HD22 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 20' ' ' VAL . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.719 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.424 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.525 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' HG23 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.719 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.525 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 130' ' ' ILE . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.171 0.51 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.573 HG22 HD12 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.631 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.476 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.541 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.431 HG22 ' HD1' ' A' ' 110' ' ' PHE . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.486 ' HG3' HD11 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HB3' HG21 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' PRO . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 HD12 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 20' ' ' VAL . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.493 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 86' ' ' ASP . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 85' ' ' THR . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.406 ' HE ' ' HA ' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HA ' HG23 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt . . . . . 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.747 HG22 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 HG13 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t . . . . . 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.478 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.569 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.629 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 138' ' ' ILE . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 HD23 ' A' ' 135' ' ' LEU . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 119.185 -0.436 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -58.91 101.24 0.12 Allowed 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.44 2.76 . . . . 0.0 112.346 174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -131.56 -58.66 0.98 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.037 0.935 . . . . 0.0 110.222 -170.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.2 t -163.45 99.93 0.92 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' A' ' 134' ' ' ARG . 2.7 mm? -80.93 71.78 7.9 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 109' ' ' GLU . 39.6 p -125.44 135.57 52.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.996 0.919 . . . . 0.0 109.887 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -148.7 149.2 31.04 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -139.53 153.82 47.54 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.824 0.85 . . . . 0.0 109.902 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -153.49 142.67 21.42 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.484 ' HB3' HG23 ' A' ' 105' ' ' THR . 12.5 p -131.33 143.81 50.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.193 0.997 . . . . 0.0 110.175 -177.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 145' ' ' LEU . 13.4 tt -147.34 144.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 122.829 0.451 . . . . 0.0 109.872 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -89.43 120.47 30.78 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 15' ' ' ALA . 50.7 mt -104.08 138.55 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.142 0.977 . . . . 0.0 108.526 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.67 10.29 5.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.375 0.67 . . . . 0.0 112.257 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -110.26 149.82 40.68 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.213 1.005 . . . . 0.0 110.381 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.61 164.51 18.14 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.956 2.437 . . . . 0.0 113.475 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.6 tt -64.34 -26.39 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.064 -177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -59.92 -42.31 93.65 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.429 0.692 . . . . 0.0 110.562 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -67.39 -50.44 59.65 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.028 0.931 . . . . 0.0 111.027 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.1 t -65.21 -43.1 95.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.276 -172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -62.3 -47.46 84.18 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.606 0.762 . . . . 0.0 110.015 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.18 -24.12 64.01 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.909 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.91 -45.6 15.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 122.828 0.451 . . . . 0.0 109.86 -178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 HD13 ' A' ' 148' ' ' ILE . 27.9 m -73.57 -34.03 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 122.881 0.472 . . . . 0.0 111.589 -175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.7 t -85.08 92.35 8.34 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -124.59 90.95 3.34 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.335 0.654 . . . . 0.0 109.523 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 tt -145.47 -49.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.707 1.203 . . . . 0.0 108.75 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.6 p -76.03 126.97 32.0 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -153.3 -175.68 5.45 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.6 m -53.08 99.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.341 0.657 . . . . 0.0 110.441 174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' HA2' ' HD3' ' A' ' 35' ' ' PRO . . . -164.03 48.28 0.3 Allowed Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.789 -172.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -69.39 -30.47 68.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.971 0.909 . . . . 0.0 111.22 -175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -130.6 21.59 5.1 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.862 0.865 . . . . 0.0 111.527 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.4 m 65.67 92.92 0.06 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.051 0.94 . . . . 0.0 112.836 176.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.532 ' HD3' ' HA2' ' A' ' 31' ' ' GLY . 3.3 Cg_endo -90.45 -81.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 124.033 3.155 . . . . 0.0 111.663 174.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -85.18 -13.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.261 0.624 . . . . 0.0 110.767 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 74.0 m -97.4 144.35 27.23 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -81.04 -56.38 4.14 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -149.86 115.52 5.57 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.518 1.127 . . . . 0.0 108.422 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 99.4 m -134.65 128.96 34.12 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.442 0.697 . . . . 0.0 110.113 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -139.92 157.69 45.29 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.179 0.992 . . . . 0.0 109.371 177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -122.05 162.39 21.27 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.431 0.692 . . . . 0.0 109.497 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -65.1 -12.84 55.16 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 16.6 pt-20 -63.06 -17.69 62.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.561 0.744 . . . . 0.0 112.195 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.12 -39.21 72.16 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.634 0.774 . . . . 0.0 110.547 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 -70.01 0.82 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.747 0.819 . . . . 0.0 110.54 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.41 110.39 0.26 Allowed Glycine 0 CA--C 1.534 1.249 0 CA-C-O 118.518 -1.156 . . . . 0.0 111.014 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.07 82.5 0.81 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.366 2.711 . . . . 0.0 111.782 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.64 173.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.447 1.099 . . . . 0.0 109.976 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.02 119.6 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.27 -22.93 21.9 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.842 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.22 152.04 42.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.482 0.713 . . . . 0.0 110.129 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 17.8 p80 -144.77 125.04 13.75 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.108 0.413 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -83.34 134.07 34.92 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.2 m -125.37 135.37 52.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.358 0.663 . . . . 0.0 109.419 -173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -150.18 103.32 0.25 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.774 -176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 41.8 ttm180 -80.21 117.66 21.2 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 168.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.92 143.3 27.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.914 0.885 . . . . 0.0 109.296 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 64' ' ' THR . 8.4 p -123.35 124.9 70.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.532 0.733 . . . . 0.0 109.563 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 42.6 p -130.92 158.83 73.91 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.42 -12.66 34.25 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.725 2.283 . . . . 0.0 113.244 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.79 -61.44 1.45 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.87 0.868 . . . . 0.0 110.739 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -123.16 164.8 17.98 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.69 0.757 . . . . 0.0 111.981 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 59' ' ' VAL . 2.7 p -132.15 106.86 8.23 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -134.95 143.89 47.13 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.98 0.512 . . . . 0.0 110.205 -173.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.4 pt-20 -122.35 133.27 54.66 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.095 0.958 . . . . 0.0 110.085 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.7 p -122.51 116.13 23.4 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.937 0.895 . . . . 0.0 109.981 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.7 ptt85 -102.83 139.12 38.82 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -137.98 117.17 12.64 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 123.07 0.548 . . . . 0.0 109.872 -175.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 9.1 mp0 -95.16 129.08 42.4 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.193 0.997 . . . . 0.0 110.212 -172.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.2 t -77.58 90.96 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 114.565 -1.198 . . . . 0.0 108.777 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 pt -81.38 -23.15 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.265 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.05 110.37 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 123.626 0.77 . . . . 0.0 109.425 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.12 104.21 11.63 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.179 0.992 . . . . 0.0 108.788 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.0 107.01 35.85 Favored Pre-proline 0 C--O 1.242 0.681 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.45 112.02 1.47 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 123.061 2.507 . . . . 0.0 112.208 -171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.18 32.46 15.04 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.528 1.131 . . . . 0.0 111.461 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -135.39 -46.62 0.69 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.79 0.836 . . . . 0.0 110.703 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.8 t -167.26 130.97 1.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.973 0.509 . . . . 0.0 109.855 177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 175.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -126.45 123.17 4.65 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.694 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 48.6 p90 -109.76 173.49 6.3 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.671 0.788 . . . . 0.0 110.282 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.9 p -142.32 120.44 12.17 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.17 0.588 . . . . 0.0 110.206 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.2 t -76.12 109.53 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 m 73.29 164.79 0.29 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.087 1.355 . . . . 0.0 110.663 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -56.75 87.83 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.691 1.196 . . . . 0.0 112.036 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 61.63 31.88 79.46 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.593 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -90.85 -68.46 0.79 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.104 0.562 . . . . 0.0 109.589 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.5 t -110.31 136.93 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 98.9 mttt -118.08 142.9 46.91 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.305 0.502 . . . . 0.0 109.679 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.547 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 89.6 m95 -131.82 97.5 4.21 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 mm -108.19 110.88 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 12.6 m-85 -106.51 101.96 11.39 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.594 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 40.6 t -84.78 125.53 32.65 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.175 0.99 . . . . 0.0 108.822 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 45.5 mtt -122.16 110.26 15.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -109.83 97.75 30.36 Favored Pre-proline 0 N--CA 1.471 0.614 0 C-N-CA 123.246 0.618 . . . . 0.0 109.968 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.81 105.77 2.07 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.773 2.315 . . . . 0.0 111.767 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 31.5 mt -81.11 170.67 15.89 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.231 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -79.19 2.34 21.41 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.327 0.651 . . . . 0.0 110.798 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.3 15.17 2.59 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.032 0.933 . . . . 0.0 111.15 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.79 -147.3 17.2 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 121.978 -0.451 . . . . 0.0 112.645 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.1 m -153.33 131.75 12.09 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.869 0.868 . . . . 0.0 110.355 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.69 111.34 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -89.72 132.05 35.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.594 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 40.5 m -130.46 105.89 8.16 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -90.83 144.69 25.45 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -178.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.9 m -141.5 106.05 4.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.54 0.736 . . . . 0.0 109.663 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.462 ' HZ2' HH21 ' A' ' 133' ' ' ARG . 46.4 t90 -90.05 116.05 27.78 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.081 0.952 . . . . 0.0 109.032 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HG22 ' A' ' 6' ' ' THR . 41.6 mt-10 -118.72 96.6 5.33 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.164 0.586 . . . . 0.0 109.583 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -95.4 114.84 26.65 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 69.3 p -85.03 166.27 32.48 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.264 1.026 . . . . 0.0 111.104 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 111' ' ' THR . 24.6 Cg_endo -59.38 -8.16 6.4 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.198 2.599 . . . . 0.0 115.022 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -63.0 -58.9 5.74 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.229 0.612 . . . . 0.0 111.117 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.06 -22.59 77.68 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.994 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.28 -41.46 99.0 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.584 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 81.2 mtt-85 -61.62 -25.35 67.3 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.56 0.744 . . . . 0.0 112.467 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -62.74 -32.65 73.82 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.562 ' HB3' ' HB2' ' A' ' 126' ' ' SER . 80.6 m-85 -85.64 -50.96 6.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.396 0.678 . . . . 0.0 110.125 174.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.584 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 24.2 t-80 -56.49 -43.05 79.3 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.697 1.599 . . . . 0.0 113.119 -174.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.62 -17.24 60.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.184 0.594 . . . . 0.0 111.992 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -85.65 -49.52 7.93 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.647 0.379 . . . . 0.0 110.613 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 126' ' ' SER . 73.7 m-85 -121.91 -50.39 2.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.629 0.371 . . . . 0.0 111.216 -173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.6 -83.69 1.01 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.5 -47.47 86.01 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.862 0.865 . . . . 0.0 111.238 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 79.2 tttt -85.54 -13.74 48.0 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.044 0.538 . . . . 0.0 111.465 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . 86.7 p -85.49 -11.61 53.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.161 0.584 . . . . 0.0 112.001 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 131' ' ' GLU . 75.2 mt -49.79 -44.07 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.933 0.493 . . . . 0.0 111.231 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.12 -35.36 80.51 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -67.72 -39.33 84.33 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.168 0.587 . . . . 0.0 111.828 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.64 -29.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.781 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 127' ' ' ILE . 44.0 mt-10 -71.67 -33.06 68.54 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.81 0.444 . . . . 0.0 110.407 171.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 ttmm -61.86 -53.71 52.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.409 0.684 . . . . 0.0 109.923 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 HH21 ' HZ2' ' A' ' 108' ' ' TRP . 11.7 ptm85 -67.8 -30.76 70.26 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.325 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.478 ' HB2' HD12 ' A' ' 5' ' ' LEU . 30.6 ttm180 -61.53 -57.88 10.34 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.259 0.624 . . . . 0.0 109.678 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 138' ' ' ILE . 47.2 mt -68.24 -30.82 69.95 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.0 1.32 . . . . 0.0 111.461 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.7 -27.45 65.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.434 0.694 . . . . 0.0 110.778 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.26 -35.46 23.38 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.126 0.57 . . . . 0.0 110.698 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.449 HD12 HD23 ' A' ' 135' ' ' LEU . 87.4 mt -64.33 -27.68 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 123.229 0.612 . . . . 0.0 110.605 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 m -97.07 -36.19 10.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.236 0.614 . . . . 0.0 110.603 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.01 -49.69 12.53 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 114.367 0.507 . . . . 0.0 114.367 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.445 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 82.5 mt -58.7 -52.56 73.82 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-O 117.939 -1.029 . . . . 0.0 111.899 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.468 ' O ' HG23 ' A' ' 146' ' ' VAL . 26.8 Cg_exo -60.48 -40.71 54.71 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.882 1.721 . . . . 0.0 112.299 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.65 -49.43 67.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.314 1.009 . . . . 0.0 110.538 174.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.4 ' O ' HG13 ' A' ' 148' ' ' ILE . 90.1 m -64.8 -42.68 94.84 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 123.734 0.814 . . . . 0.0 110.536 -177.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 11' ' ' ILE . 3.2 mm? -58.41 -41.2 84.44 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.875 0.87 . . . . 0.0 111.246 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 142' ' ' PRO . 61.1 t -69.94 -37.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.414 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.81 -40.2 87.97 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.226 0.61 . . . . 0.0 111.098 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.65 HD13 HG12 ' A' ' 24' ' ' VAL . 64.2 mt -62.24 -47.98 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.083 0.953 . . . . 0.0 109.139 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 38.4 tt0 -58.07 -50.57 73.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.624 177.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -64.6 -55.45 20.23 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.559 -1.2 . . . . 0.0 111.881 -166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.1 tp -58.57 -35.32 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 124.004 0.815 . . . . 0.0 110.697 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 94.1 mt -69.37 -45.13 70.09 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.78 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 54.6 mt-10 -69.48 -32.78 71.89 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 122.984 0.513 . . . . 0.0 112.165 -176.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.86 -38.62 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.611 0.765 . . . . 0.0 109.667 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 -30.21 62.12 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.305 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 85.2 mt -68.1 -47.56 67.89 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.755 0.822 . . . . 0.0 109.865 177.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.73 -56.7 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.897 -170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.4 t60 71.49 -39.89 0.46 Allowed 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.57 1.548 . . . . 0.0 112.042 -167.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -76.02 152.87 36.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.678 1.191 . . . . 0.0 110.592 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 67.39 -65.29 0.23 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.733 1.613 . . . . 0.0 112.63 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -63.82 92.71 0.07 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.012 0.925 . . . . 0.0 110.872 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -161.63 71.89 0.38 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.525 0.73 . . . . 0.0 109.971 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 . . . . . 0 N--CA 1.484 1.248 0 C-N-CA 124.768 1.227 . . . . 0.0 109.856 -173.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 119.071 -0.49 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.67 80.55 2.01 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.344 2.029 . . . . 0.0 110.96 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 57.1 tptt -72.05 -69.53 0.39 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.673 0.789 . . . . 0.0 109.564 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.1 t -176.54 99.7 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.28 85.05 6.45 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.73 144.98 31.48 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.801 0.44 . . . . 0.0 110.562 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -161.52 149.15 14.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.783 0.833 . . . . 0.0 109.328 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.38 161.0 37.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.355 0.662 . . . . 0.0 110.457 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -158.95 158.09 32.61 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.555 1.142 . . . . 0.0 108.204 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.6 p -141.68 156.96 45.61 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.339 0.656 . . . . 0.0 110.788 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.627 HG22 HD12 ' A' ' 145' ' ' LEU . 20.6 tt -154.74 131.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.749 0.819 . . . . 0.0 109.641 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 56.6 t30 -85.31 98.46 10.54 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.578 HG21 HD21 ' A' ' 152' ' ' LEU . 60.0 mt -82.04 120.21 33.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.451 -177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.1 77.27 1.24 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.371 0.605 . . . . 0.0 110.103 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.0 155.17 9.0 Favored Pre-proline 0 C--O 1.243 0.715 0 C-N-CA 124.586 1.154 . . . . 0.0 109.367 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.65 145.53 97.49 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.548 2.165 . . . . 0.0 112.11 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 78' ' ' ARG . 13.0 tt -57.01 -33.58 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.996 0.918 . . . . 0.0 112.481 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -37.79 81.81 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.424 0.69 . . . . 0.0 110.365 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -65.84 -45.83 80.78 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.482 0.713 . . . . 0.0 110.347 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.29 -47.07 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.119 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -57.99 -37.27 73.94 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.827 1.251 . . . . 0.0 111.433 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.21 -45.1 77.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.352 0.661 . . . . 0.0 111.631 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.4 mm? -74.35 -16.83 60.89 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 122.742 0.417 . . . . 0.0 112.022 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.56 -42.9 63.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 123.425 0.69 . . . . 0.0 111.158 171.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.3 p -98.16 101.63 13.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.156 0.582 . . . . 0.0 112.4 -170.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -158.8 137.92 11.38 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.334 1.053 . . . . 0.0 109.337 168.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -135.6 -11.16 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.37 1.068 . . . . 0.0 110.595 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 p -88.51 -56.44 3.31 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 122.749 0.419 . . . . 0.0 111.736 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 64.9 164.42 0.15 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.367 1.067 . . . . 0.0 110.906 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -93.85 -7.34 43.54 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-O 121.125 0.488 . . . . 0.0 110.437 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.99 -73.8 2.57 Favored Glycine 0 C--N 1.352 1.444 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 62.58 -82.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.221 1.408 . . . . 0.0 112.612 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -89.92 -23.99 21.44 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.664 0.786 . . . . 0.0 111.571 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.8 m -151.26 134.41 8.91 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.105 0.562 . . . . 0.0 110.079 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.65 69.53 7.91 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.676 2.251 . . . . 0.0 110.809 172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.4 m -74.19 -17.65 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.299 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.5 t -93.1 109.08 20.55 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.835 0.854 . . . . 0.0 109.263 174.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -71.21 -51.36 25.17 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -163.68 113.44 1.29 Allowed 'General case' 0 C--N 1.344 0.34 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.52 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.1 t -124.68 133.07 53.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.184 0.593 . . . . 0.0 109.53 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -104.04 117.63 34.73 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -67.33 132.05 46.94 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 123.781 0.676 . . . . 0.0 109.887 -173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.53 -24.56 67.86 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.724 1.21 . . . . 0.0 112.076 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.48 -26.28 65.13 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.542 1.137 . . . . 0.0 111.91 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.64 -35.7 61.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.078 0.951 . . . . 0.0 110.98 174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -105.32 -29.13 10.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.917 0.887 . . . . 0.0 110.743 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.12 130.77 3.93 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.093 -1.393 . . . . 0.0 110.837 -168.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.02 80.07 0.69 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.06 2.507 . . . . 0.0 112.387 -177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.46 172.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 125.169 1.388 . . . . 0.0 109.224 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.4 t -60.24 102.55 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 123.194 0.598 . . . . 0.0 110.907 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.39 -2.48 20.42 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.492 -0.616 . . . . 0.0 113.81 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.56 129.13 38.82 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 117.451 0.625 . . . . 0.0 110.22 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -100.33 123.46 44.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.373 0.669 . . . . 0.0 111.065 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.695 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 0.6 OUTLIER -100.39 102.46 13.69 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.7 m -102.13 111.38 23.63 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.28 107.24 0.65 Allowed Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.91 114.87 26.74 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -92.97 143.36 26.31 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.084 0.954 . . . . 0.0 110.292 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -134.16 111.31 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.945 0.898 . . . . 0.0 109.179 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.5 p -120.02 153.6 55.25 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 168.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -68.43 -4.78 13.59 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.577 2.185 . . . . 0.0 113.471 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -99.66 -47.13 5.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.608 0.763 . . . . 0.0 111.029 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -146.21 133.7 20.84 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.323 0.649 . . . . 0.0 111.058 -172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -114.62 124.86 52.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 108.813 176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -144.42 141.6 29.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 0.0 109.831 -174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -108.19 136.21 48.23 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.85 0.86 . . . . 0.0 109.516 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 p -124.52 130.29 52.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.522 0.729 . . . . 0.0 109.315 175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -117.41 120.77 39.16 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 14.3 m -116.51 165.88 12.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.318 1.047 . . . . 0.0 109.788 -172.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -148.98 142.24 25.07 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.879 0.472 . . . . 0.0 110.09 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 44.3 t -75.46 122.56 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 122.903 0.481 . . . . 0.0 110.243 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 92' ' ' ILE . 16.9 pt -96.14 -26.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.862 0.865 . . . . 0.0 111.692 -177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.44 120.79 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.834 0.854 . . . . 0.0 108.868 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.06 105.89 3.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.341 0.591 . . . . 0.0 111.673 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -91.04 143.98 29.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.429 1.092 . . . . 0.0 108.268 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.81 88.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.829 3.019 . . . . 0.0 113.468 -171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 65.83 -1.93 0.99 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.926 1.69 . . . . 0.0 112.975 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HA ' HD11 ' A' ' 17' ' ' ILE . 0.5 OUTLIER -86.33 -38.98 16.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.246 1.018 . . . . 0.0 109.057 -171.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 49.0 t -150.97 129.41 12.1 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.41 127.19 50.9 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 123.975 0.91 . . . . 0.0 108.608 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.67 119.76 1.11 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -122.98 175.33 6.65 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.201 1.0 . . . . 0.0 109.754 -175.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.3 p -140.08 119.0 12.55 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.97 116.62 24.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 123.997 0.919 . . . . 0.0 109.526 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.1 m 69.74 159.66 0.19 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.88 1.272 . . . . 0.0 110.461 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -60.1 88.92 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 124.2 1.0 . . . . 0.0 112.132 -173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.5 31.46 76.65 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.755 -0.657 . . . . 0.0 113.777 175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -95.02 -77.96 0.46 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.251 0.62 . . . . 0.0 110.205 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 t -108.11 132.74 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.28 135.56 54.21 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -129.36 104.95 7.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.92 . . . . 0.0 108.701 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.492 HD11 HD11 ' A' ' 72' ' ' ILE . 2.5 mp -108.3 111.95 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -105.17 105.2 15.13 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.2 t -96.07 127.7 42.31 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.507 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.9 mpt? -108.39 121.14 44.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -95.05 99.1 3.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.51 110.42 2.86 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.664 2.242 . . . . 0.0 111.84 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.67 164.76 14.14 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.558 0.743 . . . . 0.0 109.64 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -81.47 -19.95 41.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.211 0.604 . . . . 0.0 110.603 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.9 -32.18 25.29 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.062 0.945 . . . . 0.0 110.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.37 -144.01 6.48 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-O 119.925 -0.375 . . . . 0.0 112.175 -174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.1 m -154.03 121.18 5.7 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 109.193 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 21.5 t -87.1 98.46 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.507 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -78.42 120.18 22.79 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.6 m -113.45 107.04 15.3 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.477 1.111 . . . . 0.0 108.13 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 135.1 33.57 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.4 t -135.91 101.68 4.82 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -86.19 132.22 34.06 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.03 120.98 15.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -127.5 97.55 4.91 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 p -59.19 144.03 83.82 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.637 173.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.73 0.76 0.52 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.378 2.719 . . . . 0.0 114.357 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -54.71 -48.02 73.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.801 1.241 . . . . 0.0 110.543 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.22 -43.3 71.87 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.461 178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 129' ' ' GLU . 23.2 mm100 -69.77 -16.24 63.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.462 0.705 . . . . 0.0 112.452 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -66.49 -36.31 82.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.692 0.797 . . . . 0.0 109.849 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -65.68 -48.65 71.36 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.771 0.429 . . . . 0.0 110.039 172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.486 ' HB3' ' HG3' ' A' ' 129' ' ' GLU . 93.2 m-85 -66.4 -23.13 66.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.796 0.438 . . . . 0.0 111.762 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.469 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 55.4 t-80 -83.65 -23.81 31.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.815 0.446 . . . . 0.0 110.896 177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.76 -57.12 3.46 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.61 -50.9 22.16 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.925 0.89 . . . . 0.0 111.083 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -103.65 51.57 0.78 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.69 -34.4 56.21 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.517 -0.765 . . . . 0.0 114.824 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.58 -44.23 44.21 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.993 0.517 . . . . 0.0 110.592 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 128' ' ' GLU . 46.0 tttp -89.59 8.63 30.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.653 0.781 . . . . 0.0 112.071 -171.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 16.3 m -55.48 -24.88 33.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.122 0.969 . . . . 0.0 113.018 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 127' ' ' ILE . 3.6 mp -68.46 -51.95 41.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB2' ' HG2' ' A' ' 125' ' ' LYS . 1.5 mp0 -64.24 -26.96 68.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.68 0.392 . . . . 0.0 111.182 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HG3' ' HB3' ' A' ' 118' ' ' PHE . 26.4 mm-40 -67.44 -47.49 70.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.637 0.375 . . . . 0.0 110.44 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.12 -24.9 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 26.1 mm-40 -66.39 -55.95 13.36 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.26 0.624 . . . . 0.0 110.032 172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -54.76 -34.06 62.08 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.604 0.762 . . . . 0.0 111.634 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -62.89 -62.11 1.94 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.638 0.375 . . . . 0.0 111.491 173.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -65.46 -32.38 73.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.886 0.474 . . . . 0.0 112.039 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 87.4 mt -75.88 -54.88 6.22 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.976 -0.452 . . . . 0.0 110.042 -176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.09 -42.64 99.65 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.049 0.54 . . . . 0.0 111.727 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.33 -52.8 14.54 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.921 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.1 mt -62.97 -23.71 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 118.098 0.408 . . . . 0.0 111.413 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.5 m -80.1 -42.51 23.47 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 122.564 0.346 . . . . 0.0 111.296 170.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.28 -27.8 42.81 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -169.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.9 mt -68.89 -51.82 18.63 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.719 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -55.69 -35.49 93.24 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.186 1.924 . . . . 0.0 111.804 174.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -63.26 -40.68 98.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.099 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 97.9 m -63.96 -43.51 95.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.732 0.813 . . . . 0.0 111.606 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.627 HD12 HG22 ' A' ' 11' ' ' ILE . 4.3 mm? -61.31 -47.52 85.55 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.85 0.46 . . . . 0.0 110.861 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.9 t -69.94 -29.62 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.63 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.39 -45.74 62.04 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.074 0.55 . . . . 0.0 111.118 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.1 mt -58.76 -45.37 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.746 0.818 . . . . 0.0 109.715 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 13' ' ' ILE . 29.7 tt0 -65.06 -57.29 9.03 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 123.807 0.692 . . . . 0.0 110.598 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -53.08 -42.77 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.389 1.076 . . . . 0.0 112.18 -174.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.3 tt -71.6 -38.07 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.773 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 13' ' ' ILE . 4.1 pp -75.88 -30.01 58.69 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-O 119.549 -0.263 . . . . 0.0 111.236 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 48.8 mt-10 -68.3 -39.08 82.17 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 122.98 0.512 . . . . 0.0 110.363 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 159' ' ' HIS . 71.6 t -65.29 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.776 169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -71.21 -26.07 62.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.535 1.134 . . . . 0.0 112.344 -175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 79.2 mt -59.92 -52.37 65.72 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.457 0.703 . . . . 0.0 109.955 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -88.79 -14.94 35.85 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.299 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 60.06 68.05 0.81 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.5 1.52 . . . . 0.0 109.608 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.513 ' HB3' HG13 ' A' ' 154' ' ' VAL . 49.5 t60 -89.71 50.18 1.85 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.336 1.055 . . . . 0.0 111.591 -166.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 61.56 7.79 2.0 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 124.629 1.172 . . . . 0.0 113.165 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 61.11 11.29 3.36 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.647 1.179 . . . . 0.0 111.697 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -87.48 105.3 17.21 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -178.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.64 -0.695 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.59 146.24 44.27 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 123.587 2.858 . . . . 0.0 113.187 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.4 141.33 54.15 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.703 0.801 . . . . 0.0 110.638 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.6 m -55.48 -39.17 70.08 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.605 1.162 . . . . 0.0 112.195 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt -106.1 67.92 0.75 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.138 0.97 . . . . 0.0 109.963 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 84.8 m -150.03 133.32 16.41 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 113.628 -1.624 . . . . 0.0 107.985 174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.507 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 69.7 t80 -150.27 145.63 26.3 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -135.56 154.3 51.41 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.926 0.89 . . . . 0.0 109.152 177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -149.68 149.35 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.4 p -146.76 140.85 26.16 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.494 0.718 . . . . 0.0 110.21 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 145' ' ' LEU . 14.4 tt -148.48 139.97 17.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 C-N-CA 123.263 0.625 . . . . 0.0 109.379 177.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -79.27 125.52 29.59 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 152' ' ' LEU . 54.0 mt -111.09 119.24 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.55 73.48 2.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.186 0.594 . . . . 0.0 109.566 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.65 151.91 8.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.749 1.22 . . . . 0.0 108.938 -174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.96 144.95 99.69 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.404 2.069 . . . . 0.0 113.405 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.529 HD12 ' HD3' ' A' ' 97' ' ' PRO . 8.8 tt -56.89 -39.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.23 1.012 . . . . 0.0 112.609 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -60.8 -38.38 85.15 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.957 0.903 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -69.02 -40.93 78.36 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.905 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.72 -34.36 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.438 0.695 . . . . 0.0 110.042 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HD1' ' SD ' ' A' ' 95' ' ' MET . 53.5 t80 -68.52 -27.69 66.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.383 1.073 . . . . 0.0 111.06 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.61 -43.78 19.97 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.44 0.696 . . . . 0.0 111.071 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -89.11 -7.06 56.51 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.608 0.763 . . . . 0.0 112.955 -174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.63 -34.95 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 120.815 0.34 . . . . 0.0 110.764 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.7 m -152.65 86.31 1.26 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.329 1.052 . . . . 0.0 108.523 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.64 29.71 6.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.052 0.941 . . . . 0.0 109.573 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 pp -68.57 -2.66 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 124.78 1.232 . . . . 0.0 114.201 -172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.3 m -68.72 84.36 0.3 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.295 1.038 . . . . 0.0 111.764 -170.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -134.86 94.04 3.11 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -88.1 62.63 6.89 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 122.265 1.031 . . . . 0.0 111.374 -169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 35' ' ' PRO . . . 127.76 -45.97 1.11 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.102 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.56 127.55 33.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.373 0.669 . . . . 0.0 110.707 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.0 m95 72.63 -38.43 0.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.4 1.48 . . . . 0.0 112.399 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' VAL . 46.2 m -135.59 99.59 11.63 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 124.535 1.134 . . . . 0.0 109.372 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.51 ' HA ' ' HA2' ' A' ' 31' ' ' GLY . 71.8 Cg_endo -73.19 1.5 6.59 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.949 2.432 . . . . 0.0 113.187 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 34' ' ' SER . 30.1 m -71.61 -21.91 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.499 0.72 . . . . 0.0 111.772 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -92.59 77.59 4.96 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.783 0.833 . . . . 0.0 109.3 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -75.59 -39.73 57.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -150.04 120.9 7.61 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.632 0.773 . . . . 0.0 109.919 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 74.0 m -140.13 113.86 8.76 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.887 1.275 . . . . 0.0 107.75 170.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -103.17 126.79 50.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.648 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 13.6 m95 -85.15 153.27 22.78 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.024 0.93 . . . . 0.0 112.61 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -35.63 79.93 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.431 1.492 . . . . 0.0 110.829 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.648 ' HG2' ' HB3' ' A' ' 42' ' ' TRP . 12.0 pt-20 -56.75 -22.96 39.4 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 124.15 0.98 . . . . 0.0 113.033 -175.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -61.82 -47.65 84.12 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.655 0.782 . . . . 0.0 110.096 173.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 -25.96 40.87 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.314 175.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.18 145.97 15.2 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 118.201 -1.333 . . . . 0.0 111.092 -173.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.5 89.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.973 2.449 . . . . 0.0 113.271 173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.4 m -132.96 140.23 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.089 0.956 . . . . 0.0 110.604 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.62 125.26 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.62 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.96 -13.84 34.34 Favored Glycine 0 N--CA 1.469 0.886 0 CA-C-O 119.99 -0.339 . . . . 0.0 112.823 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.78 160.24 30.84 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.922 0.489 . . . . 0.0 110.067 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 70' ' ' GLU . 29.4 m170 -134.18 132.32 39.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.49 0.316 . . . . 0.0 111.257 -171.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 69' ' ' SER . 99.1 m-85 -84.81 110.99 19.23 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.8 m -92.11 106.93 18.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -127.74 99.6 0.52 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 66' ' ' GLU . 1.4 tmm_? -87.48 104.22 16.26 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -86.22 137.99 32.21 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.785 0.834 . . . . 0.0 109.779 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 2.5 p -131.42 106.29 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.657 0.742 . . . . 0.0 109.372 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 71.7 p -111.11 162.5 20.55 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 173.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 60' ' ' THR . 59.1 Cg_endo -67.76 4.45 1.41 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.566 2.177 . . . . 0.0 113.803 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.74 -48.1 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.042 0.937 . . . . 0.0 111.61 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -129.33 116.27 18.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.46 0.704 . . . . 0.0 111.09 -167.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.8 p -107.32 120.41 42.08 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -162.43 136.91 6.65 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.999 0.52 . . . . 0.0 109.798 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 37.4 tt0 -89.46 134.38 34.13 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.032 0.533 . . . . 0.0 110.038 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -116.09 115.5 26.19 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -102.31 100.53 10.71 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.2 m -88.39 119.41 28.79 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.601 0.76 . . . . 0.0 110.171 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 53' ' ' HIS . 51.9 mt-10 -96.4 116.88 29.76 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.605 1.162 . . . . 0.0 109.657 -177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.4 t -72.12 100.72 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.433 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 pt -82.43 -20.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.395 0.678 . . . . 0.0 112.067 -175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.12 135.87 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.204 1.002 . . . . 0.0 108.718 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -143.23 107.25 4.7 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.689 0.796 . . . . 0.0 109.773 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -117.43 112.17 39.49 Favored Pre-proline 0 C--O 1.241 0.643 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 175.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -57.99 -17.84 32.83 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.493 2.795 . . . . 0.0 114.615 -164.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -158.46 69.06 0.49 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.387 0.675 . . . . 0.0 109.326 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -169.31 -49.95 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.618 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 51.3 t -163.17 151.03 13.4 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.821 0.448 . . . . 0.0 110.258 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.94 112.83 5.74 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.87 132.22 8.83 Favored Glycine 0 C--O 1.24 0.497 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -137.37 131.41 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.336 1.054 . . . . 0.0 109.488 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 72.8 p -103.06 132.55 49.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.432 0.693 . . . . 0.0 109.388 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.9 t -73.31 111.03 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.1 m 70.86 162.79 0.25 Allowed 'General case' 0 CA--C 1.562 1.415 0 O-C-N 124.953 1.408 . . . . 0.0 110.183 -169.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -48.18 -39.68 21.64 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.279 1.032 . . . . 0.0 112.08 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.99 87.74 0.11 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.215 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -140.45 -75.09 0.34 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.66 154.26 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 86.9 tttt -138.86 134.33 33.18 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.501 0.72 . . . . 0.0 109.459 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -131.54 133.76 45.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.215 1.006 . . . . 0.0 108.76 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 41.5 mm -130.03 111.52 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -106.12 99.54 9.12 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -100.23 147.57 25.59 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.027 0.931 . . . . 0.0 109.472 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.411 ' SD ' ' HD1' ' A' ' 21' ' ' TYR . 17.9 ptp -148.7 112.25 5.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -107.26 113.85 61.69 Favored Pre-proline 0 C--O 1.241 0.641 0 C-N-CA 123.596 0.758 . . . . 0.0 110.064 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.529 ' HD3' HD12 ' A' ' 17' ' ' ILE . 95.1 Cg_endo -77.3 91.69 1.16 Allowed 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.573 2.182 . . . . 0.0 111.657 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 73.0 mt -76.68 173.81 11.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.479 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -79.88 -14.1 58.89 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.859 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -102.8 -10.19 19.33 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.038 0.935 . . . . 0.0 111.627 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.02 -140.4 6.64 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.9 m -146.7 116.99 7.4 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.988 0.915 . . . . 0.0 108.677 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.96 107.92 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.16 135.65 37.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.3 m -138.54 105.63 5.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.081 0.953 . . . . 0.0 108.534 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -91.39 142.11 28.03 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 176.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.526 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 32.8 t -139.98 107.03 5.44 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -93.89 141.65 28.28 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.888 0.875 . . . . 0.0 110.358 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 46.3 mt-10 -138.08 149.66 46.17 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.382 1.073 . . . . 0.0 108.952 169.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -124.17 130.09 51.94 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 166.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.571 HG23 ' H ' ' A' ' 114' ' ' GLY . 8.9 t -71.8 137.23 82.65 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.46 -17.59 60.72 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.778 2.318 . . . . 0.0 112.316 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -60.84 -43.76 97.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.316 0.646 . . . . 0.0 110.904 175.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.571 ' H ' HG23 ' A' ' 111' ' ' THR . . . -73.02 -19.21 79.51 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.546 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.2 tm0? -63.64 -33.64 76.07 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.633 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -67.16 -24.17 65.86 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.078 0.551 . . . . 0.0 111.629 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -69.15 -43.41 74.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.526 0.73 . . . . 0.0 110.318 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -72.44 -29.38 63.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.064 0.546 . . . . 0.0 110.513 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -76.48 -21.55 55.68 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.512 0.725 . . . . 0.0 110.378 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.16 -51.17 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.325 0.65 . . . . 0.0 110.373 175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -78.41 -57.14 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.165 0.586 . . . . 0.0 111.665 -174.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.61 -38.79 15.62 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.784 -174.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.59 -94.9 0.17 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.778 0.673 . . . . 0.0 113.241 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.37 -44.77 93.83 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.578 0.751 . . . . 0.0 110.175 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.58 -4.0 46.58 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.039 -0.982 . . . . 0.0 112.215 -173.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.6 t -57.83 -21.82 44.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.394 1.077 . . . . 0.0 112.504 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mp -56.01 -42.4 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.483 1.113 . . . . 0.0 110.32 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 43.2 mt-10 -58.78 -45.06 90.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.406 0.683 . . . . 0.0 111.425 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -69.52 -41.21 76.32 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.906 0.883 . . . . 0.0 112.172 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -72.87 -34.44 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -64.9 -45.07 87.47 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.892 0.477 . . . . 0.0 110.007 170.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 19.6 ttmm -60.71 -45.73 93.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.917 1.287 . . . . 0.0 111.088 -173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 51.9 mtt180 -72.09 -38.09 69.44 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.164 0.915 . . . . 0.0 111.789 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.494 ' O ' HG12 ' A' ' 138' ' ' ILE . 35.4 ttp180 -64.26 -51.25 64.49 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.54 -32.73 74.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.679 1.192 . . . . 0.0 111.256 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -30.3 71.29 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.332 0.653 . . . . 0.0 110.753 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.12 -45.94 25.2 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.451 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 134' ' ' ARG . 51.4 mm -62.72 -32.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 C-N-CA 124.051 0.94 . . . . 0.0 111.489 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 67.6 p -97.51 -50.8 4.37 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 0.0 111.366 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.05 -46.63 70.98 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.692 -0.685 . . . . 0.0 114.661 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.415 ' O ' HD23 ' A' ' 145' ' ' LEU . 71.9 mt -62.48 -56.73 27.47 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.832 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.507 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 38.0 Cg_endo -62.39 -29.84 79.81 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.946 1.764 . . . . 0.0 112.444 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.88 -39.06 90.3 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.922 0.889 . . . . 0.0 110.938 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 92.4 m -68.42 -41.79 79.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.237 0.615 . . . . 0.0 110.424 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 11' ' ' ILE . 4.2 mm? -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.547 0.739 . . . . 0.0 111.437 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.5 t -70.36 -34.35 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.386 0.674 . . . . 0.0 110.775 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.64 -51.05 68.79 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.312 0.645 . . . . 0.0 111.479 -178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 67.3 mt -61.77 -43.13 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 123.943 0.777 . . . . 0.0 110.027 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -59.2 -55.05 39.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.023 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -67.06 -37.74 84.56 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.715 0.806 . . . . 0.0 111.684 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.1 tt -70.36 -29.51 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 122.543 0.337 . . . . 0.0 110.465 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 13' ' ' ILE . 59.3 mt -78.72 -30.19 45.78 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.045 0.538 . . . . 0.0 111.62 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.64 -36.32 83.34 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.449 0.3 . . . . 0.0 110.312 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -40.44 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.211 172.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -57.28 -38.3 73.71 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.896 0.878 . . . . 0.0 111.511 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.82 -27.12 31.11 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.534 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -98.23 -75.15 0.56 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.338 0.655 . . . . 0.0 110.778 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 29.4 m80 64.3 -179.91 0.17 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.963 1.305 . . . . 0.0 111.942 -172.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -65.71 125.21 24.56 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -67.07 -54.82 17.93 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 118.95 -0.548 . . . . 0.0 111.076 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 18.6 p80 57.75 -62.24 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 127.309 2.244 . . . . 0.0 115.273 173.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -72.66 7.67 1.81 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 57.7 t60 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.293 -0.861 . . . . 0.0 108.988 179.639 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.56 113.61 1.69 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.489 2.126 . . . . 0.0 111.419 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -80.71 -176.27 5.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.753 0.821 . . . . 0.0 110.438 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.6 t -143.08 -54.0 0.39 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 88.8 mt -142.23 117.73 10.3 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.128 0.971 . . . . 0.0 108.946 177.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -163.06 132.7 4.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -141.23 147.97 39.14 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.28 169.38 17.75 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.371 0.668 . . . . 0.0 110.469 -176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -166.85 159.9 14.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -142.76 143.28 32.15 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.386 0.674 . . . . 0.0 110.569 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 145' ' ' LEU . 12.7 tt -152.27 144.86 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.437 0.695 . . . . 0.0 109.408 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -93.86 116.99 29.49 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.534 HG21 HD12 ' A' ' 152' ' ' LEU . 3.7 mp -95.26 130.85 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.08 80.96 1.74 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.98 152.95 5.45 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.791 1.237 . . . . 0.0 108.845 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 19' ' ' GLN . 47.6 Cg_endo -66.62 152.43 80.71 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.138 1.892 . . . . 0.0 112.353 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.3 tt -57.18 -35.93 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.713 0.805 . . . . 0.0 111.357 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -60.65 -42.46 97.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.046 0.938 . . . . 0.0 110.485 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 16' ' ' PRO . 5.7 tp-100 -65.13 -50.09 67.37 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.613 178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 24' ' ' VAL . 59.7 t -64.6 -35.25 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.444 0.697 . . . . 0.0 110.736 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -65.12 -29.92 70.81 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.858 0.863 . . . . 0.0 110.635 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.0 53.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.228 0.611 . . . . 0.0 110.452 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 4.3 mm? -72.5 -22.48 61.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 20' ' ' VAL . 33.0 m -78.37 -10.77 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.5 t -134.57 29.77 3.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.905 0.882 . . . . 0.0 108.941 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.619 ' HB2' ' HA ' ' A' ' 23' ' ' LEU . 24.2 t0 -78.12 79.33 4.58 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-O 122.343 1.068 . . . . 0.0 110.982 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.3 pt -119.66 -8.4 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.443 171.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.1 p -76.57 -26.3 54.93 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 111.776 -172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -86.74 55.72 3.69 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.493 0.663 . . . . 0.0 110.815 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m 62.34 21.16 12.34 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.179 1.392 . . . . 0.0 111.819 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.91 -79.23 0.26 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 -173.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -148.88 31.3 0.78 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.77 0.828 . . . . 0.0 109.912 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 76.7 m95 61.12 23.83 13.99 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.502 1.121 . . . . 0.0 111.794 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.7 m -117.21 143.36 31.68 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.807 0.843 . . . . 0.0 110.11 -174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -79.42 11.84 2.54 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.649 2.233 . . . . 0.0 112.987 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.68 -33.64 57.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.634 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 20.1 p -82.88 88.46 6.8 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.529 ' HB2' HG12 ' A' ' 59' ' ' VAL . 38.6 tt0 -60.65 -54.35 46.41 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.262 1.025 . . . . 0.0 110.667 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -132.2 113.89 13.81 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.773 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 37' ' ' CYS . 71.1 m -113.03 109.98 19.73 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 169.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 53.7 t90 -103.82 117.46 34.39 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.9 m-90 -104.6 111.91 24.78 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.683 0.793 . . . . 0.0 110.363 -171.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.07 -15.84 60.6 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.68 0.792 . . . . 0.0 110.764 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.519 ' HG2' ' HG3' ' A' ' 48' ' ' PRO . 4.7 tm-20 -52.37 -37.04 55.32 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.034 1.334 . . . . 0.0 110.914 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -57.51 -45.07 85.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.405 1.082 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.65 -43.9 62.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.944 0.498 . . . . 0.0 110.503 173.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.82 130.04 1.49 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.72 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG3' ' HG2' ' A' ' 44' ' ' GLU . 3.0 Cg_exo -73.79 83.86 1.52 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.803 2.336 . . . . 0.0 110.28 173.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.3 m -113.06 173.4 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.268 1.027 . . . . 0.0 110.882 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.8 t -68.77 90.46 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 171.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.65 63.4 0.34 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -168.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' O ' HG23 ' A' ' 71' ' ' VAL . . . -140.15 110.74 6.75 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.14 0.976 . . . . 0.0 109.128 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 6.0 p80 -108.66 121.29 44.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.243 0.617 . . . . 0.0 111.88 -172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -102.98 130.25 50.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.662 1.185 . . . . 0.0 108.284 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 86.7 m -115.88 111.54 20.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.96 0.504 . . . . 0.0 110.434 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.15 101.6 1.62 Allowed Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.808 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -85.19 119.38 25.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.372 1.069 . . . . 0.0 109.867 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -105.05 122.77 46.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 38' ' ' GLU . 13.4 p -114.64 134.49 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.093 0.557 . . . . 0.0 109.787 173.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.1 p -143.54 156.33 60.15 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 169.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -63.79 -14.29 42.07 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.392 2.061 . . . . 0.0 112.311 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -86.96 -63.27 1.33 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.358 1.063 . . . . 0.0 109.893 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -122.31 139.31 53.95 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 121.433 0.635 . . . . 0.0 111.781 -171.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m -116.8 109.58 17.29 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -138.46 154.56 48.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.459 0.704 . . . . 0.0 109.689 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -137.97 141.81 40.49 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.609 0.764 . . . . 0.0 109.044 177.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.1 p -121.91 114.67 21.33 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.386 1.074 . . . . 0.0 108.167 176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -105.7 95.78 6.05 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.949 0.881 . . . . 0.0 108.948 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.5 p -89.01 143.41 26.87 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.033 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 53' ' ' HIS . 0.6 OUTLIER -133.15 130.27 38.97 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -178.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.56 HG22 ' HB3' ' A' ' 82' ' ' TRP . 86.3 t -80.35 103.48 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.834 0.854 . . . . 0.0 110.467 -174.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG13 HG12 ' A' ' 73' ' ' VAL . 29.2 pt -74.49 -22.89 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.017 -177.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 72' ' ' ILE . 5.8 p -155.29 133.07 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.005 0.922 . . . . 0.0 109.37 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -145.16 106.54 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.179 0.514 . . . . 0.0 110.027 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 29.2 mm-40 -105.57 106.91 58.0 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.6 -4.71 10.17 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 123.125 2.55 . . . . 0.0 114.554 -164.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -140.83 23.66 2.24 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.825 0.85 . . . . 0.0 110.848 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -151.69 -54.86 0.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 77.3 m -151.53 158.98 44.3 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.186 0.595 . . . . 0.0 111.516 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -148.24 104.18 3.51 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.829 0.852 . . . . 0.0 108.953 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.92 125.61 6.05 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 123.328 0.49 . . . . 0.0 112.293 -175.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.56 ' HB3' HG22 ' A' ' 71' ' ' VAL . 20.0 p-90 -142.02 146.03 35.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.945 0.898 . . . . 0.0 110.699 -175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.7 p -109.69 127.11 54.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.616 0.767 . . . . 0.0 110.491 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 51.4 t -75.09 122.47 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.783 0.833 . . . . 0.0 109.783 177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m 54.11 69.08 0.76 Allowed 'General case' 0 CA--C 1.548 0.903 0 O-C-N 124.568 1.167 . . . . 0.0 111.476 175.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.5 t70 64.67 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.918 1.287 . . . . 0.0 111.466 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.9 38.2 0.92 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -75.9 -51.32 12.73 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.138 0.575 . . . . 0.0 109.523 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.7 t -137.42 154.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.986 1.314 . . . . 0.0 108.097 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -133.13 141.21 48.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -130.45 127.79 39.97 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.347 1.059 . . . . 0.0 108.309 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 29.4 mm -122.81 110.77 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HD1' HD11 ' A' ' 104' ' ' LEU . 86.2 m-85 -106.81 102.97 12.3 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.7 t -96.95 124.61 40.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -112.78 117.67 32.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.306 0.642 . . . . 0.0 110.168 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -96.24 104.23 16.56 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 123.929 0.892 . . . . 0.0 109.439 -177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.34 101.91 0.9 Allowed 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.173 1.915 . . . . 0.0 112.1 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -90.52 163.21 14.7 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.315 0.578 . . . . 0.0 109.95 172.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -75.57 -16.8 60.21 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.755 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.28 -17.79 14.19 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.191 0.996 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.74 -140.61 5.24 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.645 -0.531 . . . . 0.0 112.322 -175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 20' ' ' VAL . 64.4 m -153.98 124.97 7.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.486 0.714 . . . . 0.0 110.042 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 51.2 t -88.09 104.15 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.417 HD11 ' HD1' ' A' ' 93' ' ' TYR . 2.3 tm? -84.97 110.99 19.29 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.1 m -95.49 107.83 20.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.294 1.038 . . . . 0.0 108.867 169.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.78 142.36 27.74 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 51.3 m -141.84 103.09 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.57 0.748 . . . . 0.0 109.242 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -86.51 129.32 34.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.89 143.61 50.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 92.3 t80 -124.94 99.47 6.15 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 172.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.2 t -65.9 141.95 97.85 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.705 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.94 -13.69 24.12 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.046 2.497 . . . . 0.0 113.36 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.42 -49.4 75.63 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.703 0.801 . . . . 0.0 110.773 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.57 -35.09 90.74 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.717 0.636 . . . . 0.0 112.761 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -65.79 -48.97 69.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.273 0.629 . . . . 0.0 110.66 175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -62.33 -37.46 85.7 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 110.915 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -62.24 -56.08 22.08 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.885 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.2 -29.86 70.71 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.038 0.211 . . . . 0.0 110.567 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -66.6 -34.87 78.85 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.514 0.726 . . . . 0.0 110.663 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.27 -27.5 63.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.324 0.65 . . . . 0.0 110.738 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -46.57 13.6 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.151 0.581 . . . . 0.0 110.055 173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 62.7 m-85 -148.15 95.37 2.46 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.773 1.229 . . . . 0.0 108.311 -167.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.49 -70.84 0.83 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.693 1.037 . . . . 0.0 115.693 -172.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.558 ' HA ' HD13 ' A' ' 127' ' ' ILE . 10.3 m-20 -74.64 -21.94 59.17 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.222 0.609 . . . . 0.0 111.471 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 75.3 mmtt -72.32 -18.72 61.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.957 0.503 . . . . 0.0 111.517 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.3 t -68.53 -28.85 67.35 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.965 0.506 . . . . 0.0 110.427 172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.558 HD13 ' HA ' ' A' ' 124' ' ' ASP . 2.0 mp -69.95 -39.32 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.601 0.76 . . . . 0.0 109.55 175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.23 -34.56 75.02 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.992 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 22.2 mm-40 -65.26 -55.51 17.99 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.056 0.543 . . . . 0.0 110.724 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.72 -23.44 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 123.583 0.552 . . . . 0.0 111.436 -176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.49 -53.19 55.98 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.784 0.678 . . . . 0.0 109.808 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -68.55 -28.34 66.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.665 0.786 . . . . 0.0 112.086 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 13.2 mmt85 -69.46 -42.04 75.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -64.99 -49.7 69.21 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.285 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 139' ' ' THR . 95.0 mt -63.27 -51.84 64.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.57 0.748 . . . . 0.0 110.586 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -22.25 65.13 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.846 0.716 . . . . 0.0 112.105 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.71 -50.55 8.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.918 0.487 . . . . 0.0 111.207 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -68.53 -37.58 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 122.282 0.233 . . . . 0.0 111.0 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 135' ' ' LEU . 5.4 t -84.72 -28.88 26.0 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.149 0.179 . . . . 0.0 110.523 176.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.87 -60.26 2.32 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.699 -0.501 . . . . 0.0 113.935 -171.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.8 mt -54.85 -53.68 58.16 Favored Pre-proline 0 N--CA 1.486 1.353 0 C-N-CA 124.182 0.993 . . . . 0.0 113.369 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.88 -36.59 82.87 Favored 'Trans proline' 0 C--N 1.385 2.496 0 CA-C-N 121.609 1.61 . . . . 0.0 112.047 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.98 -38.98 87.04 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.181 0.593 . . . . 0.0 110.421 175.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.489 ' O ' HG13 ' A' ' 148' ' ' ILE . 87.1 m -62.79 -41.63 99.35 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.445 0.698 . . . . 0.0 110.798 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.624 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -64.49 -44.81 89.83 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.791 0.436 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.08 -34.21 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.466 0.479 . . . . 0.0 110.224 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.03 -26.27 48.32 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.715 0.806 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 144' ' ' THR . 95.6 mt -68.73 -37.01 76.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -71.75 -48.75 44.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.726 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -68.26 -35.76 78.39 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.432 0.693 . . . . 0.0 112.312 -170.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.7 tt -64.57 -38.31 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.534 HD12 HG21 ' A' ' 13' ' ' ILE . 54.1 mt -76.51 -34.82 58.59 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 123.969 0.793 . . . . 0.0 111.215 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 48.1 mt-10 -64.68 -44.84 89.03 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.167 0.292 . . . . 0.0 110.351 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.77 -36.95 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.111 0.565 . . . . 0.0 110.458 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.446 0.699 . . . . 0.0 110.757 178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.1 mt -80.2 -28.93 38.58 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.495 0.718 . . . . 0.0 110.38 174.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 20.9 mm-40 -71.09 -17.08 62.6 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.15 0.58 . . . . 0.0 110.753 171.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -81.11 66.04 6.49 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.545 0.738 . . . . 0.0 109.733 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -73.95 -21.71 59.92 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -85.39 24.33 1.18 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.665 0.786 . . . . 0.0 111.324 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -72.41 79.4 1.03 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 0.0 110.271 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -97.8 164.93 12.18 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.248 176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.645 -0.693 . . . . 0.0 109.654 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.4 mtp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -65.06 140.65 66.57 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.697 2.264 . . . . 0.0 111.805 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -144.13 -171.1 3.49 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.251 1.02 . . . . 0.0 109.227 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m 70.19 156.03 0.14 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.536 1.134 . . . . 0.0 112.611 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.689 HD21 ' HB ' ' A' ' 130' ' ' ILE . 3.9 mm? -87.48 42.84 1.06 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.871 0.868 . . . . 0.0 109.858 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.7 m -148.52 132.04 16.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.196 0.998 . . . . 0.0 109.474 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' HB2' HG12 ' A' ' 138' ' ' ILE . 59.1 t80 -161.73 154.04 19.75 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.255 1.022 . . . . 0.0 108.986 173.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.59 144.02 39.62 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.552 0.741 . . . . 0.0 109.291 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -151.18 160.28 43.94 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -154.87 152.35 29.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.529 0.732 . . . . 0.0 110.847 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -156.86 144.64 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.741 0.651 . . . . 0.0 110.049 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -96.22 105.8 17.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -87.41 151.94 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.865 0 C-N-CA 124.43 1.092 . . . . 0.0 109.311 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.96 40.62 1.19 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.343 0.657 . . . . 0.0 109.993 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 62.69 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.06 0.944 . . . . 0.0 109.664 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.63 162.51 17.94 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.724 2.283 . . . . 0.0 113.462 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.419 HG13 ' ND2' ' A' ' 77' ' ' ASN . 10.4 tp -56.12 -39.1 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.902 -170.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.0 p-10 -69.56 -38.28 77.37 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.109 0.964 . . . . 0.0 111.301 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -70.23 -37.41 74.98 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.045 0.538 . . . . 0.0 110.736 -177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.625 HG21 ' HB ' ' A' ' 102' ' ' THR . 73.9 t -64.15 -44.54 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.076 175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.495 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 90.4 t80 -59.34 -41.08 88.32 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.058 0.943 . . . . 0.0 111.392 176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.92 85.63 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.637 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.452 HD23 HD21 ' A' ' 152' ' ' LEU . 4.6 mm? -91.4 -8.88 46.67 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.521 0.728 . . . . 0.0 112.29 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -72.05 -48.11 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.398 0.679 . . . . 0.0 109.175 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.7 t -145.09 122.4 11.57 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -92.85 19.08 8.03 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.192 0.997 . . . . 0.0 111.009 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 tp -49.42 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.346 0 C-N-CA 125.5 1.52 . . . . 0.0 111.354 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 t 60.41 12.3 3.4 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 127.342 2.257 . . . . 0.0 112.688 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD3' HG23 ' A' ' 30' ' ' THR . 3.6 tmt_? -83.69 -51.42 7.27 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.583 1.153 . . . . 0.0 109.216 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.418 HG23 ' HD3' ' A' ' 29' ' ' ARG . 22.2 p -111.73 94.77 5.12 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.531 0.732 . . . . 0.0 109.547 173.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 35' ' ' PRO . . . -120.89 68.52 0.41 Allowed Glycine 0 C--N 1.34 0.759 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 168.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -72.04 -86.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.981 0.913 . . . . 0.0 112.032 -167.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -122.22 -59.15 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -174.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 p -118.52 90.99 40.64 Favored Pre-proline 0 C--O 1.244 0.805 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 170.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HB3' ' HA2' ' A' ' 31' ' ' GLY . 90.0 Cg_endo -77.94 170.88 18.17 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.145 1.897 . . . . 0.0 111.906 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 58' ' ' ASN . 36.0 m -89.16 27.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.953 173.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 72.6 m -143.41 117.05 9.21 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.177 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 13.8 tp10 -81.99 -57.48 3.39 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.674 0.789 . . . . 0.0 109.344 172.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -139.04 111.97 7.88 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 83.5 m -143.91 113.02 6.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.09 0.556 . . . . 0.0 109.892 -173.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -104.67 125.63 50.96 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.88 131.06 38.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 35.3 t70 -70.7 -20.7 62.64 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.261 0.624 . . . . 0.0 111.323 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -59.38 -31.56 69.33 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.04 0.936 . . . . 0.0 111.374 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.74 -42.82 84.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.249 1.02 . . . . 0.0 111.12 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.2 -27.33 15.58 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.439 0.696 . . . . 0.0 111.929 -177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.04 109.26 1.86 Allowed Glycine 0 C--N 1.348 1.234 0 CA-C-O 118.75 -1.028 . . . . 0.0 112.262 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -68.7 99.31 0.63 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.161 2.574 . . . . 0.0 111.55 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG22 ' HB2' ' A' ' 52' ' ' ALA . 34.5 m -121.36 172.1 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.933 0.893 . . . . 0.0 109.934 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.02 113.76 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 12.83 26.56 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 112.035 -0.426 . . . . 0.0 112.035 -175.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' HB2' HG22 ' A' ' 49' ' ' VAL . . . -90.88 172.21 8.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.498 0.719 . . . . 0.0 110.657 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -156.43 123.72 5.36 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.875 0.47 . . . . 0.0 111.719 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.627 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 15.5 p90 -103.26 128.92 50.14 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 168.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.9 m -106.62 112.16 25.03 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.544 0.737 . . . . 0.0 109.372 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.33 113.53 2.94 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.642 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.605 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 19.3 ttm180 -91.5 107.26 19.08 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 19.7 m120 -85.42 119.21 25.53 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.509 0.505 . . . . 0.0 110.224 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 14.5 p -112.05 126.23 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 44.3 p -144.55 161.49 43.65 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 125.297 1.439 . . . . 0.0 107.322 173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -61.1 -22.49 74.84 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.552 2.168 . . . . 0.0 112.02 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.54 -58.0 3.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.11 0.964 . . . . 0.0 110.58 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -134.62 148.94 50.51 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.689 0.796 . . . . 0.0 110.948 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 m -136.58 109.18 7.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -152.71 145.05 23.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.484 0.714 . . . . 0.0 109.826 -174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 40.1 tt0 -106.96 125.21 50.71 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.196 0.599 . . . . 0.0 110.498 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.0 p -119.18 132.34 55.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.189 0.996 . . . . 0.0 109.811 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.45 ' H ' ' HD2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -102.07 130.36 48.64 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 168.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -113.51 124.68 52.97 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.929 0.891 . . . . 0.0 108.753 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.4 111.5 23.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.64 1.176 . . . . 0.0 109.164 -170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.76 98.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 110.958 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.9 pt -79.03 -27.79 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.855 -178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.54 129.92 9.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.93 104.31 7.29 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.405 0.682 . . . . 0.0 110.669 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 41.3 mt-10 -121.83 118.77 29.28 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 166.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -60.12 104.43 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.265 2.643 . . . . 0.0 112.23 -171.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 21' ' ' TYR . 2.4 t-20 63.67 29.51 15.01 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.278 1.031 . . . . 0.0 110.729 176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.18 -57.08 1.32 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 81.3 m -146.72 97.48 2.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -111.05 105.16 13.82 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.81 142.46 14.28 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.16 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -135.47 176.7 8.44 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.07 0.948 . . . . 0.0 110.866 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.7 t -130.11 119.5 23.14 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.035 0.934 . . . . 0.0 109.066 176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 52.3 t -75.76 140.62 17.03 Favored 'Isoleucine or valine' 0 C--O 1.253 1.251 0 C-N-CA 123.587 0.755 . . . . 0.0 109.509 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.3 m 70.62 -88.03 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.02 0 O-C-N 125.03 1.456 . . . . 0.0 108.878 -167.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.0 t70 172.94 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.073 1.349 . . . . 0.0 107.594 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.67 44.78 97.02 Favored Glycine 0 C--N 1.34 0.804 0 O-C-N 123.535 0.522 . . . . 0.0 112.659 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -126.47 -63.84 1.06 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 79.4 t -114.45 145.75 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 176.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.11 140.63 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.51 0.724 . . . . 0.0 110.402 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -128.11 118.54 23.61 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.527 1.131 . . . . 0.0 108.488 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.1 mm -108.97 114.11 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.3 102.98 12.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.233 0.539 . . . . 0.0 109.855 174.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.4 m -94.92 134.61 37.39 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.209 1.004 . . . . 0.0 108.295 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.8 ptp -140.74 114.66 9.03 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.194 0.998 . . . . 0.0 108.512 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -118.39 119.02 33.45 Favored Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.605 -175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.81 148.89 36.84 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.536 2.158 . . . . 0.0 111.215 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -134.97 -176.96 4.42 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.31 1.444 . . . . 0.0 108.564 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.54 -34.23 69.85 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.772 0.429 . . . . 0.0 110.162 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.11 -48.75 72.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.169 0.988 . . . . 0.0 110.421 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.16 -103.81 0.18 Allowed Glycine 0 C--N 1.342 0.876 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.095 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.625 ' HB ' HG21 ' A' ' 20' ' ' VAL . 53.8 m -155.93 135.13 12.18 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.497 1.119 . . . . 0.0 110.489 177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.7 t -88.31 109.15 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 171.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.25 108.54 20.03 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.4 m -111.47 109.8 19.93 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.302 1.041 . . . . 0.0 109.278 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.43 157.2 17.32 Favored 'General case' 0 C--O 1.251 1.147 0 CA-C-O 121.39 0.614 . . . . 0.0 109.839 176.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.9 t -143.83 110.26 5.49 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.79 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.417 ' HH2' ' HA ' ' A' ' 134' ' ' ARG . 27.1 t90 -83.96 133.29 34.7 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.872 0.869 . . . . 0.0 108.853 169.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -154.09 148.23 25.8 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.914 0.486 . . . . 0.0 110.301 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -92.75 151.56 19.97 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.206 1.003 . . . . 0.0 109.593 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.2 m -87.8 130.34 47.17 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.19 0.996 . . . . 0.0 110.194 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.23 144.36 98.78 Favored 'Trans proline' 0 C--N 1.384 2.428 0 C-N-CA 123.284 2.656 . . . . 0.0 112.064 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 78.53 -23.46 0.24 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.47 1.508 . . . . 0.0 112.011 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 117' ' ' PHE . . . -61.75 -16.62 51.99 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.636 0.636 . . . . 0.0 113.805 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -60.96 -30.11 70.05 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.848 0.859 . . . . 0.0 112.507 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -72.38 -20.67 61.41 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.76 0.424 . . . . 0.0 110.562 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 61.1 t80 -51.06 -45.21 61.29 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.09 0.956 . . . . 0.0 110.374 170.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 126' ' ' SER . 97.4 m-85 -66.92 -41.88 86.3 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.038 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -58.58 -44.54 89.83 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.974 0.91 . . . . 0.0 111.157 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.67 -38.99 70.57 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.857 0.863 . . . . 0.0 111.495 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -74.04 -59.51 2.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.143 0.577 . . . . 0.0 111.443 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.467 ' HB2' ' OG ' ' A' ' 126' ' ' SER . 78.7 m-85 -128.85 -59.92 1.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.39 -64.52 4.0 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.272 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -46.21 -52.15 12.95 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.849 1.659 . . . . 0.0 112.516 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -118.27 22.08 12.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.695 0.798 . . . . 0.0 111.099 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . 70.2 m -86.22 -19.45 29.99 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.659 0.383 . . . . 0.0 110.837 167.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.4 -40.42 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.03 0.532 . . . . 0.0 110.337 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -66.34 -33.53 75.94 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -64.98 -49.11 71.54 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.906 0.882 . . . . 0.0 111.091 -175.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.689 ' HB ' HD21 ' A' ' 5' ' ' LEU . 34.8 pt -66.74 -32.91 60.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 O-C-N 123.666 0.604 . . . . 0.0 111.246 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 45.6 mt-10 -73.32 -52.66 13.09 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.09 0.556 . . . . 0.0 110.443 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -51.82 -46.29 64.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.156 1.382 . . . . 0.0 111.797 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -73.07 -39.87 65.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.571 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 131' ' ' GLU . 29.3 ptt180 -67.03 -39.16 86.92 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.4 mt -73.71 -41.21 62.88 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.773 0.829 . . . . 0.0 110.238 -175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.35 75.64 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.198 0.599 . . . . 0.0 110.717 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -70.39 -51.14 31.9 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.77 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.505 HG12 ' HB2' ' A' ' 7' ' ' PHE . 86.5 mt -64.51 -25.93 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 123.644 0.778 . . . . 0.0 111.123 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 86.5 m -75.82 -40.69 54.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.925 0.49 . . . . 0.0 110.528 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.19 -39.99 43.01 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.937 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -59.93 -51.87 77.61 Favored Pre-proline 0 CA--C 1.565 1.532 0 C-N-CA 123.987 0.915 . . . . 0.0 112.906 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.1 -37.07 78.21 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 121.789 1.659 . . . . 0.0 111.898 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -69.43 -31.88 70.49 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.634 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' ILE . 60.0 m -69.16 -43.3 74.56 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.883 0.873 . . . . 0.0 110.205 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -58.5 -47.31 84.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.335 0.654 . . . . 0.0 110.779 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.81 -30.09 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.821 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.31 -34.7 68.31 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.793 0.437 . . . . 0.0 111.168 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 144' ' ' THR . 78.7 mt -67.62 -44.02 86.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.732 0.813 . . . . 0.0 108.886 177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.509 ' O ' ' HG2' ' A' ' 153' ' ' GLU . 35.5 tt0 -61.0 -60.83 3.16 Favored 'General case' 0 C--O 1.215 -0.745 0 O-C-N 123.56 0.538 . . . . 0.0 110.076 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 20.8 ttp85 -54.52 -44.57 72.89 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.095 1.358 . . . . 0.0 112.533 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.98 -35.77 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 123.061 0.226 . . . . 0.0 110.459 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.493 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 44.3 mt -69.04 -49.2 59.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 149' ' ' GLN . 15.7 mm-40 -58.11 -47.24 83.88 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.58 1.152 . . . . 0.0 111.345 -177.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.42 -38.8 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.593 0.757 . . . . 0.0 110.952 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.523 ' HB3' ' HD2' ' A' ' 161' ' ' HIS . 18.3 mm-40 -69.31 -30.62 68.73 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.265 0.626 . . . . 0.0 111.747 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 69.5 mt -81.35 -18.51 45.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.744 0.818 . . . . 0.0 110.376 177.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.49 -31.34 26.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.57 0.748 . . . . 0.0 109.744 170.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -72.76 132.08 43.16 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.869 0.868 . . . . 0.0 109.896 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -73.42 -10.18 59.47 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.339 0.656 . . . . 0.0 111.379 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -126.38 123.63 38.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.975 0.91 . . . . 0.0 109.692 172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.523 ' HD2' ' HB3' ' A' ' 155' ' ' GLU . 11.3 t-160 -87.5 108.61 19.11 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.068 0.947 . . . . 0.0 109.647 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -81.43 -50.64 9.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.805 0.842 . . . . 0.0 110.142 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.385 -177.897 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.0 99.94 1.35 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.47 2.113 . . . . 0.0 111.748 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.55 -33.64 76.12 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.514 0.726 . . . . 0.0 110.13 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.518 ' HB2' ' HG3' ' A' ' 112' ' ' PRO . 28.9 t -124.27 150.38 45.42 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.525 1.13 . . . . 0.0 108.558 172.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.49 116.75 19.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 0.0 109.088 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -122.94 149.04 44.78 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.069 0.948 . . . . 0.0 109.191 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 54.1 t80 -149.78 147.59 28.19 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -147.34 168.09 22.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.004 0.522 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -162.99 156.3 19.62 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.9 m -145.17 145.98 31.57 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.446 0.698 . . . . 0.0 110.749 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 145' ' ' LEU . 18.4 tt -151.21 137.54 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.183 0.593 . . . . 0.0 109.61 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 47.9 t30 -83.63 136.07 34.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' HA3' ' A' ' 101' ' ' GLY . 26.4 mt -123.69 143.3 37.33 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.72 4.75 8.88 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.435 0.694 . . . . 0.0 112.538 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.65 147.27 37.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 123.938 0.895 . . . . 0.0 110.157 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.18 156.36 63.4 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.647 2.232 . . . . 0.0 112.094 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.5 tt -56.71 -38.69 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.7 -38.27 88.76 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.092 0.557 . . . . 0.0 111.038 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.6 tp-100 -69.5 -40.35 77.06 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.308 0.643 . . . . 0.0 110.388 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.79 -39.22 79.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.073 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.88 -44.67 76.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.047 0.939 . . . . 0.0 109.687 -176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.98 77.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.891 0.877 . . . . 0.0 111.196 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -60.21 -43.85 95.63 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.414 0.686 . . . . 0.0 109.225 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.9 t -74.99 -34.71 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 124.409 1.083 . . . . 0.0 111.738 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -79.96 4.24 17.49 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.261 0.625 . . . . 0.0 111.756 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.58 91.06 1.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 169.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 pt -104.24 -42.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.296 1.038 . . . . 0.0 110.902 -176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.5 p -127.1 73.1 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.265 1.026 . . . . 0.0 109.677 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -81.35 79.75 7.91 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.266 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p 48.23 71.6 0.34 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.265 1.426 . . . . 0.0 112.36 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -118.46 71.06 0.31 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.303 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -92.29 -109.79 0.1 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.191 0.596 . . . . 0.0 109.436 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -91.1 73.38 6.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.962 0.887 . . . . 0.0 109.656 -170.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -101.49 169.66 7.45 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.174 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -64.37 -16.72 56.62 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.153 1.902 . . . . 0.0 113.168 167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.57 -14.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.48 0.712 . . . . 0.0 112.616 -176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.4 p -156.86 165.7 35.47 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.999 0.52 . . . . 0.0 111.329 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -119.44 -44.77 2.55 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.089 1.355 . . . . 0.0 109.641 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -171.87 137.43 0.98 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.903 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.12 144.95 43.47 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.605 0.762 . . . . 0.0 110.717 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -129.72 115.25 17.04 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.184 -1.414 . . . . 0.0 107.184 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -124.13 117.63 25.08 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.303 0.641 . . . . 0.0 109.729 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 28.7 m-20 -69.38 -10.14 56.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.754 0.421 . . . . 0.0 111.0 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' HG2' ' HB3' ' A' ' 48' ' ' PRO . 5.3 tm-20 -58.72 -30.73 67.68 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.988 1.315 . . . . 0.0 110.391 170.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.52 -41.44 94.39 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.59 0.756 . . . . 0.0 110.788 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -69.24 -43.68 73.52 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.809 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.56 128.36 1.08 Allowed Glycine 0 C--N 1.338 0.673 0 CA-C-O 118.594 -1.114 . . . . 0.0 110.98 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HB3' ' HG2' ' A' ' 44' ' ' GLU . 43.7 Cg_endo -66.72 86.05 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.316 2.011 . . . . 0.0 110.744 173.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -114.6 165.18 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.931 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.9 t -68.07 101.59 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 126.02 -1.51 7.83 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.151 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 43' ' ' ASP . . . -64.27 108.44 1.59 Allowed 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.123 0.462 . . . . 0.0 110.922 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -83.77 141.98 31.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.953 0.501 . . . . 0.0 110.0 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 80' ' ' PHE . 17.2 m-85 -113.5 102.33 10.19 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 171.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.6 m -112.85 106.82 15.22 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.19 113.45 1.63 Allowed Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 55.5 ttt-85 -75.13 123.69 25.68 Favored 'General case' 0 C--O 1.219 -0.539 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -84.46 113.88 21.52 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -102.84 127.84 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.0 m -153.76 143.49 15.23 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.85 -24.53 10.4 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.098 2.532 . . . . 0.0 114.481 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -92.87 -39.5 11.14 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.867 0.467 . . . . 0.0 112.205 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 3.6 mmp_? -134.21 138.49 45.13 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.326 0.584 . . . . 0.0 112.299 -169.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.7 p -137.85 104.99 5.43 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.554 1.142 . . . . 0.0 108.374 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t-105 -161.59 144.76 12.35 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.995 0.918 . . . . 0.0 109.206 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp0 -84.29 134.28 34.52 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.103 0.561 . . . . 0.0 109.826 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 79.2 p -100.27 113.14 25.61 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -118.42 98.39 6.24 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.652 0.781 . . . . 0.0 109.208 -168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.8 m -100.7 167.73 10.13 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.696 0.798 . . . . 0.0 109.728 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -145.69 135.06 23.05 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.63 0.772 . . . . 0.0 109.143 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG11 ' HB2' ' A' ' 74' ' ' ALA . 65.2 t -72.07 117.52 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.976 0.51 . . . . 0.0 110.111 175.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.5 pt -88.45 -23.29 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.531 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.9 p -155.39 130.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.721 0.809 . . . . 0.0 109.603 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -147.2 107.67 4.1 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.182 0.593 . . . . 0.0 110.254 175.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -108.88 121.2 43.75 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -52.92 -27.49 35.47 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 124.005 3.137 . . . . 0.0 114.887 -164.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -147.7 62.15 1.14 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.576 0.703 . . . . 0.0 109.424 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -159.55 -49.72 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.622 176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.24 158.21 26.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.052 0.453 . . . . 0.0 110.961 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.444 ' HZ ' ' HZ ' ' A' ' 54' ' ' PHE . 71.9 t80 -145.45 120.31 9.94 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.72 128.05 4.13 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.427 ' HE1' ' HE2' ' A' ' 93' ' ' TYR . 5.5 p-90 -134.51 133.0 39.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.561 0.745 . . . . 0.0 109.446 -174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.635 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 55.2 p -98.13 120.2 38.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.65 0.78 . . . . 0.0 110.256 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 41.2 t -81.24 140.7 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.391 1.076 . . . . 0.0 110.579 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 16.8 m 60.15 68.01 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.421 1.088 . . . . 0.0 109.869 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.2 t70 64.63 -75.78 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.729 1.612 . . . . 0.0 110.6 -173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.635 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -154.72 19.47 0.59 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.767 -0.463 . . . . 0.0 113.528 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.11 -56.92 6.24 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.59 0.71 . . . . 0.0 110.78 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 48.1 t -100.78 150.91 5.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 108' ' ' TRP . 96.5 mttt -132.17 138.42 48.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.449 0.7 . . . . 0.0 109.489 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -130.65 103.85 6.86 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.33 112.65 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.084 0.553 . . . . 0.0 109.545 -172.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.427 ' HE2' ' HE1' ' A' ' 82' ' ' TRP . 9.9 m-85 -106.64 105.44 15.48 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.065 0.946 . . . . 0.0 109.236 -176.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -93.22 134.88 34.95 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.649 0.78 . . . . 0.0 109.589 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -112.3 122.73 48.55 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.963 0.905 . . . . 0.0 109.151 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 37.6 mt-10 -106.21 95.87 12.19 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.571 0.748 . . . . 0.0 109.069 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.77 106.01 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.728 2.285 . . . . 0.0 112.712 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.2 mt -88.52 172.89 9.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.285 170.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -80.78 -30.44 35.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.836 0.35 . . . . 0.0 110.356 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -80.42 -27.73 37.96 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.435 0.694 . . . . 0.0 111.398 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 13' ' ' ILE . . . 179.17 -135.31 2.52 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.305 -176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 92.1 m -154.24 134.9 13.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.693 0.797 . . . . 0.0 110.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 59.9 t -87.92 106.69 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -80.91 129.86 34.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 84.9 m -126.53 109.12 11.8 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 124.063 0.945 . . . . 0.0 109.032 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -88.22 140.12 29.81 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.0 m -139.97 103.93 4.74 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.579 0.752 . . . . 0.0 109.02 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 90' ' ' LYS . 78.0 t90 -97.58 134.38 40.87 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.43 1.092 . . . . 0.0 109.914 178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.26 126.31 26.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.611 0.764 . . . . 0.0 109.375 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -106.91 96.11 6.2 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.4 t -64.19 153.58 85.19 Favored Pre-proline 0 CA--C 1.564 1.509 0 C-N-CA 125.071 1.348 . . . . 0.0 112.024 -169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 4' ' ' SER . 24.3 Cg_exo -62.09 84.06 0.1 OUTLIER 'Trans proline' 0 C--N 1.391 2.781 0 C-N-CA 123.186 2.591 . . . . 0.0 112.417 175.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -164.27 -59.21 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.82 0.848 . . . . 0.0 109.977 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.19 -30.16 77.02 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.681 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 112' ' ' PRO . 14.9 mp0 -64.4 -45.99 85.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -68.17 -31.94 71.84 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.684 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.91 -48.76 67.68 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -62.49 -40.33 96.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.378 0.671 . . . . 0.0 110.305 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -65.0 -40.11 94.46 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.039 0.935 . . . . 0.0 111.147 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.2 -35.31 75.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.246 1.018 . . . . 0.0 110.95 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -82.78 -59.04 2.63 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.906 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -148.53 99.98 3.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.729 1.212 . . . . 0.0 108.593 -171.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.9 93.75 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.528 0.571 . . . . 0.0 114.528 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -70.41 -38.98 74.7 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 117.025 0.412 . . . . 0.0 110.802 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.32 -29.17 65.82 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.464 0.706 . . . . 0.0 110.593 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.4 t -61.46 -40.06 93.15 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.101 0.56 . . . . 0.0 110.917 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.9 mt -61.42 -40.43 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 124.177 0.923 . . . . 0.0 110.252 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.87 -58.85 5.98 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.425 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -56.49 -43.92 80.17 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.655 0.782 . . . . 0.0 112.897 -172.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 pt -67.45 -36.11 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 122.074 0.15 . . . . 0.0 111.167 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 40.8 tt0 -75.45 -54.64 6.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.058 0.543 . . . . 0.0 110.609 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.74 -46.93 71.04 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 125.272 1.429 . . . . 0.0 111.969 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -75.08 -28.64 60.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.421 0.688 . . . . 0.0 111.397 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -63.98 -48.52 76.11 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 84.6 mt -63.18 -40.97 99.05 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.305 1.042 . . . . 0.0 110.861 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.37 -31.92 73.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.777 0.831 . . . . 0.0 111.271 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -75.1 -44.64 46.16 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.98 0.512 . . . . 0.0 110.719 175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.23 -32.75 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.257 0.623 . . . . 0.0 111.547 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 33.5 m -90.22 -39.69 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.265 0.626 . . . . 0.0 111.303 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.69 -50.55 9.11 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.925 -0.58 . . . . 0.0 114.125 -170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.02 -49.33 93.86 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 117.986 -1.007 . . . . 0.0 113.022 -174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 24.9 Cg_endo -58.23 -38.4 91.2 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 121.874 1.716 . . . . 0.0 112.372 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -68.37 -33.7 74.73 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.987 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 90.4 m -64.89 -40.91 95.84 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.951 0.5 . . . . 0.0 110.502 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 11' ' ' ILE . 4.5 mm? -61.46 -48.02 83.04 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.166 0.587 . . . . 0.0 110.794 176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 89.5 t -65.67 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.927 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.66 -40.76 66.1 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.649 0.779 . . . . 0.0 111.082 -179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.31 -47.18 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.51 0.724 . . . . 0.0 109.363 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 25.4 tm0? -58.46 -45.91 87.65 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.226 1.01 . . . . 0.0 110.758 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -65.5 -54.04 33.86 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.461 1.104 . . . . 0.0 111.323 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.9 tp -61.85 -36.2 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 124.072 0.857 . . . . 0.0 110.241 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 19' ' ' GLN . 44.3 mt -61.47 -52.9 62.63 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 123.333 0.653 . . . . 0.0 110.873 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 51.7 mt-10 -53.49 -45.66 69.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.672 0.607 . . . . 0.0 112.068 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' A' ' 162' ' ' HIS . 43.5 t -69.76 -39.23 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.803 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -77.61 -13.27 59.95 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.828 0.851 . . . . 0.0 112.906 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 59.5 mt -78.53 -23.22 46.33 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.95 0.341 . . . . 0.0 110.559 174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.93 -157.92 0.82 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.647 0.779 . . . . 0.0 109.762 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.6 t60 70.9 -5.29 1.52 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.164 1.386 . . . . 0.0 112.24 170.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 55.04 58.88 4.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.438 1.095 . . . . 0.0 110.535 -169.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 62.99 -140.64 0.38 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.743 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 30.8 t60 81.2 -52.27 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.929 1.692 . . . . 0.0 110.471 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.462 ' HA ' HG11 ' A' ' 154' ' ' VAL . 36.2 p-80 47.4 52.49 12.2 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.04 1.736 . . . . 0.0 113.684 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 . . . . . 0 CA--C 1.557 1.212 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.89 175.179 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.36 -9.75 21.87 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.566 2.178 . . . . 0.0 112.289 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -155.62 -165.97 2.11 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.87 1.268 . . . . 0.0 108.574 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -155.37 -55.31 0.09 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.706 0.402 . . . . 0.0 110.433 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 84.1 mt -114.47 91.25 3.56 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.827 0.451 . . . . 0.0 110.759 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 80.4 p -137.68 134.08 35.0 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -139.34 153.79 47.77 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.83 159.11 43.66 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.529 0.732 . . . . 0.0 109.758 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -163.08 157.84 21.24 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.4 p -142.78 155.94 44.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.51 0.724 . . . . 0.0 110.531 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 145' ' ' LEU . 16.0 tt -158.04 142.21 7.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 123.538 0.735 . . . . 0.0 109.075 175.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -92.37 117.19 29.66 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 149' ' ' GLN . 50.1 mt -97.22 137.0 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.613 1.165 . . . . 0.0 108.64 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.15 51.18 2.17 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.18 145.66 19.82 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 124.136 0.974 . . . . 0.0 109.381 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HG2' ' HG3' ' A' ' 19' ' ' GLN . 19.8 Cg_endo -57.68 155.85 30.04 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 123.237 2.624 . . . . 0.0 113.37 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.69 -27.23 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.083 0.953 . . . . 0.0 112.484 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -59.54 -49.49 77.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.493 0.717 . . . . 0.0 110.657 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' HG3' ' HG2' ' A' ' 16' ' ' PRO . 39.4 mt-30 -64.61 -43.44 93.76 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.92 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.499 HG21 ' HB ' ' A' ' 102' ' ' THR . 88.2 t -60.25 -46.99 94.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.342 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -62.63 -41.02 98.78 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.352 1.061 . . . . 0.0 111.448 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.36 98.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.639 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.75 -9.36 59.64 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 53.8 t -70.9 -46.85 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 165.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -165.16 109.21 0.87 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.479 0.712 . . . . 0.0 110.481 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -117.4 7.09 12.71 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.989 0.916 . . . . 0.0 112.018 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -71.27 3.91 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -60.95 100.18 0.11 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.6 0.76 . . . . 0.0 109.61 168.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 63.66 93.44 0.06 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.048 1.339 . . . . 0.0 110.64 -175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.4 t -144.98 154.28 42.39 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.487 0.715 . . . . 0.0 109.613 177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.49 128.69 5.06 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 112.084 -0.407 . . . . 0.0 112.084 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.52 -74.89 0.64 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.691 0.796 . . . . 0.0 109.718 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -100.43 -53.09 3.19 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.836 0.855 . . . . 0.0 109.88 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.5 t -151.27 102.78 2.95 Favored Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.378 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -85.71 170.24 8.94 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.646 2.231 . . . . 0.0 113.0 175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.9 p -74.76 -30.53 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.161 168.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 69.3 m -72.95 102.04 3.36 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 123.991 0.916 . . . . 0.0 109.753 176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -60.63 -46.9 88.56 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.098 0.559 . . . . 0.0 110.891 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -162.7 136.96 6.4 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.686 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 19.6 p -138.65 110.63 7.25 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.463 0.705 . . . . 0.0 109.692 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 99.0 m95 -104.75 130.31 52.85 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -120.93 134.91 55.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.751 0.82 . . . . 0.0 109.532 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -82.5 -3.58 56.11 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.977 0.511 . . . . 0.0 110.61 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.01 -28.84 59.03 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.573 1.149 . . . . 0.0 111.805 176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.777 0.831 . . . . 0.0 111.365 177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.61 -30.9 21.45 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.99 0.516 . . . . 0.0 111.451 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 158.73 110.3 0.28 Allowed Glycine 0 C--N 1.343 0.945 0 CA-C-O 119.018 -0.879 . . . . 0.0 111.692 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.43 94.57 0.84 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.323 2.015 . . . . 0.0 110.462 174.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.35 -173.63 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.572 1.149 . . . . 0.0 109.801 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 73' ' ' VAL . 59.2 t -76.09 129.13 37.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 171.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.66 5.35 63.13 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.352 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.11 88.14 2.43 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-O 121.28 0.562 . . . . 0.0 110.146 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -77.93 130.35 36.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.316 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 33.9 p90 -137.52 154.03 49.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.19 0.996 . . . . 0.0 109.405 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.6 m -137.61 126.92 24.71 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.806 0.442 . . . . 0.0 110.215 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.67 100.97 0.89 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 42.7 ttm180 -85.26 116.59 23.7 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.555 0.742 . . . . 0.0 109.42 169.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -108.29 143.9 36.52 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.58 111.51 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.485 0.66 . . . . 0.0 109.96 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 74.4 p -105.98 158.77 31.7 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 169.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.71 -14.31 44.09 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 122.253 1.969 . . . . 0.0 112.011 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -87.24 -44.99 11.03 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.705 1.202 . . . . 0.0 110.741 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 ttm-85 -158.11 132.58 8.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.883 0.473 . . . . 0.0 110.777 -172.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.3 m -96.48 131.78 42.72 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 167.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -149.24 136.83 20.28 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.8 pt-20 -117.2 142.53 46.91 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.776 0.83 . . . . 0.0 109.692 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 p -124.18 115.24 20.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.51 0.724 . . . . 0.0 109.063 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -96.64 108.52 21.15 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.6 m -113.74 159.8 19.35 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.443 -176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.64 125.14 31.42 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 74' ' ' ALA . 42.1 t -65.95 106.08 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 pt -88.1 -12.12 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.654 0.782 . . . . 0.0 111.758 -176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' HA ' HG22 ' A' ' 50' ' ' VAL . 7.5 p -159.81 124.27 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.76 0.824 . . . . 0.0 109.453 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -131.5 105.9 7.87 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.49 0.716 . . . . 0.0 109.969 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -124.96 113.26 26.73 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.97 111.45 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.911 2.407 . . . . 0.0 112.41 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 63.49 31.9 14.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.577 1.151 . . . . 0.0 111.704 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -128.77 -58.38 1.16 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.592 0.757 . . . . 0.0 109.093 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 40.5 t -163.63 143.89 8.65 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.458 0.703 . . . . 0.0 110.012 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -135.05 108.81 8.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.8 139.03 10.64 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.926 -176.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 45.1 p90 -136.03 169.84 16.97 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.34 1.056 . . . . 0.0 109.167 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 56.6 p -126.42 117.61 23.28 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.687 0.395 . . . . 0.0 110.175 174.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.2 t -75.67 144.49 11.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 125.093 1.357 . . . . 0.0 110.339 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 19.0 m 61.19 66.6 0.87 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.771 1.229 . . . . 0.0 109.344 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.32 -75.61 0.06 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.45 1.5 . . . . 0.0 110.738 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -160.13 37.08 0.45 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.166 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 89' ' ' VAL . 17.9 t30 -88.09 -44.63 10.8 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.343 0.657 . . . . 0.0 111.379 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 HD22 ' A' ' 88' ' ' ASN . 59.7 t -122.43 120.55 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.056 0.542 . . . . 0.0 110.176 -177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 94.6 mttt -97.41 137.2 36.74 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.137 0.575 . . . . 0.0 110.518 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -126.57 105.0 8.43 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.3 mm -109.02 110.47 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.36 100.33 10.8 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.5 m -95.1 128.01 41.6 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.602 1.161 . . . . 0.0 109.118 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 58.0 mtt -121.71 130.96 53.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.541 0.737 . . . . 0.0 110.654 -169.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 24.7 mm-40 -113.26 91.94 20.9 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.227 1.011 . . . . 0.0 108.978 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 105.1 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.129 1.886 . . . . 0.0 111.177 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.0 177.39 4.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.302 0.641 . . . . 0.0 110.633 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -73.56 -31.58 63.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.727 0.811 . . . . 0.0 110.894 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -79.17 -29.68 43.1 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.961 0.904 . . . . 0.0 111.301 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.86 -123.85 1.08 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.498 -0.612 . . . . 0.0 111.883 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.499 ' HB ' HG21 ' A' ' 20' ' ' VAL . 95.2 m -153.76 130.37 10.72 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.835 0.854 . . . . 0.0 110.098 178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 52.0 t -87.8 104.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 175.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 HD13 ' A' ' 145' ' ' LEU . 2.8 tm? -80.82 133.31 35.59 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -136.08 106.19 6.33 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -90.42 139.86 30.28 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.8 m -136.99 104.15 5.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -88.58 131.41 34.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.46 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.8 mt-10 -125.17 145.26 50.04 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 36.0 t80 -126.69 115.12 18.95 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.3 p -72.01 155.95 91.35 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.597 0.759 . . . . 0.0 111.134 -177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.701 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 73.7 Cg_endo -70.47 6.96 1.33 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.811 2.341 . . . . 0.0 114.038 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -68.51 -64.93 0.77 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.75 -31.01 70.23 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.645 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.701 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 24.6 tp60 -63.46 -43.22 97.99 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.044 0.937 . . . . 0.0 110.524 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.8 -42.93 73.07 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.633 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -44.92 -55.58 5.34 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.452 1.101 . . . . 0.0 113.191 -171.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -65.49 -40.99 93.73 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.37 0.419 . . . . 0.0 111.066 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -69.51 -36.23 76.25 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.503 0.721 . . . . 0.0 111.533 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.39 -35.79 30.34 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.895 0.878 . . . . 0.0 110.07 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -86.67 -65.13 1.05 Allowed 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.154 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -81.78 -68.2 0.72 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.298 0.639 . . . . 0.0 109.82 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.49 -65.04 3.93 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.385 -0.371 . . . . 0.0 112.517 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.7 -50.46 73.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.088 0.955 . . . . 0.0 110.615 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -80.34 -21.54 42.38 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.338 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.5 t -54.59 -25.68 27.84 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.01 -39.55 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.939 0.774 . . . . 0.0 110.13 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.531 ' O ' ' HE2' ' A' ' 132' ' ' LYS . 37.6 mm-40 -61.0 -55.95 26.8 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.86 0.464 . . . . 0.0 110.757 174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -56.93 -45.82 82.46 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 123.307 0.379 . . . . 0.0 111.668 -175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.44 -33.89 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 123.151 0.282 . . . . 0.0 110.99 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.58 -62.27 1.46 Allowed 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.228 0.33 . . . . 0.0 110.225 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 128' ' ' GLU . 1.5 mppt? -63.22 -27.99 69.73 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.854 0.862 . . . . 0.0 112.95 -170.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -83.02 -37.39 24.02 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 117.907 0.321 . . . . 0.0 111.573 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.418 ' O ' HG13 ' A' ' 138' ' ' ILE . 42.9 ttp180 -60.46 -46.02 91.59 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 0.0 109.825 173.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.93 -37.82 79.14 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.566 1.146 . . . . 0.0 110.471 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.54 72.5 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.248 0.619 . . . . 0.0 111.3 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.16 -47.02 53.97 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.048 0.539 . . . . 0.0 110.355 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 134' ' ' ARG . 69.7 mt -63.39 -26.94 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.818 0.847 . . . . 0.0 110.894 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 68.2 m -81.74 -52.48 7.1 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.509 0.724 . . . . 0.0 110.282 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.23 -50.68 43.53 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.543 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.4 ' O ' HD23 ' A' ' 145' ' ' LEU . 62.2 mt -58.39 -57.65 24.8 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.236 -0.887 . . . . 0.0 112.235 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -62.37 -32.62 81.21 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 121.947 1.765 . . . . 0.0 112.451 -176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -67.71 -38.63 83.87 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.045 0.538 . . . . 0.0 111.017 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.409 ' O ' HG13 ' A' ' 148' ' ' ILE . 85.5 m -66.55 -40.58 89.13 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.505 0.722 . . . . 0.0 110.549 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.529 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -57.41 -52.57 64.83 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.425 0.69 . . . . 0.0 110.952 176.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.38 -34.4 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.42 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.45 92.63 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.212 0.605 . . . . 0.0 111.695 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 144' ' ' THR . 81.5 mt -63.39 -38.62 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.091 0.556 . . . . 0.0 109.911 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 13' ' ' ILE . 57.2 tt0 -67.09 -46.0 75.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.205 174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 154' ' ' VAL . 16.8 tpt180 -65.86 -49.59 67.57 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.036 -165.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.22 -33.24 52.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 123.944 0.898 . . . . 0.0 110.773 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 55.5 mt -70.07 -42.85 72.27 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.279 0.632 . . . . 0.0 110.784 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 44.9 mt-10 -60.64 -46.59 89.74 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.151 0.581 . . . . 0.0 110.45 178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' ARG . 64.6 t -61.24 -35.76 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.824 178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.03 -36.23 59.17 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.294 0.638 . . . . 0.0 111.366 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 91.0 mt -72.37 -32.19 66.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.978 0.511 . . . . 0.0 111.005 -177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -92.31 -65.8 0.97 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.494 0.718 . . . . 0.0 110.29 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.4 m170 61.37 169.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.349 1.06 . . . . 0.0 111.565 -170.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -93.1 93.71 8.45 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 167.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.7 t60 69.94 120.99 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.349 1.46 . . . . 0.0 109.778 -165.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -65.62 78.98 0.07 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.307 1.043 . . . . 0.0 111.061 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 175.25 39.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.98 1.712 . . . . 0.0 109.278 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 32.2 t60 . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.234 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 118.676 -0.678 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 37.9 Cg_endo -63.78 83.17 0.14 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.905 2.403 . . . . 0.0 112.094 176.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -111.92 100.26 8.76 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.1 t 67.9 135.56 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.653 1.581 . . . . 0.0 111.793 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.4 mt -90.64 51.07 1.92 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.502 0.721 . . . . 0.0 109.64 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 108' ' ' TRP . 71.2 p -127.77 134.69 49.5 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.634 0.774 . . . . 0.0 109.24 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.433 ' HD2' HD12 ' A' ' 141' ' ' ILE . 55.7 t80 -156.75 151.82 26.21 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.44 169.43 20.89 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.44 0.696 . . . . 0.0 109.947 176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -158.61 147.08 18.52 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 171.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.2 p -124.36 155.23 39.12 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.49 0.716 . . . . 0.0 110.172 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.5 HG22 HD12 ' A' ' 145' ' ' LEU . 16.5 tt -149.53 136.34 12.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.152 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -81.43 114.5 20.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mt -106.77 135.68 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.73 39.25 0.91 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.57 0.748 . . . . 0.0 110.984 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -136.41 145.8 53.23 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.062 0.945 . . . . 0.0 109.857 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.542 ' HD2' HE21 ' A' ' 19' ' ' GLN . 33.5 Cg_endo -60.98 153.01 67.01 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.857 2.371 . . . . 0.0 113.064 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -61.62 -25.41 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.876 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -55.5 -43.58 75.76 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.569 0.748 . . . . 0.0 111.537 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.542 HE21 ' HD2' ' A' ' 16' ' ' PRO . 40.4 mt-30 -71.21 -49.64 41.33 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.805 0.442 . . . . 0.0 110.693 176.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.8 t -59.52 -43.88 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.102 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -68.53 -32.6 72.67 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.62 1.168 . . . . 0.0 110.763 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.45 95.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.079 0.552 . . . . 0.0 110.874 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.86 -33.42 73.76 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.357 0.663 . . . . 0.0 110.894 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.04 -35.4 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.587 0.755 . . . . 0.0 111.113 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -75.5 84.69 2.58 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.041 0.536 . . . . 0.0 110.278 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' O ' HG12 ' A' ' 27' ' ' ILE . 35.8 t70 -81.37 154.93 26.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.917 0.887 . . . . 0.0 110.401 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 26' ' ' ASP . 3.6 pt 68.9 -23.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 C-N-CA 127.753 2.421 . . . . 0.0 113.516 -174.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . 76.4 p -75.18 125.43 28.94 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.141 0.576 . . . . 0.0 110.745 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 73.6 mtt-85 76.5 -37.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.905 1.682 . . . . 0.0 112.092 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.7 p -78.23 83.31 4.49 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.378 0.671 . . . . 0.0 110.193 176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 160.7 153.42 6.96 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 72.66 148.0 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.051 1.34 . . . . 0.0 111.249 -175.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 91.4 m95 74.09 -60.86 0.51 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.675 1.59 . . . . 0.0 109.278 -168.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.0 m -90.69 116.17 65.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.029 0.932 . . . . 0.0 108.819 171.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.45 56.38 4.49 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.594 2.863 . . . . 0.0 113.384 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.89 -31.48 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.794 0.838 . . . . 0.0 109.542 174.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 24.3 p -133.42 142.33 48.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 171.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -71.82 -51.91 20.12 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.549 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.0 mmpt? -132.43 147.9 52.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.307 0.643 . . . . 0.0 110.213 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 99.3 m -148.99 112.11 4.91 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.935 0.894 . . . . 0.0 109.438 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -100.98 118.66 37.43 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HA ' ' A' ' 28' ' ' THR . 6.0 m0 -97.23 126.34 42.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.195 0.598 . . . . 0.0 110.231 -171.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 54' ' ' PHE . 6.3 t70 -64.59 -30.59 71.62 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.851 0.86 . . . . 0.0 112.091 -170.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.06 -45.99 92.5 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 123.83 0.706 . . . . 0.0 109.133 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.26 -35.17 71.29 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.881 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.92 -28.54 68.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.109 0.563 . . . . 0.0 110.789 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.27 94.48 2.36 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.81 92.88 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.766 2.31 . . . . 0.0 112.109 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.4 m -125.95 166.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.415 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.87 97.73 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.04 6.18 6.48 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.891 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.3 172.67 9.69 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.442 0.697 . . . . 0.0 110.377 174.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -153.52 124.63 7.42 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.07 0.548 . . . . 0.0 111.084 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.609 ' HB3' ' HB2' ' A' ' 43' ' ' ASP . 9.0 p90 -96.86 120.28 36.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 167.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -114.66 112.8 23.44 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.637 0.775 . . . . 0.0 109.296 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -118.81 117.37 3.65 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -176.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 38.5 ttm180 -83.05 101.95 11.47 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 172.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -85.76 130.18 34.63 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.54 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -131.94 108.97 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.953 0.882 . . . . 0.0 109.455 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.8 p -101.83 165.94 13.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.577 1.151 . . . . 0.0 108.707 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.3 7.63 0.83 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.743 2.295 . . . . 0.0 114.168 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -128.46 -37.75 1.79 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.036 0.935 . . . . 0.0 111.519 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -126.89 153.33 45.89 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 124.106 0.962 . . . . 0.0 110.112 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.9 m -148.99 112.15 4.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.933 0.893 . . . . 0.0 108.98 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -163.63 159.37 21.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.526 0.73 . . . . 0.0 109.815 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 20.2 pt-20 -110.72 132.83 53.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.34 0.656 . . . . 0.0 110.872 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 p -110.52 116.76 31.95 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.744 0.818 . . . . 0.0 109.413 173.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -80.35 110.79 16.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -99.47 105.66 17.61 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -97.07 116.29 29.01 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.386 1.074 . . . . 0.0 110.152 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 83.9 t -68.81 115.27 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 123.797 0.839 . . . . 0.0 111.412 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.6 pt -92.43 -19.06 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.658 -176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.93 130.19 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.844 0.858 . . . . 0.0 109.081 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.3 104.95 5.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.114 0.566 . . . . 0.0 110.839 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.7 98.73 48.13 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -55.34 110.08 0.5 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.434 2.756 . . . . 0.0 113.388 -167.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.44 37.53 1.98 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.05 1.34 . . . . 0.0 111.364 177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -144.25 -42.52 0.26 Allowed 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 123.677 0.791 . . . . 0.0 110.299 167.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 61.0 m -148.75 135.61 19.86 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -143.59 105.56 4.36 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -121.52 135.79 10.74 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.613 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 24.0 p90 -133.78 -178.07 4.84 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.786 0.834 . . . . 0.0 110.813 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 64.6 p -140.09 118.4 12.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.8 t -77.65 129.27 37.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 86' ' ' ASP . 13.7 m 68.12 177.47 0.25 Allowed 'General case' 0 CA--C 1.561 1.393 0 O-C-N 124.384 1.053 . . . . 0.0 109.876 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 85' ' ' THR . 6.3 m-20 -63.43 82.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.881 0.873 . . . . 0.0 111.704 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 55.13 34.1 58.24 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 124.04 0.829 . . . . 0.0 114.098 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.634 HD22 HG23 ' A' ' 89' ' ' VAL . 12.7 t30 -92.31 -62.78 1.33 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.317 0.647 . . . . 0.0 110.34 -172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.634 HG23 HD22 ' A' ' 88' ' ' ASN . 57.4 t -107.83 141.54 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 172.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 95.3 mttt -131.34 113.59 13.96 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 118.678 0.672 . . . . 0.0 110.278 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HB2' ' NE1' ' A' ' 82' ' ' TRP . 97.2 m95 -106.43 110.32 22.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.936 0.494 . . . . 0.0 110.331 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 74.1 mt -111.55 114.79 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.33 0.652 . . . . 0.0 109.835 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -102.24 104.73 15.3 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -94.82 125.65 39.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.882 0.873 . . . . 0.0 108.911 174.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.478 ' HG3' HD23 ' A' ' 104' ' ' LEU . 1.8 mpt? -112.92 143.26 44.5 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -108.91 92.15 10.21 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 171.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.28 101.2 0.95 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.384 2.056 . . . . 0.0 111.266 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.0 mt -86.16 172.49 10.5 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.733 0.813 . . . . 0.0 110.392 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.05 2.5 34.73 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.559 0.743 . . . . 0.0 111.208 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -132.0 -17.78 2.72 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.074 0.95 . . . . 0.0 111.77 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -177.56 -149.05 7.64 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 95.1 m -154.58 132.51 11.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.918 0.887 . . . . 0.0 110.523 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.7 106.14 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 95' ' ' MET . 2.8 tm? -83.46 139.31 33.02 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.4 m -132.6 106.12 7.62 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.583 0.753 . . . . 0.0 109.106 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.619 ' HB3' HD21 ' A' ' 145' ' ' LEU . 34.7 tt0 -91.44 125.22 36.12 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.4 m -121.02 155.61 33.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.999 0.92 . . . . 0.0 109.987 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' THR . 53.8 t90 -146.54 110.69 5.05 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.105 0.962 . . . . 0.0 108.877 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -118.52 103.7 9.98 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.021 0.928 . . . . 0.0 108.706 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -91.18 115.24 27.86 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.1 m -70.78 136.36 85.5 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.256 1.023 . . . . 0.0 110.701 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.0 -7.36 3.47 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.958 3.105 . . . . 0.0 114.726 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -57.68 -44.26 85.65 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.184 0.993 . . . . 0.0 109.307 170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.31 -28.66 73.86 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.411 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.428 ' HG2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -60.7 -43.68 97.49 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -59.75 -37.14 78.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.447 0.699 . . . . 0.0 111.843 176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.26 -54.5 46.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.887 0.742 . . . . 0.0 110.355 176.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -71.86 -32.99 68.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -73.25 -30.6 63.57 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.831 0.287 . . . . 0.0 111.318 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -82.53 -51.57 7.67 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.207 0.527 . . . . 0.0 109.984 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -77.89 -56.43 4.5 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.831 0.853 . . . . 0.0 111.598 -168.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.71 -19.68 37.53 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.462 0.705 . . . . 0.0 110.685 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.33 -99.67 0.3 Allowed Glycine 0 C--N 1.353 1.525 0 O-C-N 124.021 0.826 . . . . 0.0 113.871 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.38 -40.15 77.58 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.725 0.81 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -72.27 -8.34 54.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.193 0.997 . . . . 0.0 111.977 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.2 t -58.61 -33.5 70.09 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.44 0.696 . . . . 0.0 111.725 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mm -69.02 -44.72 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.518 0.727 . . . . 0.0 110.665 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -79.27 -24.94 42.6 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.854 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -67.59 -52.21 41.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.918 0.887 . . . . 0.0 109.932 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.428 HD12 ' HG2' ' A' ' 115' ' ' GLN . 15.9 tt -67.54 -34.58 69.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 O-C-N 124.307 1.004 . . . . 0.0 110.714 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -66.47 -55.95 13.19 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.485 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 132' ' ' LYS . 29.4 ttpt -54.75 -53.57 53.28 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.114 1.366 . . . . 0.0 112.165 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -66.08 -32.2 73.53 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.339 0.4 . . . . 0.0 111.823 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.42 ' NH1' ' HB3' ' A' ' 2' ' ' PRO . 25.8 ttp-105 -68.11 -51.53 45.23 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.4 mt -58.15 -39.12 77.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.101 0.96 . . . . 0.0 111.22 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -70.47 -31.4 68.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.057 0.943 . . . . 0.0 111.141 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.56 -40.68 41.59 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.2 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.9 mt -66.2 -27.26 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.337 0.655 . . . . 0.0 111.065 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.3 m -88.89 -39.39 13.84 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.815 0.846 . . . . 0.0 110.535 174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.03 -43.72 25.88 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.138 -0.483 . . . . 0.0 114.153 -170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.433 HD12 ' HD2' ' A' ' 7' ' ' PHE . 81.3 mt -57.87 -57.11 28.01 Favored Pre-proline 0 CA--C 1.56 1.343 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.9 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.45 -29.09 89.19 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.844 1.696 . . . . 0.0 112.682 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -69.68 -37.92 76.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.55 0.74 . . . . 0.0 111.411 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.406 ' O ' HG13 ' A' ' 148' ' ' ILE . 21.0 m -66.88 -42.94 84.73 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.48 0.487 . . . . 0.0 110.307 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -57.21 -49.97 74.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.787 0.835 . . . . 0.0 111.192 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.99 -35.92 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.02 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.97 0.508 . . . . 0.0 111.59 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 144' ' ' THR . 84.9 mt -64.79 -44.96 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.209 0.604 . . . . 0.0 109.836 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -60.35 -51.37 69.8 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.335 0.397 . . . . 0.0 110.015 176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.4 OUTLIER -58.06 -56.68 18.86 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.311 -171.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.5 tp -59.17 -36.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 124.012 0.82 . . . . 0.0 110.997 -174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 90.1 mt -66.69 -42.63 86.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.541 0.336 . . . . 0.0 110.253 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.93 -35.36 80.43 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.405 0.682 . . . . 0.0 111.229 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 150' ' ' ARG . 98.9 t -67.16 -36.6 77.31 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 C-N-CA 123.747 0.819 . . . . 0.0 109.668 176.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -84.16 -15.25 47.78 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.647 0.779 . . . . 0.0 112.681 178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 49.1 mt -69.94 -33.81 72.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 170.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -76.0 -70.99 0.41 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.948 169.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 64.82 125.8 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.731 2.012 . . . . 0.0 110.198 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 68.37 66.84 0.32 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 122.292 1.044 . . . . 0.0 108.316 -164.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -159.52 149.94 19.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.608 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -63.72 125.95 25.98 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.164 0.29 . . . . 0.0 111.011 -177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -84.25 157.57 21.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.412 0.685 . . . . 0.0 110.981 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 124.093 0.957 . . . . 0.0 111.361 175.571 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 118.864 -0.588 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.748 ' HA ' HG13 ' A' ' 130' ' ' ILE . 83.4 Cg_exo -49.99 90.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.052 2.501 . . . . 0.0 112.767 166.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.95 97.83 5.53 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.793 1.237 . . . . 0.0 109.079 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 m 58.06 -75.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.574 1.55 . . . . 0.0 113.226 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD21 HG12 ' A' ' 130' ' ' ILE . 63.7 mt 81.01 86.37 0.04 OUTLIER 'General case' 0 C--N 1.357 0.93 0 C-N-CA 126.687 1.995 . . . . 0.0 108.365 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -141.59 133.26 27.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.586 -173.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HB2' HG12 ' A' ' 138' ' ' ILE . 85.2 t80 -151.65 142.44 22.88 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.765 0.826 . . . . 0.0 108.872 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -132.77 155.45 48.88 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.679 0.792 . . . . 0.0 109.732 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -142.0 156.73 45.45 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.567 0.747 . . . . 0.0 109.348 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.506 ' HB3' HG23 ' A' ' 105' ' ' THR . 32.4 p -152.03 133.52 14.6 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.899 0.88 . . . . 0.0 110.387 179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.69 149.8 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 124.141 0.976 . . . . 0.0 108.612 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -94.98 109.4 21.43 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 HD21 ' A' ' 152' ' ' LEU . 28.1 mt -90.3 130.99 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.047 0.939 . . . . 0.0 109.96 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.52 85.1 7.01 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.34 155.36 11.7 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.73 0.812 . . . . 0.0 110.702 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.61 140.06 91.97 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.546 2.164 . . . . 0.0 111.275 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.494 HD12 ' HD3' ' A' ' 97' ' ' PRO . 9.9 tt -57.88 -34.47 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 123.856 0.862 . . . . 0.0 112.563 -175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -62.07 -39.57 92.87 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.555 0.742 . . . . 0.0 111.358 175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -73.48 -38.66 65.34 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.622 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 HG21 ' HB ' ' A' ' 102' ' ' THR . 59.4 t -61.94 -40.59 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -62.63 -35.38 79.41 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.13 0.972 . . . . 0.0 111.356 175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.402 ' HB1' ' HD2' ' A' ' 163' ' ' HIS . . . -67.24 -30.07 69.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.346 0.658 . . . . 0.0 111.324 179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 152' ' ' LEU . 4.2 mm? -91.03 -17.52 26.12 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.285 0.634 . . . . 0.0 112.183 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 20' ' ' VAL . 38.3 t -68.98 -47.06 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.989 0.9 . . . . 0.0 108.58 168.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -95.13 53.49 1.55 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 113.898 -1.501 . . . . 0.0 108.584 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.69 -31.29 72.41 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.415 HG23 HG23 ' A' ' 28' ' ' THR . 9.9 tt -59.82 -39.08 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.625 0.77 . . . . 0.0 111.504 176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.415 HG23 HG23 ' A' ' 27' ' ' ILE . 47.2 p -88.32 65.06 7.87 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.885 0.85 . . . . 0.0 110.94 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -127.5 160.53 31.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.715 1.206 . . . . 0.0 108.735 172.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -60.45 104.41 0.33 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.104 0.562 . . . . 0.0 110.128 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.94 -69.86 1.15 Allowed Glycine 0 C--N 1.354 1.571 0 O-C-N 123.951 0.782 . . . . 0.0 113.207 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 56.52 -164.05 0.16 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.143 0.977 . . . . 0.0 112.415 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 74.0 m95 58.48 48.55 11.92 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.131 0.972 . . . . 0.0 109.761 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.7 m 60.88 81.38 0.24 Allowed Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.483 -1.235 . . . . 0.0 108.854 -165.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.18 98.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 123.48 2.787 . . . . 0.0 113.222 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.16 -38.7 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.699 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.9 t -67.75 103.4 1.41 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.847 0.859 . . . . 0.0 109.04 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 44.7 tt0 -60.53 -56.76 17.45 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 124.219 0.949 . . . . 0.0 111.068 -177.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 45.7 mtmt -143.19 141.91 31.27 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 47.1 t -146.27 109.71 4.77 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -109.06 124.82 51.36 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -124.68 149.39 47.24 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.846 0.858 . . . . 0.0 109.818 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.54 -6.69 5.51 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.894 1.278 . . . . 0.0 113.047 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.23 -29.93 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.802 0.841 . . . . 0.0 111.358 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -80.65 -5.63 57.21 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 123.797 0.839 . . . . 0.0 110.881 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -119.97 -157.27 0.7 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.084 1.354 . . . . 0.0 109.647 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.48 109.48 3.48 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.784 -1.009 . . . . 0.0 111.027 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.39 96.51 0.81 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.869 2.379 . . . . 0.0 111.899 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.6 166.86 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.877 0.871 . . . . 0.0 110.121 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 73' ' ' VAL . 96.1 t -68.02 110.49 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.49 -19.91 9.03 Favored Glycine 0 C--N 1.335 0.511 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.971 -177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 128.33 36.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -149.52 126.73 11.36 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.235 0.614 . . . . 0.0 110.294 -172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -138.17 161.5 36.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.346 1.058 . . . . 0.0 110.357 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.9 p -115.27 130.84 57.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.988 0.915 . . . . 0.0 111.093 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 40' ' ' CYS . . . -109.9 115.95 4.32 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 173.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' NH2' HG22 ' A' ' 64' ' ' THR . 24.8 tpt180 -74.73 103.02 4.84 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -85.12 132.37 34.32 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.05 109.72 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 122.042 0.925 . . . . 0.0 109.736 -174.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 69.0 p -119.32 159.03 47.13 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.581 1.552 . . . . 0.0 107.499 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -61.04 -22.37 74.52 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.6 2.2 . . . . 0.0 113.644 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.63 -43.96 11.57 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.247 0.619 . . . . 0.0 111.53 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -141.67 141.23 33.35 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.755 0.822 . . . . 0.0 110.583 -173.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.402 HG22 ' NH2' ' A' ' 57' ' ' ARG . 71.2 m -138.69 108.79 6.38 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.268 0.627 . . . . 0.0 110.029 -176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 59.5 t-105 -160.17 144.6 14.51 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.547 0.739 . . . . 0.0 109.773 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.9 143.82 26.32 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.6 0.36 . . . . 0.0 110.491 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.6 p -105.65 116.07 31.32 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.405 0.682 . . . . 0.0 109.734 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -87.48 101.93 14.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.252 1.021 . . . . 0.0 109.005 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -95.72 106.36 18.47 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.699 0.8 . . . . 0.0 109.768 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -100.92 108.53 20.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.033 0.933 . . . . 0.0 109.768 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 82' ' ' TRP . 42.3 t -73.03 104.93 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.66 0.743 . . . . 0.0 110.653 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD11 HD11 ' A' ' 92' ' ' ILE . 32.7 pt -88.85 -16.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 CA-C-N 114.443 -1.253 . . . . 0.0 111.722 -175.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 50' ' ' VAL . 5.6 p -148.89 128.11 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.15 105.61 4.09 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 -175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -115.8 126.73 27.4 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 166.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -53.16 96.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.605 2.87 . . . . 0.0 112.674 -171.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' MET . 4.4 m-20 71.4 -17.62 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.704 1.601 . . . . 0.0 113.143 -178.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -77.06 -38.8 51.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.549 0.613 . . . . 0.0 110.593 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 94' ' ' SER . 47.5 t -159.76 94.15 1.12 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.251 0.62 . . . . 0.0 109.59 173.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -105.02 108.57 20.16 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.45 116.87 1.42 Allowed Glycine 0 C--O 1.241 0.562 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.393 -171.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.649 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 41.7 p90 -107.69 176.22 5.22 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.883 0.873 . . . . 0.0 110.497 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.41 ' OG ' ' HA2' ' A' ' 87' ' ' GLY . 17.2 t -138.6 118.39 13.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 176.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.16 143.55 13.16 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 C-N-CA 124.191 0.996 . . . . 0.0 109.153 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER 68.47 -160.83 0.2 Allowed 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 124.927 1.291 . . . . 0.0 109.2 -174.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.474 ' H ' HG22 ' A' ' 85' ' ' THR . 7.8 p-10 -80.89 48.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.021 0.928 . . . . 0.0 111.209 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' HA2' ' OG ' ' A' ' 83' ' ' SER . . . 74.13 57.27 4.85 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.98 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -106.82 -45.76 4.11 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.093 0.557 . . . . 0.0 110.117 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.08 136.38 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -117.4 140.21 49.88 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 118.937 0.789 . . . . 0.0 110.357 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.489 ' HB3' ' HE1' ' A' ' 93' ' ' TYR . 97.1 m95 -135.86 97.92 3.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.599 1.16 . . . . 0.0 108.131 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 107' ' ' SER . 18.4 mm -109.0 110.51 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -174.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.489 ' HE1' ' HB3' ' A' ' 91' ' ' TRP . 34.5 m-85 -110.2 103.17 11.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.04 0.448 . . . . 0.0 110.364 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 79' ' ' CYS . 33.0 t -92.31 129.11 38.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.545 1.138 . . . . 0.0 109.386 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 77' ' ' ASN . 30.8 mtm -125.66 113.76 17.78 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.057 0.943 . . . . 0.0 109.432 177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -106.32 110.18 63.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 123.748 0.819 . . . . 0.0 109.618 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' HD12 ' A' ' 17' ' ' ILE . 97.7 Cg_endo -76.06 92.02 1.07 Allowed 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.885 2.39 . . . . 0.0 112.288 -174.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.1 mt -72.17 163.92 27.1 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.204 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -70.63 -8.02 48.63 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.08 0.552 . . . . 0.0 111.691 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.31 -12.81 15.0 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 124.414 1.086 . . . . 0.0 112.127 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 -130.99 2.27 Favored Glycine 0 C--N 1.347 1.179 0 N-CA-C 112.363 -0.295 . . . . 0.0 112.363 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 20' ' ' VAL . 89.7 m -153.53 129.68 10.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.853 0.861 . . . . 0.0 109.4 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.81 109.95 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD12 HD11 ' A' ' 145' ' ' LEU . 3.1 tm? -79.72 120.89 24.63 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 10' ' ' SER . 53.6 m -129.15 103.87 7.22 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.75 155.7 17.09 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.615 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . 24.0 t -142.67 104.26 4.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.036 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -92.41 131.93 37.18 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.203 0.601 . . . . 0.0 109.693 172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -144.71 109.46 4.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.197 0.522 . . . . 0.0 109.828 175.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.492 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 53.6 t80 -83.5 141.15 31.85 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 171.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -93.38 150.44 38.99 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.596 0.758 . . . . 0.0 110.359 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.62 -5.57 14.55 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.61 2.207 . . . . 0.0 112.953 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -55.74 -48.56 75.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.316 1.046 . . . . 0.0 111.283 172.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.15 -52.71 45.41 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.299 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HG2' ' HE2' ' A' ' 110' ' ' PHE . 29.7 mm-40 -60.48 -32.31 71.3 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 0.0 112.261 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -61.52 -54.9 37.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.763 0.825 . . . . 0.0 110.152 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -59.46 -44.86 92.91 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.82 0.848 . . . . 0.0 110.934 -176.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -72.19 -16.51 61.96 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.673 0.789 . . . . 0.0 111.961 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 126' ' ' SER . 81.9 t60 -83.06 -31.65 27.25 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.7 0.4 . . . . 0.0 110.997 174.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -68.97 -42.7 76.23 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -69.68 -54.15 15.22 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.997 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 61.3 m-85 -134.39 81.29 1.9 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.513 0.725 . . . . 0.0 109.073 -173.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.42 -40.75 96.51 Favored Glycine 0 N--CA 1.472 1.093 0 O-C-N 123.652 0.595 . . . . 0.0 113.401 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.99 -39.75 65.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.948 0.899 . . . . 0.0 110.717 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 62.2 mttm -89.94 10.92 22.06 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.862 -176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 119' ' ' HIS . 19.7 m -65.66 -32.06 73.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.795 0.438 . . . . 0.0 110.069 168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.1 mt -67.31 -36.87 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.848 175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HB3' ' HZ1' ' A' ' 132' ' ' LYS . 44.6 mm-40 -65.62 -46.94 77.38 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.919 0.888 . . . . 0.0 111.06 175.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -60.96 -59.02 6.03 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.915 0.759 . . . . 0.0 110.917 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.748 HG13 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -57.75 -41.87 80.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.775 0.672 . . . . 0.0 111.04 -175.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.93 -61.34 2.35 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 122.85 0.46 . . . . 0.0 111.02 -175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 128' ' ' GLU . 36.2 mtmm -64.46 -42.64 95.82 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -73.85 -21.07 60.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.127 0.571 . . . . 0.0 111.594 -176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB2' HD22 ' A' ' 5' ' ' LEU . 57.0 ttp85 -78.33 -51.79 9.57 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.353 0.661 . . . . 0.0 109.983 172.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.8 mt -66.99 -42.69 84.62 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.649 0.779 . . . . 0.0 111.484 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.81 -24.72 64.43 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.59 0.756 . . . . 0.0 111.558 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.57 -59.24 2.43 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 122.893 0.477 . . . . 0.0 110.69 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 7' ' ' PHE . 64.6 mt -60.92 -33.51 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.725 0.81 . . . . 0.0 111.802 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 34.6 m -84.99 -44.7 12.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.747 0.419 . . . . 0.0 110.165 173.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -67.03 -33.47 83.79 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 -171.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 145' ' ' LEU . 79.2 mt -63.51 -58.64 14.56 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.023 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.78 -29.71 83.55 Favored 'Trans proline' 0 C--N 1.403 3.396 0 C-N-CA 122.084 1.856 . . . . 0.0 112.77 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 139' ' ' THR . 6.4 mm-40 -64.96 -54.81 24.69 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.427 ' O ' HG13 ' A' ' 148' ' ' ILE . 37.1 m -65.92 -31.61 72.64 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.071 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.599 HD11 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -69.79 -50.06 46.78 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.724 0.81 . . . . 0.0 109.712 -174.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 75.7 t -59.81 -37.93 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 123.497 0.719 . . . . 0.0 110.398 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.1 -40.56 90.86 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.726 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 144' ' ' THR . 67.9 mt -63.06 -47.42 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.887 0.875 . . . . 0.0 110.098 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.486 ' HG3' HG23 ' A' ' 13' ' ' ILE . 43.3 tt0 -60.01 -55.14 37.69 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.625 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.481 ' O ' HG23 ' A' ' 154' ' ' VAL . 41.4 ttm180 -58.63 -43.89 89.85 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.664 -171.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.7 tt -66.09 -40.45 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 123.322 0.389 . . . . 0.0 111.708 -177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.526 ' HB3' ' HG ' ' A' ' 23' ' ' LEU . 2.8 pp -70.55 -36.9 73.92 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 52.9 mt-10 -68.99 -35.54 76.82 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.396 0.678 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 150' ' ' ARG . 89.7 t -66.22 -37.9 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.867 0.467 . . . . 0.0 110.041 174.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -70.94 -25.24 62.66 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.667 0.387 . . . . 0.0 111.255 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.0 -31.39 62.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.851 0.46 . . . . 0.0 110.273 171.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 15.1 mm-40 -71.69 -28.26 63.59 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.925 0.49 . . . . 0.0 110.093 171.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -88.25 -177.02 5.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.023 0.929 . . . . 0.0 110.014 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -77.59 86.63 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.355 0.598 . . . . 0.0 109.618 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -78.35 129.61 35.19 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.683 174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -115.63 57.25 0.74 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.768 0.827 . . . . 0.0 110.077 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 62.0 t60 63.43 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.459 1.503 . . . . 0.0 111.255 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.402 ' HD2' ' HB1' ' A' ' 22' ' ' ALA . 33.4 t-80 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.438 1.095 . . . . 0.0 108.129 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.485 1.293 0 CA-C-O 119.423 -0.323 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.76 72.93 4.93 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.771 2.314 . . . . 0.0 110.803 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -77.07 -176.97 4.24 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.582 -172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.423 ' HB2' ' HD3' ' A' ' 112' ' ' PRO . 20.9 t -75.12 173.01 11.36 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.32 0.648 . . . . 0.0 110.912 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 134' ' ' ARG . 2.2 pt? -70.03 114.8 8.54 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.602 0.715 . . . . 0.0 110.307 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 109' ' ' GLU . 43.2 p -133.73 170.84 14.97 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.754 0.822 . . . . 0.0 109.679 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -151.94 152.35 32.41 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.496 0.719 . . . . 0.0 109.174 170.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.04 164.33 39.04 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.301 1.04 . . . . 0.0 109.089 -175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -158.86 158.17 32.92 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 36.1 t -147.55 152.34 37.81 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.499 0.72 . . . . 0.0 110.034 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG22 HD12 ' A' ' 145' ' ' LEU . 19.6 tt -160.91 134.6 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.941 0.496 . . . . 0.0 110.314 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.2 t30 -87.14 101.29 13.35 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.361 0.601 . . . . 0.0 109.649 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG21 HD12 ' A' ' 152' ' ' LEU . 49.3 mt -88.38 119.01 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.838 0.855 . . . . 0.0 109.143 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.519 ' O ' HD11 ' A' ' 156' ' ' LEU . . . -70.83 81.21 0.63 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB1' ' NE2' ' A' ' 19' ' ' GLN . . . -160.85 143.89 9.71 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.184 0.994 . . . . 0.0 109.666 -176.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.414 ' O ' HG23 ' A' ' 20' ' ' VAL . 37.5 Cg_endo -65.63 132.2 30.14 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.542 2.161 . . . . 0.0 112.274 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.11 -26.65 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 124.027 0.931 . . . . 0.0 112.356 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -50.51 -48.68 56.89 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.202 1.001 . . . . 0.0 111.179 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.433 ' NE2' ' HB1' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -87.66 -30.74 20.19 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 119.492 -0.29 . . . . 0.0 111.706 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 152' ' ' LEU . 89.6 t -58.22 -49.48 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 122.617 0.367 . . . . 0.0 110.664 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -62.11 -30.55 71.1 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.213 1.005 . . . . 0.0 111.055 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.84 -30.4 51.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.95 0.9 . . . . 0.0 111.991 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.35 -12.53 49.07 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.038 0.535 . . . . 0.0 111.702 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -78.31 -43.57 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -92.92 174.44 7.24 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.395 0.678 . . . . 0.0 110.72 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.91 95.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.593 1.157 . . . . 0.0 112.254 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.4 pt -121.0 -4.98 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.468 0.707 . . . . 0.0 110.492 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.2 p -87.04 80.92 8.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.684 0.793 . . . . 0.0 111.054 -172.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -120.57 -18.8 7.7 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.108 0.963 . . . . 0.0 110.296 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 m -148.17 133.77 18.78 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.023 0.929 . . . . 0.0 109.196 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.42 33.94 0.03 OUTLIER Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -85.21 82.93 8.17 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.004 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 32.2 m-90 58.48 28.18 16.58 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.969 0.907 . . . . 0.0 111.579 176.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.0 m -64.0 137.85 97.23 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.822 0.849 . . . . 0.0 110.751 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -44.85 -34.68 8.87 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.851 3.034 . . . . 0.0 114.747 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG23 ' SG ' ' A' ' 37' ' ' CYS . 21.0 m -99.19 -18.62 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' A' ' 36' ' ' VAL . 62.4 m -137.73 100.89 4.32 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.699 0.8 . . . . 0.0 109.838 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG2' ' HE ' ' A' ' 57' ' ' ARG . 5.3 tp10 -55.2 -60.75 2.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.661 0.785 . . . . 0.0 110.944 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -158.26 148.96 20.51 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.293 1.037 . . . . 0.0 108.566 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -138.24 113.46 9.38 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -125.37 118.11 25.19 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 54' ' ' PHE . 1.4 m95 -95.68 159.17 15.12 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.602 0.715 . . . . 0.0 112.823 -175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 54' ' ' PHE . 9.0 p-10 -69.4 -26.79 64.81 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.394 -1.275 . . . . 0.0 110.348 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -55.93 -39.8 72.2 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 124.747 1.279 . . . . 0.0 109.442 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.12 -35.77 79.72 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.843 0.857 . . . . 0.0 111.262 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -75.07 -34.57 61.8 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.3 110.69 2.08 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -168.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.71 83.59 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.866 2.377 . . . . 0.0 112.635 -172.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.54 161.79 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.098 0.959 . . . . 0.0 109.704 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.48 117.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.48 -15.16 29.91 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.848 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.53 169.22 7.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 117.15 0.475 . . . . 0.0 110.036 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.12 157.33 40.21 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 122.191 -0.318 . . . . 0.0 111.494 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 44.1 p90 -142.61 159.5 42.12 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.196 0.598 . . . . 0.0 111.123 178.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 67' ' ' THR . 10.5 t -143.27 156.1 44.65 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.437 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 106.18 0.32 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 29.9 ttp180 -85.48 108.95 18.15 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 117.423 0.612 . . . . 0.0 110.479 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -86.02 131.07 34.35 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 171.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -126.46 109.81 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.371 0.668 . . . . 0.0 109.622 -178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.3 p -134.97 153.11 78.36 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.95 -21.09 70.01 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.502 2.135 . . . . 0.0 112.039 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -72.79 -49.93 27.51 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.58 1.152 . . . . 0.0 110.661 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -161.89 133.21 5.29 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.357 0.663 . . . . 0.0 110.063 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.9 m -129.77 122.79 29.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.699 0.799 . . . . 0.0 109.763 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -161.87 146.73 12.97 Favored 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.725 0.641 . . . . 0.0 109.76 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 11.2 pt-20 -97.26 136.36 37.86 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.233 0.613 . . . . 0.0 109.57 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 55' ' ' THR . 36.5 p -102.23 110.79 22.84 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -90.64 129.83 36.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.4 m -143.33 107.25 4.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.096 0.558 . . . . 0.0 109.795 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -98.92 128.84 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.339 0.656 . . . . 0.0 109.715 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.0 t -72.12 105.8 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.227 1.011 . . . . 0.0 109.601 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 22.5 pt -87.08 -22.12 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.77 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -151.92 128.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 124.109 0.964 . . . . 0.0 108.707 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -138.9 104.61 5.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.512 0.725 . . . . 0.0 109.125 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -96.08 120.48 62.75 Favored Pre-proline 0 C--O 1.245 0.831 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -57.96 107.52 0.32 Allowed 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 123.389 2.726 . . . . 0.0 112.666 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 57.41 41.45 26.26 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.76 1.224 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.67 -49.65 0.31 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.963 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 75.8 m -150.8 154.99 38.33 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.347 0.521 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -145.57 106.68 4.16 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.729 0.812 . . . . 0.0 108.985 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.69 137.35 9.59 Favored Glycine 0 C--N 1.342 0.878 0 C-N-CA 123.178 0.418 . . . . 0.0 112.195 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -148.86 138.49 21.92 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.772 0.829 . . . . 0.0 111.158 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 90' ' ' LYS . 78.7 p -99.38 127.98 45.46 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.425 0.69 . . . . 0.0 109.977 176.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 50.4 t -77.74 109.65 12.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.858 0 C-N-CA 123.002 0.521 . . . . 0.0 110.147 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.4 m 63.73 87.69 0.11 Allowed 'General case' 0 C--N 1.355 0.804 0 C-N-CA 125.229 1.412 . . . . 0.0 111.111 169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 69.73 -76.42 0.06 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.174 1.39 . . . . 0.0 110.657 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.13 36.49 0.1 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -74.95 -58.24 3.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.605 0.762 . . . . 0.0 109.243 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 11.8 t -113.4 162.5 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 34.8 ttpt -152.32 121.47 6.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.736 0.414 . . . . 0.0 109.934 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -111.44 127.35 55.65 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.3 mm -122.91 113.58 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.485 0.714 . . . . 0.0 109.357 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -97.98 133.92 41.8 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.5 m -134.75 126.14 28.37 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.401 ' N ' ' SD ' ' A' ' 95' ' ' MET . 1.4 mpt? -110.59 114.78 28.44 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -89.18 105.55 10.68 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -75.99 98.37 1.19 Allowed 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.261 1.974 . . . . 0.0 111.549 -171.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.1 mt -91.33 179.33 5.72 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 171.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.87 -49.13 8.12 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.918 0.389 . . . . 0.0 110.22 177.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.86 -29.0 60.89 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.738 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 15' ' ' ALA . . . -161.14 -156.5 8.3 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.238 -0.437 . . . . 0.0 113.105 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.0 m -151.66 125.94 9.34 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.571 1.149 . . . . 0.0 108.499 -176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 17.5 t -88.65 100.48 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD12 HD13 ' A' ' 145' ' ' LEU . 2.2 tm? -78.91 130.16 35.31 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.5 m -128.15 112.83 14.98 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 108.74 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.01 145.22 27.3 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.8 m -140.99 106.93 5.15 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.391 0.676 . . . . 0.0 110.669 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -84.52 126.47 33.33 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 169.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' THR . 51.7 mt-10 -139.28 115.88 10.67 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.765 0.826 . . . . 0.0 109.14 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -100.47 136.17 40.76 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.4 p -90.01 144.89 32.04 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 123.171 0.589 . . . . 0.0 110.112 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 58.4 Cg_endo -69.2 -0.91 7.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.228 1.952 . . . . 0.0 113.004 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -61.25 -46.88 88.57 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.44 1.096 . . . . 0.0 110.831 171.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.44 -39.1 87.43 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.412 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -57.95 -42.68 85.44 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.571 0.748 . . . . 0.0 110.841 174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.93 65.47 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.913 1.285 . . . . 0.0 111.113 -172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.06 -58.16 8.9 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.168 0.587 . . . . 0.0 111.421 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.95 -29.74 66.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 111.195 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -80.46 -31.37 37.43 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.96 0.904 . . . . 0.0 110.717 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.86 -40.11 75.94 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.168 0.587 . . . . 0.0 110.358 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -79.49 -70.42 0.51 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.458 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -98.0 -26.57 14.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.346 0.658 . . . . 0.0 111.957 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.58 -83.49 0.78 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.152 0.282 . . . . 0.0 113.362 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.21 -37.02 74.0 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.048 1.339 . . . . 0.0 111.426 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -50.25 -55.06 16.92 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.017 0.823 . . . . 0.0 109.921 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -61.33 -42.77 99.22 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 123.994 0.809 . . . . 0.0 111.951 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.72 -50.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 122.84 0.456 . . . . 0.0 111.605 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 -48.72 38.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.739 0.415 . . . . 0.0 111.282 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -62.46 -39.71 94.29 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.514 1.126 . . . . 0.0 112.682 -171.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.496 HG12 HD11 ' A' ' 5' ' ' LEU . 10.6 tt -70.87 -33.35 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.886 0.474 . . . . 0.0 110.15 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.467 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 35.7 tt0 -70.64 -37.94 73.8 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.38 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.99 -26.54 63.18 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.216 0.607 . . . . 0.0 111.634 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -68.36 -38.52 81.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.183 0.593 . . . . 0.0 109.862 170.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 5' ' ' LEU . 69.8 ttt180 -66.98 -44.35 80.67 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.216 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 131' ' ' GLU . 98.0 mt -67.42 -36.64 81.67 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.713 0.805 . . . . 0.0 110.875 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.65 84.74 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.449 0.699 . . . . 0.0 110.624 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.551 ' O ' HG12 ' A' ' 141' ' ' ILE . . . -66.92 -47.58 71.3 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.432 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 134' ' ' ARG . 87.2 mt -59.38 -29.56 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 124.631 1.172 . . . . 0.0 111.663 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.6 m -66.53 -36.97 84.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 122.915 0.486 . . . . 0.0 109.904 173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -85.04 -45.55 5.91 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.022 -176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 137' ' ' ALA . 17.1 mm -57.96 -61.99 6.35 Favored Pre-proline 0 N--CA 1.494 1.759 0 CA-C-N 118.059 0.929 . . . . 0.0 112.297 -164.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.86 -29.07 50.43 Favored 'Trans proline' 0 C--N 1.397 3.091 0 C-N-CA 122.15 1.9 . . . . 0.0 111.604 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -66.72 -40.71 88.5 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.275 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 58.4 m -63.54 -44.71 93.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.881 0.872 . . . . 0.0 110.603 177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 11' ' ' ILE . 4.4 mm? -59.08 -45.77 90.0 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.473 0.709 . . . . 0.0 111.259 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 85.3 t -68.71 -33.65 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.621 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.7 -29.32 64.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.562 0.745 . . . . 0.0 111.737 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.559 ' O ' ' HG ' ' A' ' 152' ' ' LEU . 79.8 mt -74.02 -41.3 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 173.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.421 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 54.9 tt0 -63.43 -49.29 74.29 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.097 0.159 . . . . 0.0 111.274 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -59.26 -40.41 85.92 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.627 0.771 . . . . 0.0 111.959 -170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.19 -29.22 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.14 0.576 . . . . 0.0 110.329 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 148' ' ' ILE . 35.7 mt -80.4 -24.66 39.55 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.742 0.417 . . . . 0.0 111.848 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 42.9 mt-10 -76.6 -35.08 58.34 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.055 0.542 . . . . 0.0 109.765 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.03 -35.8 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.912 0.885 . . . . 0.0 110.15 166.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -75.24 -18.2 60.16 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.139 0.976 . . . . 0.0 111.566 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.519 HD11 ' O ' ' A' ' 14' ' ' ALA . 70.5 mt -75.19 -11.94 60.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 122.173 -0.329 . . . . 0.0 110.919 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.73 -43.73 6.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.635 0.774 . . . . 0.0 110.132 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.15 -46.46 67.53 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.975 0.91 . . . . 0.0 111.324 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.7 m80 61.69 74.66 0.43 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.568 1.147 . . . . 0.0 111.45 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -88.52 92.65 9.27 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -81.61 63.58 5.96 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.701 0.8 . . . . 0.0 109.125 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 176.63 148.45 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 -173.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.7 m170 . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 169.16 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.1 mtp . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -80.37 41.57 1.16 Allowed 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.4 2.733 . . . . 0.0 113.08 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -52.32 -56.63 13.6 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.527 1.131 . . . . 0.0 110.46 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.4 t -138.32 120.22 15.41 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.692 -1.14 . . . . 0.0 107.994 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 59.8 mt -74.89 88.85 2.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.8 p -107.5 134.12 50.99 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.04 0.936 . . . . 0.0 110.34 -177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -143.72 150.6 38.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.33 149.71 29.66 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -151.59 156.25 40.09 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.886 0.474 . . . . 0.0 109.984 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 61.5 p -147.89 138.56 23.14 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.96 0.904 . . . . 0.0 110.2 -176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 145' ' ' LEU . 17.8 tt -146.08 139.56 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.458 0.703 . . . . 0.0 109.477 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 t30 -84.93 128.01 34.43 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.555 HG23 ' HA ' ' A' ' 149' ' ' GLN . 53.8 mt -109.32 130.83 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.634 1.173 . . . . 0.0 108.196 -177.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.44 73.91 3.19 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.27 142.97 2.84 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 110.699 -172.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.88 144.4 93.33 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.741 2.294 . . . . 0.0 112.044 173.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.9 tt -57.48 -27.69 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 112.717 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.49 -49.91 75.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.983 0.913 . . . . 0.0 110.978 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -79.66 -21.87 44.23 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.651 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 102' ' ' THR . 85.5 t -70.71 -43.21 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.341 0.656 . . . . 0.0 109.797 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -65.89 -34.01 77.16 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.02 174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.81 -31.29 70.17 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.167 0.587 . . . . 0.0 111.8 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD12 HG12 ' A' ' 148' ' ' ILE . 0.4 OUTLIER -77.29 -41.56 40.33 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.165 0.586 . . . . 0.0 109.508 -177.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.7 p -77.5 -38.2 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.165 0 C-N-CA 122.303 0.241 . . . . 0.0 111.401 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.2 m -84.47 12.9 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.333 0.653 . . . . 0.0 111.565 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -79.66 3.06 20.3 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.903 0.881 . . . . 0.0 111.282 174.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG13 HG23 ' A' ' 28' ' ' THR . 22.8 pt -45.75 -33.44 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 125.905 1.682 . . . . 0.0 114.095 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 27' ' ' ILE . 44.4 p -84.6 -161.84 0.61 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.924 0.89 . . . . 0.0 111.669 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 73.89 -76.4 0.06 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 125.558 1.543 . . . . 0.0 110.639 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -138.91 -34.12 0.61 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.253 1.021 . . . . 0.0 110.523 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.04 93.32 0.85 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.43 -33.22 74.37 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.805 0.842 . . . . 0.0 110.677 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -62.48 -40.39 96.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.736 0.814 . . . . 0.0 110.634 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.7 p -173.31 146.58 1.35 Allowed Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.188 0.995 . . . . 0.0 109.616 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.42 32.11 0.52 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.795 2.33 . . . . 0.0 112.803 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -74.55 -4.21 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.516 1.126 . . . . 0.0 112.242 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.0 t -103.82 112.02 24.79 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.97 -49.53 65.12 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.306 0.574 . . . . 0.0 110.51 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -147.07 129.19 15.56 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.355 -167.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.4 p -139.84 135.62 33.15 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 109.538 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 17.7 m-90 -101.66 130.09 47.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 173.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.482 ' HA ' HG21 ' A' ' 28' ' ' THR . 11.1 t90 -95.92 134.71 38.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.769 0.828 . . . . 0.0 111.32 -163.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.65 -42.07 98.14 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.796 1.238 . . . . 0.0 112.103 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.94 -32.13 67.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.112 0.565 . . . . 0.0 111.584 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -66.32 -35.51 80.56 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.472 0.709 . . . . 0.0 110.032 175.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -73.06 -39.6 65.77 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.581 0.753 . . . . 0.0 110.485 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.21 113.85 2.41 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -169.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.34 67.64 8.18 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 123.206 2.604 . . . . 0.0 112.237 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.02 170.68 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.407 1.083 . . . . 0.0 110.547 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.443 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.7 t -70.24 133.12 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.593 0.757 . . . . 0.0 109.567 175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.68 -16.09 61.57 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 120.107 -0.274 . . . . 0.0 113.119 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.71 160.26 28.43 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.131 0.572 . . . . 0.0 110.065 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -146.36 133.5 20.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.959 0.503 . . . . 0.0 110.125 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.441 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 38.6 p90 -119.13 169.53 9.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.526 1.13 . . . . 0.0 108.557 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 90.8 m -146.6 152.66 39.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.152 0.581 . . . . 0.0 109.575 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -153.74 120.52 1.04 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 174.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 6.8 ptp180 -87.25 118.34 26.6 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 117.376 0.588 . . . . 0.0 110.715 175.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' THR . 4.8 t-20 -85.91 112.38 21.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.814 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 p -103.47 111.4 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 124.059 0.944 . . . . 0.0 109.6 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 55.5 p -133.53 153.82 80.5 Favored Pre-proline 0 N--CA 1.475 0.805 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -60.58 -16.77 44.79 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.699 2.266 . . . . 0.0 113.044 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -74.53 -70.0 0.43 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.624 0.769 . . . . 0.0 110.383 170.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -137.81 149.22 46.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.063 0.545 . . . . 0.0 110.539 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 58' ' ' ASN . 80.1 m -127.71 122.78 33.81 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 41.0 t-105 -156.0 141.32 17.58 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.542 0.737 . . . . 0.0 109.295 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -94.92 119.94 34.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.465 0.706 . . . . 0.0 109.402 176.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.0 p -103.85 114.21 28.3 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.276 0.63 . . . . 0.0 109.585 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -93.57 116.93 29.46 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.832 0.853 . . . . 0.0 108.859 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -112.69 115.66 28.91 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.072 0.949 . . . . 0.0 110.046 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -98.21 123.67 42.39 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 32.3 t -69.03 104.32 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.949 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.456 HG13 HG12 ' A' ' 73' ' ' VAL . 34.1 pt -77.47 -23.95 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.657 0.783 . . . . 0.0 111.751 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG12 HG13 ' A' ' 72' ' ' ILE . 5.6 p -156.25 136.03 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.189 0.996 . . . . 0.0 108.891 177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -146.5 103.5 3.68 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.444 0.698 . . . . 0.0 109.579 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.91 101.06 5.5 Favored Pre-proline 0 C--O 1.238 0.452 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.96 113.42 1.39 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.006 2.471 . . . . 0.0 111.931 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.19 39.81 0.92 Allowed 'General case' 0 CA--C 1.554 1.102 0 O-C-N 124.861 1.351 . . . . 0.0 110.838 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -148.72 -50.28 0.16 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.53 . . . . 0.0 110.446 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.0 p -147.38 147.49 30.35 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.072 0.549 . . . . 0.0 109.982 173.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -139.55 102.47 4.47 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.96 124.83 6.5 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -144.8 149.04 34.78 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.016 0.927 . . . . 0.0 110.353 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.4 p -123.17 126.63 47.35 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.8 0.84 . . . . 0.0 110.496 -176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 84.8 t -75.53 130.41 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 172.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 86' ' ' ASP . 2.9 m 66.13 -173.56 0.18 Allowed 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 124.72 1.208 . . . . 0.0 109.356 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 85' ' ' THR . 5.5 p-10 -57.11 -28.95 63.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.639 -0.663 . . . . 0.0 111.054 174.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.3 71.51 0.03 OUTLIER Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -110.64 -51.71 2.84 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.05 0.94 . . . . 0.0 109.934 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.417 HG22 ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -121.07 145.17 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 174.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 109' ' ' GLU . 56.6 tttm -140.13 104.0 4.73 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.45 0.7 . . . . 0.0 109.334 -175.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -98.67 123.33 42.81 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.915 0.886 . . . . 0.0 109.541 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.4 mm -116.8 111.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.71 102.76 12.95 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.1 m -101.66 124.91 48.09 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.5 mtm -117.77 132.08 56.5 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.424 0.689 . . . . 0.0 109.917 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -100.42 100.12 11.36 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.582 0.753 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.67 94.75 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.022 2.481 . . . . 0.0 112.282 -177.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.5 mt -99.49 170.34 8.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.636 178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -75.95 -39.88 55.14 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -67.53 -26.39 66.3 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.046 0.938 . . . . 0.0 111.975 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.66 -140.91 6.65 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.746 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.403 ' HB ' HG21 ' A' ' 20' ' ' VAL . 92.3 m -152.99 128.19 9.79 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.38 0.672 . . . . 0.0 110.139 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.2 t -87.35 102.9 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -77.73 106.51 9.59 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -108.51 132.38 53.88 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.99 160.18 32.72 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -140.73 109.11 5.84 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.136 0.974 . . . . 0.0 109.786 173.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 35.0 t90 -84.87 118.87 24.76 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 24.5 mt-10 -126.61 91.12 3.29 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.566 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t80 -84.5 97.24 9.44 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 61.8 p -65.68 163.32 35.86 Favored Pre-proline 0 CA--C 1.557 1.218 0 C-N-CA 124.355 1.062 . . . . 0.0 112.584 -170.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.92 -12.08 3.07 Favored 'Trans proline' 0 C--N 1.392 2.83 0 C-N-CA 123.678 2.919 . . . . 0.0 114.668 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -52.73 -53.16 51.72 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.511 1.124 . . . . 0.0 111.933 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA3' ' CZ ' ' A' ' 110' ' ' PHE . . . -75.58 -37.1 41.44 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.072 -177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -56.16 -43.38 78.27 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.499 0.72 . . . . 0.0 110.209 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -63.93 -43.34 96.18 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.031 0.932 . . . . 0.0 110.626 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -61.69 -46.23 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.073 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -78.49 -27.62 46.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.303 0.641 . . . . 0.0 111.672 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -72.71 -24.63 61.02 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.207 0.603 . . . . 0.0 110.333 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -86.06 -35.82 20.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.578 0.751 . . . . 0.0 110.29 172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -69.07 -36.14 77.3 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.208 1.003 . . . . 0.0 110.916 -175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -135.23 -57.0 0.81 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.556 0.742 . . . . 0.0 110.753 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.85 -66.5 3.9 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.25 -54.93 10.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.358 0.663 . . . . 0.0 110.433 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -83.56 8.57 13.75 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.207 0.603 . . . . 0.0 111.937 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.6 t -63.68 -25.75 68.35 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.051 0.54 . . . . 0.0 110.302 172.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.42 -42.34 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.395 1.078 . . . . 0.0 110.425 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -61.15 -48.87 79.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.724 0.41 . . . . 0.0 110.213 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -57.2 -51.54 68.91 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.587 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.0 pt -76.38 -42.01 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.153 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.34 -49.55 41.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.731 0.413 . . . . 0.0 110.479 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -65.86 -37.47 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.62 0.768 . . . . 0.0 111.98 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -65.03 -36.13 83.38 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.071 0.548 . . . . 0.0 110.499 176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 138' ' ' ILE . 54.1 ttp180 -70.68 -40.62 72.85 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.376 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.89 -33.66 76.55 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.099 0.959 . . . . 0.0 110.622 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.38 -28.05 68.34 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.0 0.92 . . . . 0.0 110.838 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.43 -34.99 28.0 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.494 0.717 . . . . 0.0 111.118 176.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 134' ' ' ARG . 38.8 mm -70.52 -29.68 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.18 0.592 . . . . 0.0 109.854 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.7 m -86.43 -50.36 6.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.82 0.448 . . . . 0.0 110.118 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.65 -59.04 4.61 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.874 -169.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.4 mt -58.77 -59.02 15.07 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -169.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 -25.0 45.23 Favored 'Trans proline' 0 C--N 1.391 2.792 0 CA-C-N 121.712 1.647 . . . . 0.0 111.653 -173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -69.64 -42.83 73.75 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.702 0.801 . . . . 0.0 110.327 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.405 ' O ' HG13 ' A' ' 148' ' ' ILE . 88.9 m -65.64 -39.1 91.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.783 0.833 . . . . 0.0 110.228 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 11' ' ' ILE . 3.5 mm? -56.89 -52.32 65.63 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.769 0.828 . . . . 0.0 110.664 175.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.11 -34.22 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.905 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.3 63.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.449 0.7 . . . . 0.0 112.224 -175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.447 HG12 HD12 ' A' ' 23' ' ' LEU . 81.9 mt -66.72 -40.78 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.555 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.3 tm0? -65.28 -44.11 89.06 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.721 175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -64.82 -49.09 72.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.043 0.937 . . . . 0.0 111.467 -174.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.8 tt -64.2 -32.05 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 122.916 0.486 . . . . 0.0 111.108 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.46 HD12 HG21 ' A' ' 13' ' ' ILE . 91.8 mt -79.06 -29.63 43.56 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.488 0.715 . . . . 0.0 111.075 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.0 -30.2 44.17 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.512 0.325 . . . . 0.0 111.203 174.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.93 -33.0 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.475 0.71 . . . . 0.0 109.564 174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -59.31 -36.74 76.17 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.923 0.889 . . . . 0.0 110.569 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 99.8 mt -85.12 -38.87 18.58 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.524 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -115.9 54.04 0.83 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.939 0.896 . . . . 0.0 110.554 -171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -62.64 106.45 0.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.189 0.596 . . . . 0.0 110.639 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 72.73 9.24 5.59 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.861 1.265 . . . . 0.0 111.649 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -98.29 74.85 2.23 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 172.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -136.36 58.96 1.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -78.27 128.05 33.14 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.684 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.192 1.397 . . . . 0.0 111.261 176.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.189 0 CA-C-O 118.414 -0.803 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.82 -39.07 39.05 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.294 2.662 . . . . 0.0 113.054 171.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.1 tttm 71.12 -75.83 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.523 1.139 . . . . 0.0 111.489 167.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.0 p -164.6 -179.27 5.83 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.948 0.899 . . . . 0.0 108.993 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 93.4 mt -73.23 85.67 1.41 Allowed 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.5 t -123.91 137.72 54.59 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.184 0.594 . . . . 0.0 110.001 -174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -145.7 144.09 30.17 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.43 147.49 51.73 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 0.0 109.491 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -153.84 155.96 36.75 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.6 p -150.12 150.25 31.4 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.236 0.614 . . . . 0.0 110.551 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.603 HG22 HD12 ' A' ' 145' ' ' LEU . 18.8 tt -153.52 142.29 13.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 123.127 0.571 . . . . 0.0 109.605 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -87.86 101.83 14.1 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 149' ' ' GLN . 44.0 mt -74.56 130.26 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.14 0.976 . . . . 0.0 109.637 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.28 69.13 6.66 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-O 121.608 0.718 . . . . 0.0 109.191 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.4 145.57 5.72 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 124.638 1.175 . . . . 0.0 108.596 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.15 155.59 55.39 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.002 2.468 . . . . 0.0 112.744 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 97' ' ' PRO . 20.8 tt -69.36 -27.63 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -69.47 -30.91 68.91 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.681 0.392 . . . . 0.0 110.366 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' HG3' HD22 ' A' ' 152' ' ' LEU . 6.4 tp-100 -73.87 -45.82 48.62 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.235 1.014 . . . . 0.0 110.178 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG21 ' HB ' ' A' ' 102' ' ' THR . 84.3 t -60.98 -43.83 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.351 178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -68.74 -34.58 75.85 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.547 0.739 . . . . 0.0 110.323 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.42 -20.85 66.17 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.86 0.464 . . . . 0.0 111.333 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.98 -46.37 9.42 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.095 0.558 . . . . 0.0 110.136 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.442 HG22 HD13 ' A' ' 148' ' ' ILE . 70.9 t -76.24 -28.22 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.542 1.137 . . . . 0.0 112.478 -170.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.5 t -85.81 168.91 13.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.586 0.354 . . . . 0.0 110.324 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.6 t0 69.01 133.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.378 1.471 . . . . 0.0 112.267 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 54' ' ' PHE . 2.6 pp -100.06 -13.95 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.88 0.872 . . . . 0.0 112.623 -175.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.1 p -86.12 -64.05 1.22 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 56.2 -83.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.31 1.444 . . . . 0.0 111.744 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 p -141.05 129.07 21.96 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.781 1.232 . . . . 0.0 108.031 174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.57 17.39 56.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.123 -0.82 . . . . 0.0 114.234 -172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 64.48 106.54 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.714 1.206 . . . . 0.0 110.853 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.72 -46.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.536 1.534 . . . . 0.0 112.482 -177.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 p -166.99 164.87 9.7 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.556 1.143 . . . . 0.0 108.391 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.07 72.85 3.91 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.042 1.828 . . . . 0.0 112.007 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.1 m -80.52 3.93 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 C-N-CA 123.71 0.804 . . . . 0.0 111.722 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.41 ' SG ' ' HB3' ' A' ' 40' ' ' CYS . 45.8 t -69.36 120.28 14.93 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.431 0.693 . . . . 0.0 109.189 171.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.32 -47.7 80.87 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.701 0.8 . . . . 0.0 111.096 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HD3' ' HE1' ' A' ' 41' ' ' TRP . 39.7 ttmt -149.81 132.67 16.05 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.472 -174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.41 ' HB3' ' SG ' ' A' ' 37' ' ' CYS . 18.6 p -146.23 117.8 8.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 123.673 0.608 . . . . 0.0 110.32 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.534 ' HD1' ' HB ' ' A' ' 55' ' ' THR . 92.8 m95 -103.4 122.56 45.11 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -81.33 167.9 19.0 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.726 0.81 . . . . 0.0 111.569 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -63.55 -39.64 94.94 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.352 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.82 -22.43 64.18 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.063 1.345 . . . . 0.0 112.759 -177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -57.03 -34.44 68.21 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.987 0.915 . . . . 0.0 110.629 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -127.42 0.65 6.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.447 1.099 . . . . 0.0 111.358 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.98 138.73 1.26 Allowed Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.337 -1.257 . . . . 0.0 111.867 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -69.15 77.88 0.83 Allowed 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.911 2.408 . . . . 0.0 112.392 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.1 m -132.89 168.2 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.562 1.145 . . . . 0.0 110.285 -177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.98 94.61 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.476 0.71 . . . . 0.0 109.249 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 144.55 -28.37 1.92 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.038 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.19 33.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.012 0.525 . . . . 0.0 110.137 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 70' ' ' GLU . 28.0 p-80 -145.2 128.37 16.68 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.479 0.657 . . . . 0.0 111.237 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' HB3' HG12 ' A' ' 27' ' ' ILE . 54.4 m-85 -78.84 142.18 37.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 168.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.534 ' HB ' ' HD1' ' A' ' 41' ' ' TRP . 81.3 m -147.28 110.83 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 170.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.37 124.93 4.04 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.664 -0.52 . . . . 0.0 111.948 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -110.01 126.71 54.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.255 0.622 . . . . 0.0 110.236 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -85.34 127.57 34.39 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.75 127.54 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -155.26 141.35 12.95 Favored Pre-proline 0 CA--C 1.555 1.144 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -45.78 -32.0 8.48 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.443 2.762 . . . . 0.0 114.845 174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.83 -28.85 14.53 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.944 0.498 . . . . 0.0 112.16 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -133.2 131.83 40.82 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.37 0.605 . . . . 0.0 111.897 -170.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.2 p -145.92 122.48 11.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.072 0.949 . . . . 0.0 108.614 177.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -164.74 145.26 7.6 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.876 0.47 . . . . 0.0 109.84 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.34 152.02 45.29 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.977 0.911 . . . . 0.0 109.789 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.6 p -135.86 116.24 13.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.531 0.732 . . . . 0.0 109.344 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -95.2 96.34 9.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.081 0.943 . . . . 0.0 108.557 171.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' CD1' ' A' ' 82' ' ' TRP . 15.9 m -101.51 104.71 15.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.789 -176.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' A' ' 53' ' ' HIS . 38.5 tt0 -98.78 123.24 42.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.364 0.266 . . . . 0.0 110.406 -173.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.88 102.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 O-C-N 124.283 0.99 . . . . 0.0 110.582 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 92' ' ' ILE . 48.7 pt -87.45 -20.03 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.037 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.5 128.62 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.754 0.822 . . . . 0.0 109.44 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -144.01 103.31 4.01 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -124.13 121.68 26.2 Favored Pre-proline 0 C--O 1.244 0.811 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -52.16 103.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 123.895 3.063 . . . . 0.0 113.053 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.448 HD22 ' N ' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 63.16 29.87 16.06 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.44 1.096 . . . . 0.0 111.27 174.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.446 ' HA ' HH11 ' A' ' 78' ' ' ARG . 10.4 mmm180 -125.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.326 0.65 . . . . 0.0 110.867 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.8 m -149.12 119.59 7.4 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.784 0.434 . . . . 0.0 110.136 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -128.38 118.9 23.98 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.26 161.95 31.54 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.414 ' CD1' ' HB3' ' A' ' 69' ' ' SER . 25.2 p90 -138.06 176.69 8.48 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.09 0.956 . . . . 0.0 110.919 -173.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 60.9 m -129.48 119.72 24.22 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.766 0.826 . . . . 0.0 108.94 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 40.2 t -82.13 132.91 30.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 C-N-CA 124.059 0.944 . . . . 0.0 109.925 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 18.3 m 57.43 63.71 1.78 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.551 1.141 . . . . 0.0 110.128 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 71.54 -71.43 0.13 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.799 1.64 . . . . 0.0 110.956 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -161.53 28.9 0.29 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.29 174.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -69.22 -59.16 3.2 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.593 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 31.6 t -107.06 145.27 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -131.95 131.41 42.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -121.09 120.02 34.12 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 47.8 mm -123.05 112.49 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.436 ' CE2' ' HG2' ' A' ' 106' ' ' GLU . 52.6 m-85 -105.99 101.22 10.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 44.4 m -81.69 148.87 28.77 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 167.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 16.5 ptp -148.83 113.88 5.47 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -94.11 110.75 49.97 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.904 0.882 . . . . 0.0 110.078 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.433 ' HB3' HG21 ' A' ' 17' ' ' ILE . 77.7 Cg_endo -74.76 81.14 2.21 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.866 2.378 . . . . 0.0 112.415 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.47 157.03 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.07 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -75.41 -28.1 59.28 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.026 0.53 . . . . 0.0 110.202 174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.93 -29.23 29.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.814 0.845 . . . . 0.0 111.472 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.92 -138.15 3.47 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.082 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' HG21 ' A' ' 20' ' ' VAL . 87.5 m -154.07 125.54 7.51 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.653 0.726 . . . . 0.0 110.471 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.5 96.77 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' HD2' ' A' ' 93' ' ' TYR . 2.2 tm? -83.5 121.69 27.54 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 113.29 20.42 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.414 1.086 . . . . 0.0 109.254 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.479 ' HB2' HD21 ' A' ' 145' ' ' LEU . 0.7 OUTLIER -89.97 144.03 26.27 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 15.7 m -139.45 105.75 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 81.5 t90 -102.36 143.18 32.44 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.177 0.991 . . . . 0.0 110.009 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -138.61 144.49 39.79 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.075 0.95 . . . . 0.0 109.13 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.588 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 55.0 t80 -125.36 102.01 7.22 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 169.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.0 p -67.87 153.62 94.92 Favored Pre-proline 0 C--O 1.25 1.119 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.232 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 115' ' ' GLN . 50.2 Cg_exo -56.62 -4.88 0.95 Allowed 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.231 2.621 . . . . 0.0 115.411 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.52 -61.1 2.65 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.706 1.202 . . . . 0.0 112.331 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.04 -45.55 86.71 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.046 -0.524 . . . . 0.0 113.288 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.449 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 3.6 pt20 -67.81 -22.99 65.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.871 0.468 . . . . 0.0 111.501 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -66.4 -34.96 79.13 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.425 0.69 . . . . 0.0 110.922 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -61.97 -48.15 81.67 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.328 0.651 . . . . 0.0 110.124 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.91 -26.41 62.3 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.09 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -75.99 -25.97 56.28 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.808 . . . . 0.0 110.206 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -73.98 -44.63 54.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.486 0.714 . . . . 0.0 110.608 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.67 -56.29 3.48 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.161 0.584 . . . . 0.0 110.341 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 73.1 m-85 -99.27 62.63 1.26 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.849 0.859 . . . . 0.0 109.586 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.31 -31.68 74.56 Favored Glycine 0 N--CA 1.478 1.474 0 CA-C-N 116.479 -0.328 . . . . 0.0 113.647 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.12 -44.18 20.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.609 0.763 . . . . 0.0 110.97 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 56.8 tttp -88.78 4.82 46.2 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.019 0.928 . . . . 0.0 111.707 -174.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -63.24 -27.36 69.29 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.037 0.935 . . . . 0.0 112.004 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.5 mp -67.05 -41.85 87.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.345 0.658 . . . . 0.0 109.387 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.18 -31.88 71.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.107 0.563 . . . . 0.0 110.835 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -69.03 -54.46 15.01 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.481 0.712 . . . . 0.0 111.306 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.74 -31.16 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 134' ' ' ARG . 33.7 tt0 -74.34 -33.84 63.24 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.411 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.998 0.519 . . . . 0.0 109.649 177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -70.54 -46.44 63.58 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.75 -178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB3' HD22 ' A' ' 5' ' ' LEU . 16.9 ptt180 -70.11 -42.26 72.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.624 -175.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.78 -42.33 86.22 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-N 118.175 0.443 . . . . 0.0 110.557 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.79 -25.89 68.38 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.187 0.595 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -83.96 -48.5 9.91 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.45 0.7 . . . . 0.0 111.543 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 89.7 mt -61.63 -28.0 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.429 0.692 . . . . 0.0 110.738 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.3 m -89.07 -53.83 4.4 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.328 0.651 . . . . 0.0 110.173 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.43 -46.19 91.13 Favored Glycine 0 C--N 1.353 1.492 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 -168.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.411 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 84.5 mt -61.67 -51.08 79.01 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.921 -1.038 . . . . 0.0 112.438 -175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 51.4 Cg_exo -54.56 -43.54 57.96 Favored 'Trans proline' 0 C--N 1.396 3.054 0 C-N-CA 122.222 1.948 . . . . 0.0 112.575 175.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -60.35 -36.75 78.74 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.45 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.1 m -67.13 -42.97 83.56 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.139 0.576 . . . . 0.0 110.609 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.603 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -61.21 -45.45 94.51 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.088 0.555 . . . . 0.0 111.078 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 142' ' ' PRO . 64.6 t -66.66 -33.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.436 0.694 . . . . 0.0 110.72 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.36 -49.23 67.61 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.992 0.517 . . . . 0.0 110.992 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 24' ' ' VAL . 82.9 mt -61.94 -46.38 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.616 0.766 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.503 ' HA ' HG23 ' A' ' 13' ' ' ILE . 13.1 tm0? -57.75 -58.77 6.88 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.283 1.033 . . . . 0.0 111.556 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.9 ttp180 -66.97 -43.64 82.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.838 -173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.3 tt -59.36 -36.72 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 118.162 0.437 . . . . 0.0 110.664 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.453 HD12 HG21 ' A' ' 13' ' ' ILE . 77.4 mt -65.27 -54.2 32.83 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.943 0.897 . . . . 0.0 110.755 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -68.52 -44.69 74.06 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.384 0.674 . . . . 0.0 112.099 -173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.26 -35.03 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.486 1.114 . . . . 0.0 110.92 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -72.79 -24.45 60.93 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.478 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 86.4 mt -73.24 -41.03 64.18 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.021 0.439 . . . . 0.0 109.877 173.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -73.61 -12.01 60.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.87 0.868 . . . . 0.0 113.097 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -51.8 164.91 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.746 1.218 . . . . 0.0 114.033 -174.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.4 m170 65.12 40.58 4.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.744 1.217 . . . . 0.0 110.056 -174.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -116.85 -167.19 1.25 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.977 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -59.9 110.72 1.24 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.415 0.286 . . . . 0.0 110.672 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 66.58 86.24 0.13 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.983 1.313 . . . . 0.0 110.517 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 . . . . . 0 CA--C 1.561 1.368 0 C-N-CA 125.402 1.481 . . . . 0.0 111.357 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.79 122.04 8.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.909 2.406 . . . . 0.0 111.074 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -70.26 125.01 25.56 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.4 t -92.1 144.84 25.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.562 0.745 . . . . 0.0 112.824 -163.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -87.68 12.65 12.17 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 172.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 109' ' ' GLU . 9.1 t -133.66 133.86 42.44 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 168.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -143.25 147.15 34.36 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -136.1 145.37 45.84 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.272 1.029 . . . . 0.0 108.861 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -152.74 156.56 39.36 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.405 ' HB3' HG23 ' A' ' 105' ' ' THR . 61.0 p -154.96 134.69 12.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.215 0.606 . . . . 0.0 110.407 -175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 145' ' ' LEU . 19.9 tt -133.17 134.03 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 122.818 0.447 . . . . 0.0 110.079 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -80.53 106.66 12.71 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 15' ' ' ALA . 28.8 mt -81.87 142.46 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.175 177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.43 -1.22 20.15 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.58 0.752 . . . . 0.0 112.181 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.03 143.72 27.66 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.455 1.102 . . . . 0.0 109.637 -176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.87 162.03 14.14 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 123.304 2.669 . . . . 0.0 113.874 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.09 -25.35 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.825 1.25 . . . . 0.0 112.406 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -57.65 -51.77 68.16 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.211 0.604 . . . . 0.0 110.6 173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.423 ' HB3' HD22 ' A' ' 152' ' ' LEU . 40.4 mt-30 -70.28 -39.64 74.8 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.222 0.609 . . . . 0.0 111.789 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.8 t -60.09 -44.23 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.896 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -68.61 -38.83 80.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.234 0.613 . . . . 0.0 110.55 175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.8 -21.21 66.32 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 0.0 111.801 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HB2' HD21 ' A' ' 152' ' ' LEU . 1.3 tm? -85.79 -45.66 11.39 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.336 0.654 . . . . 0.0 109.693 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.26 -28.02 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 123.795 0.838 . . . . 0.0 111.109 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -106.58 174.83 5.72 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.985 1.314 . . . . 0.0 109.392 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 65.53 15.39 10.01 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.525 1.13 . . . . 0.0 112.294 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.73 -31.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.045 1.338 . . . . 0.0 110.859 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 73.6 p -80.94 -38.61 27.49 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.957 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.06 -37.65 88.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.464 1.105 . . . . 0.0 111.007 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.8 p -76.6 81.03 3.27 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.218 0.607 . . . . 0.0 110.018 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 163.19 77.06 0.03 OUTLIER Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -70.09 -64.11 0.95 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.907 0.883 . . . . 0.0 110.464 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -81.11 -14.44 57.71 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.023 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.3 m 62.03 87.87 0.13 Allowed Pre-proline 0 CA--C 1.554 1.108 0 O-C-N 124.624 1.203 . . . . 0.0 111.21 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -74.82 -69.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.746 2.298 . . . . 0.0 112.143 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.42 -21.03 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.096 0.958 . . . . 0.0 110.287 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HG ' ' HG ' ' A' ' 40' ' ' CYS . 23.3 t -84.0 138.47 33.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.452 0.701 . . . . 0.0 109.802 175.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' HB3' ' HG3' ' A' ' 57' ' ' ARG . 31.2 tt0 -99.04 -41.47 7.54 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 109.592 172.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -156.05 142.97 18.91 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.962 0.905 . . . . 0.0 109.795 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.721 ' HG ' ' HG ' ' A' ' 37' ' ' CYS . 94.5 m -138.56 121.71 16.88 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.455 0.702 . . . . 0.0 110.012 173.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 -102.34 146.95 27.3 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -117.52 149.77 40.07 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.955 0.343 . . . . 0.0 110.201 -174.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.57 -31.72 70.07 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.242 0.617 . . . . 0.0 110.015 173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -64.62 -32.69 74.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.285 1.034 . . . . 0.0 111.272 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.48 -34.12 73.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.875 0.87 . . . . 0.0 110.884 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -91.21 -38.45 12.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.172 0.989 . . . . 0.0 110.667 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.09 110.04 2.07 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-O 118.097 -1.39 . . . . 0.0 109.797 -169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.34 86.22 0.13 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.443 2.762 . . . . 0.0 112.666 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.3 m -119.23 173.03 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.521 1.128 . . . . 0.0 109.322 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.35 92.09 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.68 -11.02 4.91 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.397 -176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.77 159.8 27.2 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.755 0.422 . . . . 0.0 110.097 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -151.59 141.97 22.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -114.54 125.2 53.52 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.094 0.958 . . . . 0.0 108.562 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.0 m -116.85 110.93 18.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.488 0.715 . . . . 0.0 110.255 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -102.84 101.53 2.11 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.093 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG3' ' HB3' ' A' ' 38' ' ' GLU . 12.7 tpp85 -75.41 102.85 5.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 166.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -106.29 128.8 54.25 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.962 0.905 . . . . 0.0 109.199 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.31 109.31 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 123.728 0.811 . . . . 0.0 109.269 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.2 p -110.47 156.47 40.34 Favored Pre-proline 0 C--O 1.245 0.829 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.72 -23.9 28.14 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -92.34 -48.39 6.69 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 122.915 0.486 . . . . 0.0 111.998 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -140.05 132.16 27.99 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.338 0.655 . . . . 0.0 111.41 -168.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.9 m -108.62 117.17 33.48 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -151.51 139.52 20.07 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.857 0.463 . . . . 0.0 110.481 -175.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 7.3 pt-20 -98.35 129.34 45.02 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.708 0.803 . . . . 0.0 109.669 173.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 38.1 p -105.68 113.12 26.48 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -99.38 95.95 7.38 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 m -96.85 107.09 19.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.443 1.097 . . . . 0.0 109.942 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.13 112.75 24.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.86 0.464 . . . . 0.0 110.369 -178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 82' ' ' TRP . 49.7 t -58.57 104.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.081 1.352 . . . . 0.0 111.314 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 30.9 pt -87.32 -12.02 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.622 0.769 . . . . 0.0 111.676 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.23 110.21 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.425 0.69 . . . . 0.0 109.849 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.05 126.9 36.27 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 157.51 68.09 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.97 0.908 . . . . 0.0 111.726 -168.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.62 47.2 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.823 2.349 . . . . 0.0 111.088 169.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.8 m120 60.51 73.22 0.49 Allowed 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 110.248 -167.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -129.52 -59.17 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.76 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 36.1 t -161.94 96.11 1.0 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -86.41 103.25 14.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.834 0.854 . . . . 0.0 109.556 -173.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.87 139.37 13.37 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.073 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 71' ' ' VAL . 19.7 p-90 -150.81 157.23 42.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.129 0.972 . . . . 0.0 110.367 -176.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 37.6 p -124.56 124.34 42.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.727 0.811 . . . . 0.0 110.61 -177.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.15 122.28 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.646 0.779 . . . . 0.0 110.12 177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.7 m 59.99 80.59 0.2 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 125.137 1.375 . . . . 0.0 111.256 175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 66.08 -76.55 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.848 1.259 . . . . 0.0 111.021 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . -165.61 30.34 0.21 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -48.89 68.32 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.215 1.006 . . . . 0.0 108.904 -177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.03 150.17 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -143.29 131.97 22.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.755 0.422 . . . . 0.0 109.942 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -124.25 120.12 31.3 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.894 0.878 . . . . 0.0 109.377 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.4 mm -112.81 113.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.481 1.113 . . . . 0.0 108.68 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -101.49 100.85 11.34 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.629 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 33.3 t -81.21 133.08 35.39 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 19.7 mmt -110.18 112.97 25.28 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 20.7 mm-40 -113.29 85.04 8.04 Favored Pre-proline 0 N--CA 1.484 1.229 0 C-N-CA 123.264 0.626 . . . . 0.0 109.896 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.14 105.2 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.406 2.071 . . . . 0.0 112.572 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 mt -80.86 172.17 14.08 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.057 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.96 -18.0 60.46 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.439 0.696 . . . . 0.0 112.033 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -122.42 4.36 9.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.555 0.742 . . . . 0.0 112.037 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.34 -154.06 18.13 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.805 -0.518 . . . . 0.0 111.805 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.599 ' HB ' HG21 ' A' ' 20' ' ' VAL . 52.6 m -154.13 132.7 12.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.41 0.684 . . . . 0.0 110.366 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 43.6 t -87.77 104.14 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.85 123.49 27.27 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.629 ' HB ' ' HB3' ' A' ' 94' ' ' SER . 38.7 m -119.42 103.92 9.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.422 0.689 . . . . 0.0 109.295 -177.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.707 ' HB3' HD21 ' A' ' 145' ' ' LEU . 39.9 tt0 -96.63 126.57 41.9 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.8 m -131.66 107.04 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 110.117 -174.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.438 ' CH2' ' HA ' ' A' ' 134' ' ' ARG . 32.3 t90 -90.52 137.6 32.22 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.338 1.055 . . . . 0.0 110.714 177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 6' ' ' THR . 34.7 mt-10 -137.49 129.86 29.54 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.325 1.05 . . . . 0.0 108.544 172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.68 127.56 55.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.305 1.042 . . . . 0.0 108.358 175.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.9 t -72.71 143.24 84.49 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 122.756 0.422 . . . . 0.0 110.041 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.9 -18.1 61.32 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.794 2.33 . . . . 0.0 112.963 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -84.08 -11.58 56.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.414 0.686 . . . . 0.0 110.998 177.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.73 -42.44 97.17 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.546 -0.297 . . . . 0.0 113.038 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.44 -24.34 62.01 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.4 0.68 . . . . 0.0 111.202 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -63.14 -32.61 74.03 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.625 0.77 . . . . 0.0 111.349 176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -59.09 -40.13 84.36 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.107 0.48 . . . . 0.0 110.315 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -80.42 -17.93 50.37 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.647 0.779 . . . . 0.0 111.49 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -78.73 -53.62 6.95 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.433 0.693 . . . . 0.0 110.656 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.05 -27.66 68.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.447 1.099 . . . . 0.0 111.945 -173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -96.07 -57.69 2.28 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.382 0.673 . . . . 0.0 111.149 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.631 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 77.6 m-85 -97.59 -48.25 5.32 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.996 0.518 . . . . 0.0 111.445 -170.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.13 -77.01 0.59 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.886 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.7 -26.28 62.44 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.706 0.802 . . . . 0.0 112.376 -172.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.631 ' HD3' ' HB3' ' A' ' 122' ' ' PHE . 13.0 mptt -62.16 -43.57 98.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.184 0.594 . . . . 0.0 110.465 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.7 t -46.22 -44.26 16.07 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.024 1.33 . . . . 0.0 113.823 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.28 -44.06 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.397 0.679 . . . . 0.0 111.131 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -83.69 -18.61 37.39 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 119.304 -0.379 . . . . 0.0 111.659 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.46 -35.38 27.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.343 0.657 . . . . 0.0 111.134 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.4 tt -62.83 -39.46 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.0 -44.04 73.63 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.946 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -66.47 -43.67 84.82 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.203 1.001 . . . . 0.0 110.897 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.415 HH21 ' HB2' ' A' ' 137' ' ' ALA . 0.0 OUTLIER -58.68 -45.14 90.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.487 1.115 . . . . 0.0 109.598 174.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.438 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 37.8 ttp180 -63.45 -42.58 98.64 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.55 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.45 -55.9 10.25 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.808 0.843 . . . . 0.0 110.33 -178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.67 -33.84 74.69 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.127 0.971 . . . . 0.0 111.763 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 141' ' ' ILE . . . -73.88 -62.1 1.62 Allowed 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.648 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 59.9 mt -62.53 -24.26 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.034 0.534 . . . . 0.0 112.108 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.3 m -76.3 -42.85 43.92 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.655 0.382 . . . . 0.0 110.083 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.24 -26.3 66.48 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.028 -0.873 . . . . 0.0 114.591 -176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 137' ' ' ALA . 96.6 mt -65.59 -59.5 9.26 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.226 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -62.05 -27.39 79.22 Favored 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 121.987 1.791 . . . . 0.0 111.875 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.1 -43.61 86.78 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.256 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.411 ' O ' HG13 ' A' ' 148' ' ' ILE . 69.7 m -68.2 -46.25 71.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.597 0.759 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.5 mm? -55.87 -53.22 59.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.243 0.617 . . . . 0.0 111.663 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.04 -32.37 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.91 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.0 82.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.828 0.451 . . . . 0.0 111.544 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 144' ' ' THR . 74.6 mt -62.96 -45.69 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.53 0.732 . . . . 0.0 109.39 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 13' ' ' ILE . 1.7 tm0? -62.74 -45.16 94.0 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.891 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -63.92 -50.94 66.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.091 0.956 . . . . 0.0 111.459 -174.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -67.12 -30.43 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.946 0.898 . . . . 0.0 110.959 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 84.7 mt -74.5 -29.28 61.36 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.082 0.553 . . . . 0.0 111.111 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 157' ' ' GLU . 61.1 mt-10 -71.68 -35.39 70.26 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 173.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 98.1 t -62.87 -38.65 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.266 0.555 . . . . 0.0 109.814 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -61.28 -43.0 99.6 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.276 174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -62.92 -40.38 97.42 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.683 0.793 . . . . 0.0 111.634 178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 153' ' ' GLU . 53.5 mt-10 -68.53 -33.77 74.69 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.425 0.69 . . . . 0.0 111.728 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -112.05 95.26 5.37 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -58.77 106.75 0.44 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.816 0.697 . . . . 0.0 110.258 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -113.12 167.46 10.52 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.414 1.086 . . . . 0.0 109.825 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -155.4 175.51 13.79 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 108.124 175.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 68.7 117.52 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.339 1.056 . . . . 0.0 110.651 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.917 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.94 87.4 0.15 Allowed 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.537 2.158 . . . . 0.0 111.263 165.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -74.82 120.26 20.12 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.168 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m 63.71 -84.43 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.953 1.301 . . . . 0.0 110.783 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.3 mt -147.16 30.68 0.94 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.09 0.956 . . . . 0.0 110.279 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.8 t -94.86 133.78 38.21 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -137.41 149.71 47.11 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.2 33.44 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -151.15 146.42 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.6 t -137.89 144.06 41.15 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 123.658 0.783 . . . . 0.0 110.017 -172.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 145' ' ' LEU . 19.4 tt -152.96 135.39 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.426 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -82.11 120.32 25.16 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 mt -101.73 145.97 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.022 0.929 . . . . 0.0 108.794 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.77 53.32 2.53 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.608 0.763 . . . . 0.0 110.049 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.3 139.67 14.67 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.429 0.692 . . . . 0.0 110.151 -176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' O ' HG23 ' A' ' 20' ' ' VAL . 39.6 Cg_endo -67.78 143.22 60.57 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.582 2.188 . . . . 0.0 111.523 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 17.4 tt -57.59 -24.8 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.923 0.889 . . . . 0.0 112.166 -176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -50.78 -48.65 59.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.447 1.099 . . . . 0.0 111.096 175.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -87.83 -31.19 19.67 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 17' ' ' ILE . 98.6 t -57.85 -52.06 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 122.624 0.37 . . . . 0.0 110.8 -177.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -57.31 -34.74 69.04 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.74 0.816 . . . . 0.0 112.03 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.34 77.6 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.117 0.567 . . . . 0.0 110.997 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.9 -15.95 46.12 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.14 0.576 . . . . 0.0 112.389 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 148' ' ' ILE . 54.6 t -83.61 -55.13 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.458 0.703 . . . . 0.0 109.692 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -87.86 92.79 9.25 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.207 -174.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -99.16 97.68 8.76 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 166.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' H ' ' A' ' 28' ' ' THR . 16.1 pt -59.64 -56.46 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.946 170.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.636 ' H ' HG13 ' A' ' 27' ' ' ILE . 12.1 t 177.88 18.31 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.815 1.646 . . . . 0.0 109.074 -169.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.4 ttm105 -77.54 -47.95 18.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 110.441 -165.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.1 t -99.75 123.21 43.78 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.501 175.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -145.03 23.94 1.92 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -73.11 119.82 17.88 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.8 m95 65.33 14.31 9.35 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.435 1.094 . . . . 0.0 111.775 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.5 t -156.68 89.43 2.66 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -83.42 29.77 0.54 Allowed 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 123.347 2.698 . . . . 0.0 112.543 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.8 m -70.43 -32.67 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.684 0.794 . . . . 0.0 111.305 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.09 85.77 3.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HB2' HG12 ' A' ' 59' ' ' VAL . 39.9 tt0 -78.75 -57.23 3.86 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.179 0.592 . . . . 0.0 110.632 -177.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.28 114.75 9.83 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 28' ' ' THR . 63.0 m -125.15 124.55 42.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 173.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -101.56 116.33 32.51 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.588 ' HE3' ' HB3' ' A' ' 44' ' ' GLU . 2.1 p-90 -118.64 114.34 22.6 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.267 1.027 . . . . 0.0 111.266 -170.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.14 -2.46 34.46 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.58 0.752 . . . . 0.0 111.653 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.588 ' HB3' ' HE3' ' A' ' 42' ' ' TRP . 29.4 tt0 -57.65 -34.37 69.28 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.278 0.631 . . . . 0.0 110.555 170.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.24 -39.89 82.16 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 0.0 110.251 176.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -72.84 -25.09 60.99 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.297 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.55 119.99 1.59 Allowed Glycine 0 C--N 1.348 1.25 0 CA-C-O 118.442 -1.199 . . . . 0.0 110.25 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.19 89.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.985 2.457 . . . . 0.0 111.857 175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.94 155.34 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 124.243 1.017 . . . . 0.0 110.543 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -67.55 112.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.39 4.95 25.0 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.308 -173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.77 138.06 58.16 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.095 0.558 . . . . 0.0 110.224 174.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -104.18 129.32 51.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' HZ ' ' HB2' ' A' ' 44' ' ' GLU . 15.5 m-85 -124.04 102.18 7.62 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' CYS . 25.5 p -99.7 107.04 19.03 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.58 100.39 2.39 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -90.38 118.82 30.16 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.11 145.14 40.3 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.902 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.567 HG12 ' HB2' ' A' ' 38' ' ' GLU . 14.7 p -131.27 131.7 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.296 0.57 . . . . 0.0 109.618 175.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.9 p -130.74 163.94 45.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 174.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.52 -22.29 50.38 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.572 2.181 . . . . 0.0 112.8 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -80.19 -63.79 1.33 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.784 0.833 . . . . 0.0 110.418 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -148.52 164.41 34.29 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.824 0.85 . . . . 0.0 111.044 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.444 ' HB ' HG23 ' A' ' 59' ' ' VAL . 11.0 t -138.2 136.35 36.51 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.847 0.859 . . . . 0.0 109.523 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -171.69 163.7 6.55 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.958 0.903 . . . . 0.0 108.952 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -105.35 164.69 11.66 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.836 0.455 . . . . 0.0 112.046 -179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -142.63 113.97 7.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.414 1.086 . . . . 0.0 108.136 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.615 ' HD3' ' H ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -84.66 141.65 30.46 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 35.0 m -140.46 121.53 14.7 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.491 1.117 . . . . 0.0 108.553 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -99.21 126.01 44.92 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.0 t -73.06 112.17 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.074 0.95 . . . . 0.0 110.65 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.2 pt -83.31 -28.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.546 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.26 131.92 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -138.64 104.87 5.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.352 0.596 . . . . 0.0 110.799 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.1 108.01 10.45 Favored Pre-proline 0 C--O 1.239 0.5 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.57 -9.77 23.83 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.844 2.363 . . . . 0.0 114.058 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -136.97 14.04 3.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.871 0.468 . . . . 0.0 111.608 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -132.84 -57.13 0.93 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.921 0.489 . . . . 0.0 110.56 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.9 t -166.83 113.47 0.81 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.931 0.492 . . . . 0.0 110.965 -175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -116.83 110.77 18.79 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.33 144.74 15.29 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.031 0.348 . . . . 0.0 113.055 -176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 71' ' ' VAL . 25.8 p90 -128.29 -178.86 4.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.753 1.221 . . . . 0.0 110.684 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.609 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 50.4 m -132.82 120.18 21.23 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.141 0.977 . . . . 0.0 109.04 172.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.1 135.83 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.29 1.036 . . . . 0.0 110.624 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 m 56.41 71.55 0.56 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.024 1.33 . . . . 0.0 110.338 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 66.29 -74.19 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.165 1.386 . . . . 0.0 110.096 -172.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -166.65 38.89 0.25 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.686 175.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.589 HD22 HG23 ' A' ' 89' ' ' VAL . 11.1 t30 -74.48 -54.17 8.07 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.655 0.782 . . . . 0.0 109.446 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.589 HG23 HD22 ' A' ' 88' ' ' ASN . 49.2 t -111.17 159.76 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 170.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HE2' ' HB3' ' A' ' 109' ' ' GLU . 34.9 ttpt -142.98 128.36 18.89 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -123.75 134.7 53.63 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 81.5 mt -137.81 112.41 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.006 0.522 . . . . 0.0 109.703 -177.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -95.87 100.76 12.42 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 49.8 m -86.36 150.03 24.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 15.8 ptp -152.1 123.53 7.78 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.692 0.797 . . . . 0.0 109.027 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.33 99.57 24.69 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.884 0.874 . . . . 0.0 109.224 -176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' A' ' 17' ' ' ILE . 57.5 Cg_endo -68.75 103.52 1.01 Allowed 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.796 2.331 . . . . 0.0 112.122 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.24 174.65 5.89 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.126 0.57 . . . . 0.0 110.17 176.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -79.12 -35.16 42.66 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.15 0.58 . . . . 0.0 111.271 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -11.79 41.81 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.339 0.656 . . . . 0.0 111.942 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.67 -146.51 9.8 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.421 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.8 m -148.66 128.22 13.18 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.458 0.703 . . . . 0.0 109.951 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 t -89.4 102.14 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.4 138.07 35.62 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 30.3 m -138.23 106.82 5.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.947 0.899 . . . . 0.0 108.75 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -90.8 140.53 29.71 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 37.6 m -135.69 105.36 6.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.466 0.706 . . . . 0.0 109.693 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.531 ' HB3' HD11 ' A' ' 141' ' ' ILE . 83.3 t90 -93.62 155.57 17.21 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.43 1.092 . . . . 0.0 109.84 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.464 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 35.5 tt0 -155.31 135.5 13.08 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.98 0.912 . . . . 0.0 108.821 171.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -101.33 101.93 12.68 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 165.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -68.33 135.84 91.13 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.207 1.003 . . . . 0.0 110.79 -175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 115' ' ' GLN . 50.3 Cg_exo -57.5 -1.97 0.58 Allowed 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 123.851 3.034 . . . . 0.0 115.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -51.26 -69.85 0.1 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.685 1.194 . . . . 0.0 111.78 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.93 -22.05 60.19 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 116.3 -0.409 . . . . 0.0 112.936 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -61.0 -52.93 62.93 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.13 0.972 . . . . 0.0 110.055 179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -65.49 -27.63 68.62 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.342 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.27 -41.54 97.11 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -75.93 -27.56 57.64 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 122.358 0.263 . . . . 0.0 111.115 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 34.8 t-80 -66.79 -50.57 62.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.13 0.572 . . . . 0.0 111.286 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.89 -17.62 61.5 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.385 0.674 . . . . 0.0 111.126 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -75.34 -79.13 0.1 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.035 0.534 . . . . 0.0 110.248 168.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -78.56 -56.61 4.29 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.982 0.42 . . . . 0.0 110.484 -171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.57 -55.19 3.83 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.786 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.64 -56.09 8.22 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.867 0.467 . . . . 0.0 111.481 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -91.19 12.89 18.67 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -172.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.512 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 65.7 p -64.11 -29.34 70.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.09 0.471 . . . . 0.0 110.173 170.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.407 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 49.5 mm -66.48 -48.09 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.125 173.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -59.61 -37.56 78.91 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.145 0.43 . . . . 0.0 110.939 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.29 -55.37 32.21 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.924 0.89 . . . . 0.0 109.321 177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.42 -22.95 17.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.657 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.839 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 127' ' ' ILE . 11.2 mm-40 -65.79 -57.37 8.13 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -59.97 -41.17 91.39 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.432 0.693 . . . . 0.0 111.56 -176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -72.81 -37.86 67.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 138' ' ' ILE . 44.4 ttp180 -73.01 -41.98 63.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.571 0.348 . . . . 0.0 110.746 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.1 -42.5 99.58 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.022 0.929 . . . . 0.0 110.496 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.68 64.56 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.362 0.665 . . . . 0.0 111.739 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.22 -48.79 9.42 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.335 0.654 . . . . 0.0 111.244 176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 134' ' ' ARG . 67.2 mt -64.32 -25.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 122.904 0.481 . . . . 0.0 110.057 -178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 143' ' ' GLU . 31.8 m -82.79 -54.54 5.03 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -63.9 -43.8 97.0 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 115.874 1.109 . . . . 0.0 115.874 -165.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.532 ' HB ' ' HD3' ' A' ' 142' ' ' PRO . 34.2 mt -63.37 -53.13 55.41 Favored Pre-proline 0 CA--C 1.569 1.68 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.796 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.532 ' HD3' ' HB ' ' A' ' 141' ' ' ILE . 75.6 Cg_exo -51.19 -43.87 46.12 Favored 'Trans proline' 0 C--N 1.403 3.397 0 C-N-CA 122.544 2.163 . . . . 0.0 113.03 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 139' ' ' THR . 12.2 mm-40 -58.16 -40.19 80.78 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.632 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 50.7 m -65.92 -43.81 87.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.187 0.595 . . . . 0.0 110.786 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -62.38 -46.24 89.54 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.015 0.526 . . . . 0.0 111.511 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 90.5 t -66.74 -36.77 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.181 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.57 -42.72 95.46 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.631 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 24' ' ' VAL . 85.2 mt -65.7 -45.15 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 123.568 0.747 . . . . 0.0 109.923 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -60.81 -43.88 97.6 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.06 176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -69.93 -42.64 73.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.265 -168.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.409 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 20.2 tt -66.46 -33.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.356 0.41 . . . . 0.0 110.191 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 68.5 mt -68.55 -43.09 77.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.379 0.672 . . . . 0.0 110.699 175.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -62.87 -36.09 82.15 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.42 0.688 . . . . 0.0 110.71 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.3 t -63.54 -45.84 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.843 0.857 . . . . 0.0 109.67 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 158' ' ' HIS . 32.4 mm-40 -69.0 -25.86 64.72 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.081 0.552 . . . . 0.0 112.229 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 78.5 mt -70.09 -26.78 64.14 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.887 0.475 . . . . 0.0 110.937 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -119.65 17.96 12.75 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.499 0.72 . . . . 0.0 111.331 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 155' ' ' GLU . 16.9 t-80 -79.98 8.5 6.91 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.092 0.557 . . . . 0.0 112.091 -172.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -63.72 78.69 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.767 0.827 . . . . 0.0 109.89 169.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -176.09 109.02 0.09 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.052 1.341 . . . . 0.0 107.568 -173.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -137.2 91.85 2.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -159.43 111.72 2.14 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.987 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.248 0.994 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 169.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 ttm . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -50.11 130.92 29.44 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.378 2.719 . . . . 0.0 113.608 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -111.96 154.47 25.23 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.543 1.137 . . . . 0.0 108.582 175.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.3 m -60.25 152.16 25.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.784 0.434 . . . . 0.0 109.941 172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.26 85.39 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.307 0.643 . . . . 0.0 111.159 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 33.9 p -136.27 140.53 43.49 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.574 1.15 . . . . 0.0 108.439 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -156.02 153.17 29.05 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.499 1.12 . . . . 0.0 108.045 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -149.46 145.6 26.99 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -145.13 148.19 33.34 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.665 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 p -144.94 152.34 40.05 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.121 -174.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.5 133.91 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.529 0.732 . . . . 0.0 109.082 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 52.0 t30 -83.76 123.81 30.25 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 149' ' ' GLN . 63.7 mt -103.78 138.96 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 124.404 1.082 . . . . 0.0 109.242 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.69 69.83 6.07 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.247 0.619 . . . . 0.0 109.773 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.5 148.23 7.81 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 124.229 1.012 . . . . 0.0 109.978 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.65 161.31 42.16 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.678 2.252 . . . . 0.0 112.605 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.768 ' HB ' ' HB3' ' A' ' 97' ' ' PRO . 7.5 tp -55.79 -34.04 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.437 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -59.48 -46.14 89.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.683 0.793 . . . . 0.0 111.301 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.65 -51.45 59.42 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.188 0.595 . . . . 0.0 111.145 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.97 -37.89 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 123.521 0.728 . . . . 0.0 111.38 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -73.66 -45.27 53.65 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.676 0.79 . . . . 0.0 110.507 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 -21.93 64.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.968 0.507 . . . . 0.0 111.808 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD23 HG23 ' A' ' 148' ' ' ILE . 34.5 tp -86.28 -51.09 6.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.177 0.591 . . . . 0.0 110.71 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -84.53 -49.77 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.668 0.787 . . . . 0.0 112.176 -172.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.3 m -86.75 8.02 24.36 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.335 0.654 . . . . 0.0 112.696 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.03 141.19 50.93 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.99 0.516 . . . . 0.0 110.457 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -131.37 9.47 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.006 0.923 . . . . 0.0 110.807 -175.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 p -119.5 -59.2 1.85 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.87 -0.519 . . . . 0.0 111.359 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -74.12 -26.18 60.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.508 0.723 . . . . 0.0 110.95 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -61.53 -20.92 63.78 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.25 1.02 . . . . 0.0 111.953 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.81 83.73 0.48 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -147.43 3.22 0.76 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.516 0.326 . . . . 0.0 111.81 -174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.513 ' HD1' HG21 ' A' ' 59' ' ' VAL . 17.6 m-90 74.12 -22.91 0.23 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 124.549 1.139 . . . . 0.0 113.151 -177.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.499 ' HB2' ' HD3' ' A' ' 35' ' ' PRO . 14.5 m -66.91 -44.78 52.86 Favored Pre-proline 0 CA--C 1.564 1.483 0 C-N-CA 123.248 0.619 . . . . 0.0 110.889 176.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 34' ' ' SER . 5.7 Cg_exo -83.27 -168.43 0.57 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.505 2.137 . . . . 0.0 111.431 163.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.1 m -81.1 1.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.7 m -103.3 137.04 41.96 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.156 0.582 . . . . 0.0 111.052 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -110.4 -51.49 2.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.189 0.995 . . . . 0.0 109.871 173.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -151.37 122.71 7.81 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.245 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 60.4 m -137.94 122.34 18.32 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.851 0.461 . . . . 0.0 110.271 -178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -119.2 126.15 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.112 0.965 . . . . 0.0 108.976 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -123.69 110.29 14.77 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.984 0.897 . . . . 0.0 111.251 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.42 -9.57 58.95 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.557 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -76.7 1.82 16.0 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.589 1.156 . . . . 0.0 111.68 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.59 -27.45 58.06 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.463 1.105 . . . . 0.0 112.258 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -64.39 -30.49 71.53 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.894 0.478 . . . . 0.0 111.875 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -173.22 84.69 0.08 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.015 -0.881 . . . . 0.0 110.988 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.45 84.48 0.6 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.969 2.446 . . . . 0.0 111.207 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.92 178.14 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.545 1.138 . . . . 0.0 110.745 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.67 122.97 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.39 -20.07 33.15 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -172.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 144.33 56.3 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.472 0.709 . . . . 0.0 110.175 175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -141.95 123.6 15.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.982 0.513 . . . . 0.0 110.803 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -112.79 150.21 31.96 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.846 0.858 . . . . 0.0 110.875 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 m -88.54 111.82 22.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.243 0.617 . . . . 0.0 109.474 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.84 107.14 1.15 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 34.5 ttm180 -76.17 109.59 9.97 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.005 0.522 . . . . 0.0 110.141 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -86.07 113.66 22.32 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.288 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.513 HG21 ' HD1' ' A' ' 33' ' ' TRP . 7.6 p -97.53 125.64 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.708 . . . . 0.0 109.788 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.7 p -137.22 159.25 70.43 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.309 1.044 . . . . 0.0 108.225 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -58.32 -23.78 64.7 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.017 2.478 . . . . 0.0 113.187 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.46 -53.79 7.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.529 0.731 . . . . 0.0 110.622 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -156.34 144.71 19.88 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.177 0.513 . . . . 0.0 111.331 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.3 m -106.28 106.94 17.7 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 170.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 -132.33 143.63 50.0 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.043 0.537 . . . . 0.0 110.503 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 30.1 mt-10 -86.65 111.11 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.513 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.7 p -113.18 115.8 28.82 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.142 0.577 . . . . 0.0 110.642 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.0 mtm-85 -81.5 118.88 23.09 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 m -107.01 127.17 53.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.41 1.084 . . . . 0.0 110.022 -175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -98.56 113.72 25.87 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.575 0.75 . . . . 0.0 110.72 -176.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.01 104.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.941 1.297 . . . . 0.0 110.762 175.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 72' ' ' ILE . 8.0 pt -93.64 -11.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.939 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.38 130.95 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.299 1.04 . . . . 0.0 108.472 174.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -137.95 106.17 5.76 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.413 0.685 . . . . 0.0 110.855 -170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 48.7 mm-40 -127.86 153.23 78.08 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.462 1.505 . . . . 0.0 107.692 174.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -55.07 -54.48 4.34 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 122.945 2.43 . . . . 0.0 112.844 -174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -135.32 -9.72 2.22 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.761 0.824 . . . . 0.0 110.942 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 tpp180 -78.06 -32.6 50.92 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.226 0.61 . . . . 0.0 112.084 -169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 49.6 t -167.87 126.19 1.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.99 0.516 . . . . 0.0 110.336 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -134.51 105.57 6.6 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 172.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.38 145.38 16.31 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.988 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -138.58 151.05 46.95 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.513 1.125 . . . . 0.0 109.863 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.3 p -103.72 117.18 33.77 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.7 t -73.54 109.39 5.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 14.1 m 69.73 152.65 0.1 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.845 1.258 . . . . 0.0 110.469 -171.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.37 92.02 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.996 0.918 . . . . 0.0 111.84 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.06 1.53 89.65 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.1 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.0 t30 -70.57 -76.47 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.628 0.771 . . . . 0.0 111.009 -174.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.4 t -116.59 120.71 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 65.5 mttm -99.3 133.76 43.13 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -126.4 118.0 24.1 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 34.3 mm -110.74 111.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -106.6 102.75 12.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.4 m -102.45 123.95 47.13 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.847 0.859 . . . . 0.0 109.39 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 22.0 mtm -116.46 112.55 21.58 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.951 0.9 . . . . 0.0 108.974 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -107.4 95.7 14.29 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 123.683 0.793 . . . . 0.0 109.651 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.768 ' HB3' ' HB ' ' A' ' 17' ' ' ILE . 40.4 Cg_endo -65.17 105.88 0.75 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.108 2.539 . . . . 0.0 112.747 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -81.51 165.15 21.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.555 170.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -73.84 -18.64 60.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.081 0.467 . . . . 0.0 110.067 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.65 -17.26 21.46 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.989 0.916 . . . . 0.0 111.992 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.45 -141.56 5.75 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-O 119.944 -0.364 . . . . 0.0 112.753 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 94.2 m -153.39 128.62 9.77 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.93 0.892 . . . . 0.0 109.382 176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 46.4 t -87.11 108.25 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.451 HD12 HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -79.68 123.7 27.89 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 170.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.1 m -125.53 135.09 51.9 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -121.77 159.56 26.43 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 49.0 m -141.62 108.34 5.37 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.287 0.635 . . . . 0.0 109.82 168.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -85.05 109.24 18.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 40.4 mt-10 -123.51 90.37 3.27 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.466 0.706 . . . . 0.0 109.135 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -84.95 87.83 7.39 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.2 p -76.91 152.35 82.55 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.227 -174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.72 93.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.39 2.74 0 C-N-CA 123.524 2.816 . . . . 0.0 112.314 178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -173.27 -54.85 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.308 1.043 . . . . 0.0 108.286 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.01 57.09 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.757 -1.111 . . . . 0.0 113.617 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -50.69 -45.42 58.22 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.567 0.747 . . . . 0.0 111.338 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -62.22 -42.41 99.28 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.802 0.841 . . . . 0.0 111.512 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -57.59 -49.99 74.6 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.152 0.981 . . . . 0.0 111.583 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -75.5 -31.13 60.08 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.307 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -63.91 -26.58 68.66 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.089 0.955 . . . . 0.0 111.49 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -66.23 -33.34 75.52 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.706 0.402 . . . . 0.0 110.975 172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -91.51 -32.73 15.46 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.01 0.924 . . . . 0.0 111.964 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -91.13 -54.17 4.06 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.861 0.864 . . . . 0.0 110.068 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.95 -102.45 1.15 Allowed Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.394 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -74.98 -15.93 60.65 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.521 0.728 . . . . 0.0 111.365 174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -92.08 12.61 21.43 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.242 0.617 . . . . 0.0 110.422 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.1 t -68.11 -15.86 63.77 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.429 0.692 . . . . 0.0 111.695 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.94 -50.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.953 0.501 . . . . 0.0 109.762 171.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -64.48 -37.0 86.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.714 0.406 . . . . 0.0 110.572 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -52.54 -60.04 3.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.127 0.971 . . . . 0.0 111.43 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -72.68 -35.15 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 123.723 0.639 . . . . 0.0 111.303 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -67.3 -58.18 5.28 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.019 0.438 . . . . 0.0 110.555 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -68.54 -26.76 65.59 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.028 0.931 . . . . 0.0 112.074 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -72.21 -36.38 69.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -68.85 -36.8 78.6 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 123.651 0.78 . . . . 0.0 109.745 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.6 mt -76.44 -42.21 44.78 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.48 0.712 . . . . 0.0 111.335 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.51 -34.06 77.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.104 0.562 . . . . 0.0 110.752 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -82.73 -68.51 0.7 Allowed 'General case' 0 C--O 1.216 -0.677 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.548 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 53.2 mt -66.54 -25.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -166.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.3 m -82.81 -38.69 22.74 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.862 -0.524 . . . . 0.0 110.797 172.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.13 -26.12 62.62 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 113.676 -176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.419 ' O ' HD23 ' A' ' 145' ' ' LEU . 50.3 mt -65.12 -58.6 12.04 Favored Pre-proline 0 CA--C 1.56 1.33 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.429 -175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.71 -29.23 77.12 Favored 'Trans proline' 0 C--N 1.398 3.14 0 C-N-CA 121.785 1.656 . . . . 0.0 111.591 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.52 -48.88 79.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.602 0.761 . . . . 0.0 110.279 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 53.5 m -65.32 -42.47 92.92 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.709 0.804 . . . . 0.0 111.093 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.451 HD13 HD12 ' A' ' 104' ' ' LEU . 2.1 mm? -58.97 -46.92 86.9 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.835 0.854 . . . . 0.0 110.983 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 93.8 t -69.45 -33.74 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 122.966 0.506 . . . . 0.0 110.716 177.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.33 -43.15 91.88 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.187 0.595 . . . . 0.0 111.434 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 23' ' ' LEU . 90.6 mt -63.03 -40.67 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.904 0.881 . . . . 0.0 109.959 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.502 ' HA ' HG23 ' A' ' 13' ' ' ILE . 34.4 tt0 -64.97 -54.05 36.64 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.027 176.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 47.6 ttm-85 -66.5 -43.23 85.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.933 -168.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 14.6 tt -62.3 -35.29 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.304 0.642 . . . . 0.0 111.1 -176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 96.4 mt -68.65 -51.52 41.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.453 0.701 . . . . 0.0 109.962 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.33 -43.16 96.65 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.516 0.726 . . . . 0.0 111.869 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' HA ' ' CB ' ' A' ' 158' ' ' HIS . 71.9 t -64.3 -38.15 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.932 0.893 . . . . 0.0 110.973 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -81.45 -11.08 59.35 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.53 -177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 97.2 mt -78.53 -64.88 1.07 Allowed 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -151.33 -80.45 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CB ' ' HA ' ' A' ' 154' ' ' VAL . 16.4 t60 54.47 43.17 30.77 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.005 1.322 . . . . 0.0 111.567 175.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.2 p-80 54.35 8.85 0.21 Allowed 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.979 1.712 . . . . 0.0 114.245 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -164.12 86.38 0.47 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.231 0.612 . . . . 0.0 109.47 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -142.96 94.6 2.65 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -162.82 89.6 0.66 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 173.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.693 0.797 . . . . 0.0 109.002 -177.471 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 ttm . . . . . 0 CA--C 1.566 1.586 0 CA-C-O 118.412 -0.804 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -84.4 177.98 5.41 Favored 'Trans proline' 0 C--N 1.386 2.545 0 CA-C-N 121.803 1.68 . . . . 0.0 111.898 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -73.77 87.76 1.74 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.1 m 59.53 -87.28 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.431 1.092 . . . . 0.0 110.083 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.606 HD11 HG13 ' A' ' 130' ' ' ILE . 18.6 mt -155.23 88.39 1.16 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 125.269 1.428 . . . . 0.0 107.593 173.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.2 t -154.06 144.69 22.42 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.977 0.511 . . . . 0.0 110.241 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.455 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.9 t80 -147.97 141.84 25.78 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 172.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.08 157.61 45.71 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.631 0.773 . . . . 0.0 109.283 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -157.83 139.08 13.49 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 p -131.95 131.22 42.44 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.56 0.744 . . . . 0.0 109.226 177.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 145' ' ' LEU . 16.8 tt -135.39 139.14 47.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 57.2 t30 -78.53 138.24 38.31 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 171.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 15' ' ' ALA . 36.7 mt -118.27 137.64 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.36 8.57 7.28 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.789 0.722 . . . . 0.0 112.038 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -96.37 150.55 37.25 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 123.736 0.814 . . . . 0.0 110.874 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 153.98 24.62 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.188 2.592 . . . . 0.0 113.038 170.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -58.42 -26.45 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.243 1.017 . . . . 0.0 112.255 -175.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.66 -50.98 71.33 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.869 0.868 . . . . 0.0 111.049 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.588 ' HB3' HD22 ' A' ' 152' ' ' LEU . 49.9 mt-30 -66.2 -40.45 90.39 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.711 0.804 . . . . 0.0 111.526 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 102' ' ' THR . 90.4 t -62.18 -52.6 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.015 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.0 -32.85 71.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.262 1.025 . . . . 0.0 111.378 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.75 -51.47 68.22 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.66 0.6 . . . . 0.0 110.763 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.4 mt -73.86 -15.45 61.16 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 20' ' ' VAL . 56.2 t -82.89 -43.75 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.49 0.716 . . . . 0.0 110.478 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 p -153.08 90.93 1.48 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.398 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.47 77.95 0.17 Allowed 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 171.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -131.17 -4.95 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 124.24 1.016 . . . . 0.0 110.465 -172.534 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.5 m -78.36 81.14 4.73 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.191 0.996 . . . . 0.0 110.746 -165.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -138.79 -164.74 1.7 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.01 1.324 . . . . 0.0 108.956 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 27.8 m -69.15 -37.73 78.42 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.353 0.661 . . . . 0.0 110.737 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.35 39.15 0.69 Allowed Glycine 0 N--CA 1.473 1.101 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.396 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -73.64 -41.99 62.03 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.989 0.916 . . . . 0.0 110.753 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' HZ2' ' HA ' ' A' ' 27' ' ' ILE . 12.8 p-90 -103.09 6.61 38.69 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.808 0.843 . . . . 0.0 110.933 -177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 t -136.55 103.65 9.35 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 123.636 0.774 . . . . 0.0 110.072 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.6 -20.21 18.11 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.064 2.51 . . . . 0.0 112.79 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.9 m -77.88 -15.86 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.125 0.57 . . . . 0.0 111.1 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.8 t -78.23 93.26 4.58 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.832 0.853 . . . . 0.0 109.565 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -89.33 -43.28 11.04 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -140.19 127.76 21.58 Favored 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -146.87 110.58 4.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.846 0.459 . . . . 0.0 110.0 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -126.96 118.35 24.35 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 162.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 44' ' ' GLU . 92.1 m95 -107.2 130.62 54.7 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.983 0.513 . . . . 0.0 110.41 -173.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -65.67 -26.42 67.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.506 1.122 . . . . 0.0 111.848 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -64.34 -22.82 67.08 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.416 0.686 . . . . 0.0 112.272 178.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.11 -36.18 81.38 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.674 0.789 . . . . 0.0 110.727 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -98.26 -23.33 15.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.629 -173.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 155.17 95.86 0.12 Allowed Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.649 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.51 90.48 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.659 2.239 . . . . 0.0 110.232 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.6 m -115.25 168.3 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.72 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -71.68 100.97 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.05 -11.55 8.68 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.379 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.88 132.45 48.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.134 0.574 . . . . 0.0 110.406 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -152.33 130.47 11.92 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 122.665 0.386 . . . . 0.0 111.313 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.18 163.35 32.98 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.633 0.773 . . . . 0.0 110.499 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -107.45 153.12 23.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.905 0.859 . . . . 0.0 111.908 -168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.15 -168.08 14.04 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 113.989 -1.46 . . . . 0.0 109.742 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -152.87 106.02 3.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -87.51 136.33 32.99 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 123.776 0.673 . . . . 0.0 109.214 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -130.04 138.26 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.435 0.694 . . . . 0.0 109.763 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 61' ' ' PRO . 32.6 p -137.67 161.99 57.19 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 125.149 1.379 . . . . 0.0 107.616 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 60' ' ' THR . 9.9 Cg_endo -49.24 -28.09 14.23 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 123.991 3.128 . . . . 0.0 115.237 -175.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -113.51 -30.54 6.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.332 0.653 . . . . 0.0 112.355 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -123.71 134.41 53.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.035 0.445 . . . . 0.0 110.896 -162.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -128.89 118.51 22.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.891 0.876 . . . . 0.0 108.713 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -144.72 131.16 19.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 120.995 0.426 . . . . 0.0 110.229 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -84.42 116.09 22.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.052 0.941 . . . . 0.0 108.82 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.6 p -106.64 115.01 29.45 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.988 0.915 . . . . 0.0 111.004 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.719 HH21 ' HB2' ' A' ' 86' ' ' ASP . 21.2 ptt180 -100.37 122.36 43.0 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.7 m -97.46 116.09 29.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.706 0.802 . . . . 0.0 109.507 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -115.78 107.98 15.75 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.433 0.693 . . . . 0.0 110.215 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.21 101.27 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.986 0.914 . . . . 0.0 110.151 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -80.6 -17.51 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.123 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.958 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 p -154.44 134.61 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.683 0.793 . . . . 0.0 109.313 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.52 123.21 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.9 0.48 . . . . 0.0 111.619 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.94 137.13 29.92 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -55.93 93.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 124.067 3.178 . . . . 0.0 113.098 -171.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.424 ' HA ' ' HE2' ' A' ' 80' ' ' PHE . 22.8 t-20 54.93 62.03 2.7 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.496 1.518 . . . . 0.0 110.539 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.9 tpp85 -152.01 -51.71 0.12 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.943 -178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 70.3 m -147.06 117.5 7.44 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.093 0.557 . . . . 0.0 109.804 -178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 77' ' ' ASN . 97.4 m-85 -128.02 102.63 6.83 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.153 0.581 . . . . 0.0 109.455 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.57 121.52 7.11 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -136.11 135.68 39.48 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.372 0.669 . . . . 0.0 110.404 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.4 t -98.39 129.09 45.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.871 0.868 . . . . 0.0 110.33 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 86.4 t -78.28 127.01 38.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 170.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.6 m 71.91 -97.96 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.217 1.407 . . . . 0.0 110.894 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.719 ' HB2' HH21 ' A' ' 68' ' ' ARG . 34.0 t70 178.74 92.72 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -168.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.525 ' HA3' ' HD3' ' A' ' 113' ' ' LYS . . . 71.39 21.54 78.61 Favored Glycine 0 N--CA 1.467 0.744 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.593 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -99.29 -74.03 0.61 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.999 0.919 . . . . 0.0 108.862 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 25.2 t -126.5 147.38 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 -177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HE2' HG23 ' A' ' 111' ' ' THR . 47.6 mtmt -128.59 121.37 28.55 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 170.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -103.45 110.31 22.28 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 171.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.719 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 30.3 mm -107.78 111.38 35.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -105.99 148.13 28.05 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.989 0.916 . . . . 0.0 110.371 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -147.37 122.86 10.4 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.552 0.741 . . . . 0.0 109.382 172.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 95' ' ' MET . 0.4 OUTLIER -117.08 112.97 21.64 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.293 1.037 . . . . 0.0 108.219 177.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.99 101.37 37.32 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.098 0.959 . . . . 0.0 109.88 -172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.35 104.01 1.62 Allowed 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 123.036 2.49 . . . . 0.0 112.098 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.62 166.81 12.62 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.039 0.935 . . . . 0.0 110.505 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -72.7 -21.82 60.99 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.0 0.52 . . . . 0.0 110.927 175.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -91.36 -23.22 20.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.813 0.845 . . . . 0.0 111.316 177.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.21 -129.87 1.9 Allowed Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.417 -0.657 . . . . 0.0 112.506 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.533 ' HB ' HG21 ' A' ' 20' ' ' VAL . 96.6 m -155.75 127.41 7.35 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.113 0.965 . . . . 0.0 109.863 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 48.4 t -87.95 111.06 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.14 137.74 32.09 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.5 m -131.84 110.66 10.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.874 0.869 . . . . 0.0 109.706 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -91.57 144.24 25.74 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.508 0.723 . . . . 0.0 109.347 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.719 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 16.5 m -142.37 106.02 4.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.17 0.588 . . . . 0.0 109.549 171.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' A' ' 110' ' ' PHE . 58.6 t90 -86.17 113.66 22.38 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 171.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 31.5 mt-10 -121.88 102.83 8.43 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 29.7 t80 -85.69 113.74 22.13 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.459 HG23 ' HE2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -82.1 139.71 45.88 Favored Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.882 0.873 . . . . 0.0 111.22 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.41 -12.0 32.58 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 123.54 2.826 . . . . 0.0 114.331 -172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.525 ' HD3' ' HA3' ' A' ' 87' ' ' GLY . 63.4 tttm -59.79 -52.39 65.67 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.854 0.862 . . . . 0.0 111.14 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.22 -23.75 58.41 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.63 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -58.29 9.31 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.268 1.027 . . . . 0.0 110.092 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -62.33 -39.27 92.5 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.885 0.74 . . . . 0.0 112.182 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -63.12 -46.06 89.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.695 0.398 . . . . 0.0 110.632 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -68.68 -29.2 67.6 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.595 0.758 . . . . 0.0 110.4 178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -73.55 -33.01 64.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.687 1.195 . . . . 0.0 110.616 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -81.3 -29.18 34.33 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.492 0.317 . . . . 0.0 110.899 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -74.06 -44.57 53.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.136 0.575 . . . . 0.0 110.475 176.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.577 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 85.0 m-85 -116.18 71.64 0.79 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.0 -53.53 22.31 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.854 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.61 -42.67 82.03 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.267 0.627 . . . . 0.0 110.83 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 46.4 mtpt -72.08 -17.34 62.01 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.515 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.427 ' O ' HG22 ' A' ' 130' ' ' ILE . 29.0 t -52.91 -31.0 37.63 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -170.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.5 mt -63.01 -41.81 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 123.429 0.692 . . . . 0.0 110.55 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -74.26 -43.86 55.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.379 1.072 . . . . 0.0 110.398 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -64.64 -44.82 89.23 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.919 0.888 . . . . 0.0 111.697 -174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.606 HG13 HD11 ' A' ' 5' ' ' LEU . 13.9 tt -67.0 -35.04 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 O-C-N 123.56 0.537 . . . . 0.0 109.769 177.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.5 -38.1 89.85 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 124.122 0.969 . . . . 0.0 110.664 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.2 -52.11 51.19 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.246 0.618 . . . . 0.0 110.558 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.2 mmt85 -66.51 -30.86 71.28 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.949 0.5 . . . . 0.0 111.771 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -74.07 -63.65 1.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.447 0.699 . . . . 0.0 110.003 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.443 ' O ' HG22 ' A' ' 139' ' ' THR . 78.4 mt -60.96 -53.3 58.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.559 0.744 . . . . 0.0 111.669 -174.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.45 -21.67 62.59 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -84.8 -50.75 7.3 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.861 0.363 . . . . 0.0 110.666 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.89 -29.99 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.573 0.749 . . . . 0.0 112.13 -172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 135' ' ' LEU . 6.0 t -97.27 -30.06 13.19 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.151 0.581 . . . . 0.0 110.883 175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -78.64 -46.29 8.81 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 113.742 -171.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 87.5 mt -56.84 -55.04 47.74 Favored Pre-proline 0 CA--C 1.559 1.294 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.766 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 51.0 Cg_endo -64.73 -29.97 59.51 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 121.492 1.569 . . . . 0.0 112.05 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.53 -53.17 58.66 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 109.858 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.2 m -68.42 -31.89 71.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.949 0.9 . . . . 0.0 111.079 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 11' ' ' ILE . 2.8 mm? -66.84 -44.96 79.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.535 0.734 . . . . 0.0 110.518 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.27 -33.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.693 0.397 . . . . 0.0 110.419 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.45 -46.04 70.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.046 0.538 . . . . 0.0 111.22 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.02 -47.94 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.921 0.888 . . . . 0.0 109.712 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.505 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 13.9 tm0? -53.09 -51.65 61.16 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.189 0.931 . . . . 0.0 111.185 176.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -64.28 -57.22 10.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.999 -170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.3 -33.09 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 124.025 0.828 . . . . 0.0 111.528 -172.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 19' ' ' GLN . 72.6 mt -67.73 -44.2 78.15 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.375 0.67 . . . . 0.0 111.121 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 149' ' ' GLN . 73.0 mt-10 -70.93 -35.38 72.22 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.344 0.403 . . . . 0.0 110.956 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.65 -37.16 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.72 0.808 . . . . 0.0 109.711 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -71.49 -30.89 66.49 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.175 0.99 . . . . 0.0 111.388 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 95.6 mt -67.42 -41.15 85.31 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.272 0.629 . . . . 0.0 110.615 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -77.92 -26.4 48.98 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.937 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -68.83 -28.31 66.62 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.485 0.714 . . . . 0.0 109.474 173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -79.09 143.66 35.32 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.699 0.8 . . . . 0.0 109.45 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -86.46 157.46 19.8 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.631 0.772 . . . . 0.0 110.512 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -65.8 163.7 16.22 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.788 0.435 . . . . 0.0 110.974 176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -67.64 96.79 0.57 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 122.887 0.475 . . . . 0.0 110.493 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 . . . . . 0 CA--C 1.558 1.268 0 C-N-CA 125.138 1.375 . . . . 0.0 110.791 -179.508 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 58.2 mtt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 118.657 -0.687 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 12.4 Cg_endo -54.91 -64.21 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.801 2.334 . . . . 0.0 111.468 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 112' ' ' PRO . 36.3 ttpt 67.07 150.63 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.885 1.274 . . . . 0.0 112.386 168.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.0 t -144.75 -60.15 0.36 Allowed 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.936 -0.477 . . . . 0.0 110.137 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 67.8 mt -75.08 88.06 2.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.083 -176.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.2 m -147.84 134.43 19.83 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.403 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 58.9 t80 -142.08 153.85 44.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.29 146.13 26.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.76 0.824 . . . . 0.0 109.078 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 141' ' ' ILE . 37.2 t70 -149.38 151.95 34.95 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.756 177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -139.02 155.63 47.82 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.08 0.952 . . . . 0.0 110.185 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.573 HG22 HD12 ' A' ' 145' ' ' LEU . 13.9 tt -159.71 138.03 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 123.796 0.685 . . . . 0.0 109.772 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 49.8 t30 -83.55 102.61 12.27 Favored 'General case' 0 C--N 1.347 0.498 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 152' ' ' LEU . 34.8 mt -71.63 140.45 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.842 0.857 . . . . 0.0 108.858 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.31 10.15 3.99 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -107.77 151.54 41.18 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.875 0.87 . . . . 0.0 111.26 -177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.04 154.37 39.6 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.26 2.64 . . . . 0.0 113.061 171.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.496 HG12 ' HB3' ' A' ' 77' ' ' ASN . 9.4 tp -57.27 -27.72 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.293 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.11 -43.66 87.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.338 0.655 . . . . 0.0 111.191 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.629 ' HB3' HD22 ' A' ' 152' ' ' LEU . 48.3 mt-30 -75.03 -43.19 55.06 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.532 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' HB ' ' A' ' 102' ' ' THR . 82.5 t -59.08 -49.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.566 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -48.43 -48.26 37.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.937 1.695 . . . . 0.0 112.269 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.46 82.85 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.115 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.69 -14.55 59.95 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 20' ' ' VAL . 54.7 t -82.55 -27.45 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 123.59 0.756 . . . . 0.0 110.757 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 m -69.28 85.81 0.4 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.665 0.745 . . . . 0.0 110.791 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.54 -18.43 33.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.601 1.16 . . . . 0.0 110.673 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.33 99.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 O-C-N 124.546 1.154 . . . . 0.0 110.001 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.469 HG21 ' HB2' ' A' ' 40' ' ' CYS . 20.9 p 72.43 -19.7 0.29 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 127.481 2.313 . . . . 0.0 113.204 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HG2' ' H ' ' A' ' 30' ' ' THR . 30.3 ttp180 59.98 -143.29 0.55 Allowed 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 124.591 1.157 . . . . 0.0 109.503 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.481 ' H ' ' HG2' ' A' ' 29' ' ' ARG . 32.3 p -78.12 91.25 4.29 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 118.817 0.735 . . . . 0.0 110.724 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.73 46.78 2.09 Favored Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.21 -56.08 6.8 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.042 0.937 . . . . 0.0 111.046 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -138.16 5.96 2.57 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.944 0.898 . . . . 0.0 110.843 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 m -57.13 111.34 3.25 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 124.097 0.959 . . . . 0.0 112.043 -172.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -67.15 -24.17 44.83 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.99 2.46 . . . . 0.0 112.065 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.1 m -72.23 -13.73 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.906 0.882 . . . . 0.0 111.597 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 40' ' ' CYS . 48.9 t -95.89 75.98 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 173.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HB2' HG11 ' A' ' 59' ' ' VAL . 34.6 tt0 -65.43 -55.19 19.37 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.743 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -135.07 118.3 16.6 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.695 1.198 . . . . 0.0 108.193 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 22.7 p -146.07 112.41 5.83 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.868 0.867 . . . . 0.0 109.501 -176.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -104.43 114.11 28.12 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -85.08 117.33 23.98 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 167.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -58.28 -24.84 60.75 Favored 'General case' 0 CA--C 1.548 0.879 0 O-C-N 123.983 0.802 . . . . 0.0 110.718 173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 tm-20 -52.65 -34.25 50.69 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.465 1.106 . . . . 0.0 111.152 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.15 -34.76 77.0 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.66 0.784 . . . . 0.0 111.204 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -81.06 -65.75 0.97 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.396 0.678 . . . . 0.0 109.36 170.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.36 119.53 0.48 Allowed Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.105 -1.386 . . . . 0.0 110.417 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 44' ' ' GLU . 55.2 Cg_endo -66.91 89.77 0.3 Allowed 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.537 2.158 . . . . 0.0 112.141 -176.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.47 169.1 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.431 1.092 . . . . 0.0 110.349 -175.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.05 139.47 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.51 28.48 63.43 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -88.43 -179.73 6.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.845 0.858 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -147.29 122.36 10.12 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 122.756 0.422 . . . . 0.0 111.416 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.91 147.13 23.91 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 164.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.1 m -139.88 160.94 38.76 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 163.13 -158.26 30.55 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -153.28 121.14 6.06 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.835 0.854 . . . . 0.0 109.278 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -84.98 113.83 21.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 38' ' ' GLU . 5.4 p -121.52 111.42 31.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 122.06 0.934 . . . . 0.0 109.547 177.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.1 p -110.76 153.56 43.62 Favored Pre-proline 0 CA--C 1.552 1.045 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 167.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -59.88 -7.42 6.05 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.393 2.729 . . . . 0.0 116.063 -167.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 0.4 2.98 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -153.46 131.9 12.1 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.89 0.314 . . . . 0.0 110.774 -176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 59' ' ' VAL . 59.9 p -130.42 156.93 43.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.822 0.849 . . . . 0.0 110.589 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.3 t-105 -167.93 137.88 2.65 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.94 1.296 . . . . 0.0 108.731 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -83.09 119.62 24.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -102.38 113.62 27.09 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.264 0.625 . . . . 0.0 109.666 -173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -124.04 143.01 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.527 1.131 . . . . 0.0 108.277 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.7 m -147.37 146.31 29.59 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.914 0.886 . . . . 0.0 109.717 -176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -118.81 126.12 51.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.58 96.01 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.262 1.025 . . . . 0.0 109.466 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.7 pt -71.6 -21.48 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.942 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.4 p -152.01 128.58 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.057 0.943 . . . . 0.0 109.208 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -134.48 115.22 13.7 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.652 0.781 . . . . 0.0 109.587 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -136.02 117.15 11.6 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.44 115.11 2.44 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.724 2.283 . . . . 0.0 111.398 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.496 ' HB3' HG12 ' A' ' 17' ' ' ILE . 43.7 m-80 66.86 23.03 10.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.601 1.16 . . . . 0.0 112.437 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -132.61 -47.77 0.89 Allowed 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 44.2 t -164.1 125.77 2.31 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.69 0.677 . . . . 0.0 111.425 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.39 104.44 7.92 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.852 0.861 . . . . 0.0 108.975 174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.64 128.74 7.41 Favored Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -137.2 149.04 46.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.687 0.795 . . . . 0.0 109.766 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 p -102.14 118.38 36.76 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.079 0.552 . . . . 0.0 109.779 176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.9 t -77.7 116.83 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 5.9 m 70.75 154.33 0.13 Allowed 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.343 1.457 . . . . 0.0 109.864 -173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.12 95.23 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.775 0.83 . . . . 0.0 111.559 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 63.62 41.5 99.07 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.544 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 34.9 t30 -107.68 -66.03 1.06 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.442 0.697 . . . . 0.0 110.722 -178.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.34 144.63 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 44.1 mtmt -124.83 111.13 15.14 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.597 0.759 . . . . 0.0 109.269 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -95.58 118.73 32.81 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 107' ' ' SER . 40.9 mm -116.92 110.69 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -103.47 103.08 13.01 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.631 ' HB2' ' HB ' ' A' ' 105' ' ' THR . 20.7 m -101.59 128.07 48.03 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.68 0.792 . . . . 0.0 110.184 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 54.6 mtt -120.99 133.07 55.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.408 1.083 . . . . 0.0 109.651 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 103' ' ' VAL . 43.7 mt-10 -118.19 90.27 37.46 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.95 107.83 0.99 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.941 2.427 . . . . 0.0 112.112 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.5 mt -105.13 168.37 9.11 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.45 0.7 . . . . 0.0 109.463 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -84.22 -29.19 26.75 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.522 . . . . 0.0 109.777 169.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.11 -6.21 55.67 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.626 0.77 . . . . 0.0 112.074 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.45 -149.6 14.4 Favored Glycine 0 C--N 1.345 1.07 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.476 ' HB ' HG21 ' A' ' 20' ' ' VAL . 98.9 m -156.3 123.52 5.36 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.157 0.983 . . . . 0.0 109.195 172.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 96' ' ' GLU . 39.6 t -88.63 104.53 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.4 145.08 24.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 94' ' ' SER . 33.3 m -138.08 142.71 40.25 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.266 1.027 . . . . 0.0 108.813 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -122.9 136.8 54.99 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 169.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . 23.2 m -134.85 107.1 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.477 0.711 . . . . 0.0 109.386 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -92.37 110.73 22.14 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 90' ' ' LYS . 44.7 mt-10 -115.99 97.86 6.32 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.923 0.889 . . . . 0.0 109.296 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.539 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 35.6 t80 -84.64 121.38 27.55 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.9 p -74.44 159.27 83.92 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.944 0.898 . . . . 0.0 111.815 -170.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 3' ' ' LYS . 31.9 Cg_exo -59.75 -27.63 85.39 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.583 2.189 . . . . 0.0 112.509 170.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -66.99 -45.95 76.07 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.864 0.866 . . . . 0.0 110.685 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -62.05 -44.78 97.3 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.93 0.769 . . . . 0.0 112.266 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -66.02 -36.13 82.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.312 0.645 . . . . 0.0 110.374 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.412 ' HA ' ' HB3' ' A' ' 119' ' ' HIS . 37.8 ttt180 -70.64 -28.03 64.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.396 0.678 . . . . 0.0 111.428 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -64.29 -44.8 90.54 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.319 0.648 . . . . 0.0 110.117 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -68.47 -44.58 74.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.244 174.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 116' ' ' ARG . 68.8 t60 -59.52 -33.44 71.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.071 0.948 . . . . 0.0 111.373 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.88 -50.73 31.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.973 0.909 . . . . 0.0 110.52 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -77.47 -66.57 0.82 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.561 -175.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 74.8 m-85 -78.73 -64.73 1.11 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.833 0.853 . . . . 0.0 111.088 -176.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 -75.41 2.39 Favored Glycine 0 C--N 1.342 0.912 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -63.47 -54.0 43.33 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.707 0.803 . . . . 0.0 111.535 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 122' ' ' PHE . 72.6 mmtt -68.38 -7.88 35.33 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.509 0.724 . . . . 0.0 112.747 -178.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.1 m -73.73 -31.58 63.45 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 123.496 0.719 . . . . 0.0 111.102 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.62 -46.45 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.202 0.601 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.52 -32.74 66.37 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 119.684 -0.198 . . . . 0.0 110.791 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.01 -50.7 72.3 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.145 0.578 . . . . 0.0 110.976 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.515 ' HB ' HD11 ' A' ' 5' ' ' LEU . 27.2 pt -73.76 -23.37 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.458 0.703 . . . . 0.0 110.997 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -69.44 -51.43 36.32 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.262 0.625 . . . . 0.0 109.455 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -58.28 -48.38 80.64 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.264 0.978 . . . . 0.0 110.437 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -68.05 -33.26 74.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.641 0.776 . . . . 0.0 112.736 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.1 ttp-105 -69.98 -53.43 17.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 139' ' ' THR . 78.7 mt -61.91 -42.04 98.62 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.403 0.681 . . . . 0.0 110.751 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -26.77 68.47 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.893 0.877 . . . . 0.0 112.013 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.28 -46.29 20.61 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.023 0.439 . . . . 0.0 110.522 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.6 mt -65.87 -29.19 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.527 0.731 . . . . 0.0 111.205 -176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 135' ' ' LEU . 13.7 t -97.8 -31.41 12.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.667 0.387 . . . . 0.0 111.633 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -80.69 -37.06 21.07 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.597 -0.557 . . . . 0.0 114.469 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 106' ' ' GLU . 72.9 mt -66.68 -52.65 33.03 Favored Pre-proline 0 CA--C 1.562 1.435 0 CA-C-O 117.977 -1.011 . . . . 0.0 111.096 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 42.3 Cg_endo -64.27 -28.55 63.96 Favored 'Trans proline' 0 C--N 1.397 3.108 0 C-N-CA 121.783 1.655 . . . . 0.0 111.757 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.85 -47.85 83.18 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.612 0.765 . . . . 0.0 109.861 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 62.0 m -66.23 -40.39 90.25 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.854 0.861 . . . . 0.0 110.937 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 11' ' ' ILE . 3.7 mm? -61.03 -47.97 83.97 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.718 0.807 . . . . 0.0 111.385 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.34 -27.34 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 122.941 0.497 . . . . 0.0 110.783 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.41 -39.62 89.1 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.756 0.423 . . . . 0.0 110.746 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.4 mt -77.12 -34.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.572 0.749 . . . . 0.0 109.94 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -69.5 -60.36 2.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.48 0.312 . . . . 0.0 111.61 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 56.6 ttt85 -56.77 -45.44 82.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.537 1.135 . . . . 0.0 112.153 -168.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.6 tt -53.72 -48.43 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 123.779 0.674 . . . . 0.0 110.948 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.629 HD22 ' HB3' ' A' ' 19' ' ' GLN . 92.1 mt -67.21 -42.99 83.17 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.529 -173.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -68.08 -29.42 68.36 Favored 'General case' 0 N--CA 1.479 1.025 0 O-C-N 123.689 0.618 . . . . 0.0 111.805 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -82.16 -30.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.088 0.555 . . . . 0.0 110.507 175.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -76.29 -10.36 59.34 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.417 0.687 . . . . 0.0 112.101 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 73.2 mt -68.59 -42.48 78.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 0.0 110.084 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -88.49 160.57 17.44 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 9.0 t60 70.25 -65.67 0.31 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 -167.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.8 t60 63.85 115.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.6 1.56 . . . . 0.0 114.152 161.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -101.8 155.5 18.1 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.487 0.715 . . . . 0.0 109.636 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -76.78 155.12 33.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.992 0.517 . . . . 0.0 111.207 -176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -155.84 47.08 0.48 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.866 0.866 . . . . 0.0 108.817 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 76.7 m80 . . . . . 0 N--CA 1.492 1.654 0 C-N-CA 126.041 1.736 . . . . 0.0 110.095 -169.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.459 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 23.5 Cg_endo -62.06 112.66 1.59 Allowed 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.429 2.086 . . . . 0.0 110.929 167.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -68.41 -34.14 75.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.825 0.85 . . . . 0.0 110.717 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.7 t -178.35 176.48 1.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.466 1.507 . . . . 0.0 108.44 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 110' ' ' PHE . 3.8 mm? -101.07 42.79 1.1 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.549 0.69 . . . . 0.0 109.388 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -124.09 133.11 53.69 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.692 0.797 . . . . 0.0 109.096 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -155.41 134.4 12.15 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -128.69 160.94 30.91 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.078 0.951 . . . . 0.0 109.731 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -157.32 136.95 12.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.462 0.705 . . . . 0.0 109.381 174.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.7 p -114.71 146.96 40.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.336 1.055 . . . . 0.0 109.727 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 HD12 ' A' ' 145' ' ' LEU . 13.3 tt -146.92 139.54 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.418 0.687 . . . . 0.0 109.333 -178.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -88.25 130.43 35.09 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.5 mt -111.48 148.85 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -88.53 12.32 14.81 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.313 0.645 . . . . 0.0 111.58 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -105.61 146.61 33.15 Favored Pre-proline 0 N--CA 1.473 0.718 0 C-N-CA 123.89 0.876 . . . . 0.0 111.257 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.54 141.55 80.72 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.645 2.23 . . . . 0.0 111.696 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.486 HD11 ' HG3' ' A' ' 95' ' ' MET . 18.0 tt -56.67 -25.39 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 124.258 1.023 . . . . 0.0 112.253 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -52.24 -50.81 61.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.976 1.311 . . . . 0.0 111.452 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -87.13 -22.22 25.48 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.971 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG22 HD13 ' A' ' 152' ' ' LEU . 95.4 t -62.1 -52.64 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -58.11 -38.79 77.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.156 0.982 . . . . 0.0 111.15 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.99 -56.23 25.0 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.003 0.814 . . . . 0.0 110.937 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -73.2 -15.75 61.44 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.405 0.682 . . . . 0.0 112.839 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.06 -45.17 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.965 0.506 . . . . 0.0 110.264 173.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 64.5 p -83.72 -21.0 32.44 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.144 0.578 . . . . 0.0 111.608 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -71.39 96.47 1.47 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 0.0 109.837 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 pt -116.87 -45.43 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.516 0.726 . . . . 0.0 110.486 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.41 -15.84 14.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.978 0.911 . . . . 0.0 111.062 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -49.42 62.59 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.768 0.827 . . . . 0.0 110.36 -173.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.8 m -93.54 -57.0 2.72 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.41 -118.01 11.87 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.148 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 33' ' ' TRP . 24.2 tt0 -168.58 177.85 5.02 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.439 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 4.2 m-90 -56.72 -41.37 77.35 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.284 0.634 . . . . 0.0 110.061 166.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 p -128.37 88.32 52.86 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.883 170.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.72 149.02 42.49 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.224 1.949 . . . . 0.0 112.197 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.89 1.28 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.612 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . 66.4 m -102.83 116.19 32.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.977 0.911 . . . . 0.0 108.926 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 39' ' ' LYS . 32.0 tt0 -81.09 -57.56 3.47 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.533 0.683 . . . . 0.0 109.169 175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 38' ' ' GLU . 27.3 mtpp -135.36 127.53 29.97 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.24 -1.345 . . . . 0.0 108.173 -175.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 37' ' ' CYS . 72.0 m -145.33 135.05 23.47 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.081 0.552 . . . . 0.0 110.058 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.506 ' O ' ' HB2' ' A' ' 54' ' ' PHE . 77.5 m95 -103.14 118.34 36.57 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 168.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 4.3 t90 -92.5 117.28 29.78 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -171.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -55.28 -30.75 60.73 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.782 1.233 . . . . 0.0 112.392 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.97 -31.03 69.51 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.845 1.258 . . . . 0.0 111.695 -175.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -56.66 -52.24 65.68 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.471 0.709 . . . . 0.0 111.8 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -89.73 -27.3 20.15 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.095 0.558 . . . . 0.0 111.006 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.28 123.99 2.82 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 118.605 -1.108 . . . . 0.0 110.755 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.15 -53.79 4.42 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.631 2.221 . . . . 0.0 111.956 177.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.2 m 46.12 -177.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 C-N-CA 126.257 1.823 . . . . 0.0 114.29 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.1 t -92.03 83.19 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 172.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.82 85.14 0.62 Allowed Glycine 0 C--N 1.349 1.291 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.463 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.45 164.32 37.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.371 0.669 . . . . 0.0 110.289 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -128.39 144.19 51.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.777 0.831 . . . . 0.0 109.623 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 41' ' ' TRP . 20.5 p90 -153.15 125.73 8.22 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.622 0.769 . . . . 0.0 109.326 175.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.1 p -100.25 139.57 35.73 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.339 0.656 . . . . 0.0 110.23 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.87 104.99 0.46 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 12.1 ttp180 -74.61 105.11 5.56 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.103 0.477 . . . . 0.0 110.019 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -84.39 110.62 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.466 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 p -105.78 127.06 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.644 0.777 . . . . 0.0 110.399 -177.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 64.3 p -134.33 153.65 79.46 Favored Pre-proline 0 C--O 1.242 0.661 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 164.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -60.13 -18.77 53.21 Favored 'Trans proline' 0 C--N 1.377 2.026 0 C-N-CA 122.704 2.27 . . . . 0.0 111.819 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -73.01 -47.8 41.9 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.282 1.033 . . . . 0.0 110.308 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -167.93 132.86 1.82 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.197 0.599 . . . . 0.0 110.644 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 m -103.69 119.31 38.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.874 0.87 . . . . 0.0 109.162 174.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -132.18 162.03 31.91 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.95 1.3 . . . . 0.0 108.799 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 35.7 tt0 -125.2 130.26 51.77 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 174.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -105.97 115.18 29.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.968 0.907 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -94.47 99.57 11.72 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.926 0.869 . . . . 0.0 109.02 174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 m -99.94 137.78 37.93 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.877 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -115.2 125.79 53.8 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -78.38 89.21 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.162 0.585 . . . . 0.0 109.426 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.461 HG13 HG12 ' A' ' 73' ' ' VAL . 46.2 pt -63.95 -26.18 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.909 0.884 . . . . 0.0 112.101 -177.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 72' ' ' ILE . 7.1 p -160.64 138.91 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.398 1.079 . . . . 0.0 108.566 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -146.52 131.0 17.69 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 166.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -104.29 146.89 33.45 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -46.36 -38.29 20.4 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 124.409 3.406 . . . . 0.0 114.307 -165.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -164.63 54.86 0.13 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -135.97 -24.41 1.29 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.269 0.628 . . . . 0.0 111.123 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 53.1 t -164.0 152.85 13.6 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.835 0.35 . . . . 0.0 111.563 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -138.92 102.31 4.52 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -108.74 103.68 1.86 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.826 -177.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -122.49 137.92 54.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.846 1.258 . . . . 0.0 109.159 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.541 ' HB3' ' HA2' ' A' ' 87' ' ' GLY . 41.9 m -124.3 120.12 31.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.972 0.509 . . . . 0.0 110.585 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 97.9 t -72.75 136.44 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 124.984 1.314 . . . . 0.0 110.066 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 88' ' ' ASN . 7.8 m 57.38 58.7 3.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.032 1.333 . . . . 0.0 109.828 -175.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 69.98 -67.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.344 1.458 . . . . 0.0 111.036 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.541 ' HA2' ' HB3' ' A' ' 83' ' ' SER . . . -155.91 26.74 0.57 Allowed Glycine 0 C--N 1.353 1.527 0 O-C-N 123.133 0.271 . . . . 0.0 113.041 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.44 ' HB3' ' HB ' ' A' ' 85' ' ' THR . 28.8 t-20 -71.05 -64.25 0.94 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.133 0.573 . . . . 0.0 110.49 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.431 HG22 ' HD1' ' A' ' 110' ' ' PHE . 21.7 t -102.28 125.48 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -110.59 133.77 53.01 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.939 0.496 . . . . 0.0 109.868 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -131.51 124.15 29.51 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.269 1.028 . . . . 0.0 108.815 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.9 mt -130.07 110.67 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -92.61 100.2 12.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -95.49 123.34 38.98 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.486 ' HG3' HD11 ' A' ' 17' ' ' ILE . 21.2 ptp -125.28 128.04 47.63 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.318 0.647 . . . . 0.0 110.284 -173.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -106.35 108.89 62.61 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 123.897 0.879 . . . . 0.0 110.224 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HB3' HG21 ' A' ' 17' ' ' ILE . 60.7 Cg_endo -70.87 119.66 6.49 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.147 2.565 . . . . 0.0 113.012 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 47.5 mt -106.84 -1.57 22.33 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.446 0.699 . . . . 0.0 109.759 171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 71.37 -62.02 0.47 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.087 1.755 . . . . 0.0 111.158 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.08 -36.8 75.72 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.043 0.937 . . . . 0.0 110.933 171.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -146.42 -170.53 15.03 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.362 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.7 m -154.01 130.49 10.61 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.293 0.637 . . . . 0.0 110.26 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.7 t -88.47 94.96 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -82.21 130.29 35.05 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.8 m -132.44 107.74 8.69 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.923 0.889 . . . . 0.0 109.472 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' HB3' HD21 ' A' ' 145' ' ' LEU . 43.4 tt0 -90.71 132.33 35.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 36.5 t -126.64 108.87 11.5 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.334 1.054 . . . . 0.0 108.939 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -97.93 144.11 27.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.982 0.913 . . . . 0.0 109.842 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -152.93 98.63 2.34 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.847 0.859 . . . . 0.0 108.784 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 5' ' ' LEU . 93.1 t80 -80.29 106.26 12.17 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 167.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.0 p -60.88 143.28 91.68 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.848 -171.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.0 -13.64 28.64 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.929 2.419 . . . . 0.0 112.639 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -59.7 -48.04 83.24 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 170.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -69.15 -36.67 80.57 Favored Glycine 0 C--N 1.345 1.036 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.683 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.95 -39.5 94.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.54 0.736 . . . . 0.0 110.602 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -61.9 -35.05 77.23 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.736 0.814 . . . . 0.0 110.777 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -58.1 -53.73 54.97 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.977 0.798 . . . . 0.0 110.342 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -66.88 -33.39 75.49 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.058 0.543 . . . . 0.0 111.676 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -74.29 -34.91 63.68 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.587 0.755 . . . . 0.0 111.252 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -86.69 -40.15 15.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.256 0.623 . . . . 0.0 110.239 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -67.06 -53.78 27.8 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.842 0.857 . . . . 0.0 110.484 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -108.58 -66.08 1.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.117 0.567 . . . . 0.0 111.098 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.0 -53.78 3.28 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -169.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -54.1 40.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 128' ' ' GLU . 4.2 mptp? -74.37 -11.32 60.22 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.752 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t -66.73 -35.52 80.31 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.594 0.358 . . . . 0.0 110.594 174.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.23 -42.14 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.739 0.815 . . . . 0.0 110.732 -174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 125' ' ' LYS . 12.1 pt-20 -72.99 -37.7 66.9 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 125' ' ' LYS . 13.5 tp10 -66.39 -44.99 81.54 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.073 0.549 . . . . 0.0 110.979 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 5' ' ' LEU . 12.5 tt -62.17 -37.4 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 123.583 0.552 . . . . 0.0 110.46 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.01 -45.67 48.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.041 0.536 . . . . 0.0 111.278 -176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -59.18 -48.84 80.11 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.16 0.584 . . . . 0.0 110.413 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -71.14 -26.87 63.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.527 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.459 ' HD3' ' HB3' ' A' ' 2' ' ' PRO . 16.0 ttp180 -67.12 -59.32 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.418 0.449 . . . . 0.0 109.821 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.95 -38.39 86.04 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.45 0.469 . . . . 0.0 111.523 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.0 -32.22 73.53 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.074 0.55 . . . . 0.0 111.298 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -78.48 -50.89 10.82 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 122.736 0.414 . . . . 0.0 110.885 177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.5 mt -62.13 -24.78 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.322 0.649 . . . . 0.0 111.438 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 66.0 m -89.71 -42.73 11.17 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.304 0.642 . . . . 0.0 110.796 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.07 -28.69 58.08 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 114.831 0.692 . . . . 0.0 114.831 -170.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 90.3 mt -70.79 -57.73 4.92 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.946 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' O ' HG23 ' A' ' 146' ' ' VAL . 39.2 Cg_endo -62.48 -26.05 76.19 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.339 1.514 . . . . 0.0 111.782 177.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -63.82 -41.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.291 0.636 . . . . 0.0 110.561 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 89.7 m -66.23 -41.48 89.98 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.416 0.687 . . . . 0.0 110.974 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 106' ' ' GLU . 4.3 mm? -58.62 -43.21 89.58 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.574 0.35 . . . . 0.0 110.965 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 142' ' ' PRO . 87.3 t -68.49 -39.07 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.792 0.437 . . . . 0.0 110.371 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.27 -45.29 92.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.109 0.564 . . . . 0.0 111.214 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.18 -46.71 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.585 0.754 . . . . 0.0 109.958 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -55.74 -55.47 31.94 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.745 0.653 . . . . 0.0 110.576 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 31.6 ttm-85 -70.06 -42.19 73.17 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.717 -168.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.77 -34.94 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.048 0.385 . . . . 0.0 110.652 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.554 HD13 HG22 ' A' ' 20' ' ' VAL . 83.6 mt -73.69 -43.49 59.17 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.038 0.935 . . . . 0.0 111.386 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -73.13 -26.94 61.41 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.164 0.586 . . . . 0.0 111.176 -178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.8 t -76.09 -33.46 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 124.266 1.026 . . . . 0.0 109.793 171.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -70.53 -25.19 63.0 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.023 0.929 . . . . 0.0 110.755 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 94.4 mt -68.5 -20.24 64.58 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.469 0.708 . . . . 0.0 110.944 172.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -114.73 178.12 4.4 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.176 0.99 . . . . 0.0 110.727 177.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 69.1 t60 61.31 30.68 19.21 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.209 1.004 . . . . 0.0 109.671 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 47.5 m80 60.99 -84.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.489 1.116 . . . . 0.0 108.861 -165.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -153.54 168.12 27.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.862 1.265 . . . . 0.0 108.373 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -113.56 -51.57 2.8 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -168.22 138.35 2.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.764 0.665 . . . . 0.0 110.843 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.533 1.133 . . . . 0.0 108.684 173.673 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -70.6 139.02 36.39 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.672 2.248 . . . . 0.0 111.212 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 122.89 20.77 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.4 t -78.0 158.67 29.18 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.61 66.94 9.23 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.753 0.787 . . . . 0.0 110.096 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.8 p -116.77 134.52 54.69 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.695 0.798 . . . . 0.0 110.33 -175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -157.03 147.62 21.43 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.471 1.109 . . . . 0.0 108.799 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -135.81 147.83 48.46 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -144.6 159.29 43.04 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.509 0.324 . . . . 0.0 110.184 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.3 m -144.33 155.98 44.05 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.676 0.79 . . . . 0.0 110.749 -174.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.639 HG22 HD12 ' A' ' 145' ' ' LEU . 15.7 tt -153.66 141.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.648 0.779 . . . . 0.0 108.908 167.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -89.06 106.94 18.76 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 174.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 149' ' ' GLN . 48.4 mt -83.67 136.13 23.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.313 1.045 . . . . 0.0 110.068 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -85.08 61.91 7.17 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.301 0.64 . . . . 0.0 109.701 175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.13 145.65 7.02 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.299 1.04 . . . . 0.0 109.512 -177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -64.9 156.0 64.65 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.97 2.447 . . . . 0.0 113.575 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.4 tt -58.95 -28.1 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 124.568 1.147 . . . . 0.0 112.256 -176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -59.71 -46.87 87.77 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.492 0.717 . . . . 0.0 110.486 177.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -70.06 -44.38 69.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.375 0.67 . . . . 0.0 110.944 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG21 ' HB ' ' A' ' 102' ' ' THR . 89.0 t -59.85 -52.24 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.761 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -59.06 -36.52 75.2 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.362 1.065 . . . . 0.0 111.002 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.03 -42.77 99.52 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.832 0.853 . . . . 0.0 111.693 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.55 -30.63 57.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.036 0.534 . . . . 0.0 111.586 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 20' ' ' VAL . 74.4 t -71.25 -22.9 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.486 0.714 . . . . 0.0 110.968 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.0 m -57.7 -69.24 0.18 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.832 0.453 . . . . 0.0 110.395 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.47 -64.92 0.17 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.571 1.549 . . . . 0.0 113.618 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -43.04 97.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 125.677 1.591 . . . . 0.0 111.662 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 p 63.27 5.66 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.812 2.045 . . . . 0.0 113.884 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.42 -38.98 48.48 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 167.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -142.15 179.3 6.99 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.365 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 155.48 29.44 0.03 OUTLIER Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.13 -39.93 6.35 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.873 0.869 . . . . 0.0 110.063 -173.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -88.63 -47.77 8.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.873 0.869 . . . . 0.0 110.412 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -102.39 116.97 62.11 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.615 0.766 . . . . 0.0 110.128 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.71 75.12 4.12 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.408 2.739 . . . . 0.0 112.089 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.0 m -113.25 7.11 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 124.195 0.998 . . . . 0.0 110.913 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -142.89 110.58 5.85 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.367 0.667 . . . . 0.0 110.026 -174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . 10.3 tp10 -69.61 -56.65 6.7 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 165.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -172.88 142.25 1.1 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.368 1.067 . . . . 0.0 109.228 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HA2' ' A' ' 56' ' ' GLY . 40.9 m -135.0 140.78 45.93 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.383 0.673 . . . . 0.0 110.367 -176.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.493 ' O ' ' HB ' ' A' ' 55' ' ' THR . 67.7 t-105 -140.39 129.99 24.2 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.23 0.612 . . . . 0.0 109.614 174.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -123.87 111.58 16.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.39 1.076 . . . . 0.0 110.412 -176.259 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -82.26 -29.53 31.21 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.81 2.83 44.12 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.787 1.235 . . . . 0.0 111.878 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.704 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 22.4 t70 -59.45 -31.62 69.48 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.81 0.844 . . . . 0.0 110.818 172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.95 -20.1 65.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.53 1.132 . . . . 0.0 112.156 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.44 71.6 0.42 Allowed Glycine 0 C--N 1.344 1.008 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.06 76.9 4.31 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.268 2.646 . . . . 0.0 112.173 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.5 m -121.99 -177.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.652 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.41 107.66 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.88 -21.49 6.59 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.632 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.77 131.3 45.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.628 0.771 . . . . 0.0 110.658 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -101.38 146.7 27.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.775 0.43 . . . . 0.0 110.506 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -119.98 108.53 14.43 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 41' ' ' TRP . 92.5 m -79.33 111.23 15.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.49 ' HA2' ' SG ' ' A' ' 40' ' ' CYS . . . -134.99 105.27 0.54 Allowed Glycine 0 C--N 1.338 0.649 0 O-C-N 123.909 0.756 . . . . 0.0 111.249 -177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 30.5 ttm180 -82.22 113.71 20.23 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 176.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -95.14 135.84 36.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.493 0.717 . . . . 0.0 109.637 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 12.7 p -113.39 134.72 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.1 p -132.38 166.3 29.82 Favored Pre-proline 0 N--CA 1.48 1.041 0 C-N-CA 123.445 0.698 . . . . 0.0 109.812 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -55.91 -18.89 23.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 123.169 2.58 . . . . 0.0 113.198 170.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.84 -85.22 0.12 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.331 0.653 . . . . 0.0 110.625 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -134.02 162.89 30.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.643 0.777 . . . . 0.0 110.391 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 m -102.66 108.88 20.3 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -115.83 133.39 56.08 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.189 0.596 . . . . 0.0 110.008 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 34.8 tt0 -90.77 112.89 24.87 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 173.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.1 p -103.66 113.2 26.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.158 0.504 . . . . 0.0 109.705 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -100.34 95.6 6.88 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.5 m -94.02 142.9 26.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.269 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -107.17 136.16 47.48 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.137 0.575 . . . . 0.0 109.825 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG11 ' HB2' ' A' ' 74' ' ' ALA . 87.9 t -71.46 125.04 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.442 0.697 . . . . 0.0 109.937 176.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.9 pt -102.05 -19.2 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.388 0.675 . . . . 0.0 111.084 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.3 p -159.32 129.07 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.337 1.055 . . . . 0.0 109.179 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HB2' HG11 ' A' ' 71' ' ' VAL . . . -133.49 107.52 8.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.72 0.808 . . . . 0.0 109.564 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HB2' ' H ' ' A' ' 79' ' ' CYS . 20.9 mm-40 -105.26 147.53 34.71 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -59.55 -40.85 62.19 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.644 2.229 . . . . 0.0 112.457 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -167.14 87.82 0.3 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -168.49 -43.15 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.898 0.879 . . . . 0.0 109.588 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 75' ' ' GLU . 53.1 t -163.56 153.19 14.91 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.57 0.748 . . . . 0.0 110.182 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -143.83 107.93 4.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.117 0.967 . . . . 0.0 108.442 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.16 135.2 11.2 Favored Glycine 0 C--O 1.239 0.446 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.59 132.48 17.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.047 0.939 . . . . 0.0 109.095 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.5 t -96.37 119.09 34.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.691 0.796 . . . . 0.0 109.608 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.84 130.99 35.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 C-N-CA 123.964 0.906 . . . . 0.0 109.064 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 86' ' ' ASP . 5.5 m 68.04 175.02 0.27 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.514 1.126 . . . . 0.0 109.472 -172.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 85' ' ' THR . 11.7 p-10 -70.79 77.59 0.62 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 122.077 0.941 . . . . 0.0 111.009 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.401 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . 65.24 50.36 56.96 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.364 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -103.18 -61.87 1.36 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.345 0.658 . . . . 0.0 110.422 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 110' ' ' PHE . 11.3 t -115.21 135.41 55.26 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.077 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 109' ' ' GLU . 58.8 mttp -107.67 138.6 43.61 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 118.858 0.753 . . . . 0.0 109.231 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -127.66 97.07 4.72 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 170.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.5 mt -109.61 112.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -106.73 103.94 13.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.59 0.756 . . . . 0.0 109.027 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.2 m -93.25 136.52 33.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.477 0.711 . . . . 0.0 110.04 172.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -112.46 123.86 51.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.21 1.004 . . . . 0.0 108.494 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -94.61 97.53 2.47 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 123.405 0.682 . . . . 0.0 109.381 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.91 105.43 1.94 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.441 2.094 . . . . 0.0 112.081 -175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -106.78 170.62 7.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.878 0.871 . . . . 0.0 109.893 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -85.7 -22.43 27.84 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.056 0.543 . . . . 0.0 109.971 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -85.32 -10.67 56.11 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.898 0.879 . . . . 0.0 111.48 176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.45 -138.33 6.36 Favored Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.532 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.5 m -153.68 127.83 9.06 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.233 0.613 . . . . 0.0 109.942 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 35.8 t -87.88 102.8 12.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -79.26 110.5 14.6 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.1 m -107.6 107.56 18.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.396 1.078 . . . . 0.0 108.899 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.99 159.37 16.19 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -142.56 106.52 4.71 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.529 0.731 . . . . 0.0 109.959 173.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -86.18 109.36 18.85 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 168.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.6 OUTLIER -124.57 89.83 3.14 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -178.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.463 ' CD2' HG22 ' A' ' 89' ' ' VAL . 44.1 t80 -85.92 107.92 17.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.595 178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 23.7 p -72.52 150.45 91.38 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.286 0.634 . . . . 0.0 110.845 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.51 80.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.386 2.724 . . . . 0.0 113.47 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 35.5 mmtp -133.58 -62.92 0.76 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.785 1.234 . . . . 0.0 109.229 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.19 -36.85 63.74 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.755 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.99 -23.0 67.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.434 0.694 . . . . 0.0 111.228 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.406 ' HA ' ' HE ' ' A' ' 116' ' ' ARG . 0.3 OUTLIER -66.08 -42.09 89.82 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.31 0.644 . . . . 0.0 109.862 174.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -68.4 -36.87 79.75 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.628 0.58 . . . . 0.0 110.584 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -62.1 -38.26 88.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.821 0.448 . . . . 0.0 110.858 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 126' ' ' SER . 62.0 t-80 -80.64 -28.81 36.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.579 0.352 . . . . 0.0 110.956 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.56 -43.58 69.21 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.182 0.593 . . . . 0.0 109.844 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -83.85 -34.19 24.69 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.258 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.513 ' HB3' ' HB3' ' A' ' 125' ' ' LYS . 79.4 m-85 -128.97 86.12 2.4 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -53.02 -60.4 8.12 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 114.207 0.443 . . . . 0.0 114.207 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -87.96 -31.34 19.44 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.102 0.561 . . . . 0.0 111.495 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 122' ' ' PHE . 40.3 tptt -83.55 -9.52 58.89 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 122.743 0.417 . . . . 0.0 112.112 -170.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.508 ' HB3' ' HA ' ' A' ' 119' ' ' HIS . 29.4 p -58.09 -27.36 63.61 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.798 0.839 . . . . 0.0 113.216 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mp -66.1 -40.69 87.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 O-C-N 123.651 0.595 . . . . 0.0 109.977 -176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.91 -34.91 72.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.849 0.46 . . . . 0.0 110.72 173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -63.76 -49.28 73.61 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.469 0.708 . . . . 0.0 111.567 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.34 -26.41 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 122.674 0.39 . . . . 0.0 110.537 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -68.3 -49.04 63.16 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 123.748 0.655 . . . . 0.0 110.803 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -66.55 -33.43 75.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.555 0.342 . . . . 0.0 110.828 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -69.1 -39.82 78.76 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.998 0.519 . . . . 0.0 110.68 174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -63.8 -47.87 79.16 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.887 0.875 . . . . 0.0 110.14 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.5 mt -67.47 -51.14 54.88 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.552 0.741 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.25 89.43 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.423 0.689 . . . . 0.0 111.768 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -71.67 -55.11 8.32 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.419 0.449 . . . . 0.0 110.698 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -59.09 -28.41 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.301 0.64 . . . . 0.0 111.919 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.7 m -86.93 -33.19 19.77 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.884 0.474 . . . . 0.0 111.062 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -75.99 -28.6 60.29 Favored Glycine 0 N--CA 1.474 1.228 0 N-CA-C 113.55 0.18 . . . . 0.0 113.55 -177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.86 -55.54 32.32 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.695 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.82 -26.59 81.01 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 122.497 2.131 . . . . 0.0 112.977 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -66.73 -40.1 88.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.913 0.485 . . . . 0.0 110.515 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 27.5 m -65.36 -43.54 90.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.383 0.673 . . . . 0.0 110.472 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.639 HD12 HG22 ' A' ' 11' ' ' ILE . 4.6 mm? -60.08 -49.97 75.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.44 0.696 . . . . 0.0 111.324 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 74.0 t -68.11 -32.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.595 0.758 . . . . 0.0 111.115 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.0 -56.03 25.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.97 0.508 . . . . 0.0 110.755 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 75.6 mt -59.43 -44.1 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.743 0.817 . . . . 0.0 110.721 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.554 ' HA ' HG23 ' A' ' 13' ' ' ILE . 18.0 tm0? -60.02 -55.01 39.23 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.014 0.926 . . . . 0.0 111.896 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -66.52 -47.55 72.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 11.2 tt -64.22 -32.97 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.495 0.318 . . . . 0.0 111.157 -176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 33.9 mt -64.91 -45.68 84.84 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.88 0.472 . . . . 0.0 110.79 176.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.429 ' HA ' HD12 ' A' ' 156' ' ' LEU . 58.3 mt-10 -61.31 -39.53 90.84 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 123.371 0.42 . . . . 0.0 111.048 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.89 -36.89 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.663 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -73.48 -27.01 61.16 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 110.956 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 96.0 mt -63.78 -31.3 72.43 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.469 0.708 . . . . 0.0 110.136 174.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -79.26 -64.84 1.09 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 22.2 t60 68.3 139.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.661 1.584 . . . . 0.0 111.195 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 71.15 -0.83 2.93 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 124.075 0.95 . . . . 0.0 111.668 -177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -75.69 109.71 9.5 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.967 0.907 . . . . 0.0 110.451 -175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -129.76 156.62 44.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.482 1.113 . . . . 0.0 109.174 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -65.14 110.89 2.69 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 124.748 1.219 . . . . 0.0 111.089 -175.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -54.12 -55.98 2.96 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.182 2.588 . . . . 0.0 112.058 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.6 tttt 60.56 17.2 7.17 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.693 1.197 . . . . 0.0 112.42 174.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.1 t 62.83 -168.2 0.2 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.193 0.997 . . . . 0.0 110.282 -173.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 110' ' ' PHE . 61.6 mt -102.83 101.73 11.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -143.57 149.56 37.58 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.115 0.483 . . . . 0.0 110.172 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' HE2' ' HD3' ' A' ' 142' ' ' PRO . 77.0 t80 -153.17 151.29 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.411 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.13 162.25 35.95 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 0.0 109.783 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.07 154.48 17.39 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.383 1.073 . . . . 0.0 108.519 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 p -155.66 130.1 8.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.542 0.737 . . . . 0.0 109.69 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.747 HG22 HD12 ' A' ' 145' ' ' LEU . 14.9 tt -139.42 136.54 40.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 109.92 176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -85.11 112.69 20.9 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.61 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 HG13 ' A' ' 20' ' ' VAL . 33.9 mt -90.64 141.86 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.05 0.94 . . . . 0.0 108.934 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.13 -3.57 20.66 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.457 0.703 . . . . 0.0 112.615 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 13' ' ' ILE . . . -90.74 151.33 43.63 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 110.558 -175.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.04 157.78 51.26 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.648 2.232 . . . . 0.0 111.929 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -54.59 -34.75 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.333 1.053 . . . . 0.0 113.335 -171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -64.28 -51.16 64.88 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.099 0.56 . . . . 0.0 110.896 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -66.59 -38.77 87.73 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 -178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 ' HB ' ' A' ' 102' ' ' THR . 56.1 t -53.73 -59.67 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 O-C-N 124.097 0.873 . . . . 0.0 110.996 175.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -57.11 -41.73 79.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.38 -41.14 84.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.623 0.769 . . . . 0.0 111.746 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.09 -8.64 50.91 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG11 ' HE2' ' A' ' 93' ' ' TYR . 54.0 t -70.78 -45.1 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 168.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.4 m 63.79 -159.02 0.31 Allowed 'General case' 0 CA--C 1.551 0.998 0 O-C-N 124.7 1.25 . . . . 0.0 111.528 177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -126.0 -174.83 3.19 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.566 0.747 . . . . 0.0 110.655 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.528 HD13 ' H ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -125.81 -1.58 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.662 1.185 . . . . 0.0 110.699 178.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.2 p -102.56 -64.89 1.03 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.108 0.963 . . . . 0.0 111.243 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -79.31 -63.73 1.35 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.352 1.461 . . . . 0.0 110.27 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.5 m -76.29 -60.54 2.29 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.709 0.804 . . . . 0.0 109.698 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.9 112.18 0.02 OUTLIER Glycine 0 C--N 1.356 1.677 0 O-C-N 123.491 0.495 . . . . 0.0 112.209 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -68.81 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -169.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -103.21 69.57 1.02 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.928 0.491 . . . . 0.0 110.201 -169.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m 54.16 74.17 0.79 Allowed Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.923 1.289 . . . . 0.0 111.442 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 159.53 37.2 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.421 2.081 . . . . 0.0 112.544 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG23 HD21 ' A' ' 58' ' ' ASN . 17.0 m -81.83 3.67 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.613 174.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.7 m -77.94 102.72 7.48 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 169.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HG2' ' HD2' ' A' ' 39' ' ' LYS . 30.2 tt0 -68.09 -58.61 4.2 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.137 0.575 . . . . 0.0 110.989 -173.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 38' ' ' GLU . 2.0 mptp? -144.04 123.9 13.47 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.2 t -147.34 130.76 16.66 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -121.08 159.32 25.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.158 0.583 . . . . 0.0 110.192 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -120.12 151.43 39.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.979 0.912 . . . . 0.0 110.313 169.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -85.79 -2.21 58.01 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.472 1.109 . . . . 0.0 111.626 169.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 11.7 pt-20 -54.26 -24.2 17.89 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.149 0.98 . . . . 0.0 113.197 -178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -51.29 -35.6 38.33 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.447 1.099 . . . . 0.0 111.12 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -85.51 -55.16 4.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.238 1.015 . . . . 0.0 109.498 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -163.6 113.82 0.57 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-O 118.942 -0.921 . . . . 0.0 112.378 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HB3' ' HB2' ' A' ' 44' ' ' GLU . 98.5 Cg_endo -82.25 80.73 2.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.145 2.563 . . . . 0.0 112.14 176.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 30.8 m -112.87 171.89 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 123.183 0.593 . . . . 0.0 110.826 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 74' ' ' ALA . 60.5 t -66.6 118.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.47 -4.05 37.31 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.961 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 135.1 56.91 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.154 0.582 . . . . 0.0 110.089 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -150.37 142.33 23.91 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.229 0.468 . . . . 0.0 111.529 -172.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -159.16 161.34 36.22 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.71 0.631 . . . . 0.0 110.706 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.7 m -94.94 153.45 17.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.611 1.164 . . . . 0.0 111.416 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.9 -166.44 17.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.863 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -154.19 129.31 9.62 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.175 0.59 . . . . 0.0 109.905 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.501 HD21 HG23 ' A' ' 36' ' ' VAL . 27.7 t-20 -97.65 136.3 38.22 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.085 0.954 . . . . 0.0 108.897 175.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.7 p -122.9 124.18 69.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.743 0.817 . . . . 0.0 110.03 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.8 p -138.88 155.27 73.16 Favored Pre-proline 0 N--CA 1.475 0.787 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.98 -22.5 69.35 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.827 2.351 . . . . 0.0 112.859 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -77.81 -50.06 13.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.777 0.831 . . . . 0.0 110.838 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.486 HH12 ' HB2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -157.91 147.58 19.99 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.619 0.723 . . . . 0.0 111.939 171.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 m -115.57 129.52 56.55 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 174.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -151.87 152.07 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.548 0.739 . . . . 0.0 110.67 -170.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.64 120.56 25.71 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.26 0.624 . . . . 0.0 109.453 -176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 85' ' ' THR . 41.9 p -105.08 111.27 23.97 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.045 0.538 . . . . 0.0 109.836 -177.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -104.24 112.62 25.71 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.8 p -99.14 113.28 25.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.141 0.976 . . . . 0.0 110.939 -172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -106.68 108.87 20.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.969 0.907 . . . . 0.0 110.085 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 74' ' ' ALA . 48.6 t -59.79 106.02 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.845 0.858 . . . . 0.0 110.264 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 92' ' ' ILE . 37.2 pt -86.36 -15.66 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.437 0.695 . . . . 0.0 111.922 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.4 p -157.78 135.62 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.152 0.981 . . . . 0.0 109.079 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 50' ' ' VAL . . . -144.46 127.3 16.31 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.742 0.817 . . . . 0.0 110.047 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -125.8 138.22 31.58 Favored Pre-proline 0 N--CA 1.469 0.52 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -50.13 -37.36 48.13 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 124.013 3.142 . . . . 0.0 113.547 -167.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -167.8 90.18 0.31 Allowed 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -171.46 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.721 0.809 . . . . 0.0 109.095 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 97.7 m -156.36 137.71 13.89 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.776 0.83 . . . . 0.0 109.853 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -133.45 130.97 39.36 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 171.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.69 127.51 2.55 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -140.31 160.01 40.93 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.608 0.763 . . . . 0.0 110.374 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.478 ' HB2' ' HA2' ' A' ' 87' ' ' GLY . 22.5 p -110.78 117.19 32.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.06 0.944 . . . . 0.0 109.251 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 47.7 t -86.98 152.17 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.514 1.125 . . . . 0.0 110.365 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.725 HG22 HG22 ' A' ' 67' ' ' THR . 33.0 p 77.45 -74.79 0.07 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 127.104 2.161 . . . . 0.0 110.883 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -162.08 8.46 0.07 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 109.435 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' SER . . . 113.52 -11.77 23.53 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.481 -172.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.469 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 5.1 t-20 -59.34 -35.5 73.96 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.762 1.225 . . . . 0.0 111.341 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 21.8 t -120.35 146.9 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -139.8 134.71 32.17 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.859 0.864 . . . . 0.0 109.718 171.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -115.52 101.19 8.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 173.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 72' ' ' ILE . 26.8 mm -110.9 114.24 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.569 ' HE2' HG11 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -141.66 150.18 41.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.434 0.561 . . . . 0.0 111.084 177.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -136.65 145.83 45.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.156 0.982 . . . . 0.0 110.373 -168.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -110.49 112.73 24.84 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.11 95.6 8.27 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.762 0.825 . . . . 0.0 108.788 -175.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.95 108.32 2.42 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.564 2.176 . . . . 0.0 112.29 -171.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.0 mt -84.02 -177.2 6.59 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.505 0.722 . . . . 0.0 110.231 172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -70.17 -52.33 24.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.111 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.81 -22.84 23.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.793 0.837 . . . . 0.0 112.58 -173.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.89 -147.48 4.96 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.695 -0.503 . . . . 0.0 112.413 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.629 ' HB ' HG21 ' A' ' 20' ' ' VAL . 85.9 m -154.61 128.27 8.65 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.113 0.965 . . . . 0.0 109.623 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.58 109.1 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.604 HD12 HD11 ' A' ' 145' ' ' LEU . 2.2 tm? -84.31 111.55 19.51 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 78.9 m -108.22 106.91 17.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.761 0.824 . . . . 0.0 109.76 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -105.12 137.93 42.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.304 0.642 . . . . 0.0 110.337 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.2 p -140.66 112.86 7.83 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.855 0.862 . . . . 0.0 110.297 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -86.91 122.67 31.09 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.663 1.185 . . . . 0.0 108.918 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -125.36 110.52 14.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.547 ' HB3' ' HB2' ' A' ' 5' ' ' LEU . 50.2 t80 -105.28 111.09 23.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.171 0.988 . . . . 0.0 108.872 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.8 m -80.05 113.72 40.71 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.184 0.994 . . . . 0.0 109.87 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.33 85.94 0.43 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.872 2.381 . . . . 0.0 112.099 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -138.95 -64.97 0.5 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.067 0.947 . . . . 0.0 110.22 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.93 -23.51 71.08 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 113.025 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.688 0.795 . . . . 0.0 110.155 175.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -57.53 -32.25 66.88 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.554 0.742 . . . . 0.0 111.707 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -63.06 -46.23 88.48 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.066 0.229 . . . . 0.0 110.767 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -72.22 -27.15 62.34 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.553 0.341 . . . . 0.0 110.425 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -67.94 -36.68 80.53 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.155 0.582 . . . . 0.0 109.891 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.63 -31.99 47.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.211 1.005 . . . . 0.0 110.602 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -76.78 -56.13 4.87 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.462 0.705 . . . . 0.0 110.234 -176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -136.05 87.68 2.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.255 1.022 . . . . 0.0 108.93 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 127' ' ' ILE . . . -62.44 -31.02 78.08 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.014 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -58.76 -55.06 39.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.255 1.022 . . . . 0.0 110.624 177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -75.13 -19.23 60.0 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.554 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.3 t -67.41 -32.45 73.35 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.573 0.349 . . . . 0.0 111.202 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 123' ' ' GLY . 60.6 mt -63.71 -47.59 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 123.725 0.641 . . . . 0.0 110.272 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.5 -35.58 58.27 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.634 -176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HB2' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -74.34 -41.26 61.37 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.508 0.323 . . . . 0.0 110.868 -173.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG13 HD11 ' A' ' 5' ' ' LEU . 16.2 tt -59.92 -35.17 59.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 O-C-N 123.671 0.607 . . . . 0.0 110.041 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -68.58 -57.43 5.77 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 124.235 0.959 . . . . 0.0 110.268 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -63.72 -26.52 68.69 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -79.2 -43.28 24.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.272 0.629 . . . . 0.0 111.68 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -69.07 -41.49 77.5 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.41 HD23 HD12 ' A' ' 138' ' ' ILE . 95.2 mt -71.15 -31.01 67.19 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.78 -35.95 77.75 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 122.961 0.504 . . . . 0.0 111.183 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -73.51 -45.1 55.85 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.057 0.543 . . . . 0.0 110.579 175.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.41 HD12 HD23 ' A' ' 135' ' ' LEU . 92.8 mt -62.32 -31.5 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 124.053 0.941 . . . . 0.0 111.826 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.7 m -96.36 -35.53 11.17 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.766 0.826 . . . . 0.0 110.691 -177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -77.51 -56.39 3.93 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.663 -172.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.2 mt -53.39 -52.36 67.14 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.083 0.953 . . . . 0.0 113.013 -175.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.47 ' HD3' ' HE2' ' A' ' 7' ' ' PHE . 54.7 Cg_endo -65.62 -36.19 34.41 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 121.725 1.617 . . . . 0.0 112.768 -176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.4 -41.92 65.76 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.827 0.451 . . . . 0.0 110.502 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 28.0 m -63.77 -45.03 91.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.106 0.562 . . . . 0.0 109.645 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.747 HD12 HG22 ' A' ' 11' ' ' ILE . 1.5 mm? -54.78 -41.27 70.32 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.659 1.183 . . . . 0.0 111.721 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.57 -39.61 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.115 0.566 . . . . 0.0 110.932 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.52 -37.9 88.1 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.179 0.591 . . . . 0.0 111.116 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.485 HD13 HG22 ' A' ' 24' ' ' VAL . 68.2 mt -63.72 -48.39 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.44 1.096 . . . . 0.0 109.085 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' GLU . 43.4 tt0 -57.96 -47.11 83.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.022 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 154' ' ' VAL . 60.7 ttt180 -66.14 -49.13 68.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.717 1.207 . . . . 0.0 111.023 -169.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 tt -66.0 -32.88 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.018 0.527 . . . . 0.0 110.747 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.481 ' O ' ' HG ' ' A' ' 156' ' ' LEU . 24.2 mt -67.29 -45.78 75.52 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.663 0.785 . . . . 0.0 111.007 176.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 157' ' ' GLU . 49.8 mt-10 -61.5 -43.76 98.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.91 0.484 . . . . 0.0 110.585 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 150' ' ' ARG . 61.0 t -61.65 -42.82 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.22 0.608 . . . . 0.0 110.602 176.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -61.67 -36.84 82.01 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 152' ' ' LEU . 92.6 mt -73.67 -34.44 64.91 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.502 0.721 . . . . 0.0 110.666 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 153' ' ' GLU . 30.2 mm-40 -56.93 -23.02 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.172 0.589 . . . . 0.0 111.48 176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -84.01 66.23 9.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.85 0.86 . . . . 0.0 109.942 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.9 m80 60.42 99.3 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.427 1.491 . . . . 0.0 112.924 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.18 131.35 50.71 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.87 0.868 . . . . 0.0 108.784 172.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -73.64 -76.66 0.12 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.066 0.546 . . . . 0.0 109.863 -173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -128.42 5.57 5.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.402 0.681 . . . . 0.0 109.568 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.129 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 176.152 . . . . . . . . 1 1 . 1 stop_ save_